
<html lang="en"     class="pb-page"  data-request-id="c127e5fc-11e5-4621-a6f7-db61af682585"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;article:article:10.1021/jm900364m;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;issue:issue:10.1021/jmcmar.2009.52.issue-13"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Antagonists of the Calcium Receptor I. Amino Alcohol-Based Parathyroid Hormone Secretagogues" /></meta><meta name="dc.Creator" content="Robert W.  Marquis" /></meta><meta name="dc.Creator" content="Amparo M.  Lago" /></meta><meta name="dc.Creator" content="James F.  Callahan" /></meta><meta name="dc.Creator" content="Robert E. Lee  Trout" /></meta><meta name="dc.Creator" content="Maxine  Gowen" /></meta><meta name="dc.Creator" content="Eric G.  DelMar" /></meta><meta name="dc.Creator" content="Bradford C.  Van Wagenen" /></meta><meta name="dc.Creator" content="Sarah  Logan" /></meta><meta name="dc.Creator" content="Scott  Shimizu" /></meta><meta name="dc.Creator" content="John  Fox" /></meta><meta name="dc.Creator" content="Edward F.  Nemeth" /></meta><meta name="dc.Creator" content="Zheng  Yang" /></meta><meta name="dc.Creator" content="Theresa  Roethke" /></meta><meta name="dc.Creator" content="Brian R.  Smith" /></meta><meta name="dc.Creator" content="Keith W.  Ward" /></meta><meta name="dc.Creator" content="John  Lee" /></meta><meta name="dc.Creator" content="Richard M.  Keenan" /></meta><meta name="dc.Creator" content="Pradip  Bhatnagar" /></meta><meta name="dc.Description" content="Functional screening of the former SmithKline Beecham compound collection against the human calcium receptor (CaR) resulted in the identification of the amino alcohol-based hit 2 (IC50 = 11 μM). St..." /></meta><meta name="Description" content="Functional screening of the former SmithKline Beecham compound collection against the human calcium receptor (CaR) resulted in the identification of the amino alcohol-based hit 2 (IC50 = 11 μM). St..." /></meta><meta name="dc.Publisher" content=" American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="June 3, 2009" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm900364m" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2009 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm900364m" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm900364m" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm900364m" /></link>
        
    
    

<title>Antagonists of the Calcium Receptor I. Amino Alcohol-Based Parathyroid Hormone Secretagogues | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm900364m" /></meta><meta property="og:title" content="Antagonists of the Calcium Receptor I. Amino Alcohol-Based Parathyroid Hormone Secretagogues" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-13/jm900364m/production/images/large/jm-2009-00364m_0018.jpeg" /></meta><meta property="og:description" content=" Functional screening of the former SmithKline Beecham compound collection against the human calcium receptor (CaR) resulted in the identification of the amino alcohol-based hit 2 (IC50 = 11 μM). Structure−activity studies of 2 focused on the optimization of the right- and left-hand side aromatic moieties as well as the amino alcohol linker region. Critical to the optimization of this antagonist template was the discovery that the chirality of the C-2 secondary alcohol played a key role in enhancing both CaR potency as well as selectivity over the β-adrenergic receptor subtypes. These SAR studies ultimately led to the identification of 38 (NPS 2143; SB-262470A), a potent and orally active CaR antagonist. Pharmacokinetic characterization of 38 in the rat revealed that this molecule had a large volume of distribution (11 L/kg), which resulted in a prolonged systemic exposure, protracted increases in the plasma levels of PTH, and an overall lack of net bone formation effect in a rodent model of osteoporosis." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm900364m"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm900364m">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm900364m&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm900364m&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm900364m&amp;href=/doi/10.1021/jm900364m" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2009</span><span class="cit-fg-volume">, 52</span><span class="cit-fg-issue">, 13</span><span class="cit-fg-pageRange">, 3982-3993</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/52/13" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm900229p" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm900413e" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Antagonists of the Calcium Receptor I. Amino Alcohol-Based Parathyroid Hormone Secretagogues</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Robert+W.++Marquis">Robert W. Marquis</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Amparo+M.++Lago">Amparo M. Lago</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=James+F.++Callahan">James F. Callahan</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Robert+E.+Lee++Trout">Robert E. Lee Trout</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Maxine++Gowen">Maxine Gowen</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Eric+G.++DelMar">Eric G. DelMar</a></span><span class="author-xref-symbol "><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Bradford+C.++Van+Wagenen">Bradford C. Van Wagenen</a></span><span class="author-xref-symbol "><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sarah++Logan">Sarah Logan</a></span><span class="author-xref-symbol "><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Scott++Shimizu">Scott Shimizu</a></span><span class="author-xref-symbol "><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=John++Fox">John Fox</a></span><span class="author-xref-symbol "><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Edward+F.++Nemeth">Edward F. Nemeth</a></span><span class="author-xref-symbol "><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Zheng++Yang">Zheng Yang</a></span><span class="author-xref-symbol "><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Theresa++Roethke">Theresa Roethke</a></span><span class="author-xref-symbol "><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Brian+R.++Smith">Brian R. Smith</a></span><span class="author-xref-symbol "><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Keith+W.++Ward">Keith W. Ward</a></span><span class="author-xref-symbol "><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=John++Lee">John Lee</a></span><span class="author-xref-symbol "><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Richard+M.++Keenan">Richard M. Keenan</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Pradip++Bhatnagar">Pradip Bhatnagar</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text">Departments of Medicinal Chemistry, Bone and Cartilage Biology, Drug Metabolism and Pharmacokinetics, Computational and Structural Chemistry, and Cellular Biochemistry, GlaxoSmithKline, 1250 South Collegeville Road, Collegeville, Pennsylvania 19426, NPS Pharmaceuticals, 550 Hills Drive, Bedminster, New Jersey 07921</span></div><div class="corresp-info"><strong>*</strong> To whom correspondence should be addressed. Phone: 1-610-917-7368. Fax: E-mail: <a href="/cdn-cgi/l/email-protection#560439343324227801781b372427233f251631253d7835393b"><span class="__cf_email__" data-cfemail="35675a575047411b621b78544744405c467552465e1b565a58">[email protected]</span></a>. Address: Department of Medicinal Chemistry, ImmunoInflammation Center of Excellence in Drug Discovery, GlaxoSmithKline, 1250 South Collegeville Road, UP1110, Collegeville, PA 19426.</div><div class="corresp-fn" id="afn1">†Department of Medicinal Chemistry, GlaxoSmithKline.</div><div class="corresp-fn" id="afn2">‡Department of Bone and Cartilage Biology, GlaxoSmithKline.</div><div class="corresp-fn" id="afn3">§Department of Drug Metabolism and Pharmacokinetics, GlaxoSmithKline.</div><div class="corresp-fn" id="afn4">∥Department of Computational and Structural Chemistry, GlaxoSmithKline.</div><div class="corresp-fn" id="afn5">⊥Department of Cellular Biochemistry, GlaxoSmithKline.</div><div class="corresp-fn" id="afn6">#NPS Pharmaceuticals.</div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm900364m&amp;href=/doi/10.1021%2Fjm900364m" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2009</span></span><span class="cit-volume">, 52</span><span class="cit-issue">, 13</span><span class="cit-pageRange">, 3982–3993</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">June 3, 2009</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>23 March 2009</li><li><span class="item_label"><b>Published</b> online</span>3 June 2009</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 9 July 2009</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm900364m" title="DOI URL">https://doi.org/10.1021/jm900364m</a></div><div class="article_header-article-copyright"><strong>Copyright © 2009 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D3982%26pageCount%3D12%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DRobert%2BW.%2BMarquis%252C%2BAmparo%2BM.%2BLago%252C%2BJames%2BF.%2BCallahan%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D52%26issueNum%3D13%26contentID%3Djm900364m%26title%3DAntagonists%2Bof%2Bthe%2BCalcium%2BReceptor%2BI.%2BAmino%2BAlcohol-Based%2BParathyroid%2BHormone%2BSecretagogues%26numPages%3D12%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D3993%26publicationDate%3DJuly%2B2009">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm900364m"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2000</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">22</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm900364m" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Antagonists of the Calcium Receptor I. Amino Alcohol-Based Parathyroid Hormone Secretagogues&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Robert&quot;,&quot;last_name&quot;:&quot;W. Marquis&quot;},{&quot;first_name&quot;:&quot;Amparo&quot;,&quot;last_name&quot;:&quot;M. Lago&quot;},{&quot;first_name&quot;:&quot;James&quot;,&quot;last_name&quot;:&quot;F. Callahan&quot;},{&quot;first_name&quot;:&quot;Robert&quot;,&quot;last_name&quot;:&quot;E. Lee Trout&quot;},{&quot;first_name&quot;:&quot;Maxine&quot;,&quot;last_name&quot;:&quot;Gowen&quot;},{&quot;first_name&quot;:&quot;Eric&quot;,&quot;last_name&quot;:&quot;G. DelMar&quot;},{&quot;first_name&quot;:&quot;Bradford&quot;,&quot;last_name&quot;:&quot;C. Van Wagenen&quot;},{&quot;first_name&quot;:&quot;Sarah&quot;,&quot;last_name&quot;:&quot;Logan&quot;},{&quot;first_name&quot;:&quot;Scott&quot;,&quot;last_name&quot;:&quot;Shimizu&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;Fox&quot;},{&quot;first_name&quot;:&quot;Edward&quot;,&quot;last_name&quot;:&quot;F. Nemeth&quot;},{&quot;first_name&quot;:&quot;Zheng&quot;,&quot;last_name&quot;:&quot;Yang&quot;},{&quot;first_name&quot;:&quot;Theresa&quot;,&quot;last_name&quot;:&quot;Roethke&quot;},{&quot;first_name&quot;:&quot;Brian&quot;,&quot;last_name&quot;:&quot;R. Smith&quot;},{&quot;first_name&quot;:&quot;Keith&quot;,&quot;last_name&quot;:&quot;W. Ward&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;Lee&quot;},{&quot;first_name&quot;:&quot;Richard&quot;,&quot;last_name&quot;:&quot;M. Keenan&quot;},{&quot;first_name&quot;:&quot;Pradip&quot;,&quot;last_name&quot;:&quot;Bhatnagar&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2009&quot;,&quot;month&quot;:&quot;06&quot;,&quot;day&quot;:&quot;03&quot;,&quot;issue&quot;:&quot;13&quot;,&quot;volume&quot;:&quot;52&quot;,&quot;pages&quot;:&quot;3982-3993&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm900364m&quot;},&quot;abstract&quot;:&quot;Functional screening of the former SmithKline Beecham compound collection against the human calcium receptor (CaR) resulted in the identification of the amino alcohol-based hit 2 (IC50 = 11 μM). Structure−activity studies of 2 focused on the optimization of the right- and left-hand side aromatic moieties as well as the amino alcohol linker region. Critical to the optimization of this antagonist template was the discovery that the chirality of the C-2 secondary alcohol played a key role in enhancing both CaR potency as well as selectivity over the β-adrenergic receptor subtypes. These SAR studies ultimately led to the identification of 38 (NPS 2143; SB-262470A), a potent and orally active CaR antagonist. Pharmacokinetic characterization of 38 in the rat revealed that this molecule had a large volume of distribution (11 L/kg), which resulted in a prolonged systemic exposure, protracted increases in the plasma levels of PTH, and an overall lack of net bone formation effect in a rodent model of osteoporosis.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm900364m&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm900364m" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm900364m&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm900364m" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm900364m&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm900364m" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm900364m&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm900364m&amp;href=/doi/10.1021/jm900364m" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm900364m" /></input><a href="/doi/pdf/10.1021/jm900364m" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (715 KB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm900364m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm900364m%26sid%3Dliteratum%253Aachs%26pmid%3D19492813%26genre%3Darticle%26aulast%3DMarquis%26date%3D2009%26atitle%3DAntagonists%2Bof%2Bthe%2BCalcium%2BReceptor%2BI.%2BAmino%2BAlcohol-Based%2BParathyroid%2BHormone%2BSecretagogues%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D52%26issue%3D13%26spage%3D3982%26epage%3D3993%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290758" title="Anatomy">Anatomy</a>,</li><li><a href="/action/doSearch?ConceptID=291650" title="Alcohols">Alcohols</a>,</li><li><a href="/action/doSearch?ConceptID=291171" title="Antagonists">Antagonists</a>,</li><li><a href="/action/doSearch?ConceptID=291711" title="Selectivity">Selectivity</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/52/13" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-13/jm900364m/production/images/medium/jm-2009-00364m_0018.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-13/jm900364m/production/images/large/jm-2009-00364m_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900364m&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Functional screening of the former SmithKline Beecham compound collection against the human calcium receptor (CaR) resulted in the identification of the amino alcohol-based hit <b>2</b> (IC<sub>50</sub> = 11 μM). Structure−activity studies of <b>2</b> focused on the optimization of the right- and left-hand side aromatic moieties as well as the amino alcohol linker region. Critical to the optimization of this antagonist template was the discovery that the chirality of the C-2 secondary alcohol played a key role in enhancing both CaR potency as well as selectivity over the β-adrenergic receptor subtypes. These SAR studies ultimately led to the identification of <b>38</b> (NPS 2143; SB-262470A), a potent and orally active CaR antagonist. Pharmacokinetic characterization of <b>38</b> in the rat revealed that this molecule had a large volume of distribution (11 L/kg), which resulted in a prolonged systemic exposure, protracted increases in the plasma levels of PTH, and an overall lack of net bone formation effect in a rodent model of osteoporosis.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_03251" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_03251" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Bone is a dynamically remodeling tissue balanced by the interplay of osteoclasts that degrade bone and osteoblasts that produce new bone. When the resorption phase of remodeling outpaces new bone formation, the overall architecture of bone is weakened, leading ultimately to osteoporosis.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> There are currently several marketed drugs for the prevention and treatment of osteoporosis.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> The vast majority of these therapeutics are antiresorptive agents and act to slow bone loss by inhibiting osteoclast activity. The bisphosphonates, estrogens, selective estrogen receptor modulators, salmon calcitonin, the receptor activator of NK-κB ligand (RANK-L<a class="ref internalNav" href="#fn1" aria-label="a">a</a>) <div class="NLM_fn" id="fn1">a<p class="last">Abbreviations: CaR, calcium receptor; PTH, parathyroid hormone; RANK, receptor activator of NK-κB; PTHrP, parathyroid hormone-related protein; HEK, human embryonic kidney; OVX, ovariectomized; SAR, structure−activity relationship; LDA, lithium diisopropylamide; DAT, dopamine transporter; SERT, serotonin transporter; NET, norepinephrine transporter; CYP2D6, cytochrome P450 2D6; hERG, human ether-a-go-go related gene; FLIPR, fluorimetric imaging plate reader.</p></div> monoclonal antibody denosumab, and the cathepsin K inhibitor odanacatib have all demonstrated antiresorptive activity in human clinical trials but offer little or no new bone building effect. Recently, a new pharmacological approach for the treatment of osteoporosis has been introduced to the marketplace. Daily subcutaneous injections of recombinant full-length human parathyroid hormone (PTH) 1-84 (Nycomed) or teriparatide, the recombinant N-terminal PTH 1-34 amino acid fragment (Lilly), stimulate new bone formation leading to a reversal of osteoporotic bone loss in postmenopausal women.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Both PTH and teriparatide exert their bone forming effects by activating PTH/PTHrP receptors on osteoblasts and osteoblast precursor cells.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a></div><div class="NLM_p">Another approach to the identification of a new bone forming therapeutic based upon the clinically validated mechanism of action of PTH and teriparatide, would be the development of an agent that would elicit the secretion of PTH from the parathyroid gland. PTH secretion is under the strict control of the calcium receptor (CaR), a family-C, cell surface G-protein coupled receptor that is capable of detecting minute variations in extracellular calcium ion concentrations (Ca<sup>2+</sup>).<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Elevation of extracellular Ca<sup>2+</sup> concentrations activates the CaR and leads to a suppression of PTH secretion. Small molecule CaR agonists or allosteric activators, collectively known as calcimimetics, mimic elevated Ca<sup>2+</sup> concentrations and inhibit PTH secretion.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Cinacalcet, <i>N</i>-[(1<i>R</i>)-1-(1-naphthalenyl)ethyl]-3-[3-(trifluoromethyl)phenyl]-1-propanamine, (<b>1</b>, Amgen/NPS, Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>) has therapeutic utility in controlling elevated PTH levels in patients with hyperparathyroidism, demonstrating that pharmacological manipulation of the CaR by a small molecule may be used in controlling PTH secretion.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> In contrast to the inhibitory effects of high Ca<sup>2+</sup> levels or calcimimetics on PTH secretion, low circulating Ca<sup>2+</sup> levels stimulate PTH secretion. Small molecule antagonists of the CaR, known as calcilytics or negative allosteric modulators, mimic low extracellular Ca<sup>2+</sup> and stimulate PTH secretion.<a onclick="showRef(event, 'ref8 ref9 ref10 ref11 ref12 ref13 ref14 ref15 ref16 ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref8 ref9 ref10 ref11 ref12 ref13 ref14 ref15 ref16 ref17 ref18">(8-18)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-13/jm900364m/production/images/medium/jm-2009-00364m_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-13/jm900364m/production/images/large/jm-2009-00364m_0001.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Calcimimetic cinacalcet (<b>1</b>) and antagonist screening hit <b>2</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-13/jm900364m/production/images/large/jm-2009-00364m_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900364m&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">An important aspect of the pharmacology of PTH and its agonist fragments is the temporal nature of the exposure to these agents. Depending on the pattern of exposure PTH may act either as an anabolic agent, thereby building new bone, or as a catabolic agent, resulting in the loss of bone.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Prolonged exposure to PTH results in overall loss of bone as manifested in conditions such as hyperparathyroidism where PTH levels are elevated continuously. Alternatively, short intermittent exposure to elevated PTH or its fragments has an overall bone forming effect. This has been demonstrated with the daily subcutaneous administration of teriparatide which reaches <i>T</i><sub>max</sub> within 30 min, is rapidly cleared (62 L/h in women and 94 L/h in men) with a low volume of distribution (0.12 L/kg).<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> These results suggest that an orally active CaR antagonist would also have to have a pharmacokinetic/pharmacodynamic profile that is transient in nature in order to have a beneficial bone forming effect.</div><div class="NLM_p">We have reported on the in vitro and in vivo pharmacodynamic effects of the amino alcohol-based CaR antagonist <b>38</b> (NPS 2143, SB-262470-A, Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>).<a onclick="showRef(event, 'ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref8 ref9">(8, 9)</a> When tested in human embryonic kidney 293 (HEK293) cells stably expressing the human CaR, analog <b>38</b> was potent (IC<sub>50</sub> = 43 nM), it elicited PTH release from bovine parathyroid cells (EC<sub>50</sub> = 41 nM), and it increased plasma PTH levels when infused iv in rats. In the osteopenic ovariectomized (OVX) rat <b>38</b> produced sustained elevations of plasma PTH following oral administration. The prolonged elevation in PTH levels led to increased bone turnover with no changes in bone mineral density following five weeks of treatment. When coadministered with 17β-estradiol, a known antiresorptive agent, an increase in bone mass was observed. In total, these data suggested that a short-acting, orally active PTH secretagogue may have a net bone forming effect and would represent a potential new treatment for postmenopausal osteoporosis.</div><div class="NLM_p">This manuscript details the characterization of the first generation amino alcohol-based CaR antagonist hit <b>2</b> and some of the salient structure−activity relationship studies critical to the optimization of <b>2</b> that led to the identification of analog <b>38</b>.</div><div id="sec1_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i2" class="anchor-spacer"></div><h3 class="article-section__title" id="_i2"> Synthesis Chemistry</h3><div class="NLM_p">A functional assay was developed in HEK293 cells stably transfected with the human CaR to assess the ability of test compounds to block extracellular Ca<sup>2+</sup>-induced increases in intracellular Ca<sup>2+</sup>.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> A high-throughput screen of the former SmithKline Beecham compound collection in this assay format led to the identification of the amino alcohol hit <b>2</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>, Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). In an effort to optimize the potency and selectivity of <b>2</b>, this molecule was divided into three separate regions to facilitate the systematic study of each of these areas structure−activity relationships (SAR) (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>). These regions were the left-hand side benzimidazol-2-one group (designated A), the amino alcohol linking region and the right-hand-side aromatic group (designated B). The syntheses utilized to explore the SAR of each of these individual regions of <b>2</b> are detailed in Schemes <a class="ref internalNav" href="#sch1" aria-label="1">1</a>−<a class="ref internalNav" href="#sch6" aria-label="6">6</a>.</div><div class="NLM_p">The synthesis of the analogs designed to examine the SAR of the left-hand side aromatic moiety is detailed in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>. To facilitate analog synthesis the C2 racemic alcohols were utilized at this stage as the exact chirality of the C2 asymmetric center which was required for potent antagonism of the CaR had not yet been determined. Treatment of <i>iso</i>-butyric acid (<b>3</b>) with lithium diisopropylamide (LDA), followed by alkylation with <i>p</i>-methoxybenzyl chloride provided 2,2-dimethyl-3-[4-(methyloxy)phenyl]propanoic acid (not shown). This acid was then reacted with ethyl chloroformate, followed by sodium azide. The intermediate acyl azide was heated (100 °C) to effect Curtius rearrangement, and the isocyanate was captured with benzyl alcohol to yield the benzyl carbamate (not shown). Hydrogenolysis of the benzyl carbamate with hydrogen/palladium hydroxide gave (1,1-dimethyl-2-[4-(methyloxy)phenyl]ethyl)amine (<b>4</b>). Treatment of amine <b>4</b> with epichlorohydrin provided the intermediate epoxide <b>5</b>, which was reacted with a variety of alkoxides to provide a range of left-hand side substituted analogs (<b>7</b>−<b>17</b>) for profiling against the CaR.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-13/jm900364m/production/images/medium/jm-2009-00364m_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-13/jm900364m/production/images/large/jm-2009-00364m_0005.jpeg" id="gs1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Amino Alcohols by Varying the Left-Hand Side Moiety<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-13/jm900364m/production/images/large/jm-2009-00364m_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900364m&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) LDA, HMPA, <i>i</i>-butyric acid, 4-methoxy benzylchloride, −78 °C to rt; (b) <b>3</b>, TEA, acetone, H<sub>2</sub>O, ethyl chloroformate, NaN<sub>3</sub>, 0 °C to rt then toluene 100 °C benzyl alcohol, EtOH, H<sub>2</sub>, Pd(OH)<sub>2</sub>; (c) <i>i</i>-PrOH, 0 °C, epichlorohydrin; (d) NaH, DMF, ROH, <b>5</b>, 100 °C.</p></p></figure><div class="NLM_p">As outlined in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>, the synthesis of analogs designed to explore the SAR of the right-hand side aromatic moiety of <b>2</b> began with opening of 2-[(phenyloxy)methyl]oxirane (<b>18</b>) with a variety of different amines. The right-hand side amines contained within analogs <b>7</b>, <b>20</b>, <b>21</b>, and <b>22</b> were designed to explore the role of the <i>gem</i>-dimethyl group contained within <b>2</b>. Alternatively, analogs <b>23</b> and <b>24</b> were utilized to probe the optimal distance for the right-hand side aromatic group from the geminal-dimethyl moiety. Analogs <b>25</b> and <b>26</b> were incorporated in order to understand the potential role of the <i>p</i>-methoxy moiety and the extension of the π-aromatic system, respectively.</div><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-13/jm900364m/production/images/medium/jm-2009-00364m_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-13/jm900364m/production/images/large/jm-2009-00364m_0006.jpeg" id="gs2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Amino Alcohols by Varying the Right-Hand Side Moieties<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-13/jm900364m/production/images/large/jm-2009-00364m_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900364m&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) RNH<sub>2</sub>, EtOH, 80 °C.</p></p></figure><div class="NLM_p">As outlined in Schemes <a class="ref internalNav" href="#sch3" aria-label="3">3</a> and <a class="ref internalNav" href="#sch4" aria-label="4">4</a>, analogs <b>27</b> and <b>28</b> explored the role of the amino alcohol linker via either oxygen or nitrogen methylation. Treatment of <b>11</b> under standard Borsch reductive amination conditions (H<sub>2</sub>CO, NaCNBH<sub>3</sub>) provided the <i>N</i>-methylated analog <b>27</b> in 91% yield. Methylation of the hydroxyl moiety of <b>11</b> was accomplished by treatment of <b>11</b> with sodium hydride and methyl iodide to provide <b>28</b> in 49% yield. Alternatively, the role of the hydroxyl moiety was explored by simply removing this group from the amino alcohol antagonist template (Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>). Alkylation of 2,3-dichlorophenol (<b>29</b>) with 1,2-dibromoethane provided the bromide <b>30</b> in 13% isolated yield. Displacement of the bromine with (1,1-dimethyl-2-[4-(methyloxy)phenyl]ethyl)amine (<b>4</b>) provided analog <b>31</b> in 28% yield.</div><figure id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-13/jm900364m/production/images/medium/jm-2009-00364m_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-13/jm900364m/production/images/large/jm-2009-00364m_0007.jpeg" id="gs3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of <i>N</i>- and <i>O</i>-Methylated Analogs <b>27</b> and <b>28</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-13/jm900364m/production/images/large/jm-2009-00364m_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900364m&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 37% aq CH<sub>2</sub>O, NaCNBH<sub>3</sub>, CH<sub>3</sub>OH; (b) DMF, NaH, CH<sub>3</sub>I, rt.</p></p></figure><figure id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-13/jm900364m/production/images/medium/jm-2009-00364m_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-13/jm900364m/production/images/large/jm-2009-00364m_0008.jpeg" id="gs4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of des-Hydroxy Analog <b>31</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-13/jm900364m/production/images/large/jm-2009-00364m_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900364m&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) K<sub>2</sub>CO<sub>3</sub>, 1,3-dibromopropane, 2,3-dichlrorphenol, CH<sub>3</sub>CN; (b) <b>30</b>, CH<sub>2</sub>Cl<sub>2</sub>, <b>4</b>.</p></p></figure><div class="NLM_p">In an effort to understand the role of the chirality of the C2 hydroxyl moiety as a function of antagonist potency and selectivty, the racemic alcohol <b>11</b> was separated via chiral HPLC to provide the enantiomerically pure <i>R</i> (faster eluting) and <i>S</i> (slower eluting) isomers <b>32</b> and <b>33</b>, respectively (Scheme <a class="ref internalNav" href="#sch5" aria-label="5">5</a>). Assignment of the chirality of each of <b>32</b> and <b>33</b> was made possible through the chiral syntheses of each of these enantiomers beginning with the alkylation of 2,3-dichlorophenol (<b>29</b>) with the <i>R</i>- or <i>S</i>-nosyl epoxides to provide intermediates <b>34</b> and <b>35</b>, respectively. Treatment of the epoxides <b>34</b> and <b>35</b> with (1,1-dimethyl-2-[4-(methyloxy)phenyl]ethyl)amine (<b>4</b>) effected regiospecific ring-opening to provide the chiral amino alcohol antagonists <b>32</b> and <b>33</b>, respectively. Analogs <b>32</b> derived from the <i>R</i>-nosyl epoxide was shown to co-elute with the faster eluting of the two separated enantiomers, while analog <b>33</b> derived from the <i>S</i>-nosyl epoxide was shown to co-elute with the slower of the two enantiomers.</div><figure id="sch5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-13/jm900364m/production/images/medium/jm-2009-00364m_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-13/jm900364m/production/images/large/jm-2009-00364m_0009.jpeg" id="gs5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of Chiral Amino Alcohols <b>32</b> and <b>33</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-13/jm900364m/production/images/large/jm-2009-00364m_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900364m&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) HPLC separation; (b) 2,3-dichlorophenol, acetone, K<sub>2</sub>CO<sub>3</sub>, (<i>R</i>)-nosyl epoxide, reflux; (c) 2,3-dichlorophenol, acetone, K<sub>2</sub>CO<sub>3</sub>, (<i>S</i>)-nosyl epoxide, reflux; (d) <b>4</b>, ethanol, reflux.</p></p></figure><div class="NLM_p">The syntheses of antagonists utilized to study the preliminary SAR studies described above have established some of the better left- and right-hand side aromatic moieties as well as the requisite <i>R</i> chirality of the secondary C2-hydroxyl group for antagonist activity as well as selectivity. In an effort to optimize antagonist potency each of these groups was incorporated in the amino alcohol template of the original hit <b>2</b>. As shown in Scheme <a class="ref internalNav" href="#sch6" aria-label="6">6</a>, the syntheses of this optimized antagonist began with alkylation of 2-chloro-6-hydroxybenzonitrile (<b>36</b>) with <i>R</i>-nosyl epoxide to provide the chiral epoxide <b>37</b> with the C2-<i>R</i> stereochemistry. Regiospecific opening of this chiral epoxide with (1,1-dimethyl-2-(2-naphthalenyl)ethyl)amine provided antagonist <b>38</b>.</div><figure id="sch6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-13/jm900364m/production/images/medium/jm-2009-00364m_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-13/jm900364m/production/images/large/jm-2009-00364m_0010.jpeg" id="gs6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthesis of Analog <b>38</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-13/jm900364m/production/images/large/jm-2009-00364m_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900364m&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (<i>R</i>)-nosyl epoxide, acetone, K<sub>2</sub>CO<sub>3</sub>, reflux; (b) [1,1-dimethyl-2-(2-naphthalenyl)ethyl]amine, EtOH, reflux.</p></p></figure></div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i9">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_74023" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_74023" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Identification of Screening Hit <b>2</b></h3><div class="NLM_p">High-throughput screening resulted in the identification of the amino alcohol <b>2</b> as a weak antagonist of the CaR in functional and binding assays (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). Compound <b>2</b> was identified from a β-adrenoreceptor antagonist program where it had been shown to be a potent antagonist of the β<sub>2</sub>-adrenoreceptor and a potent agonist of the β<sub>1</sub>- and β<sub>3</sub>-adrenoreceptors. Further selectivity testing of <b>2</b> revealed that this basic lipophilic amine, a common pharmacophore for a variety of enzymes, also had affinity for the dopamine (DAT), serotonin (SERT), and norepinephrine (NET) transporters as well as the cytochrome P<sub>450</sub> 2D6 (CYP2D6) and the cardiac human ether-a-go-go related gene (hERG) ion channel (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>).<a onclick="showRef(event, 'ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref22 ref23">(22, 23)</a></div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Potencies and Selectivity of the Calcium Receptor Antagonist Lead <b>2</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-13/jm900364m/production/images/medium/jm-2009-00364m_0012.gif" alt="" id="gr9" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col></colgroup><thead valign="middle"><tr valign="top"><th align="center" valign="middle">assay</th><th align="center" valign="middle" char=".">conc (μM)</th></tr></thead><tbody><tr valign="top"><td align="left">CaR functional IC<sub>50</sub></td><td align="char" char=".">11.0</td></tr><tr valign="top"><td align="left">CaR binding IC<sub>50</sub></td><td align="char" char=".">31.8</td></tr><tr valign="top"><td align="left">β<sub>2</sub> binding IC<sub>50</sub></td><td align="char" char=".">0.0013</td></tr><tr valign="top"><td align="left">β<sub>1</sub> binding EC<sub>50</sub></td><td align="char" char=".">0.003</td></tr><tr valign="top"><td align="left">β<sub>3</sub> binding EC<sub>50</sub></td><td align="char" char=".">0.007</td></tr><tr valign="top"><td align="left">DAT binding IC<sub>50</sub></td><td align="char" char=".">1.20</td></tr><tr valign="top"><td align="left">SERT binding IC<sub>50</sub></td><td align="char" char=".">0.061</td></tr><tr valign="top"><td align="left">NET binding IC<sub>50</sub></td><td align="char" char=".">0.600</td></tr><tr valign="top"><td align="left">CYP2D6 binding IC<sub>50</sub></td><td align="char" char=".">1.26</td></tr><tr valign="top"><td align="left">hERG binding IC<sub>50</sub></td><td align="char" char=".">11.8</td></tr></tbody></table></div></div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Structure−Activity Studies</h3><div class="NLM_p">The initial focus of the structure activity studies was the optimization of CaR antagonist activity of <b>2</b> while also attempting to reduce the affinity of off-target interactions, most notably those on the β-adrenoreceptor family subtypes. Our initial efforts focused on the SAR of the left-hand side benzimidazol-2-one group as detailed in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Potencies of Left-Hand Side Moieties</div><p class="last"></p></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-13/jm900364m/production/images/medium/jm-2009-00364m_0013.gif" alt="" id="gr10" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead valign="middle"><tr valign="top"><th align="center" valign="middle"> </th><th align="center" valign="middle"> </th><th colspan="2" align="center" valign="middle" char=".">CaR IC<sub>50</sub> (μM)</th></tr><tr valign="top"><th align="center" valign="middle">compd</th><th align="center" valign="middle">R<sub>1</sub></th><th align="center" valign="middle" char=".">FLIPR</th><th align="center" valign="middle" char=".">binding</th></tr></thead><tbody><tr valign="top"><td align="left"><b>2</b></td><td align="left"> </td><td align="char" char=".">11<a class="ref internalNav" href="#tbl2-fn1" aria-label="a">a</a></td><td align="char" char=".">31.8</td></tr><tr valign="top"><td align="left"><b>7</b></td><td align="left">phenyl</td><td align="char" char=".">2.3</td><td align="char" char=".">2.3</td></tr><tr valign="top"><td align="left"><b>14</b></td><td align="left">2-methoxyphenyl</td><td align="char" char=".">15.6</td><td align="char" char=".">3.5</td></tr><tr valign="top"><td align="left"><b>15</b></td><td align="left"><i>n</i>-propyl</td><td align="char" char=".">16</td><td align="char" char=".">7.0</td></tr><tr valign="top"><td align="left"><b>16</b></td><td align="left"><i>i</i>-propyl</td><td align="char" char=".">6.4</td><td align="char" char=".">10</td></tr><tr valign="top"><td align="left"><b>17</b></td><td align="left"><i>n</i>-butyl</td><td align="char" char=".">2.2</td><td align="char" char=".">3.2</td></tr><tr valign="top"><td align="left"><b>8</b></td><td align="left">2-naphthyl</td><td align="char" char=".">1.4</td><td align="char" char=".">1.3</td></tr><tr valign="top"><td align="left"><b>9</b></td><td align="left">2-chlorophenyl</td><td align="char" char=".">0.49</td><td align="char" char=".">1.0</td></tr><tr valign="top"><td align="left"><b>10</b></td><td align="left">3-chlorophenyl</td><td align="char" char=".">0.47</td><td align="char" char=".">1.0</td></tr><tr valign="top"><td align="left"><b>11</b></td><td align="left">2,3-dichlorophenyl</td><td align="char" char=".">0.045</td><td align="char" char=".">0.20</td></tr><tr valign="top"><td align="left"><b>12</b></td><td align="left">2-cyanophenyl</td><td align="char" char=".">0.058</td><td align="char" char=".">0.14</td></tr><tr valign="top"><td align="left"><b>13</b></td><td align="left">2-cyano-3-chlorophenyl</td><td align="char" char=".">0.038</td><td align="char" char=".">0.070</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl2-fn1"><div class="footnote" id="tbl2-fn1"><sup>a</sup><p class="last">Functional data.</p></div></div></div><div class="NLM_p">Replacement of the benzimidazol-2-one moiety of <b>2</b> with a phenyl group provided analog <b>7</b>, which was 5- and 15-fold more potent than <b>2</b> in the fluorimetric imaging plate reader (FLIPR) and binding assays, respectively (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). Analog <b>14</b>, which incorporates the electron donating 2-methoxyphenyl group, reduced potency in both assays relative to <b>7</b>. The left-hand side alkyl analogs <b>15</b>−<b>17</b> were either less potent or equipotent to the phenyl analog <b>7</b> and warranted no further investigation. Extension of the aromatic moiety of <b>7</b> by incorporation of a 2-naphthyl group provided analog <b>8</b> with improved potency versus the lead analog <b>7</b>. Analogs <b>9</b> and <b>10</b> with an electron withdrawing chlorine group at either the 2 or 3 position of the left-hand side aromatic group resulted in a 4.7- and 2.3-fold increase in antagonist potency in the FLIPR and binding assays, respectively, relative to the unsubstituted aromatic analog <b>7</b>. The 2,3-dichloro aromatic analog <b>11</b> resulted in a further increase in potency over the monochloro analogs <b>9</b> and <b>10</b>, suggesting that added electron withdrawing capability and increased lipophilicity results in increased potency. The 2-cyanophenyl analog <b>12</b> was essentially equipotent with the 2,3-dichloro analog <b>11</b>. Incorporation of both the chlorine and cyano moieties provided <b>13</b>, which was the most potent left-hand side aromatic identified in these initial SAR studies. However, assessment of the selectivity of the more potent CaR antagonists <b>12</b> and <b>13</b> identified during the course of the left-hand side structure−activity studies revealed that, despite substantial increases in antagonist potency versus the CaR, no improvement in off-target interactions were made with either of these analogs relative to the initial screening hit <b>2</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>).</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Potencies and Selectivity of the Calcium Receptor Antagonist Hit <b>2</b> and Analogs <b>12</b> and <b>13</b></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col><col align="left" /></col></colgroup><thead valign="middle"><tr valign="top"><th align="center" valign="middle"> </th><th colspan="3" align="center" valign="middle" char=".">IC<sub>50</sub> or EC<sub>50</sub>(μM)</th></tr><tr valign="top"><th align="center" valign="middle">assay</th><th align="center" valign="middle" char="."><b>2</b></th><th align="center" valign="middle"><b>12</b></th><th align="center" valign="middle"><b>1</b>3</th></tr></thead><tbody><tr valign="top"><td align="left">CaR FLIPR IC<sub>50</sub></td><td align="char" char=".">11.0<a class="ref internalNav" href="#tbl3-fn1" aria-label="a">a</a></td><td align="left">0.045</td><td align="left">0.038</td></tr><tr valign="top"><td align="left">CaR binding IC<sub>50</sub></td><td align="char" char=".">31.8</td><td align="left">0.20</td><td align="left">0.070</td></tr><tr valign="top"><td align="left">β<sub>2</sub> binding IC<sub>50</sub></td><td align="char" char=".">0.0013</td><td align="left">0.021</td><td align="left">0.023</td></tr><tr valign="top"><td align="left">β<sub>1</sub> binding EC<sub>50</sub></td><td align="char" char=".">0.003</td><td align="left">NA</td><td align="left">NA</td></tr><tr valign="top"><td align="left">β<sub>3</sub> binding EC<sub>50</sub></td><td align="char" char=".">0.007</td><td align="left">0.02</td><td align="left">NA</td></tr><tr valign="top"><td align="left">DAT binding IC<sub>50</sub></td><td align="char" char=".">1.20</td><td align="left">0.30</td><td align="left">1.1</td></tr><tr valign="top"><td align="left">SERT binding IC<sub>50</sub></td><td align="char" char=".">0.061</td><td align="left">0.021</td><td align="left">0.034</td></tr><tr valign="top"><td align="left">NET binding IC<sub>50</sub></td><td align="char" char=".">0.600</td><td align="left">0.30</td><td align="left">1.0</td></tr><tr valign="top"><td align="left">CYP2D6 binding IC<sub>50</sub></td><td align="char" char=".">1.26</td><td align="left">0.036</td><td align="left">0.076</td></tr><tr valign="top"><td align="left">hERG binding IC<sub>50</sub></td><td align="char" char=".">11.8</td><td align="left">3.5</td><td align="left">3.6</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl3-fn1"><div class="footnote" id="tbl3-fn1"><sup>a</sup><p class="last">Functional data. NA = not active.</p></div></div></div><div class="NLM_p">The structure− activity studies to explore the role of the right-hand side moiety began with holding the left-hand side phenyl group as in analog <b>7</b> invariant (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). Initial studies probed the role of the geminal dimethyl group. Removal of the geminal dimethyl group contained within analog <b>7</b> provided <b>20</b>, which was inactive in both assays. Moving the geminal dimethyl group over one carbon provided analog <b>21</b>, which was also inactive. Similarly, analog <b>22</b> in which one of the methyl groups was removed was inactive. These results suggest strongly that the geminal dimethyl moiety contained within this amino alcohol template is playing a critical role in antagonist potency through the binding to a hydrophobic pocket within the transmembrane domain of the receptor and/or by imparting a conformational constraint to these receptor antagonists through a classic Thorpe−Ingold effect which serves to increase affinity for the receptor.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Indeed, as shown in Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>, overlay of the conformations of global energy minima of analogs <b>7</b> and <b>20</b> shows clearly that analog <b>20</b>, lacking the geminal dimethyl moiety, is in an extended conformation. In contrast, analog <b>7</b>, which contains the geminal dimethyl group, is seen to be in a C-shaped conformation with a π−π stacking interaction between the pendant aromatic moieties (distance of 3.9 Å between aromatic groups for the energy minimized conformation).<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Further modeling analysis revealed that the extended conformation of analog <b>20</b> is approximately 1.6 kcal higher in energy than the C-shaped conformer, while the extended conformation of analog <b>22</b> is approximately 0.3 kcal lower, further suggesting that the geminal dimethyl group is playing a critical role in determining the conformation of analogs such as <b>7</b>. Removal of the benzylic methylene group as in analogs <b>33</b> resulted in a complete loss in receptor potency versus analog <b>7</b>, while addition of another methylene unit as in analog <b>24</b> resulted in a loss in potency in the FLIPR assay relative to <b>7</b> but were essentially equipotent in the binding assay (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). These data suggest that it is a combination of the spacing between the two pendant aromatic groups and the conformational preference imparted by the geminal dimethyl groups through the Thorpe−Ingold effect, which permit these aromatic moieties to form a π−π stacking interaction that are important contributors to antagonist activity. Removal of the <i>p</i>-methoxy moiety to provide <b>25</b> resulted in no loss in activity relative to <b>7</b>. Analogs <b>26</b> with a 2-naphthyl left-hand side amine resulted in an increase in potency in both assays. Here again, as with the SAR studies that examined the left-hand side, the SAR studies that investigated the role of the right-hand side of the amino alcohol-based antagonist template led to improvements in potency over the parent analog <b>7</b> with the incorporation of the 2-naphthyl moiety as contained within antagonist <b>26</b>. Unfortunately, this modification did not lead to any further increase in the selectivity of this analog versus the previously discussed off-target interactions. Antagonist <b>26</b> remained a potent inhibitor of the of the monoamine transporters (SERT IC<sub>50</sub> = 0.006 μM, NET IC<sub>50</sub> = 0.20 μM, and DAT IC<sub>50</sub> = 0.30 μM) as well as hERG (IC<sub>50</sub> = 1.0 μM) and CYP2D6 (IC<sub>50</sub> = 0.078 μM). Additionally, no improvement in selectivity versus the β-adrenergic receptors was observed for analog <b>26</b> (β<sub>1</sub> and β<sub>3</sub> EC<sub>50</sub>’s = 0.023 and 0.65 μM, respectively, and β<sub>2</sub> IC<sub>50</sub> = 0.40 μM).</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Potencies of Right-Hand Side Moieties</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-13/jm900364m/production/images/medium/jm-2009-00364m_0014.gif" alt="" id="gr11" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead valign="middle"><tr valign="top"><th align="center" valign="middle"> </th><th align="center" valign="middle"> </th><th colspan="2" align="center" valign="middle">CaR IC<sub>50</sub> (μM)</th></tr><tr valign="top"><th align="center" valign="middle">compd</th><th align="center" valign="middle">R<sub>1</sub></th><th align="center" valign="middle">FLIPR</th><th align="center" valign="middle">binding</th></tr></thead><tbody><tr valign="top"><td align="left"><b>7</b></td><td align="left">C(CH<sub>3</sub>)<sub>2</sub>CH<sub>2</sub>Ph-<i>p</i>-OCH<sub>3</sub></td><td align="left">2.3</td><td align="left">2.47</td></tr><tr valign="top"><td align="left"><b>20</b></td><td align="left">(CH<sub>2</sub>)<sub>2</sub>Ph-<i>p</i>-OCH<sub>3</sub></td><td align="left">>100</td><td align="left">>10</td></tr><tr valign="top"><td align="left"><b>21</b></td><td align="left">CH<sub>2</sub>C(CH<sub>3</sub>)<sub>2</sub>Ph-<i>p</i>-OCH<sub>3</sub></td><td align="left">>100</td><td align="left">>10</td></tr><tr valign="top"><td align="left"><b>22</b></td><td align="left">CH(CH<sub>3</sub>)CH<sub>2</sub>Ph-<i>p</i>-OCH<sub>3</sub></td><td align="left">>100</td><td align="left">>10</td></tr><tr valign="top"><td align="left"><b>23</b></td><td align="left">C(CH<sub>3</sub>)<sub>2</sub>Ph-<i>p</i>-OCH<sub>3</sub></td><td align="left">>100</td><td align="left">>10</td></tr><tr valign="top"><td align="left"><b>24</b></td><td align="left">C(CH<sub>3</sub>)<sub>2</sub>(CH<sub>2</sub>)<sub>2</sub>Ph-<i>p</i>-OCH<sub>3</sub></td><td align="left">13</td><td align="left">2.78</td></tr><tr valign="top"><td align="left"><b>25</b></td><td align="left">C(CH<sub>3</sub>)<sub>2</sub>CH<sub>2</sub>Ph</td><td align="left">2.3</td><td align="left">NT<a class="ref internalNav" href="#tbl4-fn1" aria-label="a">a</a></td></tr><tr valign="top"><td align="left"><b>26</b></td><td align="left">C(CH<sub>3</sub>)<sub>2</sub>CH<sub>2</sub>-2-naphthyl</td><td align="left">0.45</td><td align="left">0.21</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl4-fn1"><div class="footnote" id="tbl4-fn1"><sup>a</sup><p class="last">NT = not tested.</p></div></div></div><figure id="fig2" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-13/jm900364m/production/images/medium/jm-2009-00364m_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-13/jm900364m/production/images/large/jm-2009-00364m_0002.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Overlay of the energy minimized structures of <b>7</b> (green) and <b>20</b> (red).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-13/jm900364m/production/images/large/jm-2009-00364m_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900364m&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The structure−activity studies focused on the central propanolamine linker were initiated around analog <b>11</b>, which was detailed above as a potent antagonist in both the FLIPR and binding assays (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>). Methylation of either the hydroxyl group or the secondary amine as in analogs <b>28</b> and <b>27</b> resulted in a significant loss in potency, suggesting that hydrogens on these atoms are critical for the formation of hydrogen bonds within the receptor active site. Analog <b>31</b> in which the hydroxyl group was removed also resulted in a significant loss in antagonist potency relative to analog <b>11</b>, further suggesting the critical role of this hydroxyl moiety in facilitating effective interaction with the receptor.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. SAR of Propanolamine Linker</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-13/jm900364m/production/images/medium/jm-2009-00364m_0015.gif" alt="" id="gr13" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead valign="middle"><tr valign="top"><th align="center" valign="middle"> </th><th align="center" valign="middle"> </th><th align="center" valign="middle"> </th><th colspan="2" align="center" valign="middle" char=".">CaR IC<sub>50</sub> (μM)</th></tr><tr valign="top"><th align="center" valign="middle">compd</th><th align="center" valign="middle">R<sub>1</sub></th><th align="center" valign="middle">R<sub>2</sub></th><th align="center" valign="middle" char=".">FLIPR</th><th align="center" valign="middle" char=".">binding</th></tr></thead><tbody><tr valign="top"><td align="left"><b>11</b></td><td align="left">OH</td><td align="left">H</td><td align="char" char=".">0.045</td><td align="char" char=".">0.20</td></tr><tr valign="top"><td align="left"><b>27</b></td><td align="left">OH</td><td align="left">CH<sub>3</sub></td><td align="char" char=".">>3.0</td><td align="char" char=".">2.3</td></tr><tr valign="top"><td align="left"><b>28</b></td><td align="left">OCH<sub>3</sub></td><td align="left">H</td><td align="char" char=".">>3.0</td><td align="char" char=".">0.95</td></tr><tr valign="top"><td align="left"><b>31</b></td><td align="left">H</td><td align="left">H</td><td align="char" char=".">2.5</td><td align="char" char=".">0.93</td></tr></tbody></table></div></div><div class="NLM_p">Assessment of the role of the stereochemistry of the C-2 secondary hydroxyl group in determining antagonist potency and selectivity was performed utilizing analog <b>11</b>, which as a racemate is a potent CaR antagonist (Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>). Upon separation of the enantiomers it was shown that the C2 <i>R</i> enantiomer <b>32</b> was 9- and 4.5-fold more potent than the <i>S</i> enantiomer <b>33</b> in the FLIPR and binding assays, respectively. These results show that the CaR has a clear stereochemical preference for the <i>R</i> enantiomer. This stereochemical preference was recapitulated in vivo in the rat where intravenous injection of the <i>R</i>-enantiomer elicited significantly higher levels of PTH over that of the less active <i>S</i>-enantiomer (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). Evaluation of the β-adrenoreceptor selectivity of the individual <i>R</i> and <i>S</i> enantiomers showed that the <i>S</i> enantiomer <b>33</b> was 300-fold more potent than the <i>R</i> enantiomer <b>32</b> as a β<sub>2</sub> adrenoreceptor antagonist. Additionally when evaluated as β<sub>3</sub> adrenoreceptor agonists, the <i>R</i> enantiomer <b>32</b> was devoid of activity while the <i>S</i> enantiomer <b>33</b> was active (Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>). If one assumes that the three-point binding model detailed in the Easson−Stedman hypothesis extends to aryloxyethyl amines such as <b>32</b> and <b>33</b>, then this stereochemical preference for adrenoreceptor activity is consistent with the plethora of available adrenoreceptor antagonist/agonist literature.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> It was also encouraging to observe that the stereochemical preference exerted by the CaR upon the amino alcohol antagonist template was opposite to that preferred by the β-adrenergic receptors examined. It is this stereochemical preference that has permitted the disassociation of CaR antagonist activity from β-adrenergic receptor activity present in the initial lead <b>2</b>. Unfortunately this stereochemical preference, which led to greater CaR potency and selectivity over the β-adrenergic receptor, did not extend further to selectivity over the monoamine transporters for analog <b>32</b> (SERT IC<sub>50</sub> = 0.027 μM, NET IC<sub>50</sub> = 0.07 μM, and DAT IC<sub>50</sub> = 1.3 μM) as well as hERG (IC<sub>50</sub> = 2.6 μM) and CYP2D6 (IC<sub>50</sub> = 0.005 μM).</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Potencies and Selectivities of the Individual Enantiomers of <b>11</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-13/jm900364m/production/images/medium/jm-2009-00364m_0016.gif" alt="" id="gr14" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="left" /></col></colgroup><thead valign="middle"><tr valign="top"><th align="center" valign="middle"> </th><th align="center" valign="middle"> </th><th colspan="3" align="center" valign="middle" char=".">IC<sub>50</sub> (μM)</th><th align="center" valign="middle">EC<sub>50</sub> (μM)</th></tr><tr valign="top"><th align="center" valign="middle">compd</th><th align="center" valign="middle">C2 chirality</th><th align="center" valign="middle" char=".">CaR FLIPR</th><th align="center" valign="middle" char=".">CaR binding</th><th align="center" valign="middle" char=".">β<sub>2</sub> binding</th><th align="center" valign="middle">β<sub>3</sub> binding</th></tr></thead><tbody><tr valign="top"><td align="left"><b>11</b></td><td align="left"><i>R</i>/<i>S</i></td><td align="char" char=".">0.045</td><td align="char" char=".">0.20</td><td align="char" char=".">0.021</td><td align="left">0.20</td></tr><tr valign="top"><td align="left"><b>32</b></td><td align="left"><i>R</i></td><td align="char" char=".">0.038</td><td align="char" char=".">0.068</td><td align="char" char=".">0.30</td><td align="left">NA<a class="ref internalNav" href="#tbl6-fn1" aria-label="a">a</a></td></tr><tr valign="top"><td align="left"><b>33</b></td><td align="left"><i>S</i></td><td align="char" char=".">0.34</td><td align="char" char=".">0.30</td><td align="char" char=".">0.001</td><td align="left">0.20</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl6-fn1"><div class="footnote" id="tbl6-fn1"><sup>a</sup><p class="last">NA = not active.</p></div></div></div><figure id="fig3" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-13/jm900364m/production/images/medium/jm-2009-00364m_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-13/jm900364m/production/images/large/jm-2009-00364m_0003.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Acute increases in plasma PTH levels following iv injection of CaR antagonists <b>32</b> or <b>33</b> (10 μmol/kg) in normal conscious rats. Values are mean ± SE, <i>n</i> = 6/group. PTH was measured using a rat PTH(1-34) immunoradiometric assay (Immutopics, San Clemente, CA), Note the greater activity of <b>32</b> (<i>R</i>-enantiomer) compared with <b>33</b> (<i>S</i>-enantiomer).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-13/jm900364m/production/images/large/jm-2009-00364m_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900364m&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">As detailed above and outlined in Scheme <a class="ref internalNav" href="#sch7" aria-label="7">7</a>, an initial understanding of the structure−activity relationships that exist within the three regions of the amino alcohol antagonist lead <b>2</b> led to the identification of the optimal left-hand side aromatic group contained within <b>13</b> and the right-hand side aromatic amine within <b>26</b> as well as the requisite <i>R</i> stereochemistry of the secondary alcohol of the propanolamine linker in <b>34</b>. In an effort to further optimize antagonist activity, the critical binding elements contained within <b>13</b>, <b>26</b>, and <b>34</b> were combined to produce analog <b>38</b>, which retained potent CaR antagonism. These potencies represent a 255- and 10600-fold increases in antagonist potency for <b>38</b> over the lead <b>2</b> in the FLIPR and binding assays, respectively (Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a>). Also encouraging was the separation of β-adrenergic receptor activity from CaR antagonist activity with analog <b>38</b>, where it was shown to be a 4.3 μM antagonist of the β<sub>2</sub> adrenergic receptor and was devoid of agonist activity at the β<sub>1</sub> or β<sub>3</sub> adrenergic receptors. This represents a 3300-fold improvement in selectivity at the β<sub>2</sub> adrenergic receptor for <b>38</b> over the screening lead <b>2</b>. Unfortunately, as with several of the analogs detailed above, no improvement in selectivity for the monoamine transporters, the hERG channel, or CYP2D6 were reduced to practice with <b>38</b> or any of the other analogs detailed within this manuscript. The small molecule X-ray crystal structure of <b>38</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>) shows this molecule to have adopted a C-shaped conformation. This structure further confirms the SAR trends discussed above in that the geminal dimethyl moiety contained within this amino alcohol antagonist template serves to impart a conformational constraint and place the pendant aromatic groups in proximity for a π−π interaction. This interaction is likely critical for potent antagonism of the CaR.</div><figure id="sch7" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-13/jm900364m/production/images/medium/jm-2009-00364m_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-13/jm900364m/production/images/large/jm-2009-00364m_0011.jpeg" id="gs7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. Combination of the SAR Studies Leading to Analog <b>38</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-13/jm900364m/production/images/large/jm-2009-00364m_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900364m&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Potencies and Selectivities of <b>2</b> and <b>38</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-13/jm900364m/production/images/medium/jm-2009-00364m_0017.gif" alt="" id="gr17" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="left" /></col></colgroup><thead valign="middle"><tr valign="top"><th align="center" valign="middle"> </th><th colspan="8" align="center" valign="middle" char=".">IC<sub>50</sub> (μM)</th><th align="center" valign="middle">EC<sub>50</sub> (μM)</th></tr><tr valign="top"><th align="center" valign="middle">compd</th><th align="center" valign="middle" char=".">CaR FLIPR</th><th align="center" valign="middle" char=".">CaR binding</th><th align="center" valign="middle" char=".">SERT binding</th><th align="center" valign="middle" char=".">NET binding</th><th align="center" valign="middle" char=".">DAT binding</th><th align="center" valign="middle" char=".">CYP2D6</th><th align="center" valign="middle" char=".">hERG binding</th><th align="center" valign="middle" char=".">β<sub>2</sub> binding</th><th align="center" valign="middle">β<sub>1</sub>/β<sub>3</sub> binding</th></tr></thead><tbody><tr valign="top"><td align="left"><b>2</b></td><td align="char" char=".">11.0</td><td align="char" char=".">31.8</td><td align="char" char=".">0.061</td><td align="char" char=".">0.60</td><td align="char" char=".">1.20</td><td align="char" char=".">1.26</td><td align="char" char=".">11.8</td><td align="char" char=".">0.0013</td><td align="left">0.003/0.007</td></tr><tr valign="top"><td align="left"><b>38</b></td><td align="char" char=".">0.043</td><td align="char" char=".">0.003</td><td align="char" char=".">0.002</td><td align="char" char=".">0.20</td><td align="char" char=".">0.20</td><td align="char" char=".">0.045</td><td align="char" char=".">3.00</td><td align="char" char=".">4.3</td><td align="left">NA/NA<a class="ref internalNav" href="#tbl7-fn1" aria-label="a">a</a></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl7-fn1"><div class="footnote" id="tbl7-fn1"><sup>a</sup><p class="last">NA = not active.</p></div></div></div><figure id="fig4" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-13/jm900364m/production/images/medium/jm-2009-00364m_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-13/jm900364m/production/images/large/jm-2009-00364m_0004.jpeg" id="gr18" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Small molecule X-ray crystal structure of the calcium receptor antagonist <b>38</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-13/jm900364m/production/images/large/jm-2009-00364m_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900364m&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Pharmacokinetics and Pharmacodynamics of <b>38</b></h3><div class="NLM_p last">Evaluation of the pharmacokinetics of amino alcohol <b>38</b> in the rat showed this compound to have an oral bioavailability of 11% with a high rate of clearance (74 mL/min/kg), a <i>T</i><sub>1/2</sub> of 2 h, and volume of distribution of 11.0 L/kg. Undoubtedly, the high volume of distribution of <b>38</b> is related to the fact that this molecule is a basic, lipophilic amine that is widely distributed into tissues and likely demonstrates lysosomotropic behavior. As has been previously disclosed and briefly summarized here for context, the efficacy of analog <b>38</b> was evaluated in the ovariectomized (OVX) rat model of postmenopausal osteoporosis following five weeks of daily oral administration of a 100 μmol/kg dose<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a>. Additionally, in this experiment, the efficacy of <b>38</b> was compared directly to the efficacy of a subcutaneously administered dose (5 μg/kg) of rat PTH (1-34). Plasma levels of analog <b>38</b> and PTH following oral administration of <b>38</b> remained elevated at the 4 h time point. The high volume of distribution of <b>38</b> is likely responsible for the prolonged exposure to <b>38</b> and the protracted PTH response. In contrast, while the plasma levels of rat PTH (1-34) achieved a similar maximum level to that observed for PTH following administration of <b>38</b>, baseline levels had been restored after only 2 h. The differing PTH exposure profiles of orally administered <b>38</b> and injected rat PTH (1-34) had markedly different effects on bone. Daily oral administration of <b>38</b> for 5 weeks resulted in an increase in both the formation of new bone and the resorption of old bone with no net increase in bone mass. In contrast, treatment with rat PTH (1-34) resulted in increased bone mass. When analog <b>38</b> was administered to OVX rats together with continuous subcutaneous infusion of the antiresorptive agent 17β-estradiol, a net increase in bone mass was observed.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i21">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_40465" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_40465" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In this paper, we have detailed the identification of the high throughput screening lead <b>2</b> as a weak antagonist of the CaR with a variety of off-target interactions. Structure−activity studies to optimize the three different portions of this amino alcohol lead in terms of both potency versus the CaR as well as off-target selectivity led to the discovery that the <i>R</i>-enantiomer of the C2 alcohol of the propanolamine linker conferred greater CaR antagonist activity with greater selectivity over the β-adrenergic receptor than that of the <i>S</i>-enantiomer but did not affect activity in other selectivity counterscreens, most notably the norepinephrine, dopamine, and serotonin monoamine transporters, the hERG ion channel and CYP2D6, all of which share an affinity for lipophilic basic amines. Further optimization efforts led to the identification of analog <b>38</b>, a potent CaR antagonist with high clearance, a large volume of distribution, and low oral bioavailability in rats. Analog <b>38</b> has been shown to increase bone mass in OVX rats when given in conjunction with the antiresorptive agent 17β-estradiol. To facilitate new bone growth, the ideal molecule should produce a transient spike of PTH release following oral administration. Efforts to design molecules with this desired pharmacokinetic and pharmacodynamic profile and greater selectivity over the hERG ion channel, monoamine transporters, and CYP2D6 will be the subject of future publications.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i22">Experimental Procedures</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_24853" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_24853" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_98" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> Calcium Receptor Inhibitor Assay</h3><div class="NLM_p">HEK 293 4.0-7 cells were constructed as described by Rogers et al.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> First, 48 h prior to running the CaR assay, frozen HEK293 CaRec4.0-c17 cells were thawed, counted, and diluted to 3 × 10<sup>5</sup>/mL (15K/50 μL). The cell medium used to dilute the cells consisted of DMEM/F12 (HAM’S) 1:1 with <span class="smallcaps smallerCapital">l</span>-glutamine, 15 mM HEPES, phenol red, 10% fetal bovine serum, and 1% penicillin−streptomycin solution. Cell solution was seeded at 15K cells/50 μL/well in Greiner poly-<span class="smallcaps smallerCapital">d</span>-lysine coated 384-well, black, clear bottom, tissue culture plates and left at room temperature for 1 h to reduce edge effect. After the first hour at room temperature, cell plates were then placed into a 37 °C, 5% CO<sub>2</sub> incubator for 48 h.</div><div class="NLM_p">On the day of the experiment, plate confluency was first checked by microscope. Wells should be ∼100% confluent in an even cell monolayer. Assay reagents were prepared fresh. Dye load buffer consisted of Hank’s buffered saline solution with 0.75 mM calcium, without magnesium, without sodium bicarbonate, with 20 mM Hepes, probenecid (2.5 mM final concentration), Fluo4 (2 μM final concentration), and brilliant black (500 μM final concentration). Compound dilution buffer consisted of Hank’s buffered saline solution without calcium, without magnesium (without sodium bicarbonate), and CHAPS (0.01% final concentration). A ligand curve plate was also prepared fresh. A 16 point curve was dispensed into a Greiner 384-well polypropylene plate. The top concentration of the ligand CaCl was 2.875 mM (final concentration), and the lowest concentration was 0.375 mM (final concentration). An EC<sub>80</sub> value was generated from the curve data.</div><div class="NLM_p last">The CaR assay began when the cell media was aspirated from the cell plate using a Tecan plate washer, leaving nothing but the cell monolayer. Dye load buffer is added to the cell plate at 20 μL/well using a multidrop, and the loaded plate was incubated for 45 min at 37 °C, 5% CO<sub>2</sub>. Compound plates were received with 1 μL of compound stamped at 5 mM top concentration (25 μM final conc in cell plate). Compound dilution buffer was added to columns 1−24 in the compound plate at 65 μL/well using a Multidrop. Column 6 was prestamped with 1 μL of DMSO to represent the high control, and column 18 received 65 μL of buffer as the low control. The compound addition takes place on a Cybi Well dispenser when 10 μL of diluted compound was added to the dye loaded cell plate. The cell plate with compound was then incubated at room temperature for 5 min.. The antagonist addition took place on the FLIPR when 10 μL of EC<sub>80</sub> challenge was added to the cell plate and fluorescence imagining proceeded for 65 s. Column 18 of the EC<sub>80</sub> challenge plate contained only buffer to represent a low control or tool antagonist.</div></div><div id="sec4_99" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> Calcium Receptor Binding Assay</h3><div class="NLM_p">HEK 293 4.0-7 cells stably transfected with the human parathyroid calcium receptor (“HuPCaR”) were scaled up in T180 tissue culture flasks. Plasma membrane is obtained by polytron homogenization or glass douncing in buffer (50 mM Tris-HCl pH 7.4, 1 mM EDTA, 3 mM MgCl<sub>2</sub>) in the presence of a protease inhibitor cocktail containing 1 μM leupeptin, 0.04 μM pepstatin, and 1 mM PMSF. Aliquoted membrane was snap frozen and stored at −80 °C. <sup>3</sup>H labeled compound was radiolabeled to a radiospecific activity of 44 Ci/mmol and was aliquoted and stored in liquid nitrogen for radiochemical stability.</div><div class="NLM_p last">A typical reaction mixture contained 2 nM <sup>3</sup>H compound ((<i>R</i>,<i>R</i>)-<i>N</i>-4′-methoxy-<i>t</i>-3-3′-methyl-1′-ethylphenyl-1-(1-naphthyl)ethylamine), or <sup>3</sup>H compound (<i>R</i>)-<i>N</i>-[2-hydroxy-3-(3-chloro-2-cyanophenoxy)propyl]-1,1-dimethyl-2-(4-methoxyphenyl)ethylamine 4−10 μg membrane in homogenization buffer containing 0.1% gelatin and 10% EtOH in a reaction volume of 0.5 mL. Incubation was performed in 12 × 75 polyethylene tubes in an ice water bath. To each tube, 25 μL of test sample in 100% EtOH was added, followed by 400 μL of cold incubation buffer and 25 μL of 40 nM <sup>3</sup>H-compound in 100% EtOH for a final concentration of 2 nM. The binding reaction was initiated by the addition of 50 μL of 80−200 ug/mL HEK 293 4.0-7 membrane diluted in incubation buffer and allowed to incubate at 4 °C for 30 min. Wash buffer was 50 mM Tris-HCl containing 0.1% PEI. Nonspecific binding was determined by the addition of 100-fold excess of unlabeled homologous ligand and was generally 20% of total binding. The binding reaction was terminated by rapid filtration onto 1% PEI pretreated GF/C filters using a Brandel harvester. Filters were placed in scintillation fluid and radioactivity assessed by liquid scintillation counting.</div></div><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> General</h3><div class="NLM_p">Except where indicated, materials and reagents were used as supplied. Nuclear magnetic resonance spectra were recorded at either 250 or 400 MHz using, respectively, a Bruker AM 250 or Bruker AC 400 spectrometer. Mass spectra were taken on a PE Syx API III instruments using electrospray (ES) ionization techniques. Elemental analyses were obtained using a Perkin-Elmer 240C elemental analyzer. Reactions were monitored by TLC analysis using Analtech Silica Gel GF or E. Merck Silica Gel 60 F-254 thin layer plates. Flash chromatography was carried out on E. Merck Kieselgel 60 (230−400 mesh) silica gel. The purity of all tested compounds, which were not analyzed via elemental analysis, were determined by high performance liquid chromatography. Method A: 5−100% acetonitrile:water (with 0.1% TFA) over 18 min with a total run time of 20 min using a 4.6 mm × 50 mm id S-5 mm, YMC Combiscreen ODS column. Method B: 5−100% acetonitrile:water (with 0.1% TFA) over 18 min with a total run time of 20 min using a 4.6 mm × 150 mm id, 5 mm, Zorbax Stablebond C8 column. All compounds analyzed by these methods possessed purities equal to or greater than 95%, with the exception of analog <b>14</b>, which is 91.7% pure by method A and 95.8% pure by method B.</div><div id="sec4_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> (1,1-Dimethyl-2-[4-(methyloxy)phenyl]ethyl)(2-oxiranylmethyl)amine (<b>5</b>)</h4><div class="NLM_p last">A solution of (1,1-dimethyl-2-[4-(methyloxy)phenyl]ethyl)amine (7.46 g, 41.6 mmol) in isopropyl alcohol (75 mL) was cooled to 0 °C under N<sub>2</sub>. Epichlorohydrin (3.2 mL, 40.8 mmol) was added dropwise and reaction stirred at 0 °C for 30 min before warming to room temperature overnight. The reaction was concentrated in vacuo and purified via column chromatography (0−12% CH<sub>3</sub>OH/CH<sub>2</sub>Cl<sub>2</sub>) to provide the title compound (45%). <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ ppm 7.08−7.16 (m, <i>J</i> = 6.25, 6.25, 5.81, 3.92 Hz, 2 H), 6.87 (s, 1 H), 6.82−6.86 (m, 2 H), 3.98 (ddd, <i>J</i> = 11.05, 8.15, 5.31 Hz, 1 H), 3.76−3.83 (m, 3 H), 3.67 (dd, <i>J</i> = 6.32, 4.04 Hz, 1 H), 3.56−3.65 (m, <i>J</i> = 11.24, 9.16, 9.16, 5.31 Hz, 2 H), 2.98 (dd, <i>J</i> = 12.13, 3.79 Hz, 1 H), 2.76−2.82 (m, 1 H), 2.75 (s, 1 H), 1.12−1.20 (m, 6 H).</div></div><div id="sec4_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> 1-((1,1-Dimethyl-2-[4-(methyloxy)phenyl]ethyl)amino)-3-(phenyloxy)-2-propanol (<b>7</b>)</h4><div class="NLM_p last">A solution of sodium hydride (95%, 0.116 g, 4.59 mmol) in DMF (6.0 mL) under N<sub>2</sub> was prepared. Phenol (0.433 g, 4.60 mmol) in DMF (6.0 mL) was added and the reaction stirred at room temperature for 15 min (1,1-dimethyl-2-[4-(methyloxy)phenyl]ethyl)(2-oxiranylmethyl)amine (0.354 g, 1.51 mmol) in DMF (4.0 mL) was added and the reaction heated at 100 °C for 20 h. The reaction was cooled and quenched with the addition of H<sub>2</sub>O. The aqueous layer was extracted two times with ethyl acetate. The combined organic layers were washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. Column chromatography (0−10% CH<sub>3</sub>OH/CH<sub>2</sub>Cl<sub>2</sub>) was used to purify. The resulting oil was dissolved in CH<sub>3</sub>CN and HCl/Et<sub>2</sub>O (1.0 N, 1.5 equiv) was added. The reaction stirred for 10−15 min and concentrated in vacuo to afford the HCl salt of the title compound (38%) as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 9.01 (s, 1 H), 8.60 (s, 1 H), 7.32 (dd, <i>J</i> = 8.97, 7.20 Hz, 2 H), 7.14 (t, <i>J</i> = 7.96 Hz, 2 H), 6.97 (t, <i>J</i> = 7.96 Hz, 3 H), 6.90 (d, <i>J</i> = 8.59 Hz, 2 H), 5.93 (d, <i>J</i> = 4.04 Hz, 1 H), 4.24 (s, 1 H), 4.03 (d, <i>J</i> = 5.31 Hz, 2 H), 3.74 (s, 3 H), 3.23 (s, 1 H), 3.06 (d, <i>J</i> = 9.60 Hz, 1 H), 2.90−2.99 (m, 2 H), 1.16−1.24 (m, 6 H). MS (ESI) 330.2 (M + H)<sup>+</sup>.</div></div><div id="sec4_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> 1-((1,1-Dimethyl-2-[4-(methyloxy)phenyl]ethyl)amino)-3-(2-naphthalenyloxy)-2-propanol (<b>8</b>)</h4><div class="NLM_p last">The title compound was prepared following the procedure above substituting 2-naphthol for phenol. The title compound (21%) was isolated as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 9.05 (s, 1 H), 8.64 (s, 1 H), 7.85 (ddd, <i>J</i> = 9.98, 6.69, 5.56 Hz, 3 H), 7.44−7.51 (m, 1 H), 7.37 (td, <i>J</i> = 7.45, 1.01 Hz, 2 H), 7.20−7.25 (m, <i>J</i> = 4.42, 4.42, 4.42, 4.42 Hz, 1 H), 7.14 (t, <i>J</i> = 8.84 Hz, 2 H), 6.90 (d, <i>J</i> = 8.84 Hz, 2 H), 6.00 (d, <i>J</i> = 4.04 Hz, 1 H), 4.30−4.39 (m, 1 H), 4.18 (t, <i>J</i> = 7.71 Hz, 2 H), 3.73 (s, 3 H), 3.31 (s, 1 H), 3.11 (d, <i>J</i> = 9.60 Hz, 1 H), 2.92−3.01 (m, 2 H), 1.17−1.26 (m, 6 H). MS (ESI) 380.2 (M + H)<sup>+</sup>.</div></div><div id="sec4_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> 1-[(2-Chlorophenyl)oxy]-3-((1,1-dimethyl-2-[4-(methyloxy)phenyl]ethyl)amino)-2-propanol (<b>9</b>)</h4><div class="NLM_p last">The title compound was prepared following the procedure above substituting 2-chlorophenol for phenol. The title compound (29%) was isolated as a white solid: <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 8.93 (s, 1 H), 8.65 (s, 1 H), 7.45 (dd, <i>J</i> = 7.96, 1.64 Hz, 1 H), 7.28−7.38 (m, 1 H), 7.13−7.24 (m, 3 H), 6.99 (td, <i>J</i> = 7.71, 1.26 Hz, 1 H), 6.90 (d, <i>J</i> = 8.84 Hz, 2 H), 5.97 (d, <i>J</i> = 4.29 Hz, 1 H), 4.28 (s, 1 H), 4.08−4.19 (m, 2 H), 3.74 (s, 3 H), 3.32 (d, <i>J</i> = 2.78 Hz, 1 H), 3.12 (d, <i>J</i> = 9.60 Hz, 1 H), 2.89−2.98 (m, 2 H), 1.16−1.25 (m, 6 H). MS (ESI) 364.2 (M + H)<sup>+</sup>.</div></div><div id="sec4_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> 1-[(3-Chlorophenyl)oxy]-3-((1,1-dimethyl-2-[4-(methyloxy)phenyl]ethyl)amino)-2-propanol (<b>10</b>)</h4><div class="NLM_p last">The title compound was prepared following the procedure above substituting 3-chlorophenol for phenol. The title compound (19%) was isolated as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 8.97 (s, 1 H), 8.59 (s, 1 H), 7.31−7.38 (m, 1 H), 7.15 (d, <i>J</i> = 8.59 Hz, 2 H), 7.06−7.11 (m, 1 H), 7.03 (dd, <i>J</i> = 7.96, 1.14 Hz, 1 H), 6.88−6.99 (m, 3 H), 5.94 (d, <i>J</i> = 4.29 Hz, 1 H), 4.23 (s, 1 H), 4.02−4.10 (m, 2 H), 3.74 (s, 3 H), 3.26 (s, 1 H), 3.05 (d, <i>J</i> = 9.09 Hz, 1 H), 2.89−2.98 (m, 2 H), 1.16−1.24 (m, 6 H). MS (ESI) 364.2 (M + H)<sup>+</sup>.</div></div><div id="sec4_1_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> 1-[(2,3-Dichlorophenyl)oxy]-3-((1,1-dimethyl-2-[4-(methyloxy)phenyl]ethyl)amino)-2-propanol (<b>11</b>)</h4><div class="NLM_p last">The title compound was prepared following the procedure above substituting 2,3-dichlorophenol for phenol. The title compound (26%) was isolated as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 8.93 (s, 1 H), 8.66 (s, 1 H), 7.32−7.40 (m, 1 H), 7.23 (ddd, <i>J</i> = 17.43, 8.34, 1.26 Hz, 2 H), 7.15 (d, <i>J</i> = 8.59 Hz, 2 H), 6.90 (d, <i>J</i> = 8.84 Hz, 2 H), 5.99 (d, <i>J</i> = 4.80 Hz, 1 H), 4.25−4.32 (m, 1 H), 4.13−4.23 (m, <i>J</i> = 11.21, 11.21, 10.17, 5.05 Hz, 2 H), 3.74 (s, 3 H), 3.29 (s, 1 H), 3.11 (d, <i>J</i> = 9.60 Hz, 1 H), 2.90−2.98 (m, 2 H), 1.16−1.24 (m, 6 H). MS (ESI) 398.0/400.0 [(M/M + 2) + H]<sup>+</sup>.</div></div><div id="sec4_1_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> 2-([3-((1,1-Dimethyl-2-[4-(methyloxy)phenyl]ethyl)amino)-2-hydroxypropyl]oxy)benzonitrile (<b>12</b>)</h4><div class="NLM_p last">The title compound was prepared following the procedure above substituting 2-[4-(methyloxy)phenyl]-2-propanamine for 2-[4-(methyloxy)phenyl]ethanamine and 2-[(2-oxiranylmethyl)oxy]benzonitrile for 2-[(phenyloxy)methyl]oxirane. The title compound (82%) was isolated as an off white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 8.92−9.16 (m, 1 H), 8.71 (br s, 1 H), 7.64−7.81 (m, 2 H), 7.32 (d, <i>J</i> = 8.59 Hz, 1 H), 7.02−7.25 (m, 3 H), 6.90 (d, <i>J</i> = 8.84 Hz, 2 H), 6.02 (br s, 1 H), 4.11−4.39 (m, 2 H), 3.59−3.83 (m, 2 H), 3.25−3.50 (m, 4 H), 3.13 (q, <i>J</i> = 9.18 Hz, 1 H), 2.81−3.03 (m, 1 H), 1.22 (s, 6 H). MS (ESI) 355.2 (M + H)<sup>+</sup>.</div></div><div id="sec4_1_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> 2-Chloro-6-([3-((1,1-dimethyl-2-[4-(methyloxy)phenyl]ethyl)amino)-2-hydroxypropyl]oxy)benzonitrile (<b>13</b>)</h4><div class="NLM_p last">The title compound was prepared following the procedure above substituting 2-cyano-3-chlorophenol for phenol. The title compound (19%) was isolated as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 9.04 (s, 1 H), 8.72 (s, 1 H), 7.71 (t, <i>J</i> = 8.34 Hz, 1 H), 7.38 (s, 1 H), 7.32 (dd, <i>J</i> = 8.34, 3.28 Hz, 1 H), 7.13 (d, <i>J</i> = 4.04 Hz, 2 H), 6.90 (d, <i>J</i> = 8.84 Hz, 2 H), 6.05 (s, 1 H), 4.29 (td, <i>J</i> = 10.23, 3.79 Hz, 3 H), 3.74 (s, 3 H), 3.29 (s, 1 H), 3.13 (s, 1 H), 2.90−2.99 (m, 2 H), 1.16−1.25 (m, 6 H). MS (ESI) 389.0 (M + H)<sup>+</sup>.</div></div><div id="sec4_1_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> 1-((1,1-Dimethyl-2-[4-(methyloxy)phenyl]ethyl)amino)-3-([2-(methyloxy)phenyl]oxy)-2-propanol (<b>14</b>)</h4><div class="NLM_p last">The title compound was prepared following the procedure above substituting guaiacol for phenol. The title compound (20%) was isolated as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 8.92 (s, 1 H), 8.59 (s, 1 H), 7.13 (d, <i>J</i> = 6.82 Hz, 2 H), 6.98−7.05 (m, <i>J</i> = 10.24, 3.69, 3.56, 3.56, 3.45, 1.52 Hz, 2 H), 6.87−6.96 (m, <i>J</i> = 14.27, 7.71, 7.33, 4.04 Hz, 4 H), 5.91 (s, 1 H), 4.19−4.27 (m, 1 H), 3.96−4.07 (m, 2 H), 3.71−3.79 (m, 6 H), 3.27 (d, <i>J</i> = 10.11 Hz, 1 H), 3.07 (d, <i>J</i> = 9.60 Hz, 1 H), 2.89−2.98 (m, 2 H), 1.15−1.25 (m, 6 H). MS (ESI) 360.2 (M + H)<sup>+</sup>.</div></div><div id="sec4_1_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> 1-((1,1-Dimethyl-2-[4-(methyloxy)phenyl]ethyl)amino)-3-(propyloxy)-2-propanol (<b>15</b>)</h4><div class="NLM_p last">The title compound was prepared following the procedure above substituting <i>n</i>-propanol for phenol. The title compound (19%) was isolated as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 8.85 (s, 1 H), 8.45 (s, 1 H), 7.09−7.17 (m, 2 H), 6.90 (d, <i>J</i> = 8.84 Hz, 2 H), 5.64 (s, 1 H), 3.99 (ddd, <i>J</i> = 10.61, 6.82, 5.81 Hz, 1 H), 3.74 (s, 3 H), 3.45 (d, <i>J</i> = 5.31 Hz, 1 H), 3.43 (d, <i>J</i> = 5.05 Hz, 1 H), 3.33 (m, 1 H), 3.11 (d, <i>J</i> = 2.78 Hz, 1 H), 3.08 (s, 1 H), 2.85−2.95 (m, 3 H), 1.47−1.56 (m, <i>J</i> = 7.20, 7.04, 7.04, 7.04, 7.04 Hz, 2 H), 1.15−1.21 (m, 6 H), 0.87 (t, <i>J</i> = 7.33 Hz, 3 H). MS (ESI) 296.2 (M + H)<sup>+</sup>.</div></div><div id="sec4_1_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> 1-((1,1-Dimethyl-2-[4-(methyloxy)phenyl]ethyl)amino)-3-[(1-methylethyl)oxy]-2-propanol (<b>16</b>)</h4><div class="NLM_p last">The title compound was prepared following the procedure above substituting isopropyl alcohol for phenol. The title compound (29%) was isolated as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 8.96 (s, 1 H), 8.49 (s, 1 H), 7.11−7.19 (m, 2 H), 6.90 (d, <i>J</i> = 8.59 Hz, 2 H), 5.61 (s, 1 H), 3.92−4.02 (m, 1 H), 3.71−3.77 (m, 3 H), 3.58 (dt, <i>J</i> = 12.13, 6.06 Hz, 1 H), 3.42−3.46 (m, 1 H), 3.33−3.40 (m, 1 H), 3.10 (t, <i>J</i> = 10.99 Hz, 1 H), 2.96 (s, 1 H), 2.84−2.94 (m, <i>J</i> = 9.22, 9.22, 7.71, 7.20 Hz, 2 H), 1.15−1.21 (m, 6 H), 1.09 (t, <i>J</i> = 6.57 Hz, 6 H). MS (ESI) 296.2 (M + H)<sup>+</sup>.</div></div><div id="sec4_1_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> 1-(Butyloxy)-3-((1,1-dimethyl-2-[4-(methyloxy)phenyl]ethyl)amino)-2-propanol (<b>17</b>)</h4><div class="NLM_p last">The title compound was prepared following the procedure above substituting <i>n</i>-butanol for phenol. The title compound (29%) was isolated as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 9.04 (s, 1 H), 8.53 (s, 1 H), 7.11−7.19 (m, 2 H), 6.90 (d, <i>J</i> = 8.84 Hz, 2 H), 3.97−4.06 (m, <i>J</i> = 6.47, 6.47, 6.19, 5.62, 4.80 Hz, 1 H), 3.67−3.76 (m, 3 H), 3.47−3.58 (m, 2 H), 3.39 (ddd, <i>J</i> = 7.07, 3.92, 3.66 Hz, 1 H), 3.35 (d, <i>J</i> = 6.06 Hz, 1 H), 3.09 (t, <i>J</i> = 10.99 Hz, 1 H), 2.85−2.97 (m, <i>J</i> = 13.55, 8.46, 7.01, 6.85 Hz, 3 H), 1.49 (td, <i>J</i> = 10.67, 6.69 Hz, 2 H), 1.33 (ddd, <i>J</i> = 19.58, 12.76, 4.55 Hz, 3 H), 1.15−1.24 (m, 6 H), 0.89 (t, <i>J</i> = 7.33 Hz, 3 H). MS (ESI) 310.2 (M + H)<sup>+</sup>.</div></div><div id="sec4_1_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> 2-[(Phenyloxy)methyl]oxirane (<b>18</b>)</h4><div class="NLM_p last">Potassium carbonate (15.1 g, 109 mmol) and epichlorohydrin (21 mL, 268 mmol) were added to a solution of phenol (5.05 g, 53.7 mmol) and CH<sub>3</sub>CN. The flask was sealed and heated at reflux for 3 days. The reaction was cooled to room temperature, filtered, washed with ethyl acetate, and concentrated. Column chromatography (0−30% ethyl acetate:hexane) provided 6.08 g (76%) of <b>18</b> as an oil. <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ ppm 7.32 (dd, <i>J</i> = 8.84, 7.33 Hz, 1 H), 7.28 (s, 1 H), 6.92−7.03 (m, 3 H), 4.24 (dd, <i>J</i> = 10.86, 3.28 Hz, 1 H), 3.99 (dd, <i>J</i> = 10.99, 5.68 Hz, 1 H), 3.33−3.45 (m, <i>J</i> = 6.09, 3.66, 2.95, 2.95 Hz, 1 H), 2.93 (d, <i>J</i> = 4.29 Hz, 1 H), 2.79 (dd, <i>J</i> = 4.93, 2.65 Hz, 1 H).</div></div><div id="sec4_1_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> 1-((2-[4-(Methyloxy)phenyl]ethyl)amino)-3-(phenyloxy)-2-propanol (<b>20</b>)</h4><div class="NLM_p last">2-[(Phenyloxy)methyl]oxirane (<b>18</b>) (0.639 g, 4.26 mmol) in ethanol (8.5 mL) was added to 2-[4-(methyloxy)phenyl]ethanamine (0.640 g, 4.23 mmol) and the reaction heated at 80 °C in a sealed flask for 20 h. The reaction was cooled to room temperature and concentrated in vacuo. Column chromatography (0−10% CH<sub>3</sub>OH:CH<sub>2</sub>Cl<sub>2</sub>) produced 0.563 g (39%) of <b>20</b> as an off-white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 9.11 (br s, 1 H), 8.90 (br s, 1 H), 7.30 (d, <i>J</i> = 8.08 Hz, 1 H), 7.24−7.37 (m, 1 H), 7.18 (d, <i>J</i> = 8.59 Hz, 2 H), 6.87−6.99 (m, 5 H), 5.92 (d, <i>J</i> = 5.05 Hz, 1 H), 4.24 (ddd, <i>J</i> = 8.91, 4.36, 4.17 Hz, 1 H), 3.98 (quin, <i>J</i> = 4.74 Hz, 2 H), 3.73 (s, 3 H), 3.15 (t, <i>J</i> = 11.62 Hz, 2 H), 3.19 (d, <i>J</i> = 19.96 Hz, 1 H), 3.05 (d, <i>J</i> = 9.85 Hz, 1 H), 2.90−2.98 (m, <i>J</i> = 11.64, 6.32, 5.23, 4.61, 4.04 Hz, 2 H). MS (ESI) 302.2 (M + H)<sup>+</sup>.</div></div><div id="sec4_1_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> 1-((2-Methyl-2-[4-(methyloxy)phenyl]propyl)amino)-3-(phenyloxy)-2-propanol (<b>21</b>)</h4><div class="NLM_p last">The title compound was prepared following the procedure above substituting 2-methyl-2-[4-(methyloxy)phenyl]-1-propanamine for 2-[4-(methyloxy)phenyl]ethanamine. The title compound (50%) was isolated as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 8.43 (br s, 2 H), 7.37 (d, <i>J</i> = 8.84 Hz, 2 H), 7.30 (dd, <i>J</i> = 8.59, 7.33 Hz, 2 H), 6.92 (d, <i>J</i> = 8.59 Hz, 4 H), 6.87−6.98 (m, 1 H), 5.91 (d, <i>J</i> = 4.80 Hz, 1 H), 4.27 (d, <i>J</i> = 3.28 Hz, 1 H), 3.86−3.99 (m, <i>J</i> = 10.11, 8.91, 8.91, 5.18 Hz, 2 H), 3.74 (s, 3 H), 3.25 (br s, 2 H), 3.10 (br s, 1 H), 2.95 (t, <i>J</i> = 10.99 Hz, 1 H), 1.41 (s, 6 H). MS (ESI) 330.2 (M + H)<sup>+</sup>.</div></div><div id="sec4_1_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> 1-((1-Methyl-2-[4-(methyloxy)phenyl]ethyl)amino)-3-(phenyloxy)-2-propanol (<b>22</b>)</h4><div class="NLM_p last">The title compound was prepared following the procedure above substituting 1-[4-(methyloxy)phenyl]-2-propanamine for 2-[4-(methyloxy)phenyl]ethanamine. The title compound (20%) was isolated as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 9.13 (br s, 1 H), 8.76 (br s, 1 H), 7.31 (dd, <i>J</i> = 8.59, 7.33 Hz, 2 H), 7.17 (d, <i>J</i> = 7.58 Hz, 2 H), 6.87−7.00 (m, 6 H), 5.94 (br s, 1 H), 4.27 (d, <i>J</i> = 4.29 Hz, 1 H), 4.00 (d, <i>J</i> = 4.80 Hz, 2 H), 3.94−4.06 (m, 1 H), 3.73 (s, 3 H), 3.41 (d, <i>J</i> = 10.11 Hz, 2 H), 3.37 (br s, 2 H), 3.28 (br s, 1 H), 3.22 (ddd, <i>J</i> = 8.91, 4.11, 3.41 Hz, 2 H), 3.11 (br s, 1 H), 3.08 (d, <i>J</i> = 9.35 Hz, 1 H), 2.61 (dddd, <i>J</i> = 10.52, 5.31, 4.04, 3.63 Hz, 1 H), 1.12 (t, <i>J</i> = 6.69 Hz, 3 H). MS (ESI) 316.2 (M + H)<sup>+</sup>.</div></div><div id="sec4_1_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> 1-((1-Methyl-1-[4-(methyloxy)phenyl]ethyl)amino)-3-(phenyloxy)-2-propanol (<b>23</b>)</h4><div class="NLM_p last">The title compound was prepared following the procedure above substituting 2-[4-(methyloxy)phenyl]-2-propanamine for 2-[4-(methyloxy)phenyl]ethanamine. The title compound (66%) was isolated as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 9.51 (br s, 1 H), 9.10 (br s, 1 H), 7.59 (m, <i>J</i> = 8.84 Hz, 2 H), 7.27 (dd, <i>J</i> = 8.59, 7.33 Hz, 2 H), 6.99 (m, <i>J</i> = 8.84 Hz, 2 H), 6.93 (t, <i>J</i> = 7.33 Hz, 1 H), 6.86 (d, <i>J</i> = 7.83 Hz, 2 H), 5.82 (d, <i>J</i> = 4.80 Hz, 1 H), 4.14 (td, <i>J</i> = 6.63, 3.16 Hz, 1 H), 3.84−3.95 (m, <i>J</i> = 5.34, 5.34, 5.12, 4.67 Hz, 2 H), 3.77 (s, 3 H), 2.77 (t, <i>J</i> = 10.74 Hz, 1 H), 2.51−2.63 (m, 1 H), 1.73 (d, <i>J</i> = 2.02 Hz, 6 H). MS (ESI) 316.2 (M + H)<sup>+</sup>.</div></div><div id="sec4_1_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> 1-((1,1-Dimethyl-3-[4-(methyloxy)phenyl]propyl)amino)-3-(phenyloxy)-2-propanol (<b>24</b>)</h4><div class="NLM_p last">The title compound was prepared following the procedure above substituting 2-methyl-4-[4-(methyloxy)phenyl]-2-butanamine for 2-[4-(methyloxy)phenyl]ethanamine. The title compound (58%) was isolated as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 9.00 (br s, 1 H), 8.57 (br s, 1 H), 7.31 (dd, <i>J</i> = 8.72, 7.20 Hz, 2 H), 7.15 (m, <i>J</i> = 8.59 Hz, 2 H), 6.97 (d, <i>J</i> = 7.07 Hz, 3 H), 6.86 (m, 2 H), 5.90 (d, <i>J</i> = 4.80 Hz, 1 H), 4.16−4.28 (m, 1 H), 4.02 (d, <i>J</i> = 5.56 Hz, 2 H), 3.72 (s, 3 H), 3.11−3.24 (m, 1 H), 2.97 (d, <i>J</i> = 9.60 Hz, 1 H), 2.56 (ddd, <i>J</i> = 7.71, 5.18, 4.29 Hz, 2 H), 1.88 (ddd, <i>J</i> = 7.52, 5.56, 4.36 Hz, 2 H), 1.37 (s, 6 H). MS (ESI) 344.2 (M + H)<sup>+</sup>.</div></div><div id="sec4_1_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> 1-([1,1-Dimethyl-2-(2-naphthalenyl)ethyl]amino)-3-(phenyloxy)-2-propanol (<b>26</b>)</h4><div class="NLM_p last">The title compound was prepared following the procedure above substituting 2-methyl-1-(2-naphthalenyl)-2-propanamine for 2-[4-(methyloxy)phenyl]ethanamine. The title compound (57%) was isolated as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 9.16 (br s, 1 H), 8.73 (br s, 1 H), 7.90 (t, <i>J</i> = 3.92 Hz, 2 H), 7.88 (s, 1 H), 7.78 (s, 1 H), 7.46−7.56 (m, <i>J</i> = 6.38, 4.83, 4.06, 4.06, 3.41, 2.02 Hz, 2 H), 7.40 (dd, <i>J</i> = 8.34, 1.52 Hz, 1 H), 7.24−7.37 (m, 2 H), 6.98 (t, <i>J</i> = 4.17 Hz, 2 H), 6.92−7.03 (m, 1 H), 5.96 (d, <i>J</i> = 4.80 Hz, 1 H), 4.29 (d, <i>J</i> = 3.79 Hz, 1 H), 4.05 (d, <i>J</i> = 5.31 Hz, 2 H), 3.30 (br s, 1 H), 3.21 (d, <i>J</i> = 2.02 Hz, 2 H), 3.12 (d, <i>J</i> = 9.60 Hz, 1 H), 1.30 (s, 6 H). MS (ESI) 350.2 (M + H)<sup>+</sup>.</div></div><div id="sec4_1_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> 1-[(2,3-Dichlorophenyl)oxy]-3-[(1,1-dimethyl-2-[4-(methyloxy)phenyl]ethyl)(methyl)amino]-2-propanol (<b>27</b>)</h4><div class="NLM_p last">Formaldehyde (37% aq, 1.8 mL, 22.2 mmol) and NaCNBH<sub>3</sub> (0.360 g, 5.73 mmol) were added to a solution of 1-[(2,3-dichlorophenyl)oxy]-3-((1,1-dimethyl-2-[4-(methyloxy)phenyl]ethyl)amino)-2-propanol (<b>11</b>, 0.580 g, 1.46 mmol) in CH<sub>3</sub>OH (15 mL) under N<sub>2</sub>. The reaction was stirred at room temperature for 5 days. Dilution with H<sub>2</sub>O was followed by extraction with CH<sub>2</sub>Cl<sub>2</sub> two times. The combined organic layers were washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. Column chromatography (0−10% CH<sub>3</sub>OH:CH<sub>2</sub>Cl<sub>2</sub>) followed by evaporation of solvent in the presence of HCl (1.0 M in Et<sub>2</sub>O) produced 0.592 g (91%) of <b>27</b> as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 9.44 (br s, 1 H), 7.36 (t, <i>J</i> = 8.21 Hz, 1 H), 7.23 (dd, <i>J</i> = 14.27, 8.46 Hz, 2 H), 7.19 (d, <i>J</i> = 8.34 Hz, 2 H), 6.91 (d, <i>J</i> = 8.59 Hz, 2 H), 6.08 (d, <i>J</i> = 3.79 Hz, 1 H), 5.97 (br s, 1 H), 4.38 (q, <i>J</i> = 7.07 Hz, 1 H), 4.23 (s, 1 H), 4.20 (q, <i>J</i> = 5.39 Hz, 2 H), 3.74 (s, 3 H), 3.67 (br s, 1 H), 3.61 (br s, 1 H), 3.02−3.10 (m, 1 H), 2.98 (br s, 1 H), 2.86−2.94 (m, 3 H), 2.34 (s, 1 H), 1.25 (d, <i>J</i> = 12.88 Hz, 6 H). MS (ESI) 412.0/414.0 [(M/M + 2) + H]<sup>+</sup>.</div></div><div id="sec4_1_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> [3-[(2,3-Dichlorophenyl)oxy]-2-(methyloxy)propyl](1,1-dimethyl-2-[4-(methyloxy)phenyl]ethyl)amine (<b>28</b>)</h4><div class="NLM_p last">To a solution of 1-[(2,3-dichlorophenyl)oxy]-3-((1,1-dimethyl-2-[4-(methyloxy)phenyl]ethyl)amino)-2-propanol (<b>11</b>, 0.612 g, 1.54 mmol) in DMF (15 mL) under N<sub>2</sub> were added sodium hydride (95%, 0.048 g, 1.90 mmol) and iodomethane (0.12 mL, 1.92 mmol). The reaction was stirred at room temperature for 5 days. Dilution with ethyl acetate was followed by washes with H<sub>2</sub>O, 0.5 M HCl, and brine. The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. Column chromatography (0−10% CH<sub>3</sub>OH:CH<sub>2</sub>Cl<sub>2</sub>) followed by evaporation of solvent in the presence of HCl (1.0 M in Et<sub>2</sub>O) gave 0.336 g (49%) of <b>28</b> as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 9.26 (br s, 1 H), 8.57 (br s, 1 H), 7.37 (d, <i>J</i> = 8.34 Hz, 1 H), 7.18−7.29 (m, 1 H), 7.24 (td, <i>J</i> = 10.99, 7.58 Hz, 2 H), 7.14 (m, <i>J</i> = 8.59 Hz, 2 H), 6.90 (m, <i>J</i> = 8.59 Hz, 2 H), 4.42 (dd, <i>J</i> = 10.74, 3.66 Hz, 1 H), 4.22 (dd, <i>J</i> = 10.61, 4.55 Hz, 1 H), 4.10 (dd, <i>J</i> = 8.72, 3.66 Hz, 1 H), 3.74 (s, 3 H), 3.51 (s, 3 H), 3.36 (br s, 1 H), 3.18 (d, <i>J</i> = 9.60 Hz, 1 H), 2.95 (s, 2 H), 1.22 (s, 6 H). MS (ESI) 412.0/414.0 [(M/M + 2) + H]<sup>+</sup>.</div></div><div id="sec4_1_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> 3-Bromopropyl 2,3-Dichlorophenyl Ether (<b>30</b>)</h4><div class="NLM_p last">Potassium carbonate (1.76 g, 12.7 mmol) and 1,3-dibromopropane (0.96 mL, 9.40 mmol) were added to a solution of 2,3-dichlorophenol (<b>29</b>, 0.512 g, 3.14 mmol) in CH<sub>3</sub>CN (25 mL). The reaction was stirred at 70 °C for 24 h. Upon cooling, the reaction was filtered, washed with CH<sub>3</sub>CN, and concentrated. Column chromatography (0−15% ethyl acetate:hexane) provided 0.115 g (13%) of <b>30</b> as an oil. <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ ppm 7.15 (q, <i>J</i> = 7.16 Hz, 1 H), 7.09 (ddd, <i>J</i> = 7.89, 3.85, 3.66 Hz, 1 H), 6.90 (dd, <i>J</i> = 8.21, 1.39 Hz, 1 H), 4.30 (t, <i>J</i> = 5.94 Hz, 2 H), 4.20 (t, <i>J</i> = 5.68 Hz, 1 H), 3.69 (t, <i>J</i> = 6.32 Hz, 1 H), 2.31−2.42 (m, <i>J</i> = 5.81, 5.81, 5.68, 5.43 Hz, 2 H).</div></div><div id="sec4_1_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> (3-[(2,3-Dichlorophenyl)oxy]propyl)(1,1-dimethyl-2-[4-(methyloxy)phenyl]ethyl)amine (<b>31</b>)</h4><div class="NLM_p last">To a solution of <b>30</b> (0.115 g, 0.405 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (1.1 mL) was added (1,1-dimethyl-2-[4-(methyloxy)phenyl]ethyl)amine (0.080 g, 0.447 mmol). The reaction mixture was stirred at room temperature for 18 h then at reflux for 4 days. The reaction was cooled and concentrated in vacuo. Column chromatography (0−10% CH<sub>3</sub>OH:CH<sub>2</sub>Cl<sub>2</sub>) followed by evaporation of solvent in the presence of HCl (1.0 M in Et<sub>2</sub>O) afforded 0.047 g (28%) of <b>31</b> as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 8.95 (br s, 2 H), 7.36 (t, <i>J</i> = 8.21 Hz, 1 H), 7.21 (dd, <i>J</i> = 18.44, 4.29 Hz, 1 H), 7.17−7.30 (m, 1 H), 7.16 (d, <i>J</i> = 8.59 Hz, 2 H), 6.89 (d, <i>J</i> = 8.59 Hz, 2 H), 4.39 (q, <i>J</i> = 7.07 Hz, 1 H), 4.25 (t, <i>J</i> = 5.94 Hz, 2 H), 3.74 (s, 3 H), 3.17 (br s, 1 H), 2.92 (s, 1 H), 2.35 (s, 1 H), 2.21 (d, <i>J</i> = 6.82 Hz, 1 H), 1.35 (t, <i>J</i> = 7.07 Hz, 1 H), 1.22 (s, 6 H). MS (ESI) 382.0/384.0 [(M/M + 2) + H]<sup>+</sup>.</div></div><div id="sec4_1_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> (2<i>R</i>)-2-([(2,3-Dichlorophenyl)oxy]methyl)oxirane (<b>34</b>)</h4><div class="NLM_p last">To a solution of 2,3-dichlorophenol (<b>29</b>, 1.03 g, 6.29 mmol) in acetone (20 mL) was added K<sub>2</sub>CO<sub>3</sub> (2.61 g, 18.9 mmol) and the reaction mixture was heated at reflux for 30 min. The reaction was cooled, (<i>R</i>)-nosyl epoxide (1.63 g, 6.31 mmol) was added, and reaction heated at reflux for 3 days. The reaction was cooled, filtered, rinsed with acetone, and concentrated in vacuo. Column chromatography (0−30% ethyl acetate:hexane) afforded 1.27 g (92%) of <b>34</b> as a clear oil. <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ ppm 7.15 (dq, <i>J</i> = 7.33, 7.16 Hz, 1 H), 7.11 (s, 1 H), 6.89 (dd, <i>J</i> = 7.83, 1.77 Hz, 1 H), 4.34 (dd, <i>J</i> = 11.24, 2.91 Hz, 1 H), 4.07 (dd, <i>J</i> = 11.12, 5.31 Hz, 1 H), 3.42 (dddd, <i>J</i> = 5.56, 3.79, 3.41, 2.40 Hz, 1 H), 2.95 (d, <i>J</i> = 4.04 Hz, 1 H), 2.86 (dd, <i>J</i> = 4.93, 2.65 Hz, 1 H).</div></div><div id="sec4_1_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> (2<i>S</i>)-2-([(2,3-Dichlorophenyl)oxy]methyl)oxirane (<b>35</b>)</h4><div class="NLM_p last">The title compound was prepared following the procedure above substituting (<i>S</i>)-nosyl epoxide for (<i>R</i>)-nosyl epoxide. The title compound (96%) was isolated as a clear oil. <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ ppm 7.15 (dt, <i>J</i> = 14.21, 7.17 Hz, 1 H), 7.11 (s, 1 H), 6.89 (dd, <i>J</i> = 7.83, 1.77 Hz, 1 H), 4.34 (dd, <i>J</i> = 11.24, 2.91 Hz, 1 H), 4.07 (dd, <i>J</i> = 11.12, 5.31 Hz, 1 H), 3.42 (dddd, <i>J</i> = 6.44, 3.03, 2.78, 2.65 Hz, 1 H), 2.95 (d, <i>J</i> = 4.29 Hz, 1 H), 2.86 (dd, <i>J</i> = 5.05, 2.53 Hz, 1 H).</div></div><div id="sec4_1_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> (2<i>R</i>)-1-[(2,3-Dichlorophenyl)oxy]-3-((1,1-dimethyl-2-[4-(methyloxy)phenyl]ethyl)amino)-2-propanol (<b>32</b>)</h4><div class="NLM_p last">(2<i>R</i>)-2-([(2,3-Dichlorophenyl)oxy]methyl)oxirane (<b>34</b>, 0.44 g, 2.03 mmol) was added to a solution of (1,1-dimethyl-2-[4-(methyloxy)phenyl]ethyl)amine (<b>4</b>, 0.359 g, 2.00 mmol) in ethanol (4.2 mL) and heated at reflux for 2 days. The reaction was cooled and concentrated in vacuo. Column chromatography (0−10% CH<sub>3</sub>OH:CH<sub>2</sub>Cl<sub>2</sub>) followed by evaporation of solvent in the presence of HCl (1.0 M in Et<sub>2</sub>O) provided 0.593 g (67%) of <b>32</b> as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 8.93 (br s, 1 H), 8.65 (br s, 1 H), 7.36 (t, <i>J</i> = 8.21 Hz, 1 H), 7.24 (ddd, <i>J</i> = 12.95, 8.40, 4.17 Hz, 2 H), 7.15 (m, <i>J</i> = 8.59 Hz, 2 H), 6.90 (m, <i>J</i> = 8.59 Hz, 2 H), 5.98 (d, <i>J</i> = 4.80 Hz, 1 H), 4.29 (t, <i>J</i> = 6.19 Hz, 1 H), 4.12−4.25 (m, <i>J</i> = 11.24, 11.24, 10.11, 5.05 Hz, 2 H), 3.74 (s, 3 H), 3.32 (d, <i>J</i> = 1.77 Hz, 1 H), 3.11 (d, <i>J</i> = 9.85 Hz, 1 H), 2.94 (s, 2 H), 1.22 (s, 6 H). MS (ESI) 398.0/400.0 [(M/M + 2) + H]<sup>+</sup>.</div></div><div id="sec4_1_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> (2<i>S</i>)-1-[(2,3-Dichlorophenyl)oxy]-3-((1,1-dimethyl-2-[4-(methyloxy)phenyl]ethyl)amino)-2-propanol (<b>33</b>)</h4><div class="NLM_p last">The title compound was prepared following the procedure above substituting (2<i>S</i>)-2-([(2,3-dichlorophenyl)oxy]methyl)oxirane (<b>35</b>). The title compound (60%) was isolated as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 8.98 (br s, 1 H), 8.68 (br s, 1 H), 7.35 (d, <i>J</i> = 8.08 Hz, 1 H), 7.24 (ddd, <i>J</i> = 12.19, 8.15, 4.17 Hz, 2 H), 7.15 (m, <i>J</i> = 8.59 Hz, 2 H), 6.90 (m, <i>J</i> = 8.59 Hz, 2 H), 5.99 (d, <i>J</i> = 4.80 Hz, 1 H), 4.30 (t, <i>J</i> = 6.19 Hz, 1 H), 4.12−4.24 (m, <i>J</i> = 10.96, 10.96, 10.17, 5.05 Hz, 2 H), 3.74 (s, 3 H), 3.30 (d, <i>J</i> = 12.63 Hz, 2 H), 3.15 (br s, 1 H), 3.11 (d, <i>J</i> = 9.60 Hz, 1 H), 2.94 (s, 2 H), 1.22 (s, 6 H). MS (ESI) 398.0/400.0 [(M/M + 2) + H]<sup>+</sup>.</div></div><div id="sec4_1_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> 2-Chloro-6-([(2<i>R</i>)-2-oxiranylmethyl]oxy)benzonitrile (<b>37</b>)</h4><div class="NLM_p">A mixture of 2-chloro-6-fluorobenzonitrile (40.17 g, 258 mmol), 18-crown-6 (22.7 g, 86 mmol), and potassium <i>tert</i>-butoxide (38 g, 387 mmol) in acetonitrile (350 mL) was heated at reflux under argon overnight, whereupon 100 mL of 5 N NaOH was added and the mixture was allowed to stir for 1 h. The acetonitrile was removed under vacuum, and the resulting alkaline solution was extracted twice with Et<sub>2</sub>O. The aqueous phase was then adjusted to pH = 4 and extracted twice with Et<sub>2</sub>O. The organic extract from the acidified aqueous phase was dried over MgSO<sub>4</sub>, filtered, and concentrated to yield 23.8 g (60%) of 2-chloro-6-hydroxybenzonitrile as a solid. <sup>1</sup>H NMR (400 MHz, CCDl<sub>3</sub>-<i>d</i>) δ ppm 7.38 (t, <i>J</i> = 8.21 Hz, 1 H), 7.04 (d, <i>J</i> = 7.58 Hz, 1 H), 6.96 (d, <i>J</i> = 8.59 Hz, 1 H), 3.65 (br s, 1 H).</div><div class="NLM_p last">To a solution of 2-chloro-6-hydroxybenzonitrile (0.45 g, 2.93 mmol) in acetone (30 mL, 0.1 M) was added potassium carbonate (1.21 g, 8.79 mmol). The resulting mixture stirred at reflux for 30 min. After cooling to room temperature, (2<i>R</i>)-2-oxiranylmethyl 3-nitrobenzenesulfonate (0.76 g, 2.93 mmol) was added. The reaction mixture was then heated to reflux and stirred overnight at that temperature. After cooling to room temperature, the reaction mixture was filtered, and the filtrate was concentrated for FCC purification (10−50% EtOAc/Hex). 2-Chloro-6-([(2<i>R</i>)-2-oxiranylmethyl]oxy)benzonitrile was obtained as a white solid (0.48 g, 79% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>-<i>d</i>) δ ppm 7.45 (t, <i>J</i> = 8.34 Hz, 1 H), 7.11 (d, <i>J</i> = 8.08 Hz, 1 H), 6.95 (d, <i>J</i> = 8.34 Hz, 1 H), 4.41 (dd, <i>J</i> = 11.49, 2.91 Hz, 1 H), 4.13 (dd, <i>J</i> = 11.37, 5.31 Hz, 1 H), 3.41 (dt, <i>J</i> = 4.11, 2.62 Hz, 1 H), 2.95 (t, <i>J</i> = 4.42 Hz, 1 H), 2.86 (dd, <i>J</i> = 4.80, 2.53 Hz, 1 H). LCMS <i>m</i>/<i>z</i> = 232 (M + Na<sup>+</sup>).</div></div><div id="sec4_1_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> 2-Chloro-6-[((2<i>R</i>)-3-([1,1-dimethyl-2-(2-naphthalenyl)ethyl]amino)-2-hydroxypropyl)oxy]benzonitrile hydrochloride (<b>38</b>)</h4><div class="NLM_p last">A solution of 2-chloro-6-([(2<i>R</i>)-2-oxiranylmethyl]oxy)benzonitrile (<b>37</b>, 0.30 g, 1.43 mmol) and [1,1-dimethyl-2-(2-naphthalenyl)ethyl]amine (0.28 g, 1.43 mmol) in anhydrous ethanol (7.2 mL, 0.2 M) was heated to reflux overnight. After cooling to room temperature, the reaction mixture was concentrated and purified by column chromatography (1% CH<sub>3</sub>OH/CH<sub>2</sub>Cl<sub>2</sub>) to give pure product. The resulting amine was treated with HCl in Et<sub>2</sub>O and subsequently dried under vacuum to generate the title compound as a white solid in the form of an HCl salt (0.54 g, 85%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>-<i>d</i>) δ ppm 7.75−7.88 (m, 3H), 7.65 (s, 1H), 7.45 (t, <i>J</i> = 4.17 Hz, 2H), 7.40−7.52 (m, 1H), 7.35 (dd, <i>J</i> = 8.46, 1.64 Hz, 1H), 7.09 (d, <i>J</i> = 8.08 Hz, 1H), 6.91 (d, <i>J</i> = 8.59 Hz, 1H), 4.15 (dd, <i>J</i> = 4.80, 2.78 Hz, 2H), 4.05 (dd, <i>J</i> = 6.44, 4.67 Hz, 1H), 3.09 (dd, <i>J</i> = 12.00, 4.42 Hz, 1H), 2.96 (d, <i>J</i> = 6.82 Hz, 1H), 2.93 (d, <i>J</i> = 2.27 Hz, 2H), 2.44 (br s, 2H), 1.19 (s, 3H), 1.18 (s, 3H). LCMS <i>m</i>/<i>z</i> = 409 (M + H<sup>+</sup>). Elemental anal. calcd: 64.72% C, 5.88% H, 6.29% N; found: 64.52% C, 5.70% H, 6.28% N.</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="si1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i56"><a href="/doi/suppl/10.1021/jm900364m">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_24261" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_24261" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">X-ray crystallographic data for antagonist <b>38</b> as well as HPLC purities with two separate conditions for antagonists <b>7</b>−<b>11</b>, <b>13</b>−<b>17</b>, <b>21</b>−<b>24</b>, <b>26</b>−<b>28</b>, and <b>31</b>−<b>33</b>. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm900364m/suppl_file/jm900364m_si_001.pdf">jm900364m_si_001.pdf (473.98 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm900364m" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_62634" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_62634" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Robert W. Marquis</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, Bone and Cartilage Biology, Drug Metabolism and Pharmacokinetics, Computational and Structural Chemistry, and Cellular Biochemistry, GlaxoSmithKline, 1250 South Collegeville Road, Collegeville, Pennsylvania 19426, NPS Pharmaceuticals, 550 Hills Drive, Bedminster, New Jersey 07921</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#570538353225237900791a362526223e241730243c7934383a"><span class="__cf_email__" data-cfemail="86d4e9e4e3f4f2a8d1a8cbe7f4f7f3eff5c6e1f5eda8e5e9eb">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Amparo M. Lago</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, Bone and Cartilage Biology, Drug Metabolism and Pharmacokinetics, Computational and Structural Chemistry, and Cellular Biochemistry, GlaxoSmithKline, 1250 South Collegeville Road, Collegeville, Pennsylvania 19426, NPS Pharmaceuticals, 550 Hills Drive, Bedminster, New Jersey 07921</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">James F. Callahan</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, Bone and Cartilage Biology, Drug Metabolism and Pharmacokinetics, Computational and Structural Chemistry, and Cellular Biochemistry, GlaxoSmithKline, 1250 South Collegeville Road, Collegeville, Pennsylvania 19426, NPS Pharmaceuticals, 550 Hills Drive, Bedminster, New Jersey 07921</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Robert E. Lee Trout</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, Bone and Cartilage Biology, Drug Metabolism and Pharmacokinetics, Computational and Structural Chemistry, and Cellular Biochemistry, GlaxoSmithKline, 1250 South Collegeville Road, Collegeville, Pennsylvania 19426, NPS Pharmaceuticals, 550 Hills Drive, Bedminster, New Jersey 07921</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Maxine Gowen</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, Bone and Cartilage Biology, Drug Metabolism and Pharmacokinetics, Computational and Structural Chemistry, and Cellular Biochemistry, GlaxoSmithKline, 1250 South Collegeville Road, Collegeville, Pennsylvania 19426, NPS Pharmaceuticals, 550 Hills Drive, Bedminster, New Jersey 07921</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Eric G. DelMar</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, Bone and Cartilage Biology, Drug Metabolism and Pharmacokinetics, Computational and Structural Chemistry, and Cellular Biochemistry, GlaxoSmithKline, 1250 South Collegeville Road, Collegeville, Pennsylvania 19426, NPS Pharmaceuticals, 550 Hills Drive, Bedminster, New Jersey 07921</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bradford C. Van Wagenen</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, Bone and Cartilage Biology, Drug Metabolism and Pharmacokinetics, Computational and Structural Chemistry, and Cellular Biochemistry, GlaxoSmithKline, 1250 South Collegeville Road, Collegeville, Pennsylvania 19426, NPS Pharmaceuticals, 550 Hills Drive, Bedminster, New Jersey 07921</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sarah Logan</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, Bone and Cartilage Biology, Drug Metabolism and Pharmacokinetics, Computational and Structural Chemistry, and Cellular Biochemistry, GlaxoSmithKline, 1250 South Collegeville Road, Collegeville, Pennsylvania 19426, NPS Pharmaceuticals, 550 Hills Drive, Bedminster, New Jersey 07921</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Scott Shimizu</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, Bone and Cartilage Biology, Drug Metabolism and Pharmacokinetics, Computational and Structural Chemistry, and Cellular Biochemistry, GlaxoSmithKline, 1250 South Collegeville Road, Collegeville, Pennsylvania 19426, NPS Pharmaceuticals, 550 Hills Drive, Bedminster, New Jersey 07921</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John Fox</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, Bone and Cartilage Biology, Drug Metabolism and Pharmacokinetics, Computational and Structural Chemistry, and Cellular Biochemistry, GlaxoSmithKline, 1250 South Collegeville Road, Collegeville, Pennsylvania 19426, NPS Pharmaceuticals, 550 Hills Drive, Bedminster, New Jersey 07921</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Edward F. Nemeth</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, Bone and Cartilage Biology, Drug Metabolism and Pharmacokinetics, Computational and Structural Chemistry, and Cellular Biochemistry, GlaxoSmithKline, 1250 South Collegeville Road, Collegeville, Pennsylvania 19426, NPS Pharmaceuticals, 550 Hills Drive, Bedminster, New Jersey 07921</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zheng Yang</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, Bone and Cartilage Biology, Drug Metabolism and Pharmacokinetics, Computational and Structural Chemistry, and Cellular Biochemistry, GlaxoSmithKline, 1250 South Collegeville Road, Collegeville, Pennsylvania 19426, NPS Pharmaceuticals, 550 Hills Drive, Bedminster, New Jersey 07921</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Theresa Roethke</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, Bone and Cartilage Biology, Drug Metabolism and Pharmacokinetics, Computational and Structural Chemistry, and Cellular Biochemistry, GlaxoSmithKline, 1250 South Collegeville Road, Collegeville, Pennsylvania 19426, NPS Pharmaceuticals, 550 Hills Drive, Bedminster, New Jersey 07921</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Brian R. Smith</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, Bone and Cartilage Biology, Drug Metabolism and Pharmacokinetics, Computational and Structural Chemistry, and Cellular Biochemistry, GlaxoSmithKline, 1250 South Collegeville Road, Collegeville, Pennsylvania 19426, NPS Pharmaceuticals, 550 Hills Drive, Bedminster, New Jersey 07921</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Keith W. Ward</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, Bone and Cartilage Biology, Drug Metabolism and Pharmacokinetics, Computational and Structural Chemistry, and Cellular Biochemistry, GlaxoSmithKline, 1250 South Collegeville Road, Collegeville, Pennsylvania 19426, NPS Pharmaceuticals, 550 Hills Drive, Bedminster, New Jersey 07921</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John Lee</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, Bone and Cartilage Biology, Drug Metabolism and Pharmacokinetics, Computational and Structural Chemistry, and Cellular Biochemistry, GlaxoSmithKline, 1250 South Collegeville Road, Collegeville, Pennsylvania 19426, NPS Pharmaceuticals, 550 Hills Drive, Bedminster, New Jersey 07921</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Richard M. Keenan</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, Bone and Cartilage Biology, Drug Metabolism and Pharmacokinetics, Computational and Structural Chemistry, and Cellular Biochemistry, GlaxoSmithKline, 1250 South Collegeville Road, Collegeville, Pennsylvania 19426, NPS Pharmaceuticals, 550 Hills Drive, Bedminster, New Jersey 07921</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Pradip Bhatnagar</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, Bone and Cartilage Biology, Drug Metabolism and Pharmacokinetics, Computational and Structural Chemistry, and Cellular Biochemistry, GlaxoSmithKline, 1250 South Collegeville Road, Collegeville, Pennsylvania 19426, NPS Pharmaceuticals, 550 Hills Drive, Bedminster, New Jersey 07921</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="ack"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i55">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_75047" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_75047" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Drs. John Gleason and Brian Metcalf for their support of this work.</p></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i57">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_47583" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_47583" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 27 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Iqbal, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inzerillo, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moonga, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baljit, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaidi, M.</span><span> </span><span class="NLM_article-title">The molecular pharmacology of osteoporosis</span> <span class="citation_source-journal">Osteoporosis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume"></span> <span class="NLM_fpage">569</span><span class="NLM_x">–</span> <span class="NLM_lpage">594</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm900364m&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjs1ehurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2003&pages=569-594&author=J.+Iqbalauthor=A.+M.+Inzerilloauthor=B.+S.+Moongaauthor=S.+Baljitauthor=M.+Zaidi&title=The+molecular+pharmacology+of+osteoporosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The molecular pharmacology of osteoporosis</span></div><div class="casAuthors">Iqbal, Jameel; Inzerillo, Angela M.; Moonga, Baljit S.; Zaidi, Mone</div><div class="citationInfo"><span class="NLM_cas:title">Osteoporosis</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">569-594</span>CODEN:
                <span class="NLM_cas:coden">69DAZ9</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Humana Press Inc.</span>)
        </div><div class="casAbstract">A review.  Skeletal remodeling requires a balance between the resorption and formation of bone.  Osteoclasts resorb bone, while osteoblasts are bone forming.  These two processes are closely coupled but independently regulated by various hormones and cytokines.  Future targets for therapeutic action in osteoporosis includes mechanisms that alter internal or external cell signaling or that directly introduce regulators of osteoclast and osteoblast function into bone.  Cellular signaling targets will likely focus on the induction of osteoclast detachment and apoptosis, while those targeting osteoblasts and undifferentiated progenitor cells will likely focus on inducing proliferation and differentiation.  Several interesting therapies are being explored for targeting proteins and drugs modulating osteoclast function to bone.  Among the topics discussed in this review are: established osteoporosis therapies, potential targets for inhibition of bone resorption; and new strategies for stimulating bone formation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqy-9NcTYEpcrVg90H21EOLACvtfcHk0lgrV5uk0puuWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjs1ehurg%253D&md5=ada1c37d524d87d1a313a4b3c859d74e</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DIqbal%26aufirst%3DJ.%26aulast%3DInzerillo%26aufirst%3DA.%2BM.%26aulast%3DMoonga%26aufirst%3DB.%2BS.%26aulast%3DBaljit%26aufirst%3DS.%26aulast%3DZaidi%26aufirst%3DM.%26atitle%3DThe%2520molecular%2520pharmacology%2520of%2520osteoporosis%26jtitle%3DOsteoporosis%26date%3D2003%26spage%3D569%26epage%3D594" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Deal, C.</span><span> </span><span class="NLM_article-title">Osteoporosis therapies: bisphosphonates, SERMS, PTH and new therapies</span> <span class="citation_source-journal">Clin. Rev. Bone Miner. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">125</span><span class="NLM_x">–</span> <span class="NLM_lpage">141</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm900364m&amp;key=10.1385%2FBMM%3A3%3A2%3A125" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm900364m&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVensbrI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2005&pages=125-141&author=C.+Deal&title=Osteoporosis+therapies%3A+bisphosphonates%2C+SERMS%2C+PTH+and+new+therapies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Osteoporosis therapies: bisphosphonates, SERMs, PTH, and new therapies</span></div><div class="casAuthors">Deal, Chad</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Reviews in Bone and Mineral Metabolism</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">125-141</span>CODEN:
                <span class="NLM_cas:coden">CRBMBF</span>;
        ISSN:<span class="NLM_cas:issn">1534-8644</span>.
    
            (<span class="NLM_cas:orgname">Humana Press Inc.</span>)
        </div><div class="casAbstract">A review.  Osteoporosis therapies include antiresorptive and anabolic agents.  Antiresorptive agents include the bisphosphonates (etidronate, alendronate, risedronate, ibandronate, and off-label use of the i.v. drugs pamidronate and zolendronate), selective estrogen receptor modulators (SERMs) (raloxifene), calcitonin, and estrogens.  An anabolic agent, teriparatide (rhPTH 1-34) was released in 2002.  New therapies may be available in the coming years, including new SERMs, strontium ranelate, and an antibody to RANK ligand.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJwzAlpmizkLVg90H21EOLACvtfcHk0lieAyFVkJiPLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVensbrI&md5=25824a38449a391c25afb09b0e6470b3</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1385%2FBMM%3A3%3A2%3A125&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1385%252FBMM%253A3%253A2%253A125%26sid%3Dliteratum%253Aachs%26aulast%3DDeal%26aufirst%3DC.%26atitle%3DOsteoporosis%2520therapies%253A%2520bisphosphonates%252C%2520SERMS%252C%2520PTH%2520and%2520new%2520therapies%26jtitle%3DClin.%2520Rev.%2520Bone%2520Miner.%2520Metab.%26date%3D2005%26volume%3D3%26spage%3D125%26epage%3D141" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2a"><span><span class="NLM_contrib-group">Rodan, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, T. J.</span><span> </span><span class="NLM_article-title">Therapeutic approaches to bone diseases</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">289</span><span class="NLM_x">, </span> <span class="NLM_fpage">1508</span><span class="NLM_x">–</span> <span class="NLM_lpage">1514</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=16&amp;doi=10.1021%2Fjm900364m&amp;key=10.1126%2Fscience.289.5484.1508" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=8&amp;doi=10.1021%2Fjm900364m&amp;key=10968781" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=32&amp;doi=10.1021%2Fjm900364m&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmt1Kgsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=2000&pages=1508-1514&author=G.+A.+Rodanauthor=T.+J.+Martin&title=Therapeutic+approaches+to+bone+diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2aR"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic approaches to bone diseases</span></div><div class="casAuthors">Rodan, Gideon A.; Martin, T. John</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">289</span>
        (<span class="NLM_cas:issue">5484</span>),
    <span class="NLM_cas:pages">1508-1514</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A review with 66 refs.  The strength and integrity of our bones depends on maintaining a delicate balance between bone resorption by osteoclasts and bone formation by osteoblasts.  As we age or as a result of disease, this delicate balancing act becomes tipped in favor of osteoclasts so that bone resorption exceeds bone formation, rendering bones brittle and prone to fracture.  A better understanding of the biol. of osteoclasts and osteoblasts is providing opportunities for developing therapeutics to treat diseases of bone.  Drugs that inhibit the formation or activity of osteoclasts are valuable for treating osteoporosis, Paget's disease, and inflammation of bone assocd. with rheumatoid arthritis or periodontal disease.  Far less attention has been paid to, promoting bone formation with, for example, growth factors or hormones, an approach that would be a valuable adjunct therapy for patients receiving inhibitors of bone resorption.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIUsDfs0wHVrVg90H21EOLACvtfcHk0lieAyFVkJiPLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmt1Kgsb4%253D&md5=3178a7237d0acb9918a7d76c760d533f</span></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=10.1126%2Fscience.289.5484.1508&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.289.5484.1508%26sid%3Dliteratum%253Aachs%26aulast%3DRodan%26aufirst%3DG.%2BA.%26aulast%3DMartin%26aufirst%3DT.%2BJ.%26atitle%3DTherapeutic%2520approaches%2520to%2520bone%2520diseases%26jtitle%3DScience%26date%3D2000%26volume%3D289%26spage%3D1508%26epage%3D1514" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Bodenner, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Redman, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riggs, A.</span><span> </span><span class="NLM_article-title">Teriparatide in the management of osteoporosis</span> <span class="citation_source-journal">Clin. Interventions Aging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">499</span><span class="NLM_x">–</span> <span class="NLM_lpage">507</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm900364m&amp;key=18225450" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm900364m&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhs1ejsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2007&pages=499-507&author=D.+Bodennerauthor=C.+Redmanauthor=A.+Riggs&title=Teriparatide+in+the+management+of+osteoporosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Teriparatide in the management of osteoporosis</span></div><div class="casAuthors">Bodenner, Donald; Redman, Carolyn; Riggs, Ann</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Interventions in Aging</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">499-507</span>CODEN:
                <span class="NLM_cas:coden">CIALBC</span>;
        ISSN:<span class="NLM_cas:issn">1176-9092</span>.
    
            (<span class="NLM_cas:orgname">Dove Medical Press (NZ) Ltd.</span>)
        </div><div class="casAbstract">A review.  Fracture of the hip is frequently a catastrophic event in the elderly, often resulting in death within a year and of the survivors, few regain pre-fracture quality of life.  Although less appreciated, fractures of the spine result in significant morbidity and are also assocd. with increased mortality compared with individuals without a fracture.  In recent years there has been an explosion in the development of new drugs for the treatment of osteoporosis.  Recombinant human parathyroid hormone (1-34) (20 μg/day) is a recent addn. to this armamentarium with a novel mechanism of action, which was approved by the US FDA for the treatment of postmenopausal osteoporosis and male osteoporosis secondary to hypogonadism in Nov. 2002.  It is the first osteoporosis treatment that leads to the formation of new bone with architecture similar to normal bone.  Intense efforts have been made to understand the effect of teriparatide on antiresorptive therapy and vice versa.  Although these relationships are not completely understood, the results of recent studies allow clinicians to begin to optimize therapeutic gains in bone mineral d. and improve anti-fracture efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoah_3atunqZbVg90H21EOLACvtfcHk0lieAyFVkJiPLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhs1ejsb4%253D&md5=ce7b8894f61d7d67e2e83b9fd03c0520</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBodenner%26aufirst%3DD.%26aulast%3DRedman%26aufirst%3DC.%26aulast%3DRiggs%26aufirst%3DA.%26atitle%3DTeriparatide%2520in%2520the%2520management%2520of%2520osteoporosis%26jtitle%3DClin.%2520Interventions%2520Aging%26date%3D2007%26volume%3D2%26spage%3D499%26epage%3D507" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit3a"><span><span class="NLM_contrib-group">Bilezikian, J. P.</span><span> </span><span class="NLM_article-title">Anabolic therepy for osteoporosis</span> <span class="citation_source-journal">Women’s Health</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">243</span><span class="NLM_x">–</span> <span class="NLM_lpage">253</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=16&amp;doi=10.1021%2Fjm900364m&amp;key=10.2217%2F17455057.3.2.243" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=32&amp;doi=10.1021%2Fjm900364m&amp;key=1%3ACAS%3A528%3ADC%252BD2sXit12qtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2007&pages=243-253&author=J.+P.+Bilezikian&title=Anabolic+therepy+for+osteoporosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3aR"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Anabolic therapy for osteoporosis</span></div><div class="casAuthors">Bilezikian, John P.</div><div class="citationInfo"><span class="NLM_cas:title">Women's Health</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">243-253</span>CODEN:
                <span class="NLM_cas:coden">WHOEAZ</span>;
        ISSN:<span class="NLM_cas:issn">1745-5057</span>.
    
            (<span class="NLM_cas:orgname">Future Medicine Ltd.</span>)
        </div><div class="casAbstract">A review.  Antiresorptive agents for osteoporosis are a cornerstone of therapy, but anabolic drugs have recently increased our options.  By directly stimulating bone formation, anabolic agents reduce fracture incidence by improving bone qualities as well as increasing bone mass.  The anabolic agent currently approved for osteoporosis, teriparatide (recombinant human parathyroid hormone[1-34]), has emerged as a major approach for selected patients with osteoporosis.  Parathyroid hormone(1-84) is also available in Europe.  Teriparatide increases bone d. and bone turnover, improves microarchitecture and changes bone size.  The incidence of vertebral and nonvertebral fractures is reduced.  A current concept in the mechanism of teriparatide action is related to its effect of stimulating processes assocd. with bone formation before processes assocd. with bone resorption.  This sequence of events has led to the concept of the anabolic window, the period of time when teriparatide is maximally anabolic.  Newer approaches to the use of teriparatide alone and in combination with antiresorptive agents has led to ways in which the anabolic window can be expanded.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKC2jWx9LbarVg90H21EOLACvtfcHk0lhkiaLx_KzR_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXit12qtL0%253D&md5=2e26b6931f831f63477e2f9a8d5f2042</span></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=10.2217%2F17455057.3.2.243&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2217%252F17455057.3.2.243%26sid%3Dliteratum%253Aachs%26aulast%3DBilezikian%26aufirst%3DJ.%2BP.%26atitle%3DAnabolic%2520therepy%2520for%2520osteoporosis%26jtitle%3DWomen%25E2%2580%2599s%2520Health%26date%3D2007%26volume%3D3%26spage%3D243%26epage%3D253" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit3b"><span><span class="NLM_contrib-group">Girotra, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rubin, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bilezikian, J. P.</span><span> </span><span class="NLM_article-title">The use of parathyroid hormone in the treatment of osteoporosis</span> <span class="citation_source-journal">Rev. Endocrinol. Metab. Disorders</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">113</span><span class="NLM_x">–</span> <span class="NLM_lpage">121</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=16&amp;doi=10.1021%2Fjm900364m&amp;key=10.1007%2Fs11154-006-9007-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=8&amp;doi=10.1021%2Fjm900364m&amp;key=17043762" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=32&amp;doi=10.1021%2Fjm900364m&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht12lsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2006&pages=113-121&author=M.+Girotraauthor=M.+R.+Rubinauthor=J.+P.+Bilezikian&title=The+use+of+parathyroid+hormone+in+the+treatment+of+osteoporosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3bR"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The use of parathyroid hormone in the treatment of osteoporosis</span></div><div class="casAuthors">Girotra, Monica; Rubin, Mishaela R.; Bilezikian, John P.</div><div class="citationInfo"><span class="NLM_cas:title">Reviews in Endocrine & Metabolic Disorders</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">113-121</span>CODEN:
                <span class="NLM_cas:coden">REMDCG</span>;
        ISSN:<span class="NLM_cas:issn">1389-9155</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Anabolic skeletal agents have recently broadened our therapeutic options for osteoporosis.  By directly stimulating bone formation, they reduce fracture incidence by improving bone qualities in addn. to increasing bone mass.  Teriparatide [recombinant human parathyroid hormone(1-34)], the only anabolic agent currently approved in the United States for osteoporosis, has emerged as a major therapeutic approach to selected patients with osteoporosis.  Teriparatide is approved for both postmenopausal women and men with osteoporosis who are at high risk for fracture.  With the use of this anabolic agent, bone d. and bone turnover increase, microarchitecture improves, and bone size is beneficially altered.  The incidence of vertebral and nonvertebral fractures is reduced with teriparatide use.  Combination therapy with parathyroid hormone and an antiresorptive does not appear to offer definitive advantages over the use of PTH or an antiresorptive alone, although recent ideas about combining these agents may offer new insights.  In order to maintain increases in bone d. acquired during PTH therapy, it is important to follow its use with an antiresorptive agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgHX2PVm7hELVg90H21EOLACvtfcHk0lhkiaLx_KzR_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht12lsg%253D%253D&md5=2c3c9d800f166a7236c3314a6730ad79</span></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=10.1007%2Fs11154-006-9007-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11154-006-9007-z%26sid%3Dliteratum%253Aachs%26aulast%3DGirotra%26aufirst%3DM.%26aulast%3DRubin%26aufirst%3DM.%2BR.%26aulast%3DBilezikian%26aufirst%3DJ.%2BP.%26atitle%3DThe%2520use%2520of%2520parathyroid%2520hormone%2520in%2520the%2520treatment%2520of%2520osteoporosis%26jtitle%3DRev.%2520Endocrinol.%2520Metab.%2520Disorders%26date%3D2006%26volume%3D7%26spage%3D113%26epage%3D121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit3c"><span><span class="NLM_contrib-group">Eriksen, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robins, D. A.</span><span> </span><span class="NLM_article-title">Teriparatide: a bone formation treatment for osteoporosis</span> <span class="citation_source-journal">Drugs Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">935</span><span class="NLM_x">–</span> <span class="NLM_lpage">948</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3c&amp;dbid=16&amp;doi=10.1021%2Fjm900364m&amp;key=10.1358%2Fdot.2004.40.11.872582" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3c&amp;dbid=32&amp;doi=10.1021%2Fjm900364m&amp;key=1%3ACAS%3A528%3ADC%252BD2MXisVSksbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2004&pages=935-948&author=E.+F.+Eriksenauthor=D.+A.+Robins&title=Teriparatide%3A+a+bone+formation+treatment+for+osteoporosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3cR"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">TERIPARATIDE: A bone formation treatment for osteoporosis</span></div><div class="casAuthors">Eriksen, Erik F.; Robins, Deborah A.</div><div class="citationInfo"><span class="NLM_cas:title">Drugs of Today</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">935-948</span>CODEN:
                <span class="NLM_cas:coden">MDACAP</span>;
        ISSN:<span class="NLM_cas:issn">0025-7656</span>.
    
            (<span class="NLM_cas:orgname">Prous Science</span>)
        </div><div class="casAbstract">A review.  Teriparatide is the recombinant human N-terminal fragment (1-34) of endogenous human parathyroid hormone, and it is the first bone anabolic agent for the treatment of osteoporosis.  When given as once-daily s.c. injections, teriparatide can reverse the course of osteoporosis by stimulating formation of new bone and restoring lost architecture.  Teriparatide (20 μg) treatment of osteoporosis in postmenopausal women rapidly increased markers of bone formation and reduced the incidence of vertebral fractures by 65% and of nonvertebral fragility fractures by 53%.  In addn., treatment with this compd. increased spine bone mineral d. by 10% and hip bone mineral d. by 3% at study endpoint.  Teriparatide is well tolerated and is not assocd. with any serious side effects.  The compd. has been approved in Europe and in the US for the treatment of osteoporosis.  Duration of treatment is 18-24 mo and the dose does not need to be adjusted for age or gender.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1JIdWJtTLw7Vg90H21EOLACvtfcHk0lhkiaLx_KzR_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXisVSksbs%253D&md5=636570477d27ee584bc02ce954ecee68</span></div><a href="/servlet/linkout?suffix=cit3c&amp;dbid=16384&amp;doi=10.1358%2Fdot.2004.40.11.872582&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1358%252Fdot.2004.40.11.872582%26sid%3Dliteratum%253Aachs%26aulast%3DEriksen%26aufirst%3DE.%2BF.%26aulast%3DRobins%26aufirst%3DD.%2BA.%26atitle%3DTeriparatide%253A%2520a%2520bone%2520formation%2520treatment%2520for%2520osteoporosis%26jtitle%3DDrugs%2520Today%26date%3D2004%26volume%3D40%26spage%3D935%26epage%3D948" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit3d"><span><span class="NLM_contrib-group">Quattrocchi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kourlas, H.</span><span> </span><span class="NLM_article-title">Teriparaitide: a review</span> <span class="citation_source-journal">Clin. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">841</span><span class="NLM_x">–</span> <span class="NLM_lpage">854</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3d&amp;dbid=16&amp;doi=10.1021%2Fjm900364m&amp;key=10.1016%2FS0149-2918%2804%2990128-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3d&amp;dbid=8&amp;doi=10.1021%2Fjm900364m&amp;key=15262455" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3d&amp;dbid=32&amp;doi=10.1021%2Fjm900364m&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmsVSisrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2004&pages=841-854&author=E.+Quattrocchiauthor=H.+Kourlas&title=Teriparaitide%3A+a+review"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3dR"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Teriparatide: a review</span></div><div class="casAuthors">Quattrocchi, Elaena; Kourlas, Helen</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Therapeutics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">841-854</span>CODEN:
                <span class="NLM_cas:coden">CLTHDG</span>;
        ISSN:<span class="NLM_cas:issn">0149-2918</span>.
    
            (<span class="NLM_cas:orgname">Excerpta Medica, Inc.</span>)
        </div><div class="casAbstract">A review.  Traditionally, the management of osteoporosis in men and women has included the use of antiresorptive agents in combination with calcium and vitamin D supplementation.  The mechanism of action of teriparatide is unique in that it possesses anabolic properties and therefore builds bone.  Since the approval of teriparatide in the United States in 2002, a great deal of interest regarding its use in osteoporosis has developed.  This article reviews the information available on the new recombinant human parathyroid hormone teriparatide (hPTH [1-34]), including its clin. pharmacol., mechanism of action, pharmacokinetic properties, clin. efficacy, safety profile, potential drug interactions, contraindications and warnings, dosage and administration, and pharmacoeconomics.  The articles included in this review were identified through searches of PubMed and MEDLINE (1966-Dec. 2003) and International Pharmaceutical Abstrs. (1970-Dec. 2003).  Search terms included teriparatide, Forteo, recombinant human parathyroid hormone (1-34), and osteoporosis.  The refs. of the identified articles were reviewed for addnl. publications.  Specific product information was also obtained from the manufacturer of teriparatide.  Teriparatide has been studied in postmenopausal women with osteoporosis, drug-induced osteoporosis (specifically, corticosteroid-induced osteoporosis), and men with osteoporosis.  The data available from various clin. trials have shown an increase in both bone mineral d. (BMD) and bone mineral content (BMC) with the use of teriparatide compared with placebo.  One study found that women treated with the 20-μg dose and the 40-μg dose were 35% and 40%, resp., less likely to have one or more new nonvertebral fractures compared with placebo (P = 0.02).  Another study compared the use of daily teriparatide 40-μg injections vs. oral daily alendronate.  Results showed that the incidence of nonvertebral fractures was significantly lower in the teriparatide group than the alendronate group (P < 0.05).  A study using 20- and 40-μg daily injections of teriparatide was performed in men with osteoporosis.  There was a statistically significant increase in lumbar spine BMD of 5.9% in the 20-μg group and 9.0% in the 40-μg group (both, P < 0.001).  In the femoral neck, a 1.5% increase in BMD occurred in the 20-μg group (P = 0.021) and a 0.9% increase in the 40-μg group (P < 0.001).  A limited no. of studies are available assessing the combination of antiresorptive medications and teriparatide; however, the available data suggest that the effects of teriparatide do not require prior stimulation of bone resorption.  Teriparatide has been shown clin. to improve BMD and BMC in postmenopausal women and in men.  Because of its anabolic capabilities, teriparatide can be used as an alternative to the traditional therapies that are currently available for the treatment of osteoporosis, with scheduled monitoring for adverse effects such as hypercalcemia and urinary calcium excretion.  In 1 study, mild hypercalcemia was seen most often 4 to 6 h after SC injection of teriparatide before returning to normal.  Urinary, calcium was obsd. to increase by 30 mg/d (0.75 mmol/d) with teriparatide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYd_uzd7xHu7Vg90H21EOLACvtfcHk0lhkiaLx_KzR_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmsVSisrc%253D&md5=d8ee703da34c306140d2278bd46ebcda</span></div><a href="/servlet/linkout?suffix=cit3d&amp;dbid=16384&amp;doi=10.1016%2FS0149-2918%2804%2990128-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0149-2918%252804%252990128-2%26sid%3Dliteratum%253Aachs%26aulast%3DQuattrocchi%26aufirst%3DE.%26aulast%3DKourlas%26aufirst%3DH.%26atitle%3DTeriparaitide%253A%2520a%2520review%26jtitle%3DClin.%2520Ther.%26date%3D2004%26volume%3D26%26spage%3D841%26epage%3D854" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit3e"><span><span class="NLM_contrib-group">Dobnig, H.</span><span> </span><span class="NLM_article-title">A review of teriparatide and its clinical efficacy in the treatment of osteoporosis</span> <span class="citation_source-journal">Expt Opin. Pharmacother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">710</span><span class="NLM_x">–</span> <span class="NLM_lpage">718</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2003&pages=710-718&author=H.+Dobnig&title=A+review+of+teriparatide+and+its+clinical+efficacy+in+the+treatment+of+osteoporosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDobnig%26aufirst%3DH.%26atitle%3DA%2520review%2520of%2520teriparatide%2520and%2520its%2520clinical%2520efficacy%2520in%2520the%2520treatment%2520of%2520osteoporosis%26jtitle%3DExpt%2520Opin.%2520Pharmacother.%26date%3D2003%26volume%3D57%26spage%3D710%26epage%3D718" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit3f"><span><span class="NLM_contrib-group">Ebling, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russell, R. G. G.</span><span> </span><span class="NLM_article-title">Teriparaitide (rhPTH1-34) for the treatment of osteoporosis</span> <span class="citation_source-journal">Int. J. Clin. Pract.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">710</span><span class="NLM_x">–</span> <span class="NLM_lpage">718</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3f&amp;dbid=8&amp;doi=10.1021%2Fjm900364m&amp;key=14627183" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2003&pages=710-718&author=P.+R.+Eblingauthor=R.+G.+G.+Russell&title=Teriparaitide+%28rhPTH1-34%29+for+the+treatment+of+osteoporosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3f&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEbling%26aufirst%3DP.%2BR.%26aulast%3DRussell%26aufirst%3DR.%2BG.%2BG.%26atitle%3DTeriparaitide%2520%2528rhPTH1-34%2529%2520for%2520the%2520treatment%2520of%2520osteoporosis%26jtitle%3DInt.%2520J.%2520Clin.%2520Pract.%26date%3D2003%26volume%3D57%26spage%3D710%26epage%3D718" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit3g"><span><span class="NLM_contrib-group">Berg, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neumeyer, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirkpatrick, P.</span><span> </span><span class="NLM_article-title">Fresh from the pipline: Teriparatide</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">257</span><span class="NLM_x">–</span> <span class="NLM_lpage">258</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2003&pages=257-258&author=C.+Bergauthor=K.+Neumeyerauthor=P.+Kirkpatrick&title=Fresh+from+the+pipline%3A+Teriparatide"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3g&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBerg%26aufirst%3DC.%26aulast%3DNeumeyer%26aufirst%3DK.%26aulast%3DKirkpatrick%26aufirst%3DP.%26atitle%3DFresh%2520from%2520the%2520pipline%253A%2520Teriparatide%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery.%26date%3D2003%26volume%3D2%26spage%3D257%26epage%3D258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Kronenberg, H. M.</span><span> </span><span class="NLM_article-title">PTHrP and skeletal development</span> <span class="citation_source-journal">Ann. New York Acad. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">1068</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">13</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm900364m&amp;key=10.1196%2Fannals.1346.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm900364m&amp;key=16831900" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm900364m&amp;key=1%3ACAS%3A528%3ADC%252BD28XntFent7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1068&publication_year=2006&pages=1-13&author=H.+M.+Kronenberg&title=PTHrP+and+skeletal+development"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">PTHrP and skeletal development</span></div><div class="casAuthors">Kronenberg, Henry M.</div><div class="citationInfo"><span class="NLM_cas:title">Annals of the New York Academy of Sciences</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">1068</span>
        (<span class="NLM_cas:issue">Skeletal Development and Remodeling in Health, Disease, and Aging</span>),
    <span class="NLM_cas:pages">1-13</span>CODEN:
                <span class="NLM_cas:coden">ANYAA9</span>;
        ISSN:<span class="NLM_cas:issn">0077-8923</span>.
    
            (<span class="NLM_cas:orgname">New York Academy of Sciences</span>)
        </div><div class="casAbstract">A review.  Parathyroid hormone-related protein (PTHrP) participates in the regulation of endochondral bone development.  After the cartilage mold is established in fetal life, perichondrial cells and chondrocytes at the ends of the mold synthesize PTHrP.  This ligand then acts on PTH/PTHrP receptors on chondrocytes.  As chondrocytes go through a program of proliferation and then further differentiation into postmitotic, hypertrophic chondrocytes, PTHrP action keeps chondrocytes proliferating and delays their further differentiation.  Indian hedgehog (Ihh) is synthesized by chondrocytes that have just stopped proliferating and is required for synthesis of PTHrP.  The feedback loop between PTHrP and Ihh serves to regulate the pace of chondrocyte differentiation and the sites at which perichondrial cells first differentiate into osteoblasts.  Activation of the PTH/PTHrP receptor leads to stimulation of both Gs and Gq family heterotrimeric G proteins.  Genetic analyses demonstrate that Gs activation mediates the action of PTHrP to keep chondrocytes proliferating, while Gq activation opposes this action.  Downstream from Gs activation, synthesis of the cyclin-cdk inhibitor, p57, is suppressed, thereby increasing the pool of proliferating chondrocytes.  PTHrP's actions to delay chondrocyte differentiation are mediated by the phosphorylation of the transcription factor, SOX9, and by suppression of synthesis of mRNA encoding the transcription factor, Runx2.  These pathways and undoubtedly others cooperate to regulate the pace of differentiation of growth plate chondrocytes in response to PTHrP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpd5cbjSE7kObVg90H21EOLACvtfcHk0lizPWVtjjC5tA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XntFent7k%253D&md5=a755c610f919729230311ee13e5f7c97</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1196%2Fannals.1346.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1196%252Fannals.1346.002%26sid%3Dliteratum%253Aachs%26aulast%3DKronenberg%26aufirst%3DH.%2BM.%26atitle%3DPTHrP%2520and%2520skeletal%2520development%26jtitle%3DAnn.%2520New%2520York%2520Acad.%2520Sci.%26date%3D2006%26volume%3D1068%26spage%3D1%26epage%3D13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit4a"><span><span class="NLM_contrib-group">Murray, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, L. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Divieti, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bringhurst, F. R.</span><span> </span><span class="NLM_article-title">Parathyroid hormone secretion and action: evidence for discrete receptors for the carboxyl-terminal region and related biological actions of carboxyl-terminal ligands</span> <span class="citation_source-journal">Endocr. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">78</span><span class="NLM_x">–</span> <span class="NLM_lpage">113</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=16&amp;doi=10.1021%2Fjm900364m&amp;key=10.1210%2Fer.2003-0024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=8&amp;doi=10.1021%2Fjm900364m&amp;key=15689574" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=32&amp;doi=10.1021%2Fjm900364m&amp;key=1%3ACAS%3A528%3ADC%252BD2MXitFykt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2005&pages=78-113&author=T.+M.+Murrayauthor=L.+G.+Raoauthor=P.+Divietiauthor=F.+R.+Bringhurst&title=Parathyroid+hormone+secretion+and+action%3A+evidence+for+discrete+receptors+for+the+carboxyl-terminal+region+and+related+biological+actions+of+carboxyl-terminal+ligands"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4aR"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Parathyroid hormone secretion and action: Evidence for discrete receptors for the carboxyl-terminal region and related biological actions of carboxyl-terminal ligands</span></div><div class="casAuthors">Murray, Timothy M.; Rao, Leticia G.; Divieti, Paola; Bringhurst, F. Richard</div><div class="citationInfo"><span class="NLM_cas:title">Endocrine Reviews</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">78-113</span>CODEN:
                <span class="NLM_cas:coden">ERVIDP</span>;
        ISSN:<span class="NLM_cas:issn">0163-769X</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">A review.  PTH is a major systemic regulator of the concns. of calcium, phosphate, and active vitamin D metabolites in blood and of cellular activity in bone.  Intermittently administered PTH and amino-terminal PTH peptide fragments or analogs also augment bone mass and currently are being introduced into clin. practice as therapies for osteoporosis.  The amino-terminal region of PTH is known to be both necessary and sufficient for full activity at PTH/PTHrP receptors (PTH1Rs), which mediate the classical biol. actions of the hormone.  It is well known that multiple carboxyl-terminal fragments of PTH are present in blood, where they comprise the major form(s) of circulating hormone, but these fragments have long been regarded as inert byproducts of PTH metab. because they neither bind to nor activate PTH1Rs.  New in vitro and in vivo evidence, together with older observations extending over the past 20 yr, now points strongly to the existence of novel large carboxyl-terminal PTH fragments in blood and to receptors for these fragments that appear to mediate unique biol. actions in bone.  This review traces the development of this field in the context of the evolution of our understanding of the "classical" receptor for amino-terminal PTH and the now convincing evidence for these receptors for carboxyl-terminal PTH.  The review summarizes current knowledge of the structure, secretion, and metab. of PTH and its circulating fragments, details available information concerning the pharmacol. and actions of carboxyl-terminal PTH receptors, and frames their likely biol. and clin. significance.  It seems likely that physiol. parathyroid regulation of calcium and bone metab. may involve receptors for circulating carboxy-terminal PTH ligands as well as the action of amino-terminal determinants within the PTH mol. on the classical PTH1R.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2K0CufOD-pbVg90H21EOLACvtfcHk0lizPWVtjjC5tA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXitFykt7w%253D&md5=8f10126cb6ff42791368e69674f606bf</span></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=10.1210%2Fer.2003-0024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fer.2003-0024%26sid%3Dliteratum%253Aachs%26aulast%3DMurray%26aufirst%3DT.%2BM.%26aulast%3DRao%26aufirst%3DL.%2BG.%26aulast%3DDivieti%26aufirst%3DP.%26aulast%3DBringhurst%26aufirst%3DF.%2BR.%26atitle%3DParathyroid%2520hormone%2520secretion%2520and%2520action%253A%2520evidence%2520for%2520discrete%2520receptors%2520for%2520the%2520carboxyl-terminal%2520region%2520and%2520related%2520biological%2520actions%2520of%2520carboxyl-terminal%2520ligands%26jtitle%3DEndocr.%2520Rev.%26date%3D2005%26volume%3D26%26spage%3D78%26epage%3D113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit4b"><span><span class="NLM_contrib-group">Gardella, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juppner, H.</span><span> </span><span class="NLM_article-title">Molecular properties of the PTH/PTHrP receptor</span> <span class="citation_source-journal">Trends Endocr. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">210</span><span class="NLM_x">–</span> <span class="NLM_lpage">217</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=16&amp;doi=10.1021%2Fjm900364m&amp;key=10.1016%2FS1043-2760%2801%2900409-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=8&amp;doi=10.1021%2Fjm900364m&amp;key=11397646" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=32&amp;doi=10.1021%2Fjm900364m&amp;key=1%3ACAS%3A528%3ADC%252BD3MXktVKktrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2001&pages=210-217&author=T.+J.+Gardellaauthor=H.+Juppner&title=Molecular+properties+of+the+PTH%2FPTHrP+receptor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4bR"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular properties of the PTH/PTHrP receptor</span></div><div class="casAuthors">Gardella, T. J.; Juppner, H.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Endocrinology and Metabolism</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">210-217</span>CODEN:
                <span class="NLM_cas:coden">TENME4</span>;
        ISSN:<span class="NLM_cas:issn">1043-2760</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review, with 97 refs.  The receptor for parathyroid hormone (PTH) and PTH-related protein (PTHrP) is a G protein-coupled receptor (GPCR) that plays a key role in controlling blood Ca2+ concn. and endochondral bone formation.  This review focuses on the mol. mechanisms by which the receptor recognizes the PTH and PTHrP peptide ligands and transmits their signal across the cell membrane.  The available data suggest that there are 2 principal components to the ligand-receptor interaction.  First, a docking interaction between the C-terminal portion of PTH(1-34) and the N-terminal extracellular domain of the receptor; and second, a weaker interaction between the N-terminal portion of the ligand and the juxtamembrane region of the receptor, which induces signal transduction.  A full understanding of these processes could lead to new PTH/PTHrP receptor ligands that are effective in controlling diseases of bone and mineral metab., such as osteoporosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqUMDlbuYU-bVg90H21EOLACvtfcHk0lizPWVtjjC5tA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXktVKktrg%253D&md5=58b25e1c414575ff527442b71065da16</span></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=10.1016%2FS1043-2760%2801%2900409-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1043-2760%252801%252900409-X%26sid%3Dliteratum%253Aachs%26aulast%3DGardella%26aufirst%3DT.%2BJ.%26aulast%3DJuppner%26aufirst%3DH.%26atitle%3DMolecular%2520properties%2520of%2520the%2520PTH%252FPTHrP%2520receptor%26jtitle%3DTrends%2520Endocr.%2520Metab.%26date%3D2001%26volume%3D12%26spage%3D210%26epage%3D217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit4c"><span><span class="NLM_contrib-group">Juppner, H.</span><span> </span><span class="NLM_article-title">Receptors for parathyroid hormone and parathyroid hormone-related peptide: exploration of their biological importance</span> <span class="citation_source-journal">Bone</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">87</span><span class="NLM_x">–</span> <span class="NLM_lpage">90</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=1999&pages=87-90&author=H.+Juppner&title=Receptors+for+parathyroid+hormone+and+parathyroid+hormone-related+peptide%3A+exploration+of+their+biological+importance"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJuppner%26aufirst%3DH.%26atitle%3DReceptors%2520for%2520parathyroid%2520hormone%2520and%2520parathyroid%2520hormone-related%2520peptide%253A%2520exploration%2520of%2520their%2520biological%2520importance%26jtitle%3DBone%26date%3D1999%26volume%3D25%26spage%3D87%26epage%3D90" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Brown, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacLeod, R. J.</span><span> </span><span class="NLM_article-title">Extracellular Calcium Sensing and Extracellular Calcium Signaling</span> <span class="citation_source-journal">Physiol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">81</span><span class="NLM_x">, </span> <span class="NLM_fpage">239</span><span class="NLM_x">–</span> <span class="NLM_lpage">297</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm900364m&amp;key=10.1152%2Fphysrev.2001.81.1.239" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm900364m&amp;key=11152759" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm900364m&amp;key=1%3ACAS%3A528%3ADC%252BD3MXitV2ktLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2001&pages=239-297&author=E.+M.+Brownauthor=R.+J.+MacLeod&title=Extracellular+Calcium+Sensing+and+Extracellular+Calcium+Signaling"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Extracellular calcium sensing and extracellular calcium signaling</span></div><div class="casAuthors">Brown, Edward M.; MacLeod, R. John</div><div class="citationInfo"><span class="NLM_cas:title">Physiological Reviews</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">239-297</span>CODEN:
                <span class="NLM_cas:coden">PHREA7</span>;
        ISSN:<span class="NLM_cas:issn">0031-9333</span>.
    
            (<span class="NLM_cas:orgname">American Physiological Society</span>)
        </div><div class="casAbstract">A review, with 481 refs.  The cloning of a G protein-coupled extracellular Ca2+ (Cao2+)-sensing receptor (CaR) has elucidated the mol. basis for many of the previously recognized effects of Cao2+ on tissues that maintain systemic Cao2+ homeostasis, esp. parathyroid chief cells and several cells in the kidney.  The availability of the cloned CaR enabled the development of DNA and antibody probes for identifying the CaR's mRNA and protein, resp., within these and other tissues.  It also permitted the identification of human diseases resulting from inactivating or activating mutations of the CaR gene and the subsequent generation of mice with targeted disruption of the CaR gene.  The characteristic alterations in parathyroid and renal function in these patients and in the mice with knockout of the CaR gene have provided valuable information on the CaR's physiol. roles in these tissues participating in mineral ion homeostasis.  Nevertheless, relatively little is known about how the CaR regulates other tissues involved in systemic Cao2+ homeostasis, particularly bone and intestine.  Moreover, there is evidence that addnl. Cao2+ sensors may exist in bone cells that mediate some or even all of the known effects of Cao2+ on these cells.  Even more remains to be learned about the CaR's function in the rapidly growing list of cells that express it but are uninvolved in systemic Cao2+ metab.  Available data suggest that the receptor serves numerous roles outside of systemic mineral ion homeostasis, ranging from the regulation of hormonal secretion and the activities of various ion channels to the longer term control of gene expression, programmed cell death (apoptosis), and cellular proliferation.  In some cases, the CaR on these non-homeostatic cells responds to local changes in Cao2+ taking place within compartments of the extracellular fluid (ECF) that communicate with the outside environment (e.g., the gastrointestinal tract).  In others, localized changes in Cao2+ within the ECF can originate from several mechanisms, including fluxes of calcium ions into or out of cellular or extracellular stores or across epithelium that absorb or secrete Ca2+.  In any event, the CaR and other receptors/sensors for Cao2+ and probably for other extracellular ions represent versatile regulators of numerous cellular functions and may serve as important therapeutic targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6uGVgKVIQybVg90H21EOLACvtfcHk0lgf6NY0Mm_F7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXitV2ktLo%253D&md5=bdaf576fbde7255da389eb9fa0d84823</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1152%2Fphysrev.2001.81.1.239&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fphysrev.2001.81.1.239%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DE.%2BM.%26aulast%3DMacLeod%26aufirst%3DR.%2BJ.%26atitle%3DExtracellular%2520Calcium%2520Sensing%2520and%2520Extracellular%2520Calcium%2520Signaling%26jtitle%3DPhysiol.%2520Rev.%26date%3D2001%26volume%3D81%26spage%3D239%26epage%3D297" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5a"><span><span class="NLM_contrib-group">Nemeth, E. F.</span><span> </span><span class="NLM_article-title">Calcium receptor-dependent regulation of cellular functions</span> <span class="citation_source-journal">News Physiol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">5</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=32&amp;doi=10.1021%2Fjm900364m&amp;key=1%3ACAS%3A528%3ADyaK2MXkslequ7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=1995&pages=1-5&author=E.+F.+Nemeth&title=Calcium+receptor-dependent+regulation+of+cellular+functions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5aR"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Ca2+ receptor-dependent regulation of cellular functions</span></div><div class="casAuthors">Nemeth, Edward F.</div><div class="citationInfo"><span class="NLM_cas:title">News in Physiological Sciences</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">Feb.</span>),
    <span class="NLM_cas:pages">1-5</span>CODEN:
                <span class="NLM_cas:coden">NEPSEY</span>;
        ISSN:<span class="NLM_cas:issn">0886-1714</span>.
    </div><div class="casAbstract">A review, with 15 refs.  A cell-surface Ca2+ receptor enables parathyroid cells to detect and respond to extracellular Ca2+.  The recent cloning of a G protein-coupled Ca2+ receptor solidifies this view.  Ca2+ receptors regulate the activity of various cells and provide novel mol. targets for new pharmaceuticals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmAYKq3zbA7LVg90H21EOLACvtfcHk0lgf6NY0Mm_F7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXkslequ7g%253D&md5=5c0358f59bb52230ca313049fa647144</span></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNemeth%26aufirst%3DE.%2BF.%26atitle%3DCalcium%2520receptor-dependent%2520regulation%2520of%2520cellular%2520functions%26jtitle%3DNews%2520Physiol.%2520Sci.%26date%3D1995%26volume%3D10%26spage%3D1%26epage%3D5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5b"><span><span class="NLM_contrib-group">Brown, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacLeod, R. J.</span><span> </span><span class="NLM_article-title">Extracellular calcium sensing and extracellular calcium signaling</span> <span class="citation_source-journal">Physiol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">81</span><span class="NLM_x">, </span> <span class="NLM_fpage">239</span><span class="NLM_x">–</span> <span class="NLM_lpage">297</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=16&amp;doi=10.1021%2Fjm900364m&amp;key=10.1152%2Fphysrev.2001.81.1.239" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=8&amp;doi=10.1021%2Fjm900364m&amp;key=11152759" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=32&amp;doi=10.1021%2Fjm900364m&amp;key=1%3ACAS%3A528%3ADC%252BD3MXitV2ktLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2001&pages=239-297&author=E.+M.+Brownauthor=R.+J.+MacLeod&title=Extracellular+calcium+sensing+and+extracellular+calcium+signaling"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5bR"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Extracellular calcium sensing and extracellular calcium signaling</span></div><div class="casAuthors">Brown, Edward M.; MacLeod, R. John</div><div class="citationInfo"><span class="NLM_cas:title">Physiological Reviews</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">239-297</span>CODEN:
                <span class="NLM_cas:coden">PHREA7</span>;
        ISSN:<span class="NLM_cas:issn">0031-9333</span>.
    
            (<span class="NLM_cas:orgname">American Physiological Society</span>)
        </div><div class="casAbstract">A review, with 481 refs.  The cloning of a G protein-coupled extracellular Ca2+ (Cao2+)-sensing receptor (CaR) has elucidated the mol. basis for many of the previously recognized effects of Cao2+ on tissues that maintain systemic Cao2+ homeostasis, esp. parathyroid chief cells and several cells in the kidney.  The availability of the cloned CaR enabled the development of DNA and antibody probes for identifying the CaR's mRNA and protein, resp., within these and other tissues.  It also permitted the identification of human diseases resulting from inactivating or activating mutations of the CaR gene and the subsequent generation of mice with targeted disruption of the CaR gene.  The characteristic alterations in parathyroid and renal function in these patients and in the mice with knockout of the CaR gene have provided valuable information on the CaR's physiol. roles in these tissues participating in mineral ion homeostasis.  Nevertheless, relatively little is known about how the CaR regulates other tissues involved in systemic Cao2+ homeostasis, particularly bone and intestine.  Moreover, there is evidence that addnl. Cao2+ sensors may exist in bone cells that mediate some or even all of the known effects of Cao2+ on these cells.  Even more remains to be learned about the CaR's function in the rapidly growing list of cells that express it but are uninvolved in systemic Cao2+ metab.  Available data suggest that the receptor serves numerous roles outside of systemic mineral ion homeostasis, ranging from the regulation of hormonal secretion and the activities of various ion channels to the longer term control of gene expression, programmed cell death (apoptosis), and cellular proliferation.  In some cases, the CaR on these non-homeostatic cells responds to local changes in Cao2+ taking place within compartments of the extracellular fluid (ECF) that communicate with the outside environment (e.g., the gastrointestinal tract).  In others, localized changes in Cao2+ within the ECF can originate from several mechanisms, including fluxes of calcium ions into or out of cellular or extracellular stores or across epithelium that absorb or secrete Ca2+.  In any event, the CaR and other receptors/sensors for Cao2+ and probably for other extracellular ions represent versatile regulators of numerous cellular functions and may serve as important therapeutic targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6uGVgKVIQybVg90H21EOLACvtfcHk0lgf6NY0Mm_F7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXitV2ktLo%253D&md5=bdaf576fbde7255da389eb9fa0d84823</span></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=10.1152%2Fphysrev.2001.81.1.239&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fphysrev.2001.81.1.239%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DE.%2BM.%26aulast%3DMacLeod%26aufirst%3DR.%2BJ.%26atitle%3DExtracellular%2520calcium%2520sensing%2520and%2520extracellular%2520calcium%2520signaling%26jtitle%3DPhysiol.%2520Rev.%26date%3D2001%26volume%3D81%26spage%3D239%26epage%3D297" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5c"><span><span class="NLM_contrib-group">Chen, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goodman, W. G.</span><span> </span><span class="NLM_article-title">Role of the calcium-sensing receptor in parathyroid gland physiology</span> <span class="citation_source-journal">Am. J. Physiol. Renal Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">286</span><span class="NLM_x">, </span> <span class="NLM_fpage">F1005</span><span class="NLM_x">–</span> <span class="NLM_lpage">F1011</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2004&pages=F1005-F1011&author=R.+A.+Chenauthor=W.+G.+Goodman&title=Role+of+the+calcium-sensing+receptor+in+parathyroid+gland+physiology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DR.%2BA.%26aulast%3DGoodman%26aufirst%3DW.%2BG.%26atitle%3DRole%2520of%2520the%2520calcium-sensing%2520receptor%2520in%2520parathyroid%2520gland%2520physiology%26jtitle%3DAm.%2520J.%2520Physiol.%2520Renal%2520Physiol.%26date%3D2004%26volume%3D286%26spage%3DF1005%26epage%3DF1011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5d"><span><span class="NLM_contrib-group">Tfelt-Hansen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, E. M.</span><span> </span><span class="NLM_article-title">The calcium-sensing receptor in normal physiology and pathophysiology: a review</span> <span class="citation_source-journal">Crit. Rev. Clin. Lab. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">35</span><span class="NLM_x">–</span> <span class="NLM_lpage">70</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5d&amp;dbid=16&amp;doi=10.1021%2Fjm900364m&amp;key=10.1080%2F10408360590886606" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5d&amp;dbid=8&amp;doi=10.1021%2Fjm900364m&amp;key=15697170" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5d&amp;dbid=32&amp;doi=10.1021%2Fjm900364m&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtFSnsbrE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2005&pages=35-70&author=J.+Tfelt-Hansenauthor=E.+M.+Brown&title=The+calcium-sensing+receptor+in+normal+physiology+and+pathophysiology%3A+a+review"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5dR"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">The Calcium-Sensing Receptor in Normal Physiology and Pathophysiology: A Review</span></div><div class="casAuthors">Tfelt-Hansen, Jacob; Brown, Edward</div><div class="citationInfo"><span class="NLM_cas:title">Critical Reviews in Clinical Laboratory Sciences</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">35-70</span>CODEN:
                <span class="NLM_cas:coden">CRCLBH</span>;
        ISSN:<span class="NLM_cas:issn">1040-8363</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis, Inc.</span>)
        </div><div class="casAbstract">A review.  The discovery of a G protein-coupled, calcium-sensing receptor (CaR) a decade ago and of diseases caused by CaR mutations provided unquestionable evidence of the CaR's crit. role in the maintenance of systemic calcium homeostasis.  On the cell membrane of the chief cells of the parathyroid glands, the CaR "senses" the extracellular calcium concn. and, subsequently, alters the release of parathyroid hormone (PTH).  The CaR is likewise functionally expressed in bone, kidney, and gut-the three major calcium-translocating organs involved in calcium homeostasis.  Intracellular signal pathways to which the CaR couples via its assocd. G proteins include phospholipase C (PLC), protein kinase B (AKT); and mitogen-activated protein kinases (MAPKs).  The receptor is widely expressed in various tissues and regulates important cellular functions in addn. to its role in maintaining systemic calcium homeostasis, i.e., protection against apoptosis, cellular proliferation, and membrane voltage.  Functionally significant mutations in the receptor have been shown to induce diseases of calcium homeostasis owing to changes in the set point for calcium-regulated PTH release as well as alterations in the renal handling of calcium.  Gain-of-function mutations cause hypocalcemia, whereas loss-of-function mutations produce hypercalcemia.  Recent studies have shown that the latter clin. presentation can also be caused by inactivating autoantibodies directed against the CaR.  Newly discovered type II allosteric activators of the CaR have been found to be effective as a medical treatment for renal secondary hyperparathyroidism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoguMPL6ZwnCrVg90H21EOLACvtfcHk0lgf6NY0Mm_F7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtFSnsbrE&md5=341363042e4477a3c4e35bba0395b201</span></div><a href="/servlet/linkout?suffix=cit5d&amp;dbid=16384&amp;doi=10.1080%2F10408360590886606&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F10408360590886606%26sid%3Dliteratum%253Aachs%26aulast%3DTfelt-Hansen%26aufirst%3DJ.%26aulast%3DBrown%26aufirst%3DE.%2BM.%26atitle%3DThe%2520calcium-sensing%2520receptor%2520in%2520normal%2520physiology%2520and%2520pathophysiology%253A%2520a%2520review%26jtitle%3DCrit.%2520Rev.%2520Clin.%2520Lab.%2520Sci.%26date%3D2005%26volume%3D42%26spage%3D35%26epage%3D70" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Nemeth, E. F.</span><span> </span><span class="NLM_article-title">Misconceptions about calcimimetics</span> <span class="citation_source-journal">Anns. N. Y. Acad. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">1068</span><span class="NLM_x">, </span> <span class="NLM_fpage">471</span><span class="NLM_x">–</span> <span class="NLM_lpage">476</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm900364m&amp;key=10.1196%2Fannals.1346.044" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm900364m&amp;key=16831944" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm900364m&amp;key=1%3ACAS%3A528%3ADC%252BD28XntFenu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1068&publication_year=2006&pages=471-476&author=E.+F.+Nemeth&title=Misconceptions+about+calcimimetics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Misconceptions about calcimimetics</span></div><div class="casAuthors">Nemeth, E. F.</div><div class="citationInfo"><span class="NLM_cas:title">Annals of the New York Academy of Sciences</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">1068</span>
        (<span class="NLM_cas:issue">Skeletal Development and Remodeling in Health, Disease, and Aging</span>),
    <span class="NLM_cas:pages">471-476</span>CODEN:
                <span class="NLM_cas:coden">ANYAA9</span>;
        ISSN:<span class="NLM_cas:issn">0077-8923</span>.
    
            (<span class="NLM_cas:orgname">New York Academy of Sciences</span>)
        </div><div class="casAbstract">A review.  Calcimimetics are ligands that activate the calcium receptor.  Some are small mols. and of these, the most extensively studied are phenylalkylamines like cinacalcet.  This compd. is a pos. allosteric modulator that selectively targets the parathyroid calcium receptor to inhibit the secretion of parathyroid hormone.  Cinacalcet is the first calcimimetic compd. to attain regulatory approval for the treatment of hyperparathyroidism resulting from end-stage renal disease.  The discovery of calcimimetics and the receptor they act on are considered with the intent of extg. lessons relevant to medical research and the discovery of new drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRtaX_piW_9bVg90H21EOLACvtfcHk0ljcKbhn7TMFdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XntFenu7c%253D&md5=81000995ddd63fc5f09aa8133b795df6</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1196%2Fannals.1346.044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1196%252Fannals.1346.044%26sid%3Dliteratum%253Aachs%26aulast%3DNemeth%26aufirst%3DE.%2BF.%26atitle%3DMisconceptions%2520about%2520calcimimetics%26jtitle%3DAnns.%2520N.%2520Y.%2520Acad.%2520Sci.%26date%3D2006%26volume%3D1068%26spage%3D471%26epage%3D476" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6a"><span><span class="NLM_contrib-group">Nemeth, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, J.</span><span> </span><span class="NLM_article-title">Compounds acting on the parathyroid calcium receptor as novel therapies for hyperparathyroidism and osteoporosis</span> <span class="citation_source-journal">Endocr. Updates</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">173</span><span class="NLM_x">–</span> <span class="NLM_lpage">202</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=32&amp;doi=10.1021%2Fjm900364m&amp;key=1%3ACAS%3A528%3ADC%252BD3sXns1ersbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2003&pages=173-202&author=E.+F.+Nemethauthor=J.+Fox&title=Compounds+acting+on+the+parathyroid+calcium+receptor+as+novel+therapies+for+hyperparathyroidism+and+osteoporosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6aR"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Compounds acting on the parathyroid calcium receptor as novel therapies for hyperparathyroidism or osteoporosis</span></div><div class="casAuthors">Nemeth, Edward F.; Fox, John</div><div class="citationInfo"><span class="NLM_cas:title">Endocrine Updates</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">Calcium-Sensing Receptor</span>),
    <span class="NLM_cas:pages">173-202</span>CODEN:
                <span class="NLM_cas:coden">ECUDF4</span>;
        ISSN:<span class="NLM_cas:issn">1566-0729</span>.
    
            (<span class="NLM_cas:orgname">Kluwer Academic Publishers</span>)
        </div><div class="casAbstract">A review on the progress made in the discovery and development of small mols. that activate or inhibit the parathyroid Ca2+ receptor and thereby inhibit or stimulate secretion of parathyroid hormone (PTH).  Manipulating the activity of the Ca2+ receptor pharmacol. is proving to be a very effective way of altering at will the circulating level of PTH.  Drugs which either increase or decrease the secretion of PTH from the parathyroid glands could be useful in treating the various forms of hyperparathyroidism or osteoporosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSaWOblqRq9LVg90H21EOLACvtfcHk0ljcKbhn7TMFdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXns1ersbw%253D&md5=37780ed86903775b2750465bf2018da5</span></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNemeth%26aufirst%3DE.%2BF.%26aulast%3DFox%26aufirst%3DJ.%26atitle%3DCompounds%2520acting%2520on%2520the%2520parathyroid%2520calcium%2520receptor%2520as%2520novel%2520therapies%2520for%2520hyperparathyroidism%2520and%2520osteoporosis%26jtitle%3DEndocr.%2520Updates%26date%3D2003%26volume%3D19%26spage%3D173%26epage%3D202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6b"><span><span class="NLM_contrib-group">Nemeth, E. F.</span><span> </span><span class="NLM_article-title">Pharmacological regulation of parathyroid hormone secretion</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">2077</span><span class="NLM_x">–</span> <span class="NLM_lpage">2087</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=16&amp;doi=10.1021%2Fjm900364m&amp;key=10.2174%2F1381612023393387" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=8&amp;doi=10.1021%2Fjm900364m&amp;key=12171519" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=32&amp;doi=10.1021%2Fjm900364m&amp;key=1%3ACAS%3A528%3ADC%252BD38XmvFOjsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2002&pages=2077-2087&author=E.+F.+Nemeth&title=Pharmacological+regulation+of+parathyroid+hormone+secretion"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6bR"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological regulation of parathyroid hormone secretion</span></div><div class="casAuthors">Nemeth, E. F.</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">2077-2087</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers</span>)
        </div><div class="casAbstract">A review.  Parathyroid hormone (PTH) is the key endocrine factor regulating systemic Ca2+ homeostasis.  Elevated levels of circulating PTH increase bone turnover and, depending on the duration of elevation, will result in net anabolic or catabolic effects on the skeleton.  Secretion of PTH from the parathyroid glands is regulated by small changes in circulating levels of Ca2+ which are detected by a Ca2+ receptor on the surface of parathyroid cells.  This G protein-coupled receptor is the primary mol. entity used by parathyroid cells to regulate secretion of PTH.  As such, the Ca2+ receptor is a unique mol. target for new drugs capable of increasing or decreasing circulating levels of PTH.  Compds. which activate the Ca2+ receptor are termed calcimimetics and they inhibit the secretion of PTH; a calcimimetic compd. is in late stage clin. trials for the treatment of both primary and secondary hyperparathyroidism.  Conversely, calcilytic compds., which are Ca2+ receptor antagonists, stimulate secretion of PTH; a calcilytic compd. is in early clin. development for the treatment of osteoporosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWJHkAPZSZLrVg90H21EOLACvtfcHk0ljcKbhn7TMFdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XmvFOjsb8%253D&md5=6eef4365891ea3f33edb8cda81df89cb</span></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=10.2174%2F1381612023393387&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1381612023393387%26sid%3Dliteratum%253Aachs%26aulast%3DNemeth%26aufirst%3DE.%2BF.%26atitle%3DPharmacological%2520regulation%2520of%2520parathyroid%2520hormone%2520secretion%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2002%26volume%3D8%26spage%3D2077%26epage%3D2087" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6c"><span><span class="NLM_contrib-group">Nemeth, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, J.</span><span> </span><span class="NLM_article-title">Calcimimetic compounds: a direct approach to controlling plasma levels of parathyroid hormone in hyperparathyroidism</span> <span class="citation_source-journal">Trends Endcrinol. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">66</span><span class="NLM_x">–</span> <span class="NLM_lpage">71</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=16&amp;doi=10.1021%2Fjm900364m&amp;key=10.1016%2FS1043-2760%2898%2900119-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=8&amp;doi=10.1021%2Fjm900364m&amp;key=10322397" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=32&amp;doi=10.1021%2Fjm900364m&amp;key=1%3ACAS%3A528%3ADyaK1MXhvVylt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=1999&pages=66-71&author=E.+F.+Nemethauthor=J.+Fox&title=Calcimimetic+compounds%3A+a+direct+approach+to+controlling+plasma+levels+of+parathyroid+hormone+in+hyperparathyroidism"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6cR"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Calcimimetic compounds: a direct approach to controlling plasma levels of parathyroid hormone in hyperparathyroidism</span></div><div class="casAuthors">Nemeth, Edward F.; Fox, John</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Endocrinology and Metabolism</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">66-71</span>CODEN:
                <span class="NLM_cas:coden">TENME4</span>;
        ISSN:<span class="NLM_cas:issn">1043-2760</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review, with 35 refs.  The Ca2+ receptor is the primary mechanism regulating the secretion of parathyroid hormone (PTH).  Ligands that activate this receptor (calcimimetics) represent a novel means of lowering plasma levels of PTH.  Two mechanistically distinct classes of calcimimetics that inhibit PTH secretion have been identified: type I calcimimetics are full agonists of the Ca2+ receptor and include Ca2+ and other polyvalent inorg. and org. cations; whereas type II calcimimetics, typified by phenylalkylamine compds., behave like pos. allosteric activators and increase, in a stereoselective manner, the sensitivity of the Ca2+ receptor to activation by extracellular Ca2+.  The phenylalkylamine calcimimetics are orally active and decrease the plasma levels of PTH and Ca2+ in patients with primary hyperparathyroidism (HPT), a disease that so far has resisted pharmacol. intervention.  Such compds. are similarly safe and effective in reducing PTH levels and preventing parathyroid cell hyperplasia in rats with HPT secondary to chronic renal insufficiency and they lower plasma levels of PTH in dialysis patients with secondary HPT.  Calcimimetic compds. may provide a novel therapy for treating both primary and secondary HPT.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIBHJYTGvjIbVg90H21EOLACvtfcHk0ljcKbhn7TMFdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXhvVylt7o%253D&md5=87993f4cc4f333c009c46fe053281759</span></div><a href="/servlet/linkout?suffix=cit6c&amp;dbid=16384&amp;doi=10.1016%2FS1043-2760%2898%2900119-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1043-2760%252898%252900119-2%26sid%3Dliteratum%253Aachs%26aulast%3DNemeth%26aufirst%3DE.%2BF.%26aulast%3DFox%26aufirst%3DJ.%26atitle%3DCalcimimetic%2520compounds%253A%2520a%2520direct%2520approach%2520to%2520controlling%2520plasma%2520levels%2520of%2520parathyroid%2520hormone%2520in%2520hyperparathyroidism%26jtitle%3DTrends%2520Endcrinol.%2520Metab.%26date%3D1999%26volume%3D10%26spage%3D66%26epage%3D71" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6d"><span><span class="NLM_contrib-group">Nemeth, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, S. A.</span><span> </span><span class="NLM_article-title">Tricking the parathyroid gland with novel calcimimetic agents</span> <span class="citation_source-journal">Nephrol., Dial., Transplant.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1923</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6d&amp;dbid=16&amp;doi=10.1021%2Fjm900364m&amp;key=10.1093%2Fndt%2F13.8.1923" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6d&amp;dbid=8&amp;doi=10.1021%2Fjm900364m&amp;key=9719139" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6d&amp;dbid=32&amp;doi=10.1021%2Fjm900364m&amp;key=1%3ACAS%3A528%3ADyaK1cXlslajtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1998&pages=1923&author=E.+F.+Nemethauthor=S.+A.+Bennett&title=Tricking+the+parathyroid+gland+with+novel+calcimimetic+agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6dR"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Tricking the parathyroid gland with novel calcimimetic agents</span></div><div class="casAuthors">Nemeth, Edward F.; Bennett, Sharon A.</div><div class="citationInfo"><span class="NLM_cas:title">Nephrology, Dialysis, Transplantation</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1923-1925</span>CODEN:
                <span class="NLM_cas:coden">NDTREA</span>;
        ISSN:<span class="NLM_cas:issn">0931-0509</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">A review, with 9 refs., which discusses: the nature of calcimimetic agents, the ability of the hyperplastic parathyroid gland to sense calcium, initial clin. experiences with calcimimetics, potential benefits from use of calcimimetic agents, and differences between treatment with vitamin D metabolites and calcimimetics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq83uDkGclX5bVg90H21EOLACvtfcHk0liIH_-r7GzeuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXlslajtLo%253D&md5=b35fcb6a28c1893a9d5787f063a2990b</span></div><a href="/servlet/linkout?suffix=cit6d&amp;dbid=16384&amp;doi=10.1093%2Fndt%2F13.8.1923&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fndt%252F13.8.1923%26sid%3Dliteratum%253Aachs%26aulast%3DNemeth%26aufirst%3DE.%2BF.%26aulast%3DBennett%26aufirst%3DS.%2BA.%26atitle%3DTricking%2520the%2520parathyroid%2520gland%2520with%2520novel%2520calcimimetic%2520agents%26jtitle%3DNephrol.%252C%2520Dial.%252C%2520Transplant.%26date%3D1998%26volume%3D13%26spage%3D1923" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Locatelli, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pontoriero, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Limbardo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tentori, F.</span><span> </span><span class="NLM_article-title">Cinacalcet hydrochloride: calcimimnetic for the treatment of hyperparathyroidism</span> <span class="citation_source-journal">Exp. Opin. Endocr. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">167</span><span class="NLM_x">–</span> <span class="NLM_lpage">179</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm900364m&amp;key=10.1586%2F17446651.1.2.167" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm900364m&amp;key=1%3ACAS%3A528%3ADC%252BD28XjsVyjtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2006&pages=167-179&author=F.+Locatelliauthor=G.+Pontorieroauthor=M.+Limbardoauthor=F.+Tentori&title=Cinacalcet+hydrochloride%3A+calcimimnetic+for+the+treatment+of+hyperparathyroidism"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Cinacalcet hydrochloride: calcimimetic for the treatment of hyperparathyroidism</span></div><div class="casAuthors">Locatelli, Francesco; Pontoriero, Giuseppe; Limardo, Monica; Tentori, Flavia</div><div class="citationInfo"><span class="NLM_cas:title">Expert Review of Endocrinology & Metabolism</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">167-179</span>CODEN:
                <span class="NLM_cas:coden">EREMBI</span>;
        ISSN:<span class="NLM_cas:issn">1744-6651</span>.
    
            (<span class="NLM_cas:orgname">Future Drugs Ltd.</span>)
        </div><div class="casAbstract">A review.  Mineral metab. disorders, including those related to secondary hyperparathyroidism, affect a large no. of patients with chronic kidney disease and are assocd. with increased relative risk of morbidity and mortality in hemodialysis patients.  The traditional therapy of secondary hyperparathyroidism based on vitamin D compds. and calcium-based phosphate binders is often limited by the increase of serum calcium and phosphorus levels limiting the dose that can be given safely, and thus, preventing the attainment of treatment targets.  Cinacalcet hydrochloride (Sensipar, Mimpara, Parareg) is the first in a new class of therapeutic agents, the calcimimetics, that increase the sensitivity of calcium-sensing receptors to the extracellular calcium ions, thus lowering parathyroid hormone prodn. and release, decreasing serum calcium and phosphorous concns. simultaneously.  Different randomized, double-blind, placebo-controlled trials evaluated the safety and ability of cinacalcet hydrochloride treatment to improve achievement of target levels of parathyroid hormone, calcium, phosphorus and calcium phosphorus product in dialysis patients.  Cinacalcet hydrochloride has also demonstrated to be effective in reducing parathyroid hormone and serum calcium concns. in patients with primary hyperparathyroidism.  On the basis of available data, calcimimetics represent an important innovation and will change the management of mineral metab. disorders in patients with chronic kidney disease and primary hyperparathyroidism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqokYx_j51YkLVg90H21EOLACvtfcHk0liIH_-r7GzeuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjsVyjtLg%253D&md5=1f846e815b348b14531f5232dd19b37a</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1586%2F17446651.1.2.167&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1586%252F17446651.1.2.167%26sid%3Dliteratum%253Aachs%26aulast%3DLocatelli%26aufirst%3DF.%26aulast%3DPontoriero%26aufirst%3DG.%26aulast%3DLimbardo%26aufirst%3DM.%26aulast%3DTentori%26aufirst%3DF.%26atitle%3DCinacalcet%2520hydrochloride%253A%2520calcimimnetic%2520for%2520the%2520treatment%2520of%2520hyperparathyroidism%26jtitle%3DExp.%2520Opin.%2520Endocr.%2520Metab.%26date%3D2006%26volume%3D1%26spage%3D167%26epage%3D179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7a"><span><span class="NLM_contrib-group">Dong, B. J.</span><span> </span><span class="NLM_article-title">Cinacalcet: an oral calcimimetic agent for the management of hyperparathyroidism</span> <span class="citation_source-journal">Clin. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">1725</span><span class="NLM_x">–</span> <span class="NLM_lpage">1751</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=16&amp;doi=10.1021%2Fjm900364m&amp;key=10.1016%2Fj.clinthera.2005.11.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=8&amp;doi=10.1021%2Fjm900364m&amp;key=16368445" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=32&amp;doi=10.1021%2Fjm900364m&amp;key=1%3ACAS%3A528%3ADC%252BD28XntlWnuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2005&pages=1725-1751&author=B.+J.+Dong&title=Cinacalcet%3A+an+oral+calcimimetic+agent+for+the+management+of+hyperparathyroidism"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7aR"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Cinacalcet: an oral calcimimetic agent for the management of hyperparathyroidism</span></div><div class="casAuthors">Dong, Betty J.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Therapeutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1725-1751</span>CODEN:
                <span class="NLM_cas:coden">CLTHDG</span>;
        ISSN:<span class="NLM_cas:issn">0149-2918</span>.
    
            (<span class="NLM_cas:orgname">Excerpta Medica, Inc.</span>)
        </div><div class="casAbstract">A review.  Uncontrolled hyperparathyroidism (HPT), particularly HPT resulting from chronic kidney disease (CKD), is assocd. with significant morbidity and cardiovascular mortality.  Traditional medical therapy (eg, vitamin D sterols, calcium, phosphate binders) has been inadequate for the management of HPT and its vascular and skeletal complications.  The goal of this article was to review the efficacy and safety profile of cinacalcet, a second-generation calcimimetic, in the management of HPT secondary to CKD, primary HPT, and parathyroid carcinoma.  MEDLINE, Web of Science, and International Pharmaceutical Abstrs. were searched from 1995 to July 2005 using the terms cinacalcet, AMG 073, KRN 1493, calcimimetics, hypercalcemia, and hyperparathyroidism.  Compared with placebo, cinacalcet significantly reduced parathyroid hormone levels within 2 to 4 h after administration (P < 0.05).  In Phase III trials involving 1136 patients with secondary HPT, 56% of those who received cinacalcet achieved the National Kidney Foundation Kidney Disease Outcomes Quality Initiative target of a redn. in parathyroid hormone to <300 pg/mL, 65% achieved a calcium-phosphorus product <55 mg2/dL2, and a resp. 49% and 46% achieved normalized serum calcium and phosphorus levels (P < 0.001).  Cinacalcet's effects were similar regardless of patients' demog. characteristics, duration or mode of dialysis, severity of HPT, or use of concomitant medical therapy.  Preliminary evidence suggests that cinacalcet may reverse cortical bone loss.  Cinacalcet was well tolerated, with nausea (31%) and vomiting (27%) being the most commonly reported adverse effects.  Hypocalcemia was transient in 5% of patients, was usually asymptomatic, and was cor. by dose redn.  Based on the available evidence, cinacalcet is effective and well tolerated in the treatment of secondary HPT and refractory parathyroid carcinoma.  Its use in primary HPT appears promising.  Further investigations are needed to det. if cinacalcet can prevent the long-term complications of HPT and reduce mortality.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpua2ISxtUru7Vg90H21EOLACvtfcHk0liIH_-r7GzeuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XntlWnuw%253D%253D&md5=fb128fa6543bc3e7dd33c05892a5979c</span></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=10.1016%2Fj.clinthera.2005.11.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.clinthera.2005.11.015%26sid%3Dliteratum%253Aachs%26aulast%3DDong%26aufirst%3DB.%2BJ.%26atitle%3DCinacalcet%253A%2520an%2520oral%2520calcimimetic%2520agent%2520for%2520the%2520management%2520of%2520hyperparathyroidism%26jtitle%3DClin.%2520Ther.%26date%3D2005%26volume%3D27%26spage%3D1725%26epage%3D1751" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7b"><span><span class="NLM_contrib-group">de Francisco, A. L. M.</span><span> </span><span class="NLM_article-title">Cinacalcet HCL: a novel therapeutic for the treatment of hyperparathyroidism</span> <span class="citation_source-journal">Exp. Opin. Pharmacother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">441</span><span class="NLM_x">–</span> <span class="NLM_lpage">452</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=16&amp;doi=10.1021%2Fjm900364m&amp;key=10.1517%2F14656566.6.3.441" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=8&amp;doi=10.1021%2Fjm900364m&amp;key=15794735" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=32&amp;doi=10.1021%2Fjm900364m&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjvVyrtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2005&pages=441-452&author=A.+L.+M.+de+Francisco&title=Cinacalcet+HCL%3A+a+novel+therapeutic+for+the+treatment+of+hyperparathyroidism"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7bR"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Cinacalcet HCl: A novel therapeutic for hyperparathyroidism</span></div><div class="casAuthors">de Francisco, Angel L. M.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Pharmacotherapy</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">441-452</span>CODEN:
                <span class="NLM_cas:coden">EOPHF7</span>;
        ISSN:<span class="NLM_cas:issn">1465-6566</span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications Ltd.</span>)
        </div><div class="casAbstract">A review.  Hyperparathyroidism (HPT) is a significant clin. concern for patients with a variety of diseases, notably the secondary HPT assocd. with chronic kidney disease requiring dialysis.  Secondary HPT is assocd. with elevated parathyroid hormone (PTH) levels, decreased levels of 1,25 dihydroxyvitamin D, and disordered mineral levels (usually high calcium and phosphorus).  If not controlled, secondary HPT can result in bone disease, vascular calcification, and ultimately, patient mortality.  Established, conventional therapies, such as 1,25 dihydroxyvitamin D analogs (vitamin D analogs) and phosphate binders, have proven to be inadequate in enabling patients to meet the National Kidney Foundation's-Kidney Disease Outcomes Quality Initiative (NKF-K/DOQI) treatment goals for PTH, calcium and phosphorus levels.  A novel therapeutic, cinacalcet HCl (formerly AMG 073; Sensipar in the US and Mimpara in Europe; Amgen, Inc.), binds directly to the calcium-sensing receptor (CaR) on the cells of the parathyroid gland, increasing the receptor's sensitivity to calcium and reducing PTH, serum calcium and phosphorus levels.  Treatment with cinacalcet in clin. trials has safely and effectively improved achievement of the NKF-K/DOQI goals.  Cinacalcet has also reduced serum calcium levels in patients with primary HPT, including parathyroid carcinoma, in the clin. trial setting.  Evidence suggesting the utility of cinacalcet in these diseases and the potential for addnl. therapeutic applications will be discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotj4JefW4n8rVg90H21EOLACvtfcHk0liIH_-r7GzeuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjvVyrtr0%253D&md5=6047d3cacc2148532f4d737c9c0c8cfc</span></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=10.1517%2F14656566.6.3.441&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14656566.6.3.441%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BFrancisco%26aufirst%3DA.%2BL.%2BM.%26atitle%3DCinacalcet%2520HCL%253A%2520a%2520novel%2520therapeutic%2520for%2520the%2520treatment%2520of%2520hyperparathyroidism%26jtitle%3DExp.%2520Opin.%2520Pharmacother.%26date%3D2005%26volume%3D6%26spage%3D441%26epage%3D452" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Nemeth, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delmar, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heaton, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conklin, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gowen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gleason, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhatnagar, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, J.</span><span> </span><span class="NLM_article-title">Calcilytic compounds: Potent and selective Ca<sup>+2</sup> receptor. antagonists that stimulate secretion of parathyroid hormone</span> <span class="citation_source-journal">J. Pharm. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">299</span><span class="NLM_x">, </span> <span class="NLM_fpage">323</span><span class="NLM_x">–</span> <span class="NLM_lpage">331</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm900364m&amp;key=11561095" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm900364m&amp;key=1%3ACAS%3A528%3ADC%252BD3MXntFWltbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=299&publication_year=2001&pages=323-331&author=E.+F.+Nemethauthor=E.+C.+Delmarauthor=W.+L.+Heatonauthor=M.+A.+Millerauthor=L.+D.+Lambertauthor=R.+L.+Conklinauthor=M.+Gowenauthor=J.+G.+Gleasonauthor=P.+K.+Bhatnagarauthor=J.+Fox&title=Calcilytic+compounds%3A+Potent+and+selective+Ca%2B2+receptor.+antagonists+that+stimulate+secretion+of+parathyroid+hormone"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Calcilytic compounds: potent and selective Ca2+ receptor antagonists that stimulate secretion of parathyroid hormone</span></div><div class="casAuthors">Nemeth, Edward F.; Delmar, Eric G.; Heaton, William L.; Miller, Michael A.; Lambert, Lyssa D.; Conklin, Rebecca L.; Gowen, Maxine; Gleason, John G.; Bhatnagar, Pradip K.; Fox, John</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">299</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">323-331</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Despite the discovery of many ions and mols. that activate the Ca2+ receptor, there are no known ligands that block this receptor.  Reported here are the pharmacodynamic properties of a small mol., NPS 2143, which acts as an antagonist at the Ca2+ receptor.  This compd. blocked (IC50 of 43 nM) increases in cytoplasmic Ca2+ concns. [Ca2+]i elicited by activating the Ca2+ receptor in HEK 293 cells expressing the human Ca2+ receptor.  NPS 2143, even when tested at much higher concns. (3 μM), did not affect the activity of a no. of other G protein-coupled receptors, including those most structurally homologous to the Ca2+ receptor.  NPS 2143 stimulated parathyroid hormone (PTH) secretion from bovine parathyroid cells (EC50 of 41 nM) over a range of extracellular Ca2+ concns. and reversed the effects of the calcimimetic compd. NPS R-467 on [Ca2+]i and on secretion of PTH.  When infused i.v. in normal rats, NPS 2143 caused a rapid and large increase in plasma levels of PTH.  Ca2+ receptor antagonists are termed calcilytics and NPS 2143 is the first substance (either at. or mol.) shown to possess such activity.  The pharmacodynamic properties of NPS 2143 together with the recently demonstrated effects of this compd. on bone formation support the view that orally active calcilytic compds. might provide a novel anabolic therapy for osteoporosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5irxzzwLOvbVg90H21EOLACvtfcHk0lg8W0RYVjNxgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXntFWltbk%253D&md5=14cedbe167bc3f0de96cec16d9ce73b4</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNemeth%26aufirst%3DE.%2BF.%26aulast%3DDelmar%26aufirst%3DE.%2BC.%26aulast%3DHeaton%26aufirst%3DW.%2BL.%26aulast%3DMiller%26aufirst%3DM.%2BA.%26aulast%3DLambert%26aufirst%3DL.%2BD.%26aulast%3DConklin%26aufirst%3DR.%2BL.%26aulast%3DGowen%26aufirst%3DM.%26aulast%3DGleason%26aufirst%3DJ.%2BG.%26aulast%3DBhatnagar%26aufirst%3DP.%2BK.%26aulast%3DFox%26aufirst%3DJ.%26atitle%3DCalcilytic%2520compounds%253A%2520Potent%2520and%2520selective%2520Ca%252B2%2520receptor.%2520antagonists%2520that%2520stimulate%2520secretion%2520of%2520parathyroid%2520hormone%26jtitle%3DJ.%2520Pharm.%2520Exp.%2520Ther.%26date%3D2001%26volume%3D299%26spage%3D323%26epage%3D331" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Gowen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stroup, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodds, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, I. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Votta, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhatnagar, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lago, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Callahan, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Del Mar, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nemuth, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, J.</span><span> </span><span class="NLM_article-title">Antagonizing the parathyroid calcium receptor stimulates parathyroid secretion and bone formation in osteopenic rats</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">1595</span><span class="NLM_x">–</span> <span class="NLM_lpage">1604</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2000&pages=1595-1604&author=M.+Gowenauthor=G.+B.+Stroupauthor=R.+A.+Doddsauthor=I.+E.+Jamesauthor=B.+J.+Vottaauthor=B.+R.+Smithauthor=P.+K.+Bhatnagarauthor=A.+M.+Lagoauthor=J.+F.+Callahanauthor=E.+G.+Del+Marauthor=M.+A.+Millerauthor=E.+F.+Nemuthauthor=J.+Fox&title=Antagonizing+the+parathyroid+calcium+receptor+stimulates+parathyroid+secretion+and+bone+formation+in+osteopenic+rats"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGowen%26aufirst%3DM.%26aulast%3DStroup%26aufirst%3DG.%2BB.%26aulast%3DDodds%26aufirst%3DR.%2BA.%26aulast%3DJames%26aufirst%3DI.%2BE.%26aulast%3DVotta%26aufirst%3DB.%2BJ.%26aulast%3DSmith%26aufirst%3DB.%2BR.%26aulast%3DBhatnagar%26aufirst%3DP.%2BK.%26aulast%3DLago%26aufirst%3DA.%2BM.%26aulast%3DCallahan%26aufirst%3DJ.%2BF.%26aulast%3DDel%2BMar%26aufirst%3DE.%2BG.%26aulast%3DMiller%26aufirst%3DM.%2BA.%26aulast%3DNemuth%26aufirst%3DE.%2BF.%26aulast%3DFox%26aufirst%3DJ.%26atitle%3DAntagonizing%2520the%2520parathyroid%2520calcium%2520receptor%2520stimulates%2520parathyroid%2520secretion%2520and%2520bone%2520formation%2520in%2520osteopenic%2520rats%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2000%26volume%3D105%26spage%3D1595%26epage%3D1604" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Arey, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seethala, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fura, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swartz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vyas, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, W.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feyen, J. H. M.</span><span> </span><span class="NLM_article-title">A Novel Calcium-Sensing Receptor Antagonist Transiently Stimulates Parathyroid Hormone Secretion in Vivo</span> <span class="citation_source-journal">Endocrinology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1131</span><span class="NLM_x">–</span> <span class="NLM_lpage">1136</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=1131-1136&author=B.+J.+Areyauthor=R.+Seethalaauthor=Z.+Maauthor=A.+Furaauthor=J.+Morinauthor=J.+Swartzauthor=V.+Vyasauthor=W.+Yangauthor=J.+H.+M.+Feyen&title=A+Novel+Calcium-Sensing+Receptor+Antagonist+Transiently+Stimulates+Parathyroid+Hormone+Secretion+in+Vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DArey%26aufirst%3DB.%2BJ.%26aulast%3DSeethala%26aufirst%3DR.%26aulast%3DMa%26aufirst%3DZ.%26aulast%3DFura%26aufirst%3DA.%26aulast%3DMorin%26aufirst%3DJ.%26aulast%3DSwartz%26aufirst%3DJ.%26aulast%3DVyas%26aufirst%3DV.%26aulast%3DYang%26aufirst%3DW.%26aulast%3DFeyen%26aufirst%3DJ.%2BH.%2BM.%26atitle%3DA%2520Novel%2520Calcium-Sensing%2520Receptor%2520Antagonist%2520Transiently%2520Stimulates%2520Parathyroid%2520Hormone%2520Secretion%2520in%2520Vivo%26jtitle%3DEndocrinology%26date%3D2005%26volume%3D5%26spage%3D1131%26epage%3D1136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Dauban, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferry, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faure, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruat, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodd, R. H.</span><span> </span><span class="NLM_article-title"><i>N</i><sup>1</sup>-Arylsulfonyl-<i>N</i><sup>2</sup>-(1-aryl)ethyl-3-phenylpropane-1,2-diamines as Novel Calcimimetics Acting on the Calcium Sensing Receptor</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">2001</span><span class="NLM_x">–</span> <span class="NLM_lpage">2004</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2000&pages=2001-2004&author=P.+Daubanauthor=S.+Ferryauthor=H.+Faureauthor=M.+Ruatauthor=R.+H.+Dodd&title=N1-Arylsulfonyl-N2-%281-aryl%29ethyl-3-phenylpropane-1%2C2-diamines+as+Novel+Calcimimetics+Acting+on+the+Calcium+Sensing+Receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDauban%26aufirst%3DP.%26aulast%3DFerry%26aufirst%3DS.%26aulast%3DFaure%26aufirst%3DH.%26aulast%3DRuat%26aufirst%3DM.%26aulast%3DDodd%26aufirst%3DR.%2BH.%26atitle%3DN1-Arylsulfonyl-N2-%25281-aryl%2529ethyl-3-phenylpropane-1%252C2-diamines%2520as%2520Novel%2520Calcimimetics%2520Acting%2520on%2520the%2520Calcium%2520Sensing%2520Receptor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2000%26volume%3D10%26spage%3D2001%26epage%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Kessler, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faure, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruat, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dauban, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodd, R. H.</span><span> </span><span class="NLM_article-title"><i>N</i><sup>2</sup>-Benzyl-<i>N</i><sup>1</sup>-(1-(1-naphthyl)ethyl)-3-phenylpropane-1,2-diamines and conformationally constrained indole analogs: development of calindol as a new calcimimetic acting at the calcium sensing receptor</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">3345</span><span class="NLM_x">–</span> <span class="NLM_lpage">3349</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=3345-3349&author=A.+Kesslerauthor=H.+Faureauthor=M.+Ruatauthor=P.+Daubanauthor=R.+H.+Dodd&title=N2-Benzyl-N1-%281-%281-naphthyl%29ethyl%29-3-phenylpropane-1%2C2-diamines+and+conformationally+constrained+indole+analogs%3A+development+of+calindol+as+a+new+calcimimetic+acting+at+the+calcium+sensing+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKessler%26aufirst%3DA.%26aulast%3DFaure%26aufirst%3DH.%26aulast%3DRuat%26aufirst%3DM.%26aulast%3DDauban%26aufirst%3DP.%26aulast%3DDodd%26aufirst%3DR.%2BH.%26atitle%3DN2-Benzyl-N1-%25281-%25281-naphthyl%2529ethyl%2529-3-phenylpropane-1%252C2-diamines%2520and%2520conformationally%2520constrained%2520indole%2520analogs%253A%2520development%2520of%2520calindol%2520as%2520a%2520new%2520calcimimetic%2520acting%2520at%2520the%2520calcium%2520sensing%2520receptor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D3345%26epage%3D3349" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Kessler, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faure, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roussanne, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferry, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruat, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dauben, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodd, R. H.</span><span> </span><span class="NLM_article-title"><i>N</i><sup>1</sup>-Arylsulfonyl-<i>N</i><sup>2</sup>-(1-(1-naphthyl)ethyl)-1,2-diaminocyclohexanes: A New Class of Calcilytic Agents Acting at the Calcium-Sensing Receptor</span> <span class="citation_source-journal">ChemBioChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1131</span><span class="NLM_x">–</span> <span class="NLM_lpage">1136</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2004&pages=1131-1136&author=A.+Kesslerauthor=H.+Faureauthor=M.+C.+Roussanneauthor=S.+Ferryauthor=M.+Ruatauthor=P.+Daubenauthor=R.+H.+Dodd&title=N1-Arylsulfonyl-N2-%281-%281-naphthyl%29ethyl%29-1%2C2-diaminocyclohexanes%3A+A+New+Class+of+Calcilytic+Agents+Acting+at+the+Calcium-Sensing+Receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKessler%26aufirst%3DA.%26aulast%3DFaure%26aufirst%3DH.%26aulast%3DRoussanne%26aufirst%3DM.%2BC.%26aulast%3DFerry%26aufirst%3DS.%26aulast%3DRuat%26aufirst%3DM.%26aulast%3DDauben%26aufirst%3DP.%26aulast%3DDodd%26aufirst%3DR.%2BH.%26atitle%3DN1-Arylsulfonyl-N2-%25281-%25281-naphthyl%2529ethyl%2529-1%252C2-diaminocyclohexanes%253A%2520A%2520New%2520Class%2520of%2520Calcilytic%2520Agents%2520Acting%2520at%2520the%2520Calcium-Sensing%2520Receptor%26jtitle%3DChemBioChem%26date%3D2004%26volume%3D5%26spage%3D1131%26epage%3D1136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Arey, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seethala, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fura, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swartz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vyas, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, W.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feyen, J. H. M.</span><span> </span><span class="NLM_article-title">A Novel Calcium-Sensing Receptor Antagonist Transiently Stimulates Parathyroid Hormone Secretion in Vivo</span> <span class="citation_source-journal">Endocrinology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1131</span><span class="NLM_x">–</span> <span class="NLM_lpage">1136</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=1131-1136&author=B.+J.+Areyauthor=R.+Seethalaauthor=Z.+Maauthor=A.+Furaauthor=J.+Morinauthor=J.+Swartzauthor=V.+Vyasauthor=W.+Yangauthor=J.+H.+M.+Feyen&title=A+Novel+Calcium-Sensing+Receptor+Antagonist+Transiently+Stimulates+Parathyroid+Hormone+Secretion+in+Vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DArey%26aufirst%3DB.%2BJ.%26aulast%3DSeethala%26aufirst%3DR.%26aulast%3DMa%26aufirst%3DZ.%26aulast%3DFura%26aufirst%3DA.%26aulast%3DMorin%26aufirst%3DJ.%26aulast%3DSwartz%26aufirst%3DJ.%26aulast%3DVyas%26aufirst%3DV.%26aulast%3DYang%26aufirst%3DW.%26aulast%3DFeyen%26aufirst%3DJ.%2BH.%2BM.%26atitle%3DA%2520Novel%2520Calcium-Sensing%2520Receptor%2520Antagonist%2520Transiently%2520Stimulates%2520Parathyroid%2520Hormone%2520Secretion%2520in%2520Vivo%26jtitle%3DEndocrinology%26date%3D2005%26volume%3D5%26spage%3D1131%26epage%3D1136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Yang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberge, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawerence, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rotella, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seethala, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feyen, J. H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dickson, J. K.,  Jr.</span><span> </span><span class="NLM_article-title">Discovery and structure−activity relationships of benzylpyrrolidine substituted aryloxypropanols as calcium-sensing receptor antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">1225</span><span class="NLM_x">–</span> <span class="NLM_lpage">1228</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=1225-1228&author=W.+Yangauthor=Y.+Wangauthor=J.+Y.+Robergeauthor=Z.+Maauthor=Y.+Liuauthor=R.+M.+Lawerenceauthor=D.+P.+Rotellaauthor=R.+Seethalaauthor=J.+H.+M.+Feyenauthor=J.+K.+Dickson&title=Discovery+and+structure%E2%88%92activity+relationships+of+benzylpyrrolidine+substituted+aryloxypropanols+as+calcium-sensing+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DRoberge%26aufirst%3DJ.%2BY.%26aulast%3DMa%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DLawerence%26aufirst%3DR.%2BM.%26aulast%3DRotella%26aufirst%3DD.%2BP.%26aulast%3DSeethala%26aufirst%3DR.%26aulast%3DFeyen%26aufirst%3DJ.%2BH.%2BM.%26aulast%3DDickson%26aufirst%3DJ.%2BK.%26atitle%3DDiscovery%2520and%2520structure%25E2%2588%2592activity%2520relationships%2520of%2520benzylpyrrolidine%2520substituted%2520aryloxypropanols%2520as%2520calcium-sensing%2520receptor%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D1225%26epage%3D1228" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Gavai, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaz, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mikkilineni, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberge, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawrence, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corte, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bednarz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dickson Jr, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seethala, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feyen, J. H. M.</span><span> </span><span class="NLM_article-title">Discovery nof novel 1-arylmethyl pyrrolidin-2-yl ethanol amines as calcium-sensing receptor antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">5478</span><span class="NLM_x">–</span> <span class="NLM_lpage">5482</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=5478-5482&author=A.+V.+Gavaiauthor=R.+J.+Vazauthor=A.+B.+Mikkilineniauthor=J.+Y.+Robergeauthor=Y.+Liuauthor=R.+M.+Lawrenceauthor=J.+R.+Corteauthor=W.+Yangauthor=M.+Bednarzauthor=J.+K.+Dickson+Jrauthor=Z.+Maauthor=R.+Seethalaauthor=J.+H.+M.+Feyen&title=Discovery+nof+novel+1-arylmethyl+pyrrolidin-2-yl+ethanol+amines+as+calcium-sensing+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGavai%26aufirst%3DA.%2BV.%26aulast%3DVaz%26aufirst%3DR.%2BJ.%26aulast%3DMikkilineni%26aufirst%3DA.%2BB.%26aulast%3DRoberge%26aufirst%3DJ.%2BY.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DLawrence%26aufirst%3DR.%2BM.%26aulast%3DCorte%26aufirst%3DJ.%2BR.%26aulast%3DYang%26aufirst%3DW.%26aulast%3DBednarz%26aufirst%3DM.%26aulast%3DDickson%2BJr%26aufirst%3DJ.%2BK.%26aulast%3DMa%26aufirst%3DZ.%26aulast%3DSeethala%26aufirst%3DR.%26aulast%3DFeyen%26aufirst%3DJ.%2BH.%2BM.%26atitle%3DDiscovery%2520nof%2520novel%25201-arylmethyl%2520pyrrolidin-2-yl%2520ethanol%2520amines%2520as%2520calcium-sensing%2520receptor%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D5478%26epage%3D5482" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Shcherbakova, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balandrin, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghatak, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heaton, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conklin, R. L.</span><span> </span><span class="NLM_article-title">3<i>H</i>-Quinazolin-4-ones as a new calcilytic template for the potential treatment of osteoporosis</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">1557</span><span class="NLM_x">–</span> <span class="NLM_lpage">1560</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=1557-1560&author=I.+Shcherbakovaauthor=M.+F.+Balandrinauthor=J.+Foxauthor=A.+Ghatakauthor=W.+Heatonauthor=R.+L.+Conklin&title=3H-Quinazolin-4-ones+as+a+new+calcilytic+template+for+the+potential+treatment+of+osteoporosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShcherbakova%26aufirst%3DI.%26aulast%3DBalandrin%26aufirst%3DM.%2BF.%26aulast%3DFox%26aufirst%3DJ.%26aulast%3DGhatak%26aufirst%3DA.%26aulast%3DHeaton%26aufirst%3DW.%26aulast%3DConklin%26aufirst%3DR.%2BL.%26atitle%3D3H-Quinazolin-4-ones%2520as%2520a%2520new%2520calcilytic%2520template%2520for%2520the%2520potential%2520treatment%2520of%2520osteoporosis%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D1557%26epage%3D1560" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Shcherbakova, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geoffroy, O. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nair, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swierczek, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balandrin, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heaton, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conklin, R. L.</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">2537</span><span class="NLM_x">–</span> <span class="NLM_lpage">2540</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Shcherbakova%2C+I.%3B+Huang%2C+G.%3B+Geoffroy%2C+O.+J.%3B+Nair%2C+S.+K.%3B+Swierczek%2C+K.%3B+Balandrin%2C+M.+F.%3B+Fox%2C+J.%3B+Heaton%2C+W.+L.%3B+Conklin%2C+R.+L.Bioorg.+Med.+Chem.+Lett.+2005%2C+15%2C+2537%E2%80%932540"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShcherbakova%26aufirst%3DI.%26aulast%3DHuang%26aufirst%3DG.%26aulast%3DGeoffroy%26aufirst%3DO.%2BJ.%26aulast%3DNair%26aufirst%3DS.%2BK.%26aulast%3DSwierczek%26aufirst%3DK.%26aulast%3DBalandrin%26aufirst%3DM.%2BF.%26aulast%3DFox%26aufirst%3DJ.%26aulast%3DHeaton%26aufirst%3DW.%2BL.%26aulast%3DConklin%26aufirst%3DR.%2BL.%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D2537%26epage%3D2540" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Dobnig, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, R. T.</span><span> </span><span class="NLM_article-title">Evidence that intermittent treatment with parathyroid hormone increases bone formation in adult rats by activation of bone lining cells</span> <span class="citation_source-journal">Endocrinology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">136</span><span class="NLM_x">, </span> <span class="NLM_fpage">3632</span><span class="NLM_x">–</span> <span class="NLM_lpage">3638</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=1995&pages=3632-3638&author=H.+Dobnigauthor=R.+T.+Turner&title=Evidence+that+intermittent+treatment+with+parathyroid+hormone+increases+bone+formation+in+adult+rats+by+activation+of+bone+lining+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDobnig%26aufirst%3DH.%26aulast%3DTurner%26aufirst%3DR.%2BT.%26atitle%3DEvidence%2520that%2520intermittent%2520treatment%2520with%2520parathyroid%2520hormone%2520increases%2520bone%2520formation%2520in%2520adult%2520rats%2520by%2520activation%2520of%2520bone%2520lining%2520cells%26jtitle%3DEndocrinology%26date%3D1995%26volume%3D136%26spage%3D3632%26epage%3D3638" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit19a"><span><span class="NLM_contrib-group">Ishizuya, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yokose, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hori, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshiki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamaguchi, A.</span><span> </span><span class="NLM_article-title">Parathyroid hormone exerts disparate effects on osteoclast differentiation depending on exposure time in rat osteoblastic cells</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x">, </span> <span class="NLM_fpage">2961</span><span class="NLM_x">–</span> <span class="NLM_lpage">2970</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=1997&pages=2961-2970&author=T.+Ishizuyaauthor=S.+Yokoseauthor=M.+Horiauthor=T.+Nodaauthor=T.+Sudaauthor=S.+Yoshikiauthor=A.+Yamaguchi&title=Parathyroid+hormone+exerts+disparate+effects+on+osteoclast+differentiation+depending+on+exposure+time+in+rat+osteoblastic+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DIshizuya%26aufirst%3DT.%26aulast%3DYokose%26aufirst%3DS.%26aulast%3DHori%26aufirst%3DM.%26aulast%3DNoda%26aufirst%3DT.%26aulast%3DSuda%26aufirst%3DT.%26aulast%3DYoshiki%26aufirst%3DS.%26aulast%3DYamaguchi%26aufirst%3DA.%26atitle%3DParathyroid%2520hormone%2520exerts%2520disparate%2520effects%2520on%2520osteoclast%2520differentiation%2520depending%2520on%2520exposure%2520time%2520in%2520rat%2520osteoblastic%2520cells%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D1997%26volume%3D99%26spage%3D2961%26epage%3D2970" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit19b"><span><span class="NLM_contrib-group">Frolik, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Black, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cain, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Satterwhite, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown-Augsburger, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hock, J. M.</span><span> </span><span class="NLM_article-title">Anabolic and catabolic bone effects of human parathyroid hormone (1-34) are predicted by duration of hormone exposure</span> <span class="citation_source-journal">Bone</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">372</span><span class="NLM_x">–</span> <span class="NLM_lpage">379</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2003&pages=372-379&author=C.+A.+Frolikauthor=E.+C.+Blackauthor=R.+L.+Cainauthor=J.+H.+Satterwhiteauthor=P.+L.+Brown-Augsburgerauthor=M.+Satoauthor=J.+M.+Hock&title=Anabolic+and+catabolic+bone+effects+of+human+parathyroid+hormone+%281-34%29+are+predicted+by+duration+of+hormone+exposure"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFrolik%26aufirst%3DC.%2BA.%26aulast%3DBlack%26aufirst%3DE.%2BC.%26aulast%3DCain%26aufirst%3DR.%2BL.%26aulast%3DSatterwhite%26aufirst%3DJ.%2BH.%26aulast%3DBrown-Augsburger%26aufirst%3DP.%2BL.%26aulast%3DSato%26aufirst%3DM.%26aulast%3DHock%26aufirst%3DJ.%2BM.%26atitle%3DAnabolic%2520and%2520catabolic%2520bone%2520effects%2520of%2520human%2520parathyroid%2520hormone%2520%25281-34%2529%2520are%2520predicted%2520by%2520duration%2520of%2520hormone%2520exposure%26jtitle%3DBone%26date%3D2003%26volume%3D33%26spage%3D372%26epage%3D379" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit19c"><span><span class="NLM_contrib-group">Onyia, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Helvering, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelbert, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dow, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maran, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lotinun, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halladay, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miles, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kulkarni, N. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ambrose, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, Y. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frolik, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bryant, H. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, R. T.</span><span> </span><span class="NLM_article-title">Molecular profile of catabolic versus anabolic treatment regimens of parathyroid hormone (PTH) in rat bone: an analysis of DNA microarray</span> <span class="citation_source-journal">J. Cell. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x">, </span> <span class="NLM_fpage">403</span><span class="NLM_x">–</span> <span class="NLM_lpage">418</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2005&pages=403-418&author=J.+E.+Onyiaauthor=L.+M.+Helveringauthor=L.+Gelbertauthor=T.+Weiauthor=S.+Huangauthor=P.+Chenauthor=E.+R.+Dowauthor=A.+Maranauthor=M.+Zhangauthor=S.+Lotinunauthor=D.+L.+Halladayauthor=R.+R.+Milesauthor=N.+H.+Kulkarniauthor=E.+M.+Ambroseauthor=Y.+L.+Maauthor=C.+A.+Frolikauthor=M.+Satoauthor=H.+U.+Bryantauthor=R.+T.+Turner&title=Molecular+profile+of+catabolic+versus+anabolic+treatment+regimens+of+parathyroid+hormone+%28PTH%29+in+rat+bone%3A+an+analysis+of+DNA+microarray"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOnyia%26aufirst%3DJ.%2BE.%26aulast%3DHelvering%26aufirst%3DL.%2BM.%26aulast%3DGelbert%26aufirst%3DL.%26aulast%3DWei%26aufirst%3DT.%26aulast%3DHuang%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DP.%26aulast%3DDow%26aufirst%3DE.%2BR.%26aulast%3DMaran%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DLotinun%26aufirst%3DS.%26aulast%3DHalladay%26aufirst%3DD.%2BL.%26aulast%3DMiles%26aufirst%3DR.%2BR.%26aulast%3DKulkarni%26aufirst%3DN.%2BH.%26aulast%3DAmbrose%26aufirst%3DE.%2BM.%26aulast%3DMa%26aufirst%3DY.%2BL.%26aulast%3DFrolik%26aufirst%3DC.%2BA.%26aulast%3DSato%26aufirst%3DM.%26aulast%3DBryant%26aufirst%3DH.%2BU.%26aulast%3DTurner%26aufirst%3DR.%2BT.%26atitle%3DMolecular%2520profile%2520of%2520catabolic%2520versus%2520anabolic%2520treatment%2520regimens%2520of%2520parathyroid%2520hormone%2520%2528PTH%2529%2520in%2520rat%2520bone%253A%2520an%2520analysis%2520of%2520DNA%2520microarray%26jtitle%3DJ.%2520Cell.%2520Biochem.%26date%3D2005%26volume%3D95%26spage%3D403%26epage%3D418" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Fraher, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klein, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marier, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freeman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hendy, G. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glotzman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hodsman, A. B.</span><span> </span><span class="NLM_article-title">Comparison of the pharmacokinetics of parenteral parathyroid hormone-(1−34) [PTH-(1-34)] and PTH-related peptide-(1-34) in healthy young humans</span> <span class="citation_source-journal">J. Clin. Endocr. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">80</span><span class="NLM_x">, </span> <span class="NLM_fpage">60</span><span class="NLM_x">–</span> <span class="NLM_lpage">64</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm900364m&amp;key=10.1210%2Fjc.80.1.60" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm900364m&amp;key=7829640" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm900364m&amp;key=1%3ACAS%3A528%3ADyaK2MXjt1OktL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=1995&pages=60-64&author=L.+J.+Fraherauthor=K.+Kleinauthor=R.+Marierauthor=D.+Freemanauthor=G.+N.+Hendyauthor=D.+Glotzmanauthor=A.+B.+Hodsman&title=Comparison+of+the+pharmacokinetics+of+parenteral+parathyroid+hormone-%281%E2%88%9234%29+%5BPTH-%281-34%29%5D+and+PTH-related+peptide-%281-34%29+in+healthy+young+humans"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison of the pharmacokinetics of parenteral parathyroid hormone-(1-34) [PTH-(1-34)] and PTH-related peptide-(1-34) in healthy young humans</span></div><div class="casAuthors">Fraher, L. J.; Klein, K.; Marier, R.; Freeman, D.; Hendy, G. N.; Goltzman, D.; Hodsman, A. B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Endocrinology and Metabolism</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">60-4</span>CODEN:
                <span class="NLM_cas:coden">JCEMAZ</span>;
        ISSN:<span class="NLM_cas:issn">0021-972X</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">The amino-terminal fragments of human PTH[hPTH-(1-34)] and PTH-related peptide [PTHrP-(1-34)] appear to be equipotent in several rodent models.  However, continuous i.v. infusions of these peptides to young human volunteers suggested that a 10-fold higher molar dose of PTHrP was required to produce comparable circulating levels of the peptide and biochem. responses similar to PTH.  As PTHrP has a wide variety of target tissues in mammalian species and may, therefore, play a paracrine, rather than an endocrine, hormonal role in vivo, we evaluated whether enhanced metabolic clearance of injected PTHrP might explain its apparently reduced potency as a PTH-like hormone.  Ten healthy subjects [age, 25 yr] received in random order either hPTH-(1-34) or hPTHrP-(1-34) given by bolus i.v. injections in a dose of 10.7 nmol.  Measurements of plasma immunoreactive peptide indicated a comparable vol. of distribution for each, but the apparent t1/2 (8.3 min) and plasma clearance (4.0 L/min) for hPTHrP were accelerated compared to those of hPTH (t1/2, 10.2 min; clearance, 2.0 L/min).  Peak plasma cAMP levels were 9-fold lower in response to hPTHrP (29.5 vs. 190 pmol/L), and increases in urinary cAMP excretion were 5-fold lower (2.1 vs. 11.2 nmol/mmol creatine).  No major differences were obsd. in the urinary excretion of phosphate, Ca, or Na between the two peptides.  Although hPTHrP-(1-34) has a 2-fold higher MCR than hPTH-(1-34), this may not explain the more than 5-fold lower plasma or urinary cAMP response to PTHrP in humans.  The comparable effects of PTH and PTHrP on urinary phosphate, Ca, and Na may indicate a non-cAMP-dependent pathway for these responses, although the intracellular pool of cAMP generated to either peptide, and thus the local target tissue response, could not be estd. in the present study.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHfoMHmij3ybVg90H21EOLACvtfcHk0lhx1d-oD3Oe1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXjt1OktL4%253D&md5=f684656f2b98fa5c1fd4876d1a78aa64</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1210%2Fjc.80.1.60&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fjc.80.1.60%26sid%3Dliteratum%253Aachs%26aulast%3DFraher%26aufirst%3DL.%2BJ.%26aulast%3DKlein%26aufirst%3DK.%26aulast%3DMarier%26aufirst%3DR.%26aulast%3DFreeman%26aufirst%3DD.%26aulast%3DHendy%26aufirst%3DG.%2BN.%26aulast%3DGlotzman%26aufirst%3DD.%26aulast%3DHodsman%26aufirst%3DA.%2BB.%26atitle%3DComparison%2520of%2520the%2520pharmacokinetics%2520of%2520parenteral%2520parathyroid%2520hormone-%25281%25E2%2588%259234%2529%2520%255BPTH-%25281-34%2529%255D%2520and%2520PTH-related%2520peptide-%25281-34%2529%2520in%2520healthy%2520young%2520humans%26jtitle%3DJ.%2520Clin.%2520Endocr.%2520Metab.%26date%3D1995%26volume%3D80%26spage%3D60%26epage%3D64" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit20a"><span><span class="NLM_contrib-group">Revel, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sorbera, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, L.</span><span> </span><span class="NLM_article-title">Teriparatide: treatment of osteoporosis parathyroid hormone analog</span> <span class="citation_source-journal">Drugs Future</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">803</span><span class="NLM_x">–</span> <span class="NLM_lpage">808</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20a&amp;dbid=16&amp;doi=10.1021%2Fjm900364m&amp;key=10.1358%2Fdof.2000.025.08.589014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20a&amp;dbid=32&amp;doi=10.1021%2Fjm900364m&amp;key=1%3ACAS%3A528%3ADC%252BD3cXnvV2msL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2000&pages=803-808&author=L.+Revelauthor=L.+A.+Sorberaauthor=L.+Martin&title=Teriparatide%3A+treatment+of+osteoporosis+parathyroid+hormone+analog"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20aR"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Teriparatide: Treatment of osteoporosis parathyroid hormone analog</span></div><div class="casAuthors">Revel, L.; Sorbera, L. A.; Martin, L.</div><div class="citationInfo"><span class="NLM_cas:title">Drugs of the Future</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">803-808</span>CODEN:
                <span class="NLM_cas:coden">DRFUD4</span>;
        ISSN:<span class="NLM_cas:issn">0377-8282</span>.
    
            (<span class="NLM_cas:orgname">Prous Science</span>)
        </div><div class="casAbstract">A review with 25 refs. on the pharmacol., pharmacokinetics and clin. studies of teriparatide in patients with osteoporosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGquunAG-KMkQbVg90H21EOLACvtfcHk0lgWOQkwAgF8BQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXnvV2msL4%253D&md5=d7391aff52d08e8b247886dd08db6592</span></div><a href="/servlet/linkout?suffix=cit20a&amp;dbid=16384&amp;doi=10.1358%2Fdof.2000.025.08.589014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1358%252Fdof.2000.025.08.589014%26sid%3Dliteratum%253Aachs%26aulast%3DRevel%26aufirst%3DL.%26aulast%3DSorbera%26aufirst%3DL.%2BA.%26aulast%3DMartin%26aufirst%3DL.%26atitle%3DTeriparatide%253A%2520treatment%2520of%2520osteoporosis%2520parathyroid%2520hormone%2520analog%26jtitle%3DDrugs%2520Future%26date%3D2000%26volume%3D25%26spage%3D803%26epage%3D808" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Nemeth, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steffey, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hammerland, L. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hung, B. C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Wagenen, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DelMar, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balandrin, M. F.</span><span> </span><span class="NLM_article-title">Calcimimetics with potent and selective activity on the parathyroid calcium receptor</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x">, </span> <span class="NLM_fpage">4040</span><span class="NLM_x">–</span> <span class="NLM_lpage">4045</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=1998&pages=4040-4045&author=E.+F.+Nemethauthor=M.+E.+Steffeyauthor=L.+G.+Hammerlandauthor=B.+C.+P.+Hungauthor=B.+C.+van+Wagenenauthor=E.+G.+DelMarauthor=M.+F.+Balandrin&title=Calcimimetics+with+potent+and+selective+activity+on+the+parathyroid+calcium+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNemeth%26aufirst%3DE.%2BF.%26aulast%3DSteffey%26aufirst%3DM.%2BE.%26aulast%3DHammerland%26aufirst%3DL.%2BG.%26aulast%3DHung%26aufirst%3DB.%2BC.%2BP.%26aulast%3Dvan%2BWagenen%26aufirst%3DB.%2BC.%26aulast%3DDelMar%26aufirst%3DE.%2BG.%26aulast%3DBalandrin%26aufirst%3DM.%2BF.%26atitle%3DCalcimimetics%2520with%2520potent%2520and%2520selective%2520activity%2520on%2520the%2520parathyroid%2520calcium%2520receptor%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1998%26volume%3D95%26spage%3D4040%26epage%3D4045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Crivori, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poggesi, I.</span><span> </span><span class="NLM_article-title">Predictive model for identifying potential CYP2D6 Inhibitors</span> <span class="citation_source-journal">Basic Clin. Pharm. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">96</span><span class="NLM_x">, </span> <span class="NLM_fpage">251</span><span class="NLM_x">–</span> <span class="NLM_lpage">253</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm900364m&amp;key=10.1111%2Fj.1742-7843.2005.pto960320.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm900364m&amp;key=15733226" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm900364m&amp;key=1%3ACAS%3A528%3ADC%252BD2MXisFSlsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=2005&pages=251-253&author=P.+Crivoriauthor=I.+Poggesi&title=Predictive+model+for+identifying+potential+CYP2D6+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Predictive model for identifying potential CYP2D6 inhibitors</span></div><div class="casAuthors">Crivori, Patrizia; Poggesi, Italo</div><div class="citationInfo"><span class="NLM_cas:title">Basic & Clinical Pharmacology & Toxicology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">251-253</span>CODEN:
                <span class="NLM_cas:coden">BCPTBO</span>;
        ISSN:<span class="NLM_cas:issn">1742-7835</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A model for predicting the cytochrome P 450 2D6 (CYP2D6) inhibition potential based on the mol. structures of drug candidates was developed and evaluated using Almond program.  The QSPR model was developed by correlating the exptl. inhibition consts. with the unscaled descriptors calcd. for all conformers generated for the training set.  GRIND descriptors appear to be a valuable tool for modeling CYP2D6 inhibitors.  Although the exptl. data utilized to train the model comes from different labs, the GRIND-based model appears robust and useful to predict CYP2D6 inhibition consts. of external sets of compds.  The performance of this model is at least as good as that reported for other computational models of CYP2D6 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoK2FQqoXFbirVg90H21EOLACvtfcHk0lgWOQkwAgF8BQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXisFSlsrY%253D&md5=0fda143645d8ff0a469957247294c70c</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1111%2Fj.1742-7843.2005.pto960320.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1742-7843.2005.pto960320.x%26sid%3Dliteratum%253Aachs%26aulast%3DCrivori%26aufirst%3DP.%26aulast%3DPoggesi%26aufirst%3DI.%26atitle%3DPredictive%2520model%2520for%2520identifying%2520potential%2520CYP2D6%2520Inhibitors%26jtitle%3DBasic%2520Clin.%2520Pharm.%2520Toxicol.%26date%3D2005%26volume%3D96%26spage%3D251%26epage%3D253" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit22a"><span><span class="NLM_contrib-group">Ekins, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gianpaolo, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Binkley, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillespie, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ring, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winkel, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wrighton, S. A.</span><span> </span><span class="NLM_article-title">Three- and four dimensional-quantitative structure−activity relationship (3D/4D-QSAR) analyses of CYP2D6 inhibitors</span> <span class="citation_source-journal">Pharmacogenetics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">477</span><span class="NLM_x">–</span> <span class="NLM_lpage">489</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22a&amp;dbid=8&amp;doi=10.1021%2Fjm900364m&amp;key=10780267" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22a&amp;dbid=32&amp;doi=10.1021%2Fjm900364m&amp;key=1%3ACAS%3A528%3ADyaK1MXmtlGjs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1999&pages=477-489&author=S.+Ekinsauthor=B.+Gianpaoloauthor=S.+Binkleyauthor=J.+S.+Gillespieauthor=B.+J.+Ringauthor=J.+H.+Winkelauthor=S.+A.+Wrighton&title=Three-+and+four+dimensional-quantitative+structure%E2%88%92activity+relationship+%283D%2F4D-QSAR%29+analyses+of+CYP2D6+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22aR"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Three and four dimensional-quantitative structure activity relationship (3D/4D-QSAR) analyses of CYP2D6 inhibitors</span></div><div class="casAuthors">Ekins, Sean; Bravi, Gianpaolo; Binkley, Shelly; Gillespie, Jennifer S.; Ring, Barbara J.; Wikel, James H.; Wrighton, Steven A.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacogenetics</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">477-489</span>CODEN:
                <span class="NLM_cas:coden">PHMCEE</span>;
        ISSN:<span class="NLM_cas:issn">0960-314X</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Three- and four-dimensional quant. structure activity relationship (3D/4D-QSAR) pharmacophore models of competitive inhibitors of CYP2D6 were constructed using data from our lab. or the literature.  The 3D-QSAR pharmacophore models of the common structural features of CYP2D6 inhibitors were built using the program Catalyst (Mol. Simulations, San Diego, CA, USA).  These 3D-QSAR models were compared with 3D and 4D-QSAR partial least squares (PLS) models which were constructed using mol. surface-weighted holistic invariant mol. (MS-WHIM) descriptors of size and shape of inhibitors.  The first Catalyst model was generated from multiple conformers of competitive inhibitors (n = 20) of CYP2D6 mediated bufurolol 1'-hydroxylation.  This model demonstrated a correlation of obsd. and predicted Ki (apparent) values of r = 0.75.  A second Catalyst model was constructed from literature derived Ki (apparent) values (n = 31) for the inhibition of CYP2D6.  This model provided a correlation of obsd. and predicted inhibition for CYP2D6 of r = 0.91.  Both Catalyst Ki pharmacophores were then validated by predicting the Ki (apparent) of a test set of known CYP2D6 inhibitors (n = 15).  Ten out of 15 of these Ki (apparent) values were predicted to be within one log residual of the obsd. value using our CYP2D6 inhibitor model, while the literature model predicted nine out of 15 values.  Similarly, 3D- and 4D-QSARs derived from PLS MS-WHIM for our dataset yielded predictable models as assessed using cross-validation.  The corresponding cross-validated PLS MS-WHIM model for the literature dataset yielded a comparable 3D-QSAR and improved 4D-QSAR value.  Such computational models will aid in future prediction of drug-drug interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcRiE7XUQvY7Vg90H21EOLACvtfcHk0lgWOQkwAgF8BQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmtlGjs7w%253D&md5=b714320963218c19c858e31376b9b528</span></div><a href="/servlet/linkout?suffix=cit22a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEkins%26aufirst%3DS.%26aulast%3DGianpaolo%26aufirst%3DB.%26aulast%3DBinkley%26aufirst%3DS.%26aulast%3DGillespie%26aufirst%3DJ.%2BS.%26aulast%3DRing%26aufirst%3DB.%2BJ.%26aulast%3DWinkel%26aufirst%3DJ.%2BH.%26aulast%3DWrighton%26aufirst%3DS.%2BA.%26atitle%3DThree-%2520and%2520four%2520dimensional-quantitative%2520structure%25E2%2588%2592activity%2520relationship%2520%25283D%252F4D-QSAR%2529%2520analyses%2520of%2520CYP2D6%2520inhibitors%26jtitle%3DPharmacogenetics%26date%3D1999%26volume%3D9%26spage%3D477%26epage%3D489" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit22b"><span><span class="NLM_contrib-group">De Groot, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ackland, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horne, V. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alex, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, B. C.</span><span> </span><span class="NLM_article-title">Novel approach to predicting P450-mediated drug metabolism: development of a combined protein and pharmacophore model for CYP2D6</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">1515</span><span class="NLM_x">–</span> <span class="NLM_lpage">1524</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm981118h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=1515-1524&author=M.+J.+De+Grootauthor=M.+J.+Acklandauthor=V.+A.+Horneauthor=A.+A.+Alexauthor=B.+C.+Jones&title=Novel+approach+to+predicting+P450-mediated+drug+metabolism%3A+development+of+a+combined+protein+and+pharmacophore+model+for+CYP2D6"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22b&amp;dbid=16384&amp;doi=10.1021%2Fjm981118h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm981118h%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BGroot%26aufirst%3DM.%2BJ.%26aulast%3DAckland%26aufirst%3DM.%2BJ.%26aulast%3DHorne%26aufirst%3DV.%2BA.%26aulast%3DAlex%26aufirst%3DA.%2BA.%26aulast%3DJones%26aufirst%3DB.%2BC.%26atitle%3DNovel%2520approach%2520to%2520predicting%2520P450-mediated%2520drug%2520metabolism%253A%2520development%2520of%2520a%2520combined%2520protein%2520and%2520pharmacophore%2520model%2520for%2520CYP2D6%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26spage%3D1515%26epage%3D1524" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit22d"><span><span class="NLM_contrib-group">Rowland, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blaney, F. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smyth, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leydon, V. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oxbrow, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tennant, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Modi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eggleston, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chenery, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridges, A. M.</span><span> </span><span class="NLM_article-title">Crystal structure of the human cytochrome P450 2D6</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">281</span><span class="NLM_x">, </span> <span class="NLM_fpage">7614</span><span class="NLM_x">–</span> <span class="NLM_lpage">7622</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2006&pages=7614-7622&author=P.+Rowlandauthor=F.+E.+Blaneyauthor=M.+G.+Smythauthor=J.+J.+Jonesauthor=V.+R.+Leydonauthor=A.+K.+Oxbrowauthor=C.+J.+Lewisauthor=M.+G.+Tennantauthor=S.+Modiauthor=D.+S.+Egglestonauthor=R.+J.+Cheneryauthor=A.+M.+Bridges&title=Crystal+structure+of+the+human+cytochrome+P450+2D6"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRowland%26aufirst%3DP.%26aulast%3DBlaney%26aufirst%3DF.%2BE.%26aulast%3DSmyth%26aufirst%3DM.%2BG.%26aulast%3DJones%26aufirst%3DJ.%2BJ.%26aulast%3DLeydon%26aufirst%3DV.%2BR.%26aulast%3DOxbrow%26aufirst%3DA.%2BK.%26aulast%3DLewis%26aufirst%3DC.%2BJ.%26aulast%3DTennant%26aufirst%3DM.%2BG.%26aulast%3DModi%26aufirst%3DS.%26aulast%3DEggleston%26aufirst%3DD.%2BS.%26aulast%3DChenery%26aufirst%3DR.%2BJ.%26aulast%3DBridges%26aufirst%3DA.%2BM.%26atitle%3DCrystal%2520structure%2520of%2520the%2520human%2520cytochrome%2520P450%25202D6%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2006%26volume%3D281%26spage%3D7614%26epage%3D7622" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Mitcheson, J. S.</span><span> </span><span class="NLM_article-title">hERG potassium channels and the structural basis of drug-induced arrhythmias</span> <span class="citation_source-journal">Chem. Res. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">1005</span><span class="NLM_x">–</span> <span class="NLM_lpage">1010</span></span><div class="citationLinks">[<a href="/doi/10.1021/tx800035b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2008&pages=1005-1010&author=J.+S.+Mitcheson&title=hERG+potassium+channels+and+the+structural+basis+of+drug-induced+arrhythmias"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Ftx800035b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx800035b%26sid%3Dliteratum%253Aachs%26aulast%3DMitcheson%26aufirst%3DJ.%2BS.%26atitle%3DhERG%2520potassium%2520channels%2520and%2520the%2520structural%2520basis%2520of%2520drug-induced%2520arrhythmias%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2008%26volume%3D21%26spage%3D1005%26epage%3D1010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit23a"><span><span class="NLM_contrib-group">Kramer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beck, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kriegel, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, T.</span><span> </span><span class="NLM_article-title">A composite model for hERG blockade</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">254</span><span class="NLM_x">–</span> <span class="NLM_lpage">265</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2008&pages=254-265&author=C.+Kramerauthor=B.+Beckauthor=J.+M.+Kriegelauthor=T.+Clark&title=A+composite+model+for+hERG+blockade"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKramer%26aufirst%3DC.%26aulast%3DBeck%26aufirst%3DB.%26aulast%3DKriegel%26aufirst%3DJ.%2BM.%26aulast%3DClark%26aufirst%3DT.%26atitle%3DA%2520composite%2520model%2520for%2520hERG%2520blockade%26jtitle%3DChemMedChem%26date%3D2008%26volume%3D3%26spage%3D254%26epage%3D265" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit23b"><span><span class="NLM_contrib-group">Stansfeld, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gedeck, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gosling, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitcheson, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutcliffe, M. J.</span><span> </span><span class="NLM_article-title">Drug block of the hERG potassium channel: insights from modeling</span> <span class="citation_source-journal">Proteins: Struct., Funct., Bioinf.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">568</span><span class="NLM_x">–</span> <span class="NLM_lpage">580</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2007&pages=568-580&author=P.+J.+Stansfeldauthor=P.+Gedeckauthor=M.+Goslingauthor=B.+Coxauthor=J.+S.+Mitchesonauthor=M.+J.+Sutcliffe&title=Drug+block+of+the+hERG+potassium+channel%3A+insights+from+modeling"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStansfeld%26aufirst%3DP.%2BJ.%26aulast%3DGedeck%26aufirst%3DP.%26aulast%3DGosling%26aufirst%3DM.%26aulast%3DCox%26aufirst%3DB.%26aulast%3DMitcheson%26aufirst%3DJ.%2BS.%26aulast%3DSutcliffe%26aufirst%3DM.%2BJ.%26atitle%3DDrug%2520block%2520of%2520the%2520hERG%2520potassium%2520channel%253A%2520insights%2520from%2520modeling%26jtitle%3DProteins%253A%2520Struct.%252C%2520Funct.%252C%2520Bioinf.%26date%3D2007%26volume%3D68%26spage%3D568%26epage%3D580" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit23c"><span><span class="NLM_contrib-group">Sanguinetti, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tristani-Firouzi, M.</span><span> </span><span class="NLM_article-title">hERG potassium channels and cardiac arrhythmia</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">440</span><span class="NLM_x">, </span> <span class="NLM_fpage">463</span><span class="NLM_x">–</span> <span class="NLM_lpage">469</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23c&amp;dbid=16&amp;doi=10.1021%2Fjm900364m&amp;key=10.1038%2Fnature04710" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23c&amp;dbid=8&amp;doi=10.1021%2Fjm900364m&amp;key=16554806" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23c&amp;dbid=32&amp;doi=10.1021%2Fjm900364m&amp;key=1%3ACAS%3A528%3ADC%252BD28Xis1OlsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=440&publication_year=2006&pages=463-469&author=M.+C.+Sanguinettiauthor=M.+Tristani-Firouzi&title=hERG+potassium+channels+and+cardiac+arrhythmia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23cR"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">hERG potassium channels and cardiac arrhythmia</span></div><div class="casAuthors">Sanguinetti, Michael C.; Tristani-Firouzi, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">440</span>
        (<span class="NLM_cas:issue">7083</span>),
    <span class="NLM_cas:pages">463-469</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  HERG potassium channels are essential for normal elec. activity in the heart.  Inherited mutations in the HERG gene cause long QT syndrome, a disorder that predisposes individuals to life-threatening arrhythmias.  Arrhythmia can also be induced by a blockage of hERG channels by a surprisingly diverse group of drugs.  This side effect is a common reason for drug failure in preclin. safety trials.  Insights gained from the crystal structures of other potassium channels have helped our understanding of the block of hERG channels and the mechanisms of gating.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopS3WBEpuAUrVg90H21EOLACvtfcHk0ljhYjIEqfJBZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xis1OlsLs%253D&md5=3f355dcd51da3488d73c7c91cbe8d3b8</span></div><a href="/servlet/linkout?suffix=cit23c&amp;dbid=16384&amp;doi=10.1038%2Fnature04710&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature04710%26sid%3Dliteratum%253Aachs%26aulast%3DSanguinetti%26aufirst%3DM.%2BC.%26aulast%3DTristani-Firouzi%26aufirst%3DM.%26atitle%3DhERG%2520potassium%2520channels%2520and%2520cardiac%2520arrhythmia%26jtitle%3DNature%26date%3D2006%26volume%3D440%26spage%3D463%26epage%3D469" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit23d"><span><span class="NLM_contrib-group">Sanguinetti, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitcheson, J. S.</span><span> </span><span class="NLM_article-title">Predicting drug−hERG channel interactions that cause acquired long QT syndrome</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">119</span><span class="NLM_x">–</span> <span class="NLM_lpage">124</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2005&pages=119-124&author=M.+C.+Sanguinettiauthor=J.+S.+Mitcheson&title=Predicting+drug%E2%88%92hERG+channel+interactions+that+cause+acquired+long+QT+syndrome"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSanguinetti%26aufirst%3DM.%2BC.%26aulast%3DMitcheson%26aufirst%3DJ.%2BS.%26atitle%3DPredicting%2520drug%25E2%2588%2592hERG%2520channel%2520interactions%2520that%2520cause%2520acquired%2520long%2520QT%2520syndrome%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2005%26volume%3D26%26spage%3D119%26epage%3D124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit23e"><span><span class="NLM_contrib-group">Fernandez, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghanta, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kauffman, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanguinetti, M. C.</span><span> </span><span class="NLM_article-title">Physiochemical features of the hERG channel binding site</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x">, </span> <span class="NLM_fpage">10120</span><span class="NLM_x">–</span> <span class="NLM_lpage">10127</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=10120-10127&author=D.+Fernandezauthor=A.+Ghantaauthor=G.+W.+Kauffmanauthor=M.+C.+Sanguinetti&title=Physiochemical+features+of+the+hERG+channel+binding+site"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFernandez%26aufirst%3DD.%26aulast%3DGhanta%26aufirst%3DA.%26aulast%3DKauffman%26aufirst%3DG.%2BW.%26aulast%3DSanguinetti%26aufirst%3DM.%2BC.%26atitle%3DPhysiochemical%2520features%2520of%2520the%2520hERG%2520channel%2520binding%2520site%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D10120%26epage%3D10127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Tonioli, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crisma, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Formaggio, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peggion, C.</span><span> </span><span class="NLM_article-title">Control of peptide conformation by the Thorpe-Ingold effect (C-α tetrasubstitution)</span> <span class="citation_source-journal">Biopolymers</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">396</span><span class="NLM_x">–</span> <span class="NLM_lpage">419</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2001&pages=396-419&author=C.+Tonioliauthor=M.+Crismaauthor=F.+Formaggioauthor=C.+Peggion&title=Control+of+peptide+conformation+by+the+Thorpe-Ingold+effect+%28C-%CE%B1+tetrasubstitution%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTonioli%26aufirst%3DC.%26aulast%3DCrisma%26aufirst%3DM.%26aulast%3DFormaggio%26aufirst%3DF.%26aulast%3DPeggion%26aufirst%3DC.%26atitle%3DControl%2520of%2520peptide%2520conformation%2520by%2520the%2520Thorpe-Ingold%2520effect%2520%2528C-%25CE%25B1%2520tetrasubstitution%2529%26jtitle%3DBiopolymers%26date%3D2001%26volume%3D60%26spage%3D396%26epage%3D419" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><div class="note"><p class="first last">The conformational search of global energy minima for analogs <b>7</b> and <b>22</b> were carried out using the BatchMin module in Maestro. The conformational space was explored by 2000 iterations of Monte Carlo multiple minimum (MCMM) torsional angle sampling procedure in BatchMin, and the energy of each conformation was determined by the OPLS-2005 force field in GB/SA water solvation model.</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=The+conformational+search+of+global+energy+minima+for+analogs+7+and+22+were+carried+out+using+the+BatchMin+module+in+Maestro.+The+conformational+space+was+explored+by+2000+iterations+of+Monte+Carlo+multiple+minimum+%28MCMM%29+torsional+angle+sampling+procedure+in+BatchMin%2C+and+the+energy+of+each+conformation+was+determined+by+the+OPLS-2005+force+field+in+GB%2FSA+water+solvation+model."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Easson, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stedman, E.</span><span> </span><span class="NLM_article-title">Studies on the relationship between chemical constitution and physiological action. V. Molecular dissymmetry and physiological activity</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1933</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">1257</span><span class="NLM_x">–</span> <span class="NLM_lpage">1266</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=1933&pages=1257-1266&author=L.+H.+Eassonauthor=E.+Stedman&title=Studies+on+the+relationship+between+chemical+constitution+and+physiological+action.+V.+Molecular+dissymmetry+and+physiological+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEasson%26aufirst%3DL.%2BH.%26aulast%3DStedman%26aufirst%3DE.%26atitle%3DStudies%2520on%2520the%2520relationship%2520between%2520chemical%2520constitution%2520and%2520physiological%2520action.%2520V.%2520Molecular%2520dissymmetry%2520and%2520physiological%2520activity%26jtitle%3DBiochem.%2520J.%26date%3D1933%26volume%3D31%26spage%3D1257%26epage%3D1266" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit26a"><span><span class="NLM_contrib-group">Testa, B.</span><span> </span><span class="NLM_article-title">Mechanisms of chiral recognition in pharmacology</span> <span class="citation_source-journal">Acta Pharm. Nord.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">137</span><span class="NLM_x">–</span> <span class="NLM_lpage">143</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26a&amp;dbid=32&amp;doi=10.1021%2Fjm900364m&amp;key=1%3ACAS%3A528%3ADyaK3cXlvVCjt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1990&pages=137-143&author=B.+Testa&title=Mechanisms+of+chiral+recognition+in+pharmacology"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26aR"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms of chiral recognition in pharmacology.  The Easson-Stedman model revisited</span></div><div class="casAuthors">Testa, Bernard</div><div class="citationInfo"><span class="NLM_cas:title">Acta Pharmaceutica Nordica</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">137-44</span>CODEN:
                <span class="NLM_cas:coden">APNOEE</span>;
        ISSN:<span class="NLM_cas:issn">1100-1801</span>.
    </div><div class="casAbstract">A review with 30 refs.  The three-point attachment Easson-Stedman model is critically examd. and its limitations discussed.  Four proposals are formulated to render it more realistic in terms of binding interactions and mechanisms of chiral recognition.  The ligand should be viewed as a stereo-electronic pharmacophore, one of the interactions may be a repulsive one, the model could be rendered quant. by incorporating intrinsic binding energies of functional groups; and chiral recognition in the activation step can be depicted by viewing one of the sites as a trigger/catalytic group.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlZPKeSJtuP7Vg90H21EOLACvtfcHk0lg4YFUEFXQI1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXlvVCjt7s%253D&md5=7339a86e59c08ae82aad8a0933f4206a</span></div><a href="/servlet/linkout?suffix=cit26a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTesta%26aufirst%3DB.%26atitle%3DMechanisms%2520of%2520chiral%2520recognition%2520in%2520pharmacology%26jtitle%3DActa%2520Pharm.%2520Nord.%26date%3D1990%26volume%3D2%26spage%3D137%26epage%3D143" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit26b"><span><span class="NLM_contrib-group">Ruffolo, Jr., R. R.</span><span> </span><span class="NLM_article-title">Chirality in α-and β-adrenoreceptor agonists and antagonists</span>. Tetrahedron<span class="NLM_x"> </span><span class="NLM_year">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">9953</span><span class="NLM_x">–</span> <span class="NLM_lpage">9980</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1991&author=R.+R.+Ruffolo%2C+Jr.&title=Chirality+in+%CE%B1-and+%CE%B2-adrenoreceptor+agonists+and+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DRuffolo%252C%2BJr.%26aufirst%3DR.%2BR.%26atitle%3DChirality%2520in%2520%25CE%25B1-and%2520%25CE%25B2-adrenoreceptor%2520agonists%2520and%2520antagonists%26jtitle%3DTetrahedron%26date%3D1991%26volume%3D47%26spage%3D9953%26epage%3D9980" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="ref27_1"><span><span class="NLM_contrib-group">Rogers, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunn, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hebert, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nemeth, E.</span><span> </span><span class="NLM_article-title">Pharmacological comparison of bovine parathyroid, human parathyroid, and rat kidney calcium receptors expressed in HEK 293 cells</span> <span class="citation_source-journal">J. Bone Miner. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl. 1</span><span class="NLM_x">) </span> <span class="NLM_fpage">S483</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=1995&pages=S483&issue=Suppl.+1&author=K.+Rogersauthor=C.+Dunnauthor=S.+Hebertauthor=E.+Brownauthor=E.+Nemeth&title=Pharmacological+comparison+of+bovine+parathyroid%2C+human+parathyroid%2C+and+rat+kidney+calcium+receptors+expressed+in+HEK+293+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=ref27_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRogers%26aufirst%3DK.%26aulast%3DDunn%26aufirst%3DC.%26aulast%3DHebert%26aufirst%3DS.%26aulast%3DBrown%26aufirst%3DE.%26aulast%3DNemeth%26aufirst%3DE.%26atitle%3DPharmacological%2520comparison%2520of%2520bovine%2520parathyroid%252C%2520human%2520parathyroid%252C%2520and%2520rat%2520kidney%2520calcium%2520receptors%2520expressed%2520in%2520HEK%2520293%2520cells%26jtitle%3DJ.%2520Bone%2520Miner.%2520Res.%26date%3D1995%26volume%3D10%26issue%3DSuppl.%25201%26spage%3DS483" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2','cit2a'],'ref3':['cit3','cit3a','cit3b','cit3c','cit3d','cit3e','cit3f','cit3g'],'ref4':['cit4','cit4a','cit4b','cit4c'],'ref5':['cit5','cit5a','cit5b','cit5c','cit5d'],'ref6':['cit6','cit6a','cit6b','cit6c','cit6d'],'ref7':['cit7','cit7a','cit7b'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19','cit19a','cit19b','cit19c'],'ref20':['cit20','cit20a'],'ref21':['cit21'],'ref22':['cit22','cit22a','cit22b','cit22d'],'ref23':['cit23','cit23a','cit23b','cit23c','cit23d','cit23e'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26','cit26a','cit26b'],'ref27':['ref27_1']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 22 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Birgit
I. Gaiser, Mia Danielsen, Emil Marcher-Rørsted, Kira Røpke Jørgensen, Tomasz M. Wróbel, Mikael Frykman, Henrik Johansson, Hans Bräuner-Osborne, David E. Gloriam, Jesper Mosolff Mathiesen, <span class="NLM_string-name hlFld-ContribAuthor">Daniel Sejer Pedersen</span>. </span><span class="cited-content_cbyCitation_article-title">Probing the Existence of a Metastable Binding Site at the β2-Adrenergic Receptor with Homobivalent Bitopic Ligands. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (17)
                                     , 7806-7839. <a href="https://doi.org/10.1021/acs.jmedchem.9b00595" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00595</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00595&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00595%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DProbing%252Bthe%252BExistence%252Bof%252Ba%252BMetastable%252BBinding%252BSite%252Bat%252Bthe%252B%2525CE%2525B22-Adrenergic%252BReceptor%252Bwith%252BHomobivalent%252BBitopic%252BLigands%26aulast%3DGaiser%26aufirst%3DBirgit%2BI.%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D06042019%26date%3D15082019%26date%3D12072019%26volume%3D62%26issue%3D17%26spage%3D7806%26epage%3D7839" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wenhua  Ou</span>, <span class="hlFld-ContribAuthor ">Sandraliz  Espinosa</span>, <span class="hlFld-ContribAuthor ">Héctor J.  Meléndez</span>, <span class="hlFld-ContribAuthor ">Silvia M.  Farré</span>, <span class="hlFld-ContribAuthor ">Jaime L.  Alvarez</span>, <span class="hlFld-ContribAuthor ">Valerie  Torres</span>, <span class="hlFld-ContribAuthor ">Ileanne  Martínez</span>, <span class="hlFld-ContribAuthor ">Kiara M.  Santiago</span>, and <span class="hlFld-ContribAuthor ">Margarita  Ortiz-Marciales</span>  . </span><span class="cited-content_cbyCitation_article-title">Asymmetric Synthesis of Nonracemic Primary Amines via Spiroborate-Catalyzed Reduction of Pure (E)- and (Z)-O-Benzyloximes: Applications toward the Synthesis of Calcimimetic Agents. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2013,</strong> <em>78 </em>
                                    (11)
                                     , 5314-5327. <a href="https://doi.org/10.1021/jo400371x" title="DOI URL">https://doi.org/10.1021/jo400371x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jo400371x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjo400371x%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DAsymmetric%252BSynthesis%252Bof%252BNonracemic%252BPrimary%252BAmines%252Bvia%252BSpiroborate-Catalyzed%252BReduction%252Bof%252BPure%252B%252528E%252529-%252Band%252B%252528Z%252529-O-Benzyloximes%25253A%252BApplications%252Btoward%252Bthe%252BSynthesis%252Bof%252BCalcimimetic%252BAgents%26aulast%3DOu%26aufirst%3DWenhua%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D04032013%26date%3D13052013%26date%3D07062013%26date%3D02052013%26volume%3D78%26issue%3D11%26spage%3D5314%26epage%3D5327" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">John G.  Allen</span>, <span class="hlFld-ContribAuthor ">Christopher  Fotsch</span> and <span class="hlFld-ContribAuthor ">Philip  Babij</span>  . </span><span class="cited-content_cbyCitation_article-title">Emerging Targets in Osteoporosis Disease Modification. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2010,</strong> <em>53 </em>
                                    (11)
                                     , 4332-4353. <a href="https://doi.org/10.1021/jm9018756" title="DOI URL">https://doi.org/10.1021/jm9018756</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm9018756&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm9018756%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DEmerging%252BTargets%252Bin%252BOsteoporosis%252BDisease%252BModification%26aulast%3DAllen%26aufirst%3DJohn%2BG.%26date%3D2010%26date%3D2010%26date%3D2009%26date%3D20122009%26date%3D10032010%26date%3D10062010%26volume%3D53%26issue%3D11%26spage%3D4332%26epage%3D4353" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Leo  Widler</span>, <span class="hlFld-ContribAuthor ">Eva  Altmann</span>, <span class="hlFld-ContribAuthor ">René  Beerli</span>, <span class="hlFld-ContribAuthor ">Werner  Breitenstein</span>, <span class="hlFld-ContribAuthor ">Rochdi  Bouhelal</span>, <span class="hlFld-ContribAuthor ">Thomas  Buhl</span>, <span class="hlFld-ContribAuthor ">Rainer  Gamse</span>, <span class="hlFld-ContribAuthor ">Marc  Gerspacher</span>, <span class="hlFld-ContribAuthor ">Christine  Halleux</span>, <span class="hlFld-ContribAuthor ">Markus R.  John</span>, <span class="hlFld-ContribAuthor ">Hansjoerg  Lehmann</span>, <span class="hlFld-ContribAuthor ">Oskar  Kalb</span>, <span class="hlFld-ContribAuthor ">Michaela  Kneissel</span>, <span class="hlFld-ContribAuthor ">Martin  Missbach</span>, <span class="hlFld-ContribAuthor ">Irene R.  Müller</span>, <span class="hlFld-ContribAuthor ">Sibylle  Reidemeister</span>, <span class="hlFld-ContribAuthor ">Johanne  Renaud</span>, <span class="hlFld-ContribAuthor ">Agnes  Taillardat</span>, <span class="hlFld-ContribAuthor ">Ruben  Tommasi</span>, <span class="hlFld-ContribAuthor ">Sven  Weiler</span>, <span class="hlFld-ContribAuthor ">Romain M.  Wolf</span> and <span class="hlFld-ContribAuthor ">Klaus  Seuwen</span>  . </span><span class="cited-content_cbyCitation_article-title">1-Alkyl-4-phenyl-6-alkoxy-1H-quinazolin-2-ones: A Novel Series of Potent Calcium-Sensing Receptor Antagonists. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2010,</strong> <em>53 </em>
                                    (5)
                                     , 2250-2263. <a href="https://doi.org/10.1021/jm901811v" title="DOI URL">https://doi.org/10.1021/jm901811v</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm901811v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm901811v%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3D1-Alkyl-4-phenyl-6-alkoxy-1H-quinazolin-2-ones%25253A%252BA%252BNovel%252BSeries%252Bof%252BPotent%252BCalcium-Sensing%252BReceptor%252BAntagonists%26aulast%3DWidler%26aufirst%3DLeo%26date%3D2010%26date%3D2010%26date%3D2009%26date%3D08122009%26date%3D16022010%26date%3D11032010%26volume%3D53%26issue%3D5%26spage%3D2250%26epage%3D2263" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Robert W.  Marquis</span>, <span class="hlFld-ContribAuthor ">Amparo M.  Lago</span>, <span class="hlFld-ContribAuthor ">James F.  Callahan</span>, <span class="hlFld-ContribAuthor ">Attiq  Rahman</span>, <span class="hlFld-ContribAuthor ">Xiaoyang  Dong</span>, <span class="hlFld-ContribAuthor ">George B.  Stroup</span>, <span class="hlFld-ContribAuthor ">Sandra  Hoffman</span>, <span class="hlFld-ContribAuthor ">Maxine  Gowen</span>, <span class="hlFld-ContribAuthor ">Eric G.  DelMar</span>, <span class="hlFld-ContribAuthor ">Bradford C.  Van Wagenen</span>, <span class="hlFld-ContribAuthor ">Sarah  Logan</span>, <span class="hlFld-ContribAuthor ">Scott  Shimizu</span>, <span class="hlFld-ContribAuthor ">John  Fox</span>, <span class="hlFld-ContribAuthor ">Edward F.  Nemeth</span>, <span class="hlFld-ContribAuthor ">Theresa  Roethke</span>, <span class="hlFld-ContribAuthor ">Brian R.  Smith</span>, <span class="hlFld-ContribAuthor ">Keith W.  Ward</span> and <span class="hlFld-ContribAuthor ">Pradip  Bhatnagar</span>  . </span><span class="cited-content_cbyCitation_article-title">Antagonists of the Calcium Receptor. 2. Amino Alcohol-Based Parathyroid Hormone Secretagogues. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2009,</strong> <em>52 </em>
                                    (21)
                                     , 6599-6605. <a href="https://doi.org/10.1021/jm900563e" title="DOI URL">https://doi.org/10.1021/jm900563e</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm900563e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm900563e%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DAntagonists%252Bof%252Bthe%252BCalcium%252BReceptor.%252B2.%252BAmino%252BAlcohol-Based%252BParathyroid%252BHormone%252BSecretagogues%26aulast%3DMarquis%26aufirst%3DRobert%2BW.%26date%3D2009%26date%3D2009%26date%3D2009%26date%3D06052009%26date%3D12102009%26date%3D12112009%26volume%3D52%26issue%3D21%26spage%3D6599%26epage%3D6605" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fanny  Bery</span>, <span class="hlFld-ContribAuthor ">Mathilde  Cancel</span>, <span class="hlFld-ContribAuthor ">Aurélie  Chantôme</span>, <span class="hlFld-ContribAuthor ">Roseline  Guibon</span>, <span class="hlFld-ContribAuthor ">Franck  Bruyère</span>, <span class="hlFld-ContribAuthor ">François  Rozet</span>, <span class="hlFld-ContribAuthor ">Karine  Mahéo</span>, <span class="hlFld-ContribAuthor ">Gaëlle  Fromont</span>. </span><span class="cited-content_cbyCitation_article-title">The Calcium-Sensing Receptor is A Marker and Potential Driver of Neuroendocrine Differentiation in Prostate Cancer. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2020,</strong> <em>12 </em>
                                    (4)
                                     , 860. <a href="https://doi.org/10.3390/cancers12040860" title="DOI URL">https://doi.org/10.3390/cancers12040860</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers12040860&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers12040860%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DThe%252BCalcium-Sensing%252BReceptor%252Bis%252BA%252BMarker%252Band%252BPotential%252BDriver%252Bof%252BNeuroendocrine%252BDifferentiation%252Bin%252BProstate%252BCancer%26aulast%3DBery%26aufirst%3DFanny%26date%3D2020%26date%3D2020%26volume%3D12%26issue%3D4%26spage%3D860" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">María L.  López-Rodríguez</span>, <span class="hlFld-ContribAuthor ">Bellinda  Benhamú</span>, <span class="hlFld-ContribAuthor ">Henar  Vázquez-Villa</span>. </span><span class="cited-content_cbyCitation_article-title">Allosteric modulators targeting GPCRs. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 195-241. <a href="https://doi.org/10.1016/B978-0-12-816228-6.00011-8" title="DOI URL">https://doi.org/10.1016/B978-0-12-816228-6.00011-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-816228-6.00011-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-816228-6.00011-8%26sid%3Dliteratum%253Aachs%26atitle%3DAllosteric%252Bmodulators%252Btargeting%252BGPCRs%26aulast%3DL%25C3%25B3pez-Rodr%25C3%25ADguez%26aufirst%3DMar%25C3%25ADa%2BL.%26date%3D2020%26spage%3D195%26epage%3D241%26pub%3DElsevier%26atitle%3DGPCRs%26date%3D2020%26volume%3D289" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ye-Fu  Zhu</span>, <span class="hlFld-ContribAuthor ">Bo-Le  Wei</span>, <span class="hlFld-ContribAuthor ">Wen-Qiong  Wang</span>, <span class="hlFld-ContribAuthor ">Li-Jiang  Xuan</span>. </span><span class="cited-content_cbyCitation_article-title">A facile and efficient method for synthesis of β-iodocarboxylates from terminal epoxides. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2019,</strong> <em>60 </em>
                                    (50)
                                     , 151353. <a href="https://doi.org/10.1016/j.tetlet.2019.151353" title="DOI URL">https://doi.org/10.1016/j.tetlet.2019.151353</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2019.151353&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2019.151353%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DA%252Bfacile%252Band%252Befficient%252Bmethod%252Bfor%252Bsynthesis%252Bof%252B%2525CE%2525B2-iodocarboxylates%252Bfrom%252Bterminal%252Bepoxides%26aulast%3DZhu%26aufirst%3DYe-Fu%26date%3D2019%26volume%3D60%26issue%3D50%26spage%3D151353" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yao  Chen</span>, <span class="hlFld-ContribAuthor ">Yuan  Ju</span>, <span class="hlFld-ContribAuthor ">Chungen  Li</span>, <span class="hlFld-ContribAuthor ">Tao  Yang</span>, <span class="hlFld-ContribAuthor ">Yong  Deng</span>, <span class="hlFld-ContribAuthor ">Youfu  Luo</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, and antibacterial evaluation of novel derivatives of NPS-2143 for the treatment of methicillin-resistant S. aureus (MRSA) infection. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Antibiotics</span><span> <strong>2019,</strong> <em>72 </em>
                                    (7)
                                     , 545-554. <a href="https://doi.org/10.1038/s41429-019-0177-9" title="DOI URL">https://doi.org/10.1038/s41429-019-0177-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41429-019-0177-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41429-019-0177-9%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Antibiotics%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Band%252Bantibacterial%252Bevaluation%252Bof%252Bnovel%252Bderivatives%252Bof%252BNPS-2143%252Bfor%252Bthe%252Btreatment%252Bof%252Bmethicillin-resistant%252BS.%252Baureus%252B%252528MRSA%252529%252Binfection%26aulast%3DChen%26aufirst%3DYao%26date%3D2019%26date%3D2019%26volume%3D72%26issue%3D7%26spage%3D545%26epage%3D554" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaoying  Zhang</span>, <span class="hlFld-ContribAuthor ">Tao  Jin</span>, <span class="hlFld-ContribAuthor ">Na  Shi</span>, <span class="hlFld-ContribAuthor ">Linbo  Yao</span>, <span class="hlFld-ContribAuthor ">Xinmin  Yang</span>, <span class="hlFld-ContribAuthor ">Chenxia  Han</span>, <span class="hlFld-ContribAuthor ">Li  Wen</span>, <span class="hlFld-ContribAuthor ">Dan  Du</span>, <span class="hlFld-ContribAuthor ">Peter  Szatmary</span>, <span class="hlFld-ContribAuthor ">Rajarshi  Mukherjee</span>, <span class="hlFld-ContribAuthor ">Tingting  Liu</span>, <span class="hlFld-ContribAuthor ">Qing  Xia</span>, <span class="hlFld-ContribAuthor ">David N.  Criddle</span>, <span class="hlFld-ContribAuthor ">Wei  Huang</span>, <span class="hlFld-ContribAuthor ">Michael  Chvanov</span>, <span class="hlFld-ContribAuthor ">Robert  Sutton</span>. </span><span class="cited-content_cbyCitation_article-title">Mechanisms of Pancreatic Injury Induced by Basic Amino Acids Differ Between L-Arginine, L-Ornithine, and L-Histidine. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Physiology</span><span> <strong>2019,</strong> <em>9 </em><a href="https://doi.org/10.3389/fphys.2018.01922" title="DOI URL">https://doi.org/10.3389/fphys.2018.01922</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fphys.2018.01922&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffphys.2018.01922%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Physiology%26atitle%3DMechanisms%252Bof%252BPancreatic%252BInjury%252BInduced%252Bby%252BBasic%252BAmino%252BAcids%252BDiffer%252BBetween%252BL-Arginine%25252C%252BL-Ornithine%25252C%252Band%252BL-Histidine%26aulast%3DZhang%26aufirst%3DXiaoying%26date%3D2019%26date%3D2019%26volume%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhen  Xiao</span>, <span class="hlFld-ContribAuthor ">Juanjuan  Li</span>, <span class="hlFld-ContribAuthor ">Qiang  Yue</span>, <span class="hlFld-ContribAuthor ">Qian  Zhang</span>, <span class="hlFld-ContribAuthor ">Dong  Li</span>. </span><span class="cited-content_cbyCitation_article-title">An efficient and atom-economical route to
              N
              -aryl amino alcohols from primary amines. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2018,</strong> <em>8 </em>
                                    (60)
                                     , 34304-34308. <a href="https://doi.org/10.1039/C8RA07355D" title="DOI URL">https://doi.org/10.1039/C8RA07355D</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8RA07355D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8RA07355D%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DAn%252Befficient%252Band%252Batom-economical%252Broute%252Bto%252BN%252B-aryl%252Bamino%252Balcohols%252Bfrom%252Bprimary%252Bamines%26aulast%3DXiao%26aufirst%3DZhen%26date%3D2018%26date%3D2018%26volume%3D8%26issue%3D60%26spage%3D34304%26epage%3D34308" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shumei  Wang</span>, <span class="hlFld-ContribAuthor ">Liyun  Qiu</span>, <span class="hlFld-ContribAuthor ">Haiyan  Song</span>, <span class="hlFld-ContribAuthor ">Ningning  Dang</span>. </span><span class="cited-content_cbyCitation_article-title">NPS - 2143 (hydrochloride) inhibits melanoma cancer cell proliferation and induces autophagy and apoptosis. </span><span class="cited-content_cbyCitation_journal-name">médecine/sciences</span><span> <strong>2018,</strong> <em>34 </em>, 87-93. <a href="https://doi.org/10.1051/medsci/201834f115" title="DOI URL">https://doi.org/10.1051/medsci/201834f115</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1051/medsci/201834f115&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1051%2Fmedsci%2F201834f115%26sid%3Dliteratum%253Aachs%26jtitle%3Dm%25C3%25A9decine%252Fsciences%26atitle%3DNPS%252B-%252B2143%252B%252528hydrochloride%252529%252Binhibits%252Bmelanoma%252Bcancer%252Bcell%252Bproliferation%252Band%252Binduces%252Bautophagy%252Band%252Bapoptosis%26aulast%3DWang%26aufirst%3DShumei%26date%3D2018%26date%3D2018%26volume%3D34%26spage%3D87%26epage%3D93" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Edward F.  Nemeth</span>, <span class="hlFld-ContribAuthor ">Bradford C.  Van Wagenen</span>, <span class="hlFld-ContribAuthor ">Manuel F.  Balandrin</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and Development of Calcimimetic and Calcilytic Compounds. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2018,</strong>,, 1-86. <a href="https://doi.org/10.1016/bs.pmch.2017.12.001" title="DOI URL">https://doi.org/10.1016/bs.pmch.2017.12.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/bs.pmch.2017.12.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fbs.pmch.2017.12.001%26sid%3Dliteratum%253Aachs%26atitle%3DDiscovery%252Band%252BDevelopment%252Bof%252BCalcimimetic%252Band%252BCalcilytic%252BCompounds%26aulast%3DNemeth%26aufirst%3DEdward%2BF.%26date%3D2018%26spage%3D1%26epage%3D86%26pub%3DElsevier%26date%3D2018%26volume%3D57" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Furqan Ahmad  Saddique</span>, <span class="hlFld-ContribAuthor ">Ameer Fawad  Zahoor</span>, <span class="hlFld-ContribAuthor ">Sadia  Faiz</span>, <span class="hlFld-ContribAuthor ">Syed Ali Raza  Naqvi</span>, <span class="hlFld-ContribAuthor ">Muhammad  Usman</span>, <span class="hlFld-ContribAuthor ">Matloob  Ahmad</span>. </span><span class="cited-content_cbyCitation_article-title">Recent trends in ring opening of epoxides by amines as nucleophiles. </span><span class="cited-content_cbyCitation_journal-name">Synthetic Communications</span><span> <strong>2016,</strong> <em>46 </em>
                                    (10)
                                     , 831-868. <a href="https://doi.org/10.1080/00397911.2016.1170148" title="DOI URL">https://doi.org/10.1080/00397911.2016.1170148</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/00397911.2016.1170148&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F00397911.2016.1170148%26sid%3Dliteratum%253Aachs%26jtitle%3DSynthetic%2520Communications%26atitle%3DRecent%252Btrends%252Bin%252Bring%252Bopening%252Bof%252Bepoxides%252Bby%252Bamines%252Bas%252Bnucleophiles%26aulast%3DSaddique%26aufirst%3DFurqan%2BAhmad%26date%3D2016%26date%3D2016%26volume%3D46%26issue%3D10%26spage%3D831%26epage%3D868" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">E.F.  Nemeth</span>. </span><span class="cited-content_cbyCitation_article-title">Allosteric modulators of the extracellular calcium receptor. </span><span class="cited-content_cbyCitation_journal-name">Drug Discovery Today: Technologies</span><span> <strong>2013,</strong> <em>10 </em>
                                    (2)
                                     , e277-e284. <a href="https://doi.org/10.1016/j.ddtec.2012.11.002" title="DOI URL">https://doi.org/10.1016/j.ddtec.2012.11.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ddtec.2012.11.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ddtec.2012.11.002%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Discovery%2520Today%253A%2520Technologies%26atitle%3DAllosteric%252Bmodulators%252Bof%252Bthe%252Bextracellular%252Bcalcium%252Breceptor%26aulast%3DNemeth%26aufirst%3DE.F.%26date%3D2013%26volume%3D10%26issue%3D2%26spage%3De277%26epage%3De284" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Henrik  Johansson</span>, <span class="hlFld-ContribAuthor ">Thomas  Cailly</span>, <span class="hlFld-ContribAuthor ">Alex  Rojas Bie Thomsen</span>, <span class="hlFld-ContribAuthor ">Hans  Bräuner-Osborne</span>, <span class="hlFld-ContribAuthor ">Daniel  Sejer Pedersen</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of the calcilytic ligand NPS 2143. </span><span class="cited-content_cbyCitation_journal-name">Beilstein Journal of Organic Chemistry</span><span> <strong>2013,</strong> <em>9 </em>, 1383-1387. <a href="https://doi.org/10.3762/bjoc.9.154" title="DOI URL">https://doi.org/10.3762/bjoc.9.154</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3762/bjoc.9.154&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3762%2Fbjoc.9.154%26sid%3Dliteratum%253Aachs%26jtitle%3DBeilstein%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DSynthesis%252Bof%252Bthe%252Bcalcilytic%252Bligand%252BNPS%252B2143%26aulast%3DJohansson%26aufirst%3DHenrik%26date%3D2013%26date%3D2013%26volume%3D9%26spage%3D1383%26epage%3D1387" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Donald T  Ward</span>, <span class="hlFld-ContribAuthor ">Daniela  Riccardi</span>. </span><span class="cited-content_cbyCitation_article-title">New concepts in calcium-sensing receptor pharmacology and signalling. </span><span class="cited-content_cbyCitation_journal-name">British Journal of Pharmacology</span><span> <strong>2012,</strong> <em>165 </em>
                                    (1)
                                     , 35-48. <a href="https://doi.org/10.1111/j.1476-5381.2011.01511.x" title="DOI URL">https://doi.org/10.1111/j.1476-5381.2011.01511.x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/j.1476-5381.2011.01511.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fj.1476-5381.2011.01511.x%26sid%3Dliteratum%253Aachs%26jtitle%3DBritish%2520Journal%2520of%2520Pharmacology%26atitle%3DNew%252Bconcepts%252Bin%252Bcalcium-sensing%252Breceptor%252Bpharmacology%252Band%252Bsignalling%26aulast%3DWard%26aufirst%3DDonald%2BT%26date%3D2012%26date%3D2011%26volume%3D165%26issue%3D1%26spage%3D35%26epage%3D48" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shuichi  Kimura</span>, <span class="hlFld-ContribAuthor ">Takashi  Nakagawa</span>, <span class="hlFld-ContribAuthor ">Yushi  Matsuo</span>, <span class="hlFld-ContribAuthor ">Yuji  Ishida</span>, <span class="hlFld-ContribAuthor ">Yoshihisa  Okamoto</span>, <span class="hlFld-ContribAuthor ">Mikio  Hayashi</span>. </span><span class="cited-content_cbyCitation_article-title">JTT-305, an orally active calcium-sensing receptor antagonist, stimulates transient parathyroid hormone release and bone formation in ovariectomized rats. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Pharmacology</span><span> <strong>2011,</strong> <em>668 </em>
                                    (1-2)
                                     , 331-336. <a href="https://doi.org/10.1016/j.ejphar.2011.07.015" title="DOI URL">https://doi.org/10.1016/j.ejphar.2011.07.015</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejphar.2011.07.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejphar.2011.07.015%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Pharmacology%26atitle%3DJTT-305%25252C%252Ban%252Borally%252Bactive%252Bcalcium-sensing%252Breceptor%252Bantagonist%25252C%252Bstimulates%252Btransient%252Bparathyroid%252Bhormone%252Brelease%252Band%252Bbone%252Bformation%252Bin%252Bovariectomized%252Brats%26aulast%3DKimura%26aufirst%3DShuichi%26date%3D2011%26volume%3D668%26issue%3D1-2%26spage%3D331%26epage%3D336" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anson K.  Abraham</span>, <span class="hlFld-ContribAuthor ">Tristan S.  Maurer</span>, <span class="hlFld-ContribAuthor ">Amit S.  Kalgutkar</span>, <span class="hlFld-ContribAuthor ">Xiang  Gao</span>, <span class="hlFld-ContribAuthor ">Mei  Li</span>, <span class="hlFld-ContribAuthor ">David R.  Healy</span>, <span class="hlFld-ContribAuthor ">Donna N.  Petersen</span>, <span class="hlFld-ContribAuthor ">David A.  Griffith</span>, <span class="hlFld-ContribAuthor ">Donald E.  Mager</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacodynamic Model of Parathyroid Hormone Modulation by a Negative Allosteric Modulator of the Calcium-Sensing Receptor. </span><span class="cited-content_cbyCitation_journal-name">The AAPS Journal</span><span> <strong>2011,</strong> <em>13 </em>
                                    (2)
                                     , 265-273. <a href="https://doi.org/10.1208/s12248-011-9266-9" title="DOI URL">https://doi.org/10.1208/s12248-011-9266-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1208/s12248-011-9266-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1208%2Fs12248-011-9266-9%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520AAPS%2520Journal%26atitle%3DPharmacodynamic%252BModel%252Bof%252BParathyroid%252BHormone%252BModulation%252Bby%252Ba%252BNegative%252BAllosteric%252BModulator%252Bof%252Bthe%252BCalcium-Sensing%252BReceptor%26aulast%3DAbraham%26aufirst%3DAnson%2BK.%26date%3D2011%26date%3D2011%26volume%3D13%26issue%3D2%26spage%3D265%26epage%3D273" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Leo  Widler</span>. </span><span class="cited-content_cbyCitation_article-title">Calcilytics: antagonists of the calcium-sensing receptor for the treatment of osteoporosis. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2011,</strong> <em>3 </em>
                                    (5)
                                     , 535-547. <a href="https://doi.org/10.4155/fmc.11.17" title="DOI URL">https://doi.org/10.4155/fmc.11.17</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc.11.17&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc.11.17%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DCalcilytics%25253A%252Bantagonists%252Bof%252Bthe%252Bcalcium-sensing%252Breceptor%252Bfor%252Bthe%252Btreatment%252Bof%252Bosteoporosis%26aulast%3DWidler%26aufirst%3DLeo%26date%3D2011%26volume%3D3%26issue%3D5%26spage%3D535%26epage%3D547" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stephan  Urwyler</span>, . </span><span class="cited-content_cbyCitation_article-title">Allosteric Modulation of Family C G-Protein-Coupled Receptors: from Molecular Insights to Therapeutic Perspectives. </span><span class="cited-content_cbyCitation_journal-name">Pharmacological Reviews</span><span> <strong>2011,</strong> <em>63 </em>
                                    (1)
                                     , 59-126. <a href="https://doi.org/10.1124/pr.109.002501" title="DOI URL">https://doi.org/10.1124/pr.109.002501</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/pr.109.002501&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fpr.109.002501%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacological%2520Reviews%26atitle%3DAllosteric%252BModulation%252Bof%252BFamily%252BC%252BG-Protein-Coupled%252BReceptors%25253A%252Bfrom%252BMolecular%252BInsights%252Bto%252BTherapeutic%252BPerspectives%26aulast%3DUrwyler%26aufirst%3DStephan%26date%3D2011%26date%3D2011%26volume%3D63%26issue%3D1%26spage%3D59%26epage%3D126" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yuko  Shinagawa</span>, <span class="hlFld-ContribAuthor ">Teruhiko  Inoue</span>, <span class="hlFld-ContribAuthor ">Kazuyuki  Hirata</span>, <span class="hlFld-ContribAuthor ">Takeo  Katsushima</span>, <span class="hlFld-ContribAuthor ">Takashi  Nakagawa</span>, <span class="hlFld-ContribAuthor ">Yushi  Matsuo</span>, <span class="hlFld-ContribAuthor ">Masanori  Shindo</span>, <span class="hlFld-ContribAuthor ">Hiromasa  Hashimoto</span>. </span><span class="cited-content_cbyCitation_article-title">New aminopropandiol derivatives as orally available and short-acting calcium-sensing receptor antagonists. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2010,</strong> <em>20 </em>
                                    (12)
                                     , 3809-3813. <a href="https://doi.org/10.1016/j.bmcl.2010.04.035" title="DOI URL">https://doi.org/10.1016/j.bmcl.2010.04.035</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2010.04.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2010.04.035%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DNew%252Baminopropandiol%252Bderivatives%252Bas%252Borally%252Bavailable%252Band%252Bshort-acting%252Bcalcium-sensing%252Breceptor%252Bantagonists%26aulast%3DShinagawa%26aufirst%3DYuko%26date%3D2010%26volume%3D20%26issue%3D12%26spage%3D3809%26epage%3D3813" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-13/jm900364m/production/images/medium/jm-2009-00364m_0018.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-13/jm900364m/production/images/large/jm-2009-00364m_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900364m&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-13/jm900364m/production/images/medium/jm-2009-00364m_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-13/jm900364m/production/images/large/jm-2009-00364m_0001.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Calcimimetic cinacalcet (<b>1</b>) and antagonist screening hit <b>2</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-13/jm900364m/production/images/large/jm-2009-00364m_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900364m&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-13/jm900364m/production/images/medium/jm-2009-00364m_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-13/jm900364m/production/images/large/jm-2009-00364m_0005.jpeg" id="rightTab-gs1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Amino Alcohols by Varying the Left-Hand Side Moiety<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-13/jm900364m/production/images/large/jm-2009-00364m_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900364m&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) LDA, HMPA, <i>i</i>-butyric acid, 4-methoxy benzylchloride, −78 °C to rt; (b) <b>3</b>, TEA, acetone, H<sub>2</sub>O, ethyl chloroformate, NaN<sub>3</sub>, 0 °C to rt then toluene 100 °C benzyl alcohol, EtOH, H<sub>2</sub>, Pd(OH)<sub>2</sub>; (c) <i>i</i>-PrOH, 0 °C, epichlorohydrin; (d) NaH, DMF, ROH, <b>5</b>, 100 °C.</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-13/jm900364m/production/images/medium/jm-2009-00364m_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-13/jm900364m/production/images/large/jm-2009-00364m_0006.jpeg" id="rightTab-gs2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Amino Alcohols by Varying the Right-Hand Side Moieties<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-13/jm900364m/production/images/large/jm-2009-00364m_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900364m&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) RNH<sub>2</sub>, EtOH, 80 °C.</p></p></figure><figure data-id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-13/jm900364m/production/images/medium/jm-2009-00364m_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-13/jm900364m/production/images/large/jm-2009-00364m_0007.jpeg" id="rightTab-gs3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of <i>N</i>- and <i>O</i>-Methylated Analogs <b>27</b> and <b>28</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-13/jm900364m/production/images/large/jm-2009-00364m_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900364m&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 37% aq CH<sub>2</sub>O, NaCNBH<sub>3</sub>, CH<sub>3</sub>OH; (b) DMF, NaH, CH<sub>3</sub>I, rt.</p></p></figure><figure data-id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-13/jm900364m/production/images/medium/jm-2009-00364m_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-13/jm900364m/production/images/large/jm-2009-00364m_0008.jpeg" id="rightTab-gs4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of des-Hydroxy Analog <b>31</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-13/jm900364m/production/images/large/jm-2009-00364m_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900364m&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) K<sub>2</sub>CO<sub>3</sub>, 1,3-dibromopropane, 2,3-dichlrorphenol, CH<sub>3</sub>CN; (b) <b>30</b>, CH<sub>2</sub>Cl<sub>2</sub>, <b>4</b>.</p></p></figure><figure data-id="sch5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-13/jm900364m/production/images/medium/jm-2009-00364m_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-13/jm900364m/production/images/large/jm-2009-00364m_0009.jpeg" id="rightTab-gs5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of Chiral Amino Alcohols <b>32</b> and <b>33</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-13/jm900364m/production/images/large/jm-2009-00364m_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900364m&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) HPLC separation; (b) 2,3-dichlorophenol, acetone, K<sub>2</sub>CO<sub>3</sub>, (<i>R</i>)-nosyl epoxide, reflux; (c) 2,3-dichlorophenol, acetone, K<sub>2</sub>CO<sub>3</sub>, (<i>S</i>)-nosyl epoxide, reflux; (d) <b>4</b>, ethanol, reflux.</p></p></figure><figure data-id="sch6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-13/jm900364m/production/images/medium/jm-2009-00364m_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-13/jm900364m/production/images/large/jm-2009-00364m_0010.jpeg" id="rightTab-gs6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthesis of Analog <b>38</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-13/jm900364m/production/images/large/jm-2009-00364m_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900364m&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (<i>R</i>)-nosyl epoxide, acetone, K<sub>2</sub>CO<sub>3</sub>, reflux; (b) [1,1-dimethyl-2-(2-naphthalenyl)ethyl]amine, EtOH, reflux.</p></p></figure><figure data-id="fig2" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-13/jm900364m/production/images/medium/jm-2009-00364m_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-13/jm900364m/production/images/large/jm-2009-00364m_0002.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Overlay of the energy minimized structures of <b>7</b> (green) and <b>20</b> (red).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-13/jm900364m/production/images/large/jm-2009-00364m_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900364m&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-13/jm900364m/production/images/medium/jm-2009-00364m_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-13/jm900364m/production/images/large/jm-2009-00364m_0003.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Acute increases in plasma PTH levels following iv injection of CaR antagonists <b>32</b> or <b>33</b> (10 μmol/kg) in normal conscious rats. Values are mean ± SE, <i>n</i> = 6/group. PTH was measured using a rat PTH(1-34) immunoradiometric assay (Immutopics, San Clemente, CA), Note the greater activity of <b>32</b> (<i>R</i>-enantiomer) compared with <b>33</b> (<i>S</i>-enantiomer).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-13/jm900364m/production/images/large/jm-2009-00364m_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900364m&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch7" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-13/jm900364m/production/images/medium/jm-2009-00364m_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-13/jm900364m/production/images/large/jm-2009-00364m_0011.jpeg" id="rightTab-gs7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. Combination of the SAR Studies Leading to Analog <b>38</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-13/jm900364m/production/images/large/jm-2009-00364m_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900364m&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-13/jm900364m/production/images/medium/jm-2009-00364m_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-13/jm900364m/production/images/large/jm-2009-00364m_0004.jpeg" id="rightTab-gr18" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Small molecule X-ray crystal structure of the calcium receptor antagonist <b>38</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-13/jm900364m/production/images/large/jm-2009-00364m_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900364m&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i57">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_62010" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_62010" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 27 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Iqbal, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inzerillo, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moonga, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baljit, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaidi, M.</span><span> </span><span class="NLM_article-title">The molecular pharmacology of osteoporosis</span> <span class="citation_source-journal">Osteoporosis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume"></span> <span class="NLM_fpage">569</span><span class="NLM_x">–</span> <span class="NLM_lpage">594</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm900364m&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjs1ehurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2003&pages=569-594&author=J.+Iqbalauthor=A.+M.+Inzerilloauthor=B.+S.+Moongaauthor=S.+Baljitauthor=M.+Zaidi&title=The+molecular+pharmacology+of+osteoporosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The molecular pharmacology of osteoporosis</span></div><div class="casAuthors">Iqbal, Jameel; Inzerillo, Angela M.; Moonga, Baljit S.; Zaidi, Mone</div><div class="citationInfo"><span class="NLM_cas:title">Osteoporosis</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">569-594</span>CODEN:
                <span class="NLM_cas:coden">69DAZ9</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Humana Press Inc.</span>)
        </div><div class="casAbstract">A review.  Skeletal remodeling requires a balance between the resorption and formation of bone.  Osteoclasts resorb bone, while osteoblasts are bone forming.  These two processes are closely coupled but independently regulated by various hormones and cytokines.  Future targets for therapeutic action in osteoporosis includes mechanisms that alter internal or external cell signaling or that directly introduce regulators of osteoclast and osteoblast function into bone.  Cellular signaling targets will likely focus on the induction of osteoclast detachment and apoptosis, while those targeting osteoblasts and undifferentiated progenitor cells will likely focus on inducing proliferation and differentiation.  Several interesting therapies are being explored for targeting proteins and drugs modulating osteoclast function to bone.  Among the topics discussed in this review are: established osteoporosis therapies, potential targets for inhibition of bone resorption; and new strategies for stimulating bone formation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqy-9NcTYEpcrVg90H21EOLACvtfcHk0lg6yyuoSktRjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjs1ehurg%253D&md5=ada1c37d524d87d1a313a4b3c859d74e</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DIqbal%26aufirst%3DJ.%26aulast%3DInzerillo%26aufirst%3DA.%2BM.%26aulast%3DMoonga%26aufirst%3DB.%2BS.%26aulast%3DBaljit%26aufirst%3DS.%26aulast%3DZaidi%26aufirst%3DM.%26atitle%3DThe%2520molecular%2520pharmacology%2520of%2520osteoporosis%26jtitle%3DOsteoporosis%26date%3D2003%26spage%3D569%26epage%3D594" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Deal, C.</span><span> </span><span class="NLM_article-title">Osteoporosis therapies: bisphosphonates, SERMS, PTH and new therapies</span> <span class="citation_source-journal">Clin. Rev. Bone Miner. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">125</span><span class="NLM_x">–</span> <span class="NLM_lpage">141</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm900364m&amp;key=10.1385%2FBMM%3A3%3A2%3A125" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm900364m&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVensbrI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2005&pages=125-141&author=C.+Deal&title=Osteoporosis+therapies%3A+bisphosphonates%2C+SERMS%2C+PTH+and+new+therapies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Osteoporosis therapies: bisphosphonates, SERMs, PTH, and new therapies</span></div><div class="casAuthors">Deal, Chad</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Reviews in Bone and Mineral Metabolism</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">125-141</span>CODEN:
                <span class="NLM_cas:coden">CRBMBF</span>;
        ISSN:<span class="NLM_cas:issn">1534-8644</span>.
    
            (<span class="NLM_cas:orgname">Humana Press Inc.</span>)
        </div><div class="casAbstract">A review.  Osteoporosis therapies include antiresorptive and anabolic agents.  Antiresorptive agents include the bisphosphonates (etidronate, alendronate, risedronate, ibandronate, and off-label use of the i.v. drugs pamidronate and zolendronate), selective estrogen receptor modulators (SERMs) (raloxifene), calcitonin, and estrogens.  An anabolic agent, teriparatide (rhPTH 1-34) was released in 2002.  New therapies may be available in the coming years, including new SERMs, strontium ranelate, and an antibody to RANK ligand.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJwzAlpmizkLVg90H21EOLACvtfcHk0lgzEPcHHcOlaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVensbrI&md5=25824a38449a391c25afb09b0e6470b3</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1385%2FBMM%3A3%3A2%3A125&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1385%252FBMM%253A3%253A2%253A125%26sid%3Dliteratum%253Aachs%26aulast%3DDeal%26aufirst%3DC.%26atitle%3DOsteoporosis%2520therapies%253A%2520bisphosphonates%252C%2520SERMS%252C%2520PTH%2520and%2520new%2520therapies%26jtitle%3DClin.%2520Rev.%2520Bone%2520Miner.%2520Metab.%26date%3D2005%26volume%3D3%26spage%3D125%26epage%3D141" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2a"><span><span class="NLM_contrib-group">Rodan, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, T. J.</span><span> </span><span class="NLM_article-title">Therapeutic approaches to bone diseases</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">289</span><span class="NLM_x">, </span> <span class="NLM_fpage">1508</span><span class="NLM_x">–</span> <span class="NLM_lpage">1514</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=16&amp;doi=10.1021%2Fjm900364m&amp;key=10.1126%2Fscience.289.5484.1508" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=8&amp;doi=10.1021%2Fjm900364m&amp;key=10968781" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=32&amp;doi=10.1021%2Fjm900364m&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmt1Kgsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=2000&pages=1508-1514&author=G.+A.+Rodanauthor=T.+J.+Martin&title=Therapeutic+approaches+to+bone+diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2aR"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic approaches to bone diseases</span></div><div class="casAuthors">Rodan, Gideon A.; Martin, T. John</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">289</span>
        (<span class="NLM_cas:issue">5484</span>),
    <span class="NLM_cas:pages">1508-1514</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A review with 66 refs.  The strength and integrity of our bones depends on maintaining a delicate balance between bone resorption by osteoclasts and bone formation by osteoblasts.  As we age or as a result of disease, this delicate balancing act becomes tipped in favor of osteoclasts so that bone resorption exceeds bone formation, rendering bones brittle and prone to fracture.  A better understanding of the biol. of osteoclasts and osteoblasts is providing opportunities for developing therapeutics to treat diseases of bone.  Drugs that inhibit the formation or activity of osteoclasts are valuable for treating osteoporosis, Paget's disease, and inflammation of bone assocd. with rheumatoid arthritis or periodontal disease.  Far less attention has been paid to, promoting bone formation with, for example, growth factors or hormones, an approach that would be a valuable adjunct therapy for patients receiving inhibitors of bone resorption.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIUsDfs0wHVrVg90H21EOLACvtfcHk0lgzEPcHHcOlaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmt1Kgsb4%253D&md5=3178a7237d0acb9918a7d76c760d533f</span></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=10.1126%2Fscience.289.5484.1508&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.289.5484.1508%26sid%3Dliteratum%253Aachs%26aulast%3DRodan%26aufirst%3DG.%2BA.%26aulast%3DMartin%26aufirst%3DT.%2BJ.%26atitle%3DTherapeutic%2520approaches%2520to%2520bone%2520diseases%26jtitle%3DScience%26date%3D2000%26volume%3D289%26spage%3D1508%26epage%3D1514" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Bodenner, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Redman, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riggs, A.</span><span> </span><span class="NLM_article-title">Teriparatide in the management of osteoporosis</span> <span class="citation_source-journal">Clin. Interventions Aging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">499</span><span class="NLM_x">–</span> <span class="NLM_lpage">507</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm900364m&amp;key=18225450" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm900364m&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhs1ejsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2007&pages=499-507&author=D.+Bodennerauthor=C.+Redmanauthor=A.+Riggs&title=Teriparatide+in+the+management+of+osteoporosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Teriparatide in the management of osteoporosis</span></div><div class="casAuthors">Bodenner, Donald; Redman, Carolyn; Riggs, Ann</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Interventions in Aging</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">499-507</span>CODEN:
                <span class="NLM_cas:coden">CIALBC</span>;
        ISSN:<span class="NLM_cas:issn">1176-9092</span>.
    
            (<span class="NLM_cas:orgname">Dove Medical Press (NZ) Ltd.</span>)
        </div><div class="casAbstract">A review.  Fracture of the hip is frequently a catastrophic event in the elderly, often resulting in death within a year and of the survivors, few regain pre-fracture quality of life.  Although less appreciated, fractures of the spine result in significant morbidity and are also assocd. with increased mortality compared with individuals without a fracture.  In recent years there has been an explosion in the development of new drugs for the treatment of osteoporosis.  Recombinant human parathyroid hormone (1-34) (20 μg/day) is a recent addn. to this armamentarium with a novel mechanism of action, which was approved by the US FDA for the treatment of postmenopausal osteoporosis and male osteoporosis secondary to hypogonadism in Nov. 2002.  It is the first osteoporosis treatment that leads to the formation of new bone with architecture similar to normal bone.  Intense efforts have been made to understand the effect of teriparatide on antiresorptive therapy and vice versa.  Although these relationships are not completely understood, the results of recent studies allow clinicians to begin to optimize therapeutic gains in bone mineral d. and improve anti-fracture efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoah_3atunqZbVg90H21EOLACvtfcHk0lgzEPcHHcOlaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhs1ejsb4%253D&md5=ce7b8894f61d7d67e2e83b9fd03c0520</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBodenner%26aufirst%3DD.%26aulast%3DRedman%26aufirst%3DC.%26aulast%3DRiggs%26aufirst%3DA.%26atitle%3DTeriparatide%2520in%2520the%2520management%2520of%2520osteoporosis%26jtitle%3DClin.%2520Interventions%2520Aging%26date%3D2007%26volume%3D2%26spage%3D499%26epage%3D507" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit3a"><span><span class="NLM_contrib-group">Bilezikian, J. P.</span><span> </span><span class="NLM_article-title">Anabolic therepy for osteoporosis</span> <span class="citation_source-journal">Women’s Health</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">243</span><span class="NLM_x">–</span> <span class="NLM_lpage">253</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=16&amp;doi=10.1021%2Fjm900364m&amp;key=10.2217%2F17455057.3.2.243" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=32&amp;doi=10.1021%2Fjm900364m&amp;key=1%3ACAS%3A528%3ADC%252BD2sXit12qtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2007&pages=243-253&author=J.+P.+Bilezikian&title=Anabolic+therepy+for+osteoporosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3aR"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Anabolic therapy for osteoporosis</span></div><div class="casAuthors">Bilezikian, John P.</div><div class="citationInfo"><span class="NLM_cas:title">Women's Health</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">243-253</span>CODEN:
                <span class="NLM_cas:coden">WHOEAZ</span>;
        ISSN:<span class="NLM_cas:issn">1745-5057</span>.
    
            (<span class="NLM_cas:orgname">Future Medicine Ltd.</span>)
        </div><div class="casAbstract">A review.  Antiresorptive agents for osteoporosis are a cornerstone of therapy, but anabolic drugs have recently increased our options.  By directly stimulating bone formation, anabolic agents reduce fracture incidence by improving bone qualities as well as increasing bone mass.  The anabolic agent currently approved for osteoporosis, teriparatide (recombinant human parathyroid hormone[1-34]), has emerged as a major approach for selected patients with osteoporosis.  Parathyroid hormone(1-84) is also available in Europe.  Teriparatide increases bone d. and bone turnover, improves microarchitecture and changes bone size.  The incidence of vertebral and nonvertebral fractures is reduced.  A current concept in the mechanism of teriparatide action is related to its effect of stimulating processes assocd. with bone formation before processes assocd. with bone resorption.  This sequence of events has led to the concept of the anabolic window, the period of time when teriparatide is maximally anabolic.  Newer approaches to the use of teriparatide alone and in combination with antiresorptive agents has led to ways in which the anabolic window can be expanded.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKC2jWx9LbarVg90H21EOLACvtfcHk0lgzEPcHHcOlaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXit12qtL0%253D&md5=2e26b6931f831f63477e2f9a8d5f2042</span></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=10.2217%2F17455057.3.2.243&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2217%252F17455057.3.2.243%26sid%3Dliteratum%253Aachs%26aulast%3DBilezikian%26aufirst%3DJ.%2BP.%26atitle%3DAnabolic%2520therepy%2520for%2520osteoporosis%26jtitle%3DWomen%25E2%2580%2599s%2520Health%26date%3D2007%26volume%3D3%26spage%3D243%26epage%3D253" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit3b"><span><span class="NLM_contrib-group">Girotra, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rubin, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bilezikian, J. P.</span><span> </span><span class="NLM_article-title">The use of parathyroid hormone in the treatment of osteoporosis</span> <span class="citation_source-journal">Rev. Endocrinol. Metab. Disorders</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">113</span><span class="NLM_x">–</span> <span class="NLM_lpage">121</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=16&amp;doi=10.1021%2Fjm900364m&amp;key=10.1007%2Fs11154-006-9007-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=8&amp;doi=10.1021%2Fjm900364m&amp;key=17043762" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=32&amp;doi=10.1021%2Fjm900364m&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht12lsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2006&pages=113-121&author=M.+Girotraauthor=M.+R.+Rubinauthor=J.+P.+Bilezikian&title=The+use+of+parathyroid+hormone+in+the+treatment+of+osteoporosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3bR"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The use of parathyroid hormone in the treatment of osteoporosis</span></div><div class="casAuthors">Girotra, Monica; Rubin, Mishaela R.; Bilezikian, John P.</div><div class="citationInfo"><span class="NLM_cas:title">Reviews in Endocrine & Metabolic Disorders</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">113-121</span>CODEN:
                <span class="NLM_cas:coden">REMDCG</span>;
        ISSN:<span class="NLM_cas:issn">1389-9155</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Anabolic skeletal agents have recently broadened our therapeutic options for osteoporosis.  By directly stimulating bone formation, they reduce fracture incidence by improving bone qualities in addn. to increasing bone mass.  Teriparatide [recombinant human parathyroid hormone(1-34)], the only anabolic agent currently approved in the United States for osteoporosis, has emerged as a major therapeutic approach to selected patients with osteoporosis.  Teriparatide is approved for both postmenopausal women and men with osteoporosis who are at high risk for fracture.  With the use of this anabolic agent, bone d. and bone turnover increase, microarchitecture improves, and bone size is beneficially altered.  The incidence of vertebral and nonvertebral fractures is reduced with teriparatide use.  Combination therapy with parathyroid hormone and an antiresorptive does not appear to offer definitive advantages over the use of PTH or an antiresorptive alone, although recent ideas about combining these agents may offer new insights.  In order to maintain increases in bone d. acquired during PTH therapy, it is important to follow its use with an antiresorptive agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgHX2PVm7hELVg90H21EOLACvtfcHk0lhxe0eaUdGyJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht12lsg%253D%253D&md5=2c3c9d800f166a7236c3314a6730ad79</span></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=10.1007%2Fs11154-006-9007-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11154-006-9007-z%26sid%3Dliteratum%253Aachs%26aulast%3DGirotra%26aufirst%3DM.%26aulast%3DRubin%26aufirst%3DM.%2BR.%26aulast%3DBilezikian%26aufirst%3DJ.%2BP.%26atitle%3DThe%2520use%2520of%2520parathyroid%2520hormone%2520in%2520the%2520treatment%2520of%2520osteoporosis%26jtitle%3DRev.%2520Endocrinol.%2520Metab.%2520Disorders%26date%3D2006%26volume%3D7%26spage%3D113%26epage%3D121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit3c"><span><span class="NLM_contrib-group">Eriksen, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robins, D. A.</span><span> </span><span class="NLM_article-title">Teriparatide: a bone formation treatment for osteoporosis</span> <span class="citation_source-journal">Drugs Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">935</span><span class="NLM_x">–</span> <span class="NLM_lpage">948</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3c&amp;dbid=16&amp;doi=10.1021%2Fjm900364m&amp;key=10.1358%2Fdot.2004.40.11.872582" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3c&amp;dbid=32&amp;doi=10.1021%2Fjm900364m&amp;key=1%3ACAS%3A528%3ADC%252BD2MXisVSksbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2004&pages=935-948&author=E.+F.+Eriksenauthor=D.+A.+Robins&title=Teriparatide%3A+a+bone+formation+treatment+for+osteoporosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3cR"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">TERIPARATIDE: A bone formation treatment for osteoporosis</span></div><div class="casAuthors">Eriksen, Erik F.; Robins, Deborah A.</div><div class="citationInfo"><span class="NLM_cas:title">Drugs of Today</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">935-948</span>CODEN:
                <span class="NLM_cas:coden">MDACAP</span>;
        ISSN:<span class="NLM_cas:issn">0025-7656</span>.
    
            (<span class="NLM_cas:orgname">Prous Science</span>)
        </div><div class="casAbstract">A review.  Teriparatide is the recombinant human N-terminal fragment (1-34) of endogenous human parathyroid hormone, and it is the first bone anabolic agent for the treatment of osteoporosis.  When given as once-daily s.c. injections, teriparatide can reverse the course of osteoporosis by stimulating formation of new bone and restoring lost architecture.  Teriparatide (20 μg) treatment of osteoporosis in postmenopausal women rapidly increased markers of bone formation and reduced the incidence of vertebral fractures by 65% and of nonvertebral fragility fractures by 53%.  In addn., treatment with this compd. increased spine bone mineral d. by 10% and hip bone mineral d. by 3% at study endpoint.  Teriparatide is well tolerated and is not assocd. with any serious side effects.  The compd. has been approved in Europe and in the US for the treatment of osteoporosis.  Duration of treatment is 18-24 mo and the dose does not need to be adjusted for age or gender.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1JIdWJtTLw7Vg90H21EOLACvtfcHk0lhxe0eaUdGyJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXisVSksbs%253D&md5=636570477d27ee584bc02ce954ecee68</span></div><a href="/servlet/linkout?suffix=cit3c&amp;dbid=16384&amp;doi=10.1358%2Fdot.2004.40.11.872582&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1358%252Fdot.2004.40.11.872582%26sid%3Dliteratum%253Aachs%26aulast%3DEriksen%26aufirst%3DE.%2BF.%26aulast%3DRobins%26aufirst%3DD.%2BA.%26atitle%3DTeriparatide%253A%2520a%2520bone%2520formation%2520treatment%2520for%2520osteoporosis%26jtitle%3DDrugs%2520Today%26date%3D2004%26volume%3D40%26spage%3D935%26epage%3D948" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit3d"><span><span class="NLM_contrib-group">Quattrocchi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kourlas, H.</span><span> </span><span class="NLM_article-title">Teriparaitide: a review</span> <span class="citation_source-journal">Clin. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">841</span><span class="NLM_x">–</span> <span class="NLM_lpage">854</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3d&amp;dbid=16&amp;doi=10.1021%2Fjm900364m&amp;key=10.1016%2FS0149-2918%2804%2990128-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3d&amp;dbid=8&amp;doi=10.1021%2Fjm900364m&amp;key=15262455" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3d&amp;dbid=32&amp;doi=10.1021%2Fjm900364m&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmsVSisrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2004&pages=841-854&author=E.+Quattrocchiauthor=H.+Kourlas&title=Teriparaitide%3A+a+review"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3dR"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Teriparatide: a review</span></div><div class="casAuthors">Quattrocchi, Elaena; Kourlas, Helen</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Therapeutics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">841-854</span>CODEN:
                <span class="NLM_cas:coden">CLTHDG</span>;
        ISSN:<span class="NLM_cas:issn">0149-2918</span>.
    
            (<span class="NLM_cas:orgname">Excerpta Medica, Inc.</span>)
        </div><div class="casAbstract">A review.  Traditionally, the management of osteoporosis in men and women has included the use of antiresorptive agents in combination with calcium and vitamin D supplementation.  The mechanism of action of teriparatide is unique in that it possesses anabolic properties and therefore builds bone.  Since the approval of teriparatide in the United States in 2002, a great deal of interest regarding its use in osteoporosis has developed.  This article reviews the information available on the new recombinant human parathyroid hormone teriparatide (hPTH [1-34]), including its clin. pharmacol., mechanism of action, pharmacokinetic properties, clin. efficacy, safety profile, potential drug interactions, contraindications and warnings, dosage and administration, and pharmacoeconomics.  The articles included in this review were identified through searches of PubMed and MEDLINE (1966-Dec. 2003) and International Pharmaceutical Abstrs. (1970-Dec. 2003).  Search terms included teriparatide, Forteo, recombinant human parathyroid hormone (1-34), and osteoporosis.  The refs. of the identified articles were reviewed for addnl. publications.  Specific product information was also obtained from the manufacturer of teriparatide.  Teriparatide has been studied in postmenopausal women with osteoporosis, drug-induced osteoporosis (specifically, corticosteroid-induced osteoporosis), and men with osteoporosis.  The data available from various clin. trials have shown an increase in both bone mineral d. (BMD) and bone mineral content (BMC) with the use of teriparatide compared with placebo.  One study found that women treated with the 20-μg dose and the 40-μg dose were 35% and 40%, resp., less likely to have one or more new nonvertebral fractures compared with placebo (P = 0.02).  Another study compared the use of daily teriparatide 40-μg injections vs. oral daily alendronate.  Results showed that the incidence of nonvertebral fractures was significantly lower in the teriparatide group than the alendronate group (P < 0.05).  A study using 20- and 40-μg daily injections of teriparatide was performed in men with osteoporosis.  There was a statistically significant increase in lumbar spine BMD of 5.9% in the 20-μg group and 9.0% in the 40-μg group (both, P < 0.001).  In the femoral neck, a 1.5% increase in BMD occurred in the 20-μg group (P = 0.021) and a 0.9% increase in the 40-μg group (P < 0.001).  A limited no. of studies are available assessing the combination of antiresorptive medications and teriparatide; however, the available data suggest that the effects of teriparatide do not require prior stimulation of bone resorption.  Teriparatide has been shown clin. to improve BMD and BMC in postmenopausal women and in men.  Because of its anabolic capabilities, teriparatide can be used as an alternative to the traditional therapies that are currently available for the treatment of osteoporosis, with scheduled monitoring for adverse effects such as hypercalcemia and urinary calcium excretion.  In 1 study, mild hypercalcemia was seen most often 4 to 6 h after SC injection of teriparatide before returning to normal.  Urinary, calcium was obsd. to increase by 30 mg/d (0.75 mmol/d) with teriparatide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYd_uzd7xHu7Vg90H21EOLACvtfcHk0lhxe0eaUdGyJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmsVSisrc%253D&md5=d8ee703da34c306140d2278bd46ebcda</span></div><a href="/servlet/linkout?suffix=cit3d&amp;dbid=16384&amp;doi=10.1016%2FS0149-2918%2804%2990128-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0149-2918%252804%252990128-2%26sid%3Dliteratum%253Aachs%26aulast%3DQuattrocchi%26aufirst%3DE.%26aulast%3DKourlas%26aufirst%3DH.%26atitle%3DTeriparaitide%253A%2520a%2520review%26jtitle%3DClin.%2520Ther.%26date%3D2004%26volume%3D26%26spage%3D841%26epage%3D854" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit3e"><span><span class="NLM_contrib-group">Dobnig, H.</span><span> </span><span class="NLM_article-title">A review of teriparatide and its clinical efficacy in the treatment of osteoporosis</span> <span class="citation_source-journal">Expt Opin. Pharmacother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">710</span><span class="NLM_x">–</span> <span class="NLM_lpage">718</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2003&pages=710-718&author=H.+Dobnig&title=A+review+of+teriparatide+and+its+clinical+efficacy+in+the+treatment+of+osteoporosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDobnig%26aufirst%3DH.%26atitle%3DA%2520review%2520of%2520teriparatide%2520and%2520its%2520clinical%2520efficacy%2520in%2520the%2520treatment%2520of%2520osteoporosis%26jtitle%3DExpt%2520Opin.%2520Pharmacother.%26date%3D2003%26volume%3D57%26spage%3D710%26epage%3D718" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit3f"><span><span class="NLM_contrib-group">Ebling, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russell, R. G. G.</span><span> </span><span class="NLM_article-title">Teriparaitide (rhPTH1-34) for the treatment of osteoporosis</span> <span class="citation_source-journal">Int. J. Clin. Pract.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">710</span><span class="NLM_x">–</span> <span class="NLM_lpage">718</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3f&amp;dbid=8&amp;doi=10.1021%2Fjm900364m&amp;key=14627183" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2003&pages=710-718&author=P.+R.+Eblingauthor=R.+G.+G.+Russell&title=Teriparaitide+%28rhPTH1-34%29+for+the+treatment+of+osteoporosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3f&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEbling%26aufirst%3DP.%2BR.%26aulast%3DRussell%26aufirst%3DR.%2BG.%2BG.%26atitle%3DTeriparaitide%2520%2528rhPTH1-34%2529%2520for%2520the%2520treatment%2520of%2520osteoporosis%26jtitle%3DInt.%2520J.%2520Clin.%2520Pract.%26date%3D2003%26volume%3D57%26spage%3D710%26epage%3D718" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit3g"><span><span class="NLM_contrib-group">Berg, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neumeyer, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirkpatrick, P.</span><span> </span><span class="NLM_article-title">Fresh from the pipline: Teriparatide</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">257</span><span class="NLM_x">–</span> <span class="NLM_lpage">258</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2003&pages=257-258&author=C.+Bergauthor=K.+Neumeyerauthor=P.+Kirkpatrick&title=Fresh+from+the+pipline%3A+Teriparatide"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3g&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBerg%26aufirst%3DC.%26aulast%3DNeumeyer%26aufirst%3DK.%26aulast%3DKirkpatrick%26aufirst%3DP.%26atitle%3DFresh%2520from%2520the%2520pipline%253A%2520Teriparatide%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery.%26date%3D2003%26volume%3D2%26spage%3D257%26epage%3D258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Kronenberg, H. M.</span><span> </span><span class="NLM_article-title">PTHrP and skeletal development</span> <span class="citation_source-journal">Ann. New York Acad. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">1068</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">13</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm900364m&amp;key=10.1196%2Fannals.1346.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm900364m&amp;key=16831900" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm900364m&amp;key=1%3ACAS%3A528%3ADC%252BD28XntFent7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1068&publication_year=2006&pages=1-13&author=H.+M.+Kronenberg&title=PTHrP+and+skeletal+development"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">PTHrP and skeletal development</span></div><div class="casAuthors">Kronenberg, Henry M.</div><div class="citationInfo"><span class="NLM_cas:title">Annals of the New York Academy of Sciences</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">1068</span>
        (<span class="NLM_cas:issue">Skeletal Development and Remodeling in Health, Disease, and Aging</span>),
    <span class="NLM_cas:pages">1-13</span>CODEN:
                <span class="NLM_cas:coden">ANYAA9</span>;
        ISSN:<span class="NLM_cas:issn">0077-8923</span>.
    
            (<span class="NLM_cas:orgname">New York Academy of Sciences</span>)
        </div><div class="casAbstract">A review.  Parathyroid hormone-related protein (PTHrP) participates in the regulation of endochondral bone development.  After the cartilage mold is established in fetal life, perichondrial cells and chondrocytes at the ends of the mold synthesize PTHrP.  This ligand then acts on PTH/PTHrP receptors on chondrocytes.  As chondrocytes go through a program of proliferation and then further differentiation into postmitotic, hypertrophic chondrocytes, PTHrP action keeps chondrocytes proliferating and delays their further differentiation.  Indian hedgehog (Ihh) is synthesized by chondrocytes that have just stopped proliferating and is required for synthesis of PTHrP.  The feedback loop between PTHrP and Ihh serves to regulate the pace of chondrocyte differentiation and the sites at which perichondrial cells first differentiate into osteoblasts.  Activation of the PTH/PTHrP receptor leads to stimulation of both Gs and Gq family heterotrimeric G proteins.  Genetic analyses demonstrate that Gs activation mediates the action of PTHrP to keep chondrocytes proliferating, while Gq activation opposes this action.  Downstream from Gs activation, synthesis of the cyclin-cdk inhibitor, p57, is suppressed, thereby increasing the pool of proliferating chondrocytes.  PTHrP's actions to delay chondrocyte differentiation are mediated by the phosphorylation of the transcription factor, SOX9, and by suppression of synthesis of mRNA encoding the transcription factor, Runx2.  These pathways and undoubtedly others cooperate to regulate the pace of differentiation of growth plate chondrocytes in response to PTHrP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpd5cbjSE7kObVg90H21EOLACvtfcHk0ljksslAYHvGQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XntFent7k%253D&md5=a755c610f919729230311ee13e5f7c97</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1196%2Fannals.1346.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1196%252Fannals.1346.002%26sid%3Dliteratum%253Aachs%26aulast%3DKronenberg%26aufirst%3DH.%2BM.%26atitle%3DPTHrP%2520and%2520skeletal%2520development%26jtitle%3DAnn.%2520New%2520York%2520Acad.%2520Sci.%26date%3D2006%26volume%3D1068%26spage%3D1%26epage%3D13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit4a"><span><span class="NLM_contrib-group">Murray, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, L. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Divieti, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bringhurst, F. R.</span><span> </span><span class="NLM_article-title">Parathyroid hormone secretion and action: evidence for discrete receptors for the carboxyl-terminal region and related biological actions of carboxyl-terminal ligands</span> <span class="citation_source-journal">Endocr. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">78</span><span class="NLM_x">–</span> <span class="NLM_lpage">113</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=16&amp;doi=10.1021%2Fjm900364m&amp;key=10.1210%2Fer.2003-0024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=8&amp;doi=10.1021%2Fjm900364m&amp;key=15689574" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=32&amp;doi=10.1021%2Fjm900364m&amp;key=1%3ACAS%3A528%3ADC%252BD2MXitFykt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2005&pages=78-113&author=T.+M.+Murrayauthor=L.+G.+Raoauthor=P.+Divietiauthor=F.+R.+Bringhurst&title=Parathyroid+hormone+secretion+and+action%3A+evidence+for+discrete+receptors+for+the+carboxyl-terminal+region+and+related+biological+actions+of+carboxyl-terminal+ligands"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4aR"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Parathyroid hormone secretion and action: Evidence for discrete receptors for the carboxyl-terminal region and related biological actions of carboxyl-terminal ligands</span></div><div class="casAuthors">Murray, Timothy M.; Rao, Leticia G.; Divieti, Paola; Bringhurst, F. Richard</div><div class="citationInfo"><span class="NLM_cas:title">Endocrine Reviews</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">78-113</span>CODEN:
                <span class="NLM_cas:coden">ERVIDP</span>;
        ISSN:<span class="NLM_cas:issn">0163-769X</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">A review.  PTH is a major systemic regulator of the concns. of calcium, phosphate, and active vitamin D metabolites in blood and of cellular activity in bone.  Intermittently administered PTH and amino-terminal PTH peptide fragments or analogs also augment bone mass and currently are being introduced into clin. practice as therapies for osteoporosis.  The amino-terminal region of PTH is known to be both necessary and sufficient for full activity at PTH/PTHrP receptors (PTH1Rs), which mediate the classical biol. actions of the hormone.  It is well known that multiple carboxyl-terminal fragments of PTH are present in blood, where they comprise the major form(s) of circulating hormone, but these fragments have long been regarded as inert byproducts of PTH metab. because they neither bind to nor activate PTH1Rs.  New in vitro and in vivo evidence, together with older observations extending over the past 20 yr, now points strongly to the existence of novel large carboxyl-terminal PTH fragments in blood and to receptors for these fragments that appear to mediate unique biol. actions in bone.  This review traces the development of this field in the context of the evolution of our understanding of the "classical" receptor for amino-terminal PTH and the now convincing evidence for these receptors for carboxyl-terminal PTH.  The review summarizes current knowledge of the structure, secretion, and metab. of PTH and its circulating fragments, details available information concerning the pharmacol. and actions of carboxyl-terminal PTH receptors, and frames their likely biol. and clin. significance.  It seems likely that physiol. parathyroid regulation of calcium and bone metab. may involve receptors for circulating carboxy-terminal PTH ligands as well as the action of amino-terminal determinants within the PTH mol. on the classical PTH1R.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2K0CufOD-pbVg90H21EOLACvtfcHk0ljksslAYHvGQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXitFykt7w%253D&md5=8f10126cb6ff42791368e69674f606bf</span></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=10.1210%2Fer.2003-0024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fer.2003-0024%26sid%3Dliteratum%253Aachs%26aulast%3DMurray%26aufirst%3DT.%2BM.%26aulast%3DRao%26aufirst%3DL.%2BG.%26aulast%3DDivieti%26aufirst%3DP.%26aulast%3DBringhurst%26aufirst%3DF.%2BR.%26atitle%3DParathyroid%2520hormone%2520secretion%2520and%2520action%253A%2520evidence%2520for%2520discrete%2520receptors%2520for%2520the%2520carboxyl-terminal%2520region%2520and%2520related%2520biological%2520actions%2520of%2520carboxyl-terminal%2520ligands%26jtitle%3DEndocr.%2520Rev.%26date%3D2005%26volume%3D26%26spage%3D78%26epage%3D113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit4b"><span><span class="NLM_contrib-group">Gardella, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juppner, H.</span><span> </span><span class="NLM_article-title">Molecular properties of the PTH/PTHrP receptor</span> <span class="citation_source-journal">Trends Endocr. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">210</span><span class="NLM_x">–</span> <span class="NLM_lpage">217</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=16&amp;doi=10.1021%2Fjm900364m&amp;key=10.1016%2FS1043-2760%2801%2900409-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=8&amp;doi=10.1021%2Fjm900364m&amp;key=11397646" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=32&amp;doi=10.1021%2Fjm900364m&amp;key=1%3ACAS%3A528%3ADC%252BD3MXktVKktrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2001&pages=210-217&author=T.+J.+Gardellaauthor=H.+Juppner&title=Molecular+properties+of+the+PTH%2FPTHrP+receptor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4bR"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular properties of the PTH/PTHrP receptor</span></div><div class="casAuthors">Gardella, T. J.; Juppner, H.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Endocrinology and Metabolism</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">210-217</span>CODEN:
                <span class="NLM_cas:coden">TENME4</span>;
        ISSN:<span class="NLM_cas:issn">1043-2760</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review, with 97 refs.  The receptor for parathyroid hormone (PTH) and PTH-related protein (PTHrP) is a G protein-coupled receptor (GPCR) that plays a key role in controlling blood Ca2+ concn. and endochondral bone formation.  This review focuses on the mol. mechanisms by which the receptor recognizes the PTH and PTHrP peptide ligands and transmits their signal across the cell membrane.  The available data suggest that there are 2 principal components to the ligand-receptor interaction.  First, a docking interaction between the C-terminal portion of PTH(1-34) and the N-terminal extracellular domain of the receptor; and second, a weaker interaction between the N-terminal portion of the ligand and the juxtamembrane region of the receptor, which induces signal transduction.  A full understanding of these processes could lead to new PTH/PTHrP receptor ligands that are effective in controlling diseases of bone and mineral metab., such as osteoporosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqUMDlbuYU-bVg90H21EOLACvtfcHk0ljksslAYHvGQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXktVKktrg%253D&md5=58b25e1c414575ff527442b71065da16</span></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=10.1016%2FS1043-2760%2801%2900409-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1043-2760%252801%252900409-X%26sid%3Dliteratum%253Aachs%26aulast%3DGardella%26aufirst%3DT.%2BJ.%26aulast%3DJuppner%26aufirst%3DH.%26atitle%3DMolecular%2520properties%2520of%2520the%2520PTH%252FPTHrP%2520receptor%26jtitle%3DTrends%2520Endocr.%2520Metab.%26date%3D2001%26volume%3D12%26spage%3D210%26epage%3D217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit4c"><span><span class="NLM_contrib-group">Juppner, H.</span><span> </span><span class="NLM_article-title">Receptors for parathyroid hormone and parathyroid hormone-related peptide: exploration of their biological importance</span> <span class="citation_source-journal">Bone</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">87</span><span class="NLM_x">–</span> <span class="NLM_lpage">90</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=1999&pages=87-90&author=H.+Juppner&title=Receptors+for+parathyroid+hormone+and+parathyroid+hormone-related+peptide%3A+exploration+of+their+biological+importance"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJuppner%26aufirst%3DH.%26atitle%3DReceptors%2520for%2520parathyroid%2520hormone%2520and%2520parathyroid%2520hormone-related%2520peptide%253A%2520exploration%2520of%2520their%2520biological%2520importance%26jtitle%3DBone%26date%3D1999%26volume%3D25%26spage%3D87%26epage%3D90" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Brown, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacLeod, R. J.</span><span> </span><span class="NLM_article-title">Extracellular Calcium Sensing and Extracellular Calcium Signaling</span> <span class="citation_source-journal">Physiol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">81</span><span class="NLM_x">, </span> <span class="NLM_fpage">239</span><span class="NLM_x">–</span> <span class="NLM_lpage">297</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm900364m&amp;key=10.1152%2Fphysrev.2001.81.1.239" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm900364m&amp;key=11152759" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm900364m&amp;key=1%3ACAS%3A528%3ADC%252BD3MXitV2ktLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2001&pages=239-297&author=E.+M.+Brownauthor=R.+J.+MacLeod&title=Extracellular+Calcium+Sensing+and+Extracellular+Calcium+Signaling"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Extracellular calcium sensing and extracellular calcium signaling</span></div><div class="casAuthors">Brown, Edward M.; MacLeod, R. John</div><div class="citationInfo"><span class="NLM_cas:title">Physiological Reviews</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">239-297</span>CODEN:
                <span class="NLM_cas:coden">PHREA7</span>;
        ISSN:<span class="NLM_cas:issn">0031-9333</span>.
    
            (<span class="NLM_cas:orgname">American Physiological Society</span>)
        </div><div class="casAbstract">A review, with 481 refs.  The cloning of a G protein-coupled extracellular Ca2+ (Cao2+)-sensing receptor (CaR) has elucidated the mol. basis for many of the previously recognized effects of Cao2+ on tissues that maintain systemic Cao2+ homeostasis, esp. parathyroid chief cells and several cells in the kidney.  The availability of the cloned CaR enabled the development of DNA and antibody probes for identifying the CaR's mRNA and protein, resp., within these and other tissues.  It also permitted the identification of human diseases resulting from inactivating or activating mutations of the CaR gene and the subsequent generation of mice with targeted disruption of the CaR gene.  The characteristic alterations in parathyroid and renal function in these patients and in the mice with knockout of the CaR gene have provided valuable information on the CaR's physiol. roles in these tissues participating in mineral ion homeostasis.  Nevertheless, relatively little is known about how the CaR regulates other tissues involved in systemic Cao2+ homeostasis, particularly bone and intestine.  Moreover, there is evidence that addnl. Cao2+ sensors may exist in bone cells that mediate some or even all of the known effects of Cao2+ on these cells.  Even more remains to be learned about the CaR's function in the rapidly growing list of cells that express it but are uninvolved in systemic Cao2+ metab.  Available data suggest that the receptor serves numerous roles outside of systemic mineral ion homeostasis, ranging from the regulation of hormonal secretion and the activities of various ion channels to the longer term control of gene expression, programmed cell death (apoptosis), and cellular proliferation.  In some cases, the CaR on these non-homeostatic cells responds to local changes in Cao2+ taking place within compartments of the extracellular fluid (ECF) that communicate with the outside environment (e.g., the gastrointestinal tract).  In others, localized changes in Cao2+ within the ECF can originate from several mechanisms, including fluxes of calcium ions into or out of cellular or extracellular stores or across epithelium that absorb or secrete Ca2+.  In any event, the CaR and other receptors/sensors for Cao2+ and probably for other extracellular ions represent versatile regulators of numerous cellular functions and may serve as important therapeutic targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6uGVgKVIQybVg90H21EOLACvtfcHk0lgGaD6BEUdTLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXitV2ktLo%253D&md5=bdaf576fbde7255da389eb9fa0d84823</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1152%2Fphysrev.2001.81.1.239&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fphysrev.2001.81.1.239%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DE.%2BM.%26aulast%3DMacLeod%26aufirst%3DR.%2BJ.%26atitle%3DExtracellular%2520Calcium%2520Sensing%2520and%2520Extracellular%2520Calcium%2520Signaling%26jtitle%3DPhysiol.%2520Rev.%26date%3D2001%26volume%3D81%26spage%3D239%26epage%3D297" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5a"><span><span class="NLM_contrib-group">Nemeth, E. F.</span><span> </span><span class="NLM_article-title">Calcium receptor-dependent regulation of cellular functions</span> <span class="citation_source-journal">News Physiol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">5</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=32&amp;doi=10.1021%2Fjm900364m&amp;key=1%3ACAS%3A528%3ADyaK2MXkslequ7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=1995&pages=1-5&author=E.+F.+Nemeth&title=Calcium+receptor-dependent+regulation+of+cellular+functions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5aR"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Ca2+ receptor-dependent regulation of cellular functions</span></div><div class="casAuthors">Nemeth, Edward F.</div><div class="citationInfo"><span class="NLM_cas:title">News in Physiological Sciences</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">Feb.</span>),
    <span class="NLM_cas:pages">1-5</span>CODEN:
                <span class="NLM_cas:coden">NEPSEY</span>;
        ISSN:<span class="NLM_cas:issn">0886-1714</span>.
    </div><div class="casAbstract">A review, with 15 refs.  A cell-surface Ca2+ receptor enables parathyroid cells to detect and respond to extracellular Ca2+.  The recent cloning of a G protein-coupled Ca2+ receptor solidifies this view.  Ca2+ receptors regulate the activity of various cells and provide novel mol. targets for new pharmaceuticals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmAYKq3zbA7LVg90H21EOLACvtfcHk0lgGaD6BEUdTLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXkslequ7g%253D&md5=5c0358f59bb52230ca313049fa647144</span></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNemeth%26aufirst%3DE.%2BF.%26atitle%3DCalcium%2520receptor-dependent%2520regulation%2520of%2520cellular%2520functions%26jtitle%3DNews%2520Physiol.%2520Sci.%26date%3D1995%26volume%3D10%26spage%3D1%26epage%3D5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5b"><span><span class="NLM_contrib-group">Brown, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacLeod, R. J.</span><span> </span><span class="NLM_article-title">Extracellular calcium sensing and extracellular calcium signaling</span> <span class="citation_source-journal">Physiol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">81</span><span class="NLM_x">, </span> <span class="NLM_fpage">239</span><span class="NLM_x">–</span> <span class="NLM_lpage">297</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=16&amp;doi=10.1021%2Fjm900364m&amp;key=10.1152%2Fphysrev.2001.81.1.239" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=8&amp;doi=10.1021%2Fjm900364m&amp;key=11152759" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=32&amp;doi=10.1021%2Fjm900364m&amp;key=1%3ACAS%3A528%3ADC%252BD3MXitV2ktLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2001&pages=239-297&author=E.+M.+Brownauthor=R.+J.+MacLeod&title=Extracellular+calcium+sensing+and+extracellular+calcium+signaling"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5bR"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Extracellular calcium sensing and extracellular calcium signaling</span></div><div class="casAuthors">Brown, Edward M.; MacLeod, R. John</div><div class="citationInfo"><span class="NLM_cas:title">Physiological Reviews</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">239-297</span>CODEN:
                <span class="NLM_cas:coden">PHREA7</span>;
        ISSN:<span class="NLM_cas:issn">0031-9333</span>.
    
            (<span class="NLM_cas:orgname">American Physiological Society</span>)
        </div><div class="casAbstract">A review, with 481 refs.  The cloning of a G protein-coupled extracellular Ca2+ (Cao2+)-sensing receptor (CaR) has elucidated the mol. basis for many of the previously recognized effects of Cao2+ on tissues that maintain systemic Cao2+ homeostasis, esp. parathyroid chief cells and several cells in the kidney.  The availability of the cloned CaR enabled the development of DNA and antibody probes for identifying the CaR's mRNA and protein, resp., within these and other tissues.  It also permitted the identification of human diseases resulting from inactivating or activating mutations of the CaR gene and the subsequent generation of mice with targeted disruption of the CaR gene.  The characteristic alterations in parathyroid and renal function in these patients and in the mice with knockout of the CaR gene have provided valuable information on the CaR's physiol. roles in these tissues participating in mineral ion homeostasis.  Nevertheless, relatively little is known about how the CaR regulates other tissues involved in systemic Cao2+ homeostasis, particularly bone and intestine.  Moreover, there is evidence that addnl. Cao2+ sensors may exist in bone cells that mediate some or even all of the known effects of Cao2+ on these cells.  Even more remains to be learned about the CaR's function in the rapidly growing list of cells that express it but are uninvolved in systemic Cao2+ metab.  Available data suggest that the receptor serves numerous roles outside of systemic mineral ion homeostasis, ranging from the regulation of hormonal secretion and the activities of various ion channels to the longer term control of gene expression, programmed cell death (apoptosis), and cellular proliferation.  In some cases, the CaR on these non-homeostatic cells responds to local changes in Cao2+ taking place within compartments of the extracellular fluid (ECF) that communicate with the outside environment (e.g., the gastrointestinal tract).  In others, localized changes in Cao2+ within the ECF can originate from several mechanisms, including fluxes of calcium ions into or out of cellular or extracellular stores or across epithelium that absorb or secrete Ca2+.  In any event, the CaR and other receptors/sensors for Cao2+ and probably for other extracellular ions represent versatile regulators of numerous cellular functions and may serve as important therapeutic targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6uGVgKVIQybVg90H21EOLACvtfcHk0lgGaD6BEUdTLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXitV2ktLo%253D&md5=bdaf576fbde7255da389eb9fa0d84823</span></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=10.1152%2Fphysrev.2001.81.1.239&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fphysrev.2001.81.1.239%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DE.%2BM.%26aulast%3DMacLeod%26aufirst%3DR.%2BJ.%26atitle%3DExtracellular%2520calcium%2520sensing%2520and%2520extracellular%2520calcium%2520signaling%26jtitle%3DPhysiol.%2520Rev.%26date%3D2001%26volume%3D81%26spage%3D239%26epage%3D297" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5c"><span><span class="NLM_contrib-group">Chen, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goodman, W. G.</span><span> </span><span class="NLM_article-title">Role of the calcium-sensing receptor in parathyroid gland physiology</span> <span class="citation_source-journal">Am. J. Physiol. Renal Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">286</span><span class="NLM_x">, </span> <span class="NLM_fpage">F1005</span><span class="NLM_x">–</span> <span class="NLM_lpage">F1011</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2004&pages=F1005-F1011&author=R.+A.+Chenauthor=W.+G.+Goodman&title=Role+of+the+calcium-sensing+receptor+in+parathyroid+gland+physiology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DR.%2BA.%26aulast%3DGoodman%26aufirst%3DW.%2BG.%26atitle%3DRole%2520of%2520the%2520calcium-sensing%2520receptor%2520in%2520parathyroid%2520gland%2520physiology%26jtitle%3DAm.%2520J.%2520Physiol.%2520Renal%2520Physiol.%26date%3D2004%26volume%3D286%26spage%3DF1005%26epage%3DF1011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5d"><span><span class="NLM_contrib-group">Tfelt-Hansen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, E. M.</span><span> </span><span class="NLM_article-title">The calcium-sensing receptor in normal physiology and pathophysiology: a review</span> <span class="citation_source-journal">Crit. Rev. Clin. Lab. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">35</span><span class="NLM_x">–</span> <span class="NLM_lpage">70</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5d&amp;dbid=16&amp;doi=10.1021%2Fjm900364m&amp;key=10.1080%2F10408360590886606" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5d&amp;dbid=8&amp;doi=10.1021%2Fjm900364m&amp;key=15697170" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5d&amp;dbid=32&amp;doi=10.1021%2Fjm900364m&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtFSnsbrE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2005&pages=35-70&author=J.+Tfelt-Hansenauthor=E.+M.+Brown&title=The+calcium-sensing+receptor+in+normal+physiology+and+pathophysiology%3A+a+review"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5dR"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">The Calcium-Sensing Receptor in Normal Physiology and Pathophysiology: A Review</span></div><div class="casAuthors">Tfelt-Hansen, Jacob; Brown, Edward</div><div class="citationInfo"><span class="NLM_cas:title">Critical Reviews in Clinical Laboratory Sciences</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">35-70</span>CODEN:
                <span class="NLM_cas:coden">CRCLBH</span>;
        ISSN:<span class="NLM_cas:issn">1040-8363</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis, Inc.</span>)
        </div><div class="casAbstract">A review.  The discovery of a G protein-coupled, calcium-sensing receptor (CaR) a decade ago and of diseases caused by CaR mutations provided unquestionable evidence of the CaR's crit. role in the maintenance of systemic calcium homeostasis.  On the cell membrane of the chief cells of the parathyroid glands, the CaR "senses" the extracellular calcium concn. and, subsequently, alters the release of parathyroid hormone (PTH).  The CaR is likewise functionally expressed in bone, kidney, and gut-the three major calcium-translocating organs involved in calcium homeostasis.  Intracellular signal pathways to which the CaR couples via its assocd. G proteins include phospholipase C (PLC), protein kinase B (AKT); and mitogen-activated protein kinases (MAPKs).  The receptor is widely expressed in various tissues and regulates important cellular functions in addn. to its role in maintaining systemic calcium homeostasis, i.e., protection against apoptosis, cellular proliferation, and membrane voltage.  Functionally significant mutations in the receptor have been shown to induce diseases of calcium homeostasis owing to changes in the set point for calcium-regulated PTH release as well as alterations in the renal handling of calcium.  Gain-of-function mutations cause hypocalcemia, whereas loss-of-function mutations produce hypercalcemia.  Recent studies have shown that the latter clin. presentation can also be caused by inactivating autoantibodies directed against the CaR.  Newly discovered type II allosteric activators of the CaR have been found to be effective as a medical treatment for renal secondary hyperparathyroidism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoguMPL6ZwnCrVg90H21EOLACvtfcHk0lgGaD6BEUdTLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtFSnsbrE&md5=341363042e4477a3c4e35bba0395b201</span></div><a href="/servlet/linkout?suffix=cit5d&amp;dbid=16384&amp;doi=10.1080%2F10408360590886606&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F10408360590886606%26sid%3Dliteratum%253Aachs%26aulast%3DTfelt-Hansen%26aufirst%3DJ.%26aulast%3DBrown%26aufirst%3DE.%2BM.%26atitle%3DThe%2520calcium-sensing%2520receptor%2520in%2520normal%2520physiology%2520and%2520pathophysiology%253A%2520a%2520review%26jtitle%3DCrit.%2520Rev.%2520Clin.%2520Lab.%2520Sci.%26date%3D2005%26volume%3D42%26spage%3D35%26epage%3D70" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Nemeth, E. F.</span><span> </span><span class="NLM_article-title">Misconceptions about calcimimetics</span> <span class="citation_source-journal">Anns. N. Y. Acad. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">1068</span><span class="NLM_x">, </span> <span class="NLM_fpage">471</span><span class="NLM_x">–</span> <span class="NLM_lpage">476</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm900364m&amp;key=10.1196%2Fannals.1346.044" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm900364m&amp;key=16831944" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm900364m&amp;key=1%3ACAS%3A528%3ADC%252BD28XntFenu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1068&publication_year=2006&pages=471-476&author=E.+F.+Nemeth&title=Misconceptions+about+calcimimetics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Misconceptions about calcimimetics</span></div><div class="casAuthors">Nemeth, E. F.</div><div class="citationInfo"><span class="NLM_cas:title">Annals of the New York Academy of Sciences</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">1068</span>
        (<span class="NLM_cas:issue">Skeletal Development and Remodeling in Health, Disease, and Aging</span>),
    <span class="NLM_cas:pages">471-476</span>CODEN:
                <span class="NLM_cas:coden">ANYAA9</span>;
        ISSN:<span class="NLM_cas:issn">0077-8923</span>.
    
            (<span class="NLM_cas:orgname">New York Academy of Sciences</span>)
        </div><div class="casAbstract">A review.  Calcimimetics are ligands that activate the calcium receptor.  Some are small mols. and of these, the most extensively studied are phenylalkylamines like cinacalcet.  This compd. is a pos. allosteric modulator that selectively targets the parathyroid calcium receptor to inhibit the secretion of parathyroid hormone.  Cinacalcet is the first calcimimetic compd. to attain regulatory approval for the treatment of hyperparathyroidism resulting from end-stage renal disease.  The discovery of calcimimetics and the receptor they act on are considered with the intent of extg. lessons relevant to medical research and the discovery of new drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRtaX_piW_9bVg90H21EOLACvtfcHk0lhzew4uNvmbcQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XntFenu7c%253D&md5=81000995ddd63fc5f09aa8133b795df6</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1196%2Fannals.1346.044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1196%252Fannals.1346.044%26sid%3Dliteratum%253Aachs%26aulast%3DNemeth%26aufirst%3DE.%2BF.%26atitle%3DMisconceptions%2520about%2520calcimimetics%26jtitle%3DAnns.%2520N.%2520Y.%2520Acad.%2520Sci.%26date%3D2006%26volume%3D1068%26spage%3D471%26epage%3D476" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6a"><span><span class="NLM_contrib-group">Nemeth, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, J.</span><span> </span><span class="NLM_article-title">Compounds acting on the parathyroid calcium receptor as novel therapies for hyperparathyroidism and osteoporosis</span> <span class="citation_source-journal">Endocr. Updates</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">173</span><span class="NLM_x">–</span> <span class="NLM_lpage">202</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=32&amp;doi=10.1021%2Fjm900364m&amp;key=1%3ACAS%3A528%3ADC%252BD3sXns1ersbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2003&pages=173-202&author=E.+F.+Nemethauthor=J.+Fox&title=Compounds+acting+on+the+parathyroid+calcium+receptor+as+novel+therapies+for+hyperparathyroidism+and+osteoporosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6aR"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Compounds acting on the parathyroid calcium receptor as novel therapies for hyperparathyroidism or osteoporosis</span></div><div class="casAuthors">Nemeth, Edward F.; Fox, John</div><div class="citationInfo"><span class="NLM_cas:title">Endocrine Updates</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">Calcium-Sensing Receptor</span>),
    <span class="NLM_cas:pages">173-202</span>CODEN:
                <span class="NLM_cas:coden">ECUDF4</span>;
        ISSN:<span class="NLM_cas:issn">1566-0729</span>.
    
            (<span class="NLM_cas:orgname">Kluwer Academic Publishers</span>)
        </div><div class="casAbstract">A review on the progress made in the discovery and development of small mols. that activate or inhibit the parathyroid Ca2+ receptor and thereby inhibit or stimulate secretion of parathyroid hormone (PTH).  Manipulating the activity of the Ca2+ receptor pharmacol. is proving to be a very effective way of altering at will the circulating level of PTH.  Drugs which either increase or decrease the secretion of PTH from the parathyroid glands could be useful in treating the various forms of hyperparathyroidism or osteoporosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSaWOblqRq9LVg90H21EOLACvtfcHk0lhzew4uNvmbcQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXns1ersbw%253D&md5=37780ed86903775b2750465bf2018da5</span></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNemeth%26aufirst%3DE.%2BF.%26aulast%3DFox%26aufirst%3DJ.%26atitle%3DCompounds%2520acting%2520on%2520the%2520parathyroid%2520calcium%2520receptor%2520as%2520novel%2520therapies%2520for%2520hyperparathyroidism%2520and%2520osteoporosis%26jtitle%3DEndocr.%2520Updates%26date%3D2003%26volume%3D19%26spage%3D173%26epage%3D202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6b"><span><span class="NLM_contrib-group">Nemeth, E. F.</span><span> </span><span class="NLM_article-title">Pharmacological regulation of parathyroid hormone secretion</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">2077</span><span class="NLM_x">–</span> <span class="NLM_lpage">2087</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=16&amp;doi=10.1021%2Fjm900364m&amp;key=10.2174%2F1381612023393387" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=8&amp;doi=10.1021%2Fjm900364m&amp;key=12171519" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=32&amp;doi=10.1021%2Fjm900364m&amp;key=1%3ACAS%3A528%3ADC%252BD38XmvFOjsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2002&pages=2077-2087&author=E.+F.+Nemeth&title=Pharmacological+regulation+of+parathyroid+hormone+secretion"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6bR"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological regulation of parathyroid hormone secretion</span></div><div class="casAuthors">Nemeth, E. F.</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">2077-2087</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers</span>)
        </div><div class="casAbstract">A review.  Parathyroid hormone (PTH) is the key endocrine factor regulating systemic Ca2+ homeostasis.  Elevated levels of circulating PTH increase bone turnover and, depending on the duration of elevation, will result in net anabolic or catabolic effects on the skeleton.  Secretion of PTH from the parathyroid glands is regulated by small changes in circulating levels of Ca2+ which are detected by a Ca2+ receptor on the surface of parathyroid cells.  This G protein-coupled receptor is the primary mol. entity used by parathyroid cells to regulate secretion of PTH.  As such, the Ca2+ receptor is a unique mol. target for new drugs capable of increasing or decreasing circulating levels of PTH.  Compds. which activate the Ca2+ receptor are termed calcimimetics and they inhibit the secretion of PTH; a calcimimetic compd. is in late stage clin. trials for the treatment of both primary and secondary hyperparathyroidism.  Conversely, calcilytic compds., which are Ca2+ receptor antagonists, stimulate secretion of PTH; a calcilytic compd. is in early clin. development for the treatment of osteoporosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWJHkAPZSZLrVg90H21EOLACvtfcHk0lhzew4uNvmbcQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XmvFOjsb8%253D&md5=6eef4365891ea3f33edb8cda81df89cb</span></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=10.2174%2F1381612023393387&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1381612023393387%26sid%3Dliteratum%253Aachs%26aulast%3DNemeth%26aufirst%3DE.%2BF.%26atitle%3DPharmacological%2520regulation%2520of%2520parathyroid%2520hormone%2520secretion%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2002%26volume%3D8%26spage%3D2077%26epage%3D2087" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6c"><span><span class="NLM_contrib-group">Nemeth, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, J.</span><span> </span><span class="NLM_article-title">Calcimimetic compounds: a direct approach to controlling plasma levels of parathyroid hormone in hyperparathyroidism</span> <span class="citation_source-journal">Trends Endcrinol. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">66</span><span class="NLM_x">–</span> <span class="NLM_lpage">71</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=16&amp;doi=10.1021%2Fjm900364m&amp;key=10.1016%2FS1043-2760%2898%2900119-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=8&amp;doi=10.1021%2Fjm900364m&amp;key=10322397" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=32&amp;doi=10.1021%2Fjm900364m&amp;key=1%3ACAS%3A528%3ADyaK1MXhvVylt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=1999&pages=66-71&author=E.+F.+Nemethauthor=J.+Fox&title=Calcimimetic+compounds%3A+a+direct+approach+to+controlling+plasma+levels+of+parathyroid+hormone+in+hyperparathyroidism"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6cR"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Calcimimetic compounds: a direct approach to controlling plasma levels of parathyroid hormone in hyperparathyroidism</span></div><div class="casAuthors">Nemeth, Edward F.; Fox, John</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Endocrinology and Metabolism</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">66-71</span>CODEN:
                <span class="NLM_cas:coden">TENME4</span>;
        ISSN:<span class="NLM_cas:issn">1043-2760</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review, with 35 refs.  The Ca2+ receptor is the primary mechanism regulating the secretion of parathyroid hormone (PTH).  Ligands that activate this receptor (calcimimetics) represent a novel means of lowering plasma levels of PTH.  Two mechanistically distinct classes of calcimimetics that inhibit PTH secretion have been identified: type I calcimimetics are full agonists of the Ca2+ receptor and include Ca2+ and other polyvalent inorg. and org. cations; whereas type II calcimimetics, typified by phenylalkylamine compds., behave like pos. allosteric activators and increase, in a stereoselective manner, the sensitivity of the Ca2+ receptor to activation by extracellular Ca2+.  The phenylalkylamine calcimimetics are orally active and decrease the plasma levels of PTH and Ca2+ in patients with primary hyperparathyroidism (HPT), a disease that so far has resisted pharmacol. intervention.  Such compds. are similarly safe and effective in reducing PTH levels and preventing parathyroid cell hyperplasia in rats with HPT secondary to chronic renal insufficiency and they lower plasma levels of PTH in dialysis patients with secondary HPT.  Calcimimetic compds. may provide a novel therapy for treating both primary and secondary HPT.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIBHJYTGvjIbVg90H21EOLACvtfcHk0lhzew4uNvmbcQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXhvVylt7o%253D&md5=87993f4cc4f333c009c46fe053281759</span></div><a href="/servlet/linkout?suffix=cit6c&amp;dbid=16384&amp;doi=10.1016%2FS1043-2760%2898%2900119-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1043-2760%252898%252900119-2%26sid%3Dliteratum%253Aachs%26aulast%3DNemeth%26aufirst%3DE.%2BF.%26aulast%3DFox%26aufirst%3DJ.%26atitle%3DCalcimimetic%2520compounds%253A%2520a%2520direct%2520approach%2520to%2520controlling%2520plasma%2520levels%2520of%2520parathyroid%2520hormone%2520in%2520hyperparathyroidism%26jtitle%3DTrends%2520Endcrinol.%2520Metab.%26date%3D1999%26volume%3D10%26spage%3D66%26epage%3D71" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6d"><span><span class="NLM_contrib-group">Nemeth, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, S. A.</span><span> </span><span class="NLM_article-title">Tricking the parathyroid gland with novel calcimimetic agents</span> <span class="citation_source-journal">Nephrol., Dial., Transplant.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1923</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6d&amp;dbid=16&amp;doi=10.1021%2Fjm900364m&amp;key=10.1093%2Fndt%2F13.8.1923" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6d&amp;dbid=8&amp;doi=10.1021%2Fjm900364m&amp;key=9719139" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6d&amp;dbid=32&amp;doi=10.1021%2Fjm900364m&amp;key=1%3ACAS%3A528%3ADyaK1cXlslajtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1998&pages=1923&author=E.+F.+Nemethauthor=S.+A.+Bennett&title=Tricking+the+parathyroid+gland+with+novel+calcimimetic+agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6dR"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Tricking the parathyroid gland with novel calcimimetic agents</span></div><div class="casAuthors">Nemeth, Edward F.; Bennett, Sharon A.</div><div class="citationInfo"><span class="NLM_cas:title">Nephrology, Dialysis, Transplantation</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1923-1925</span>CODEN:
                <span class="NLM_cas:coden">NDTREA</span>;
        ISSN:<span class="NLM_cas:issn">0931-0509</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">A review, with 9 refs., which discusses: the nature of calcimimetic agents, the ability of the hyperplastic parathyroid gland to sense calcium, initial clin. experiences with calcimimetics, potential benefits from use of calcimimetic agents, and differences between treatment with vitamin D metabolites and calcimimetics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq83uDkGclX5bVg90H21EOLACvtfcHk0lhzew4uNvmbcQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXlslajtLo%253D&md5=b35fcb6a28c1893a9d5787f063a2990b</span></div><a href="/servlet/linkout?suffix=cit6d&amp;dbid=16384&amp;doi=10.1093%2Fndt%2F13.8.1923&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fndt%252F13.8.1923%26sid%3Dliteratum%253Aachs%26aulast%3DNemeth%26aufirst%3DE.%2BF.%26aulast%3DBennett%26aufirst%3DS.%2BA.%26atitle%3DTricking%2520the%2520parathyroid%2520gland%2520with%2520novel%2520calcimimetic%2520agents%26jtitle%3DNephrol.%252C%2520Dial.%252C%2520Transplant.%26date%3D1998%26volume%3D13%26spage%3D1923" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Locatelli, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pontoriero, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Limbardo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tentori, F.</span><span> </span><span class="NLM_article-title">Cinacalcet hydrochloride: calcimimnetic for the treatment of hyperparathyroidism</span> <span class="citation_source-journal">Exp. Opin. Endocr. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">167</span><span class="NLM_x">–</span> <span class="NLM_lpage">179</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm900364m&amp;key=10.1586%2F17446651.1.2.167" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm900364m&amp;key=1%3ACAS%3A528%3ADC%252BD28XjsVyjtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2006&pages=167-179&author=F.+Locatelliauthor=G.+Pontorieroauthor=M.+Limbardoauthor=F.+Tentori&title=Cinacalcet+hydrochloride%3A+calcimimnetic+for+the+treatment+of+hyperparathyroidism"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Cinacalcet hydrochloride: calcimimetic for the treatment of hyperparathyroidism</span></div><div class="casAuthors">Locatelli, Francesco; Pontoriero, Giuseppe; Limardo, Monica; Tentori, Flavia</div><div class="citationInfo"><span class="NLM_cas:title">Expert Review of Endocrinology & Metabolism</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">167-179</span>CODEN:
                <span class="NLM_cas:coden">EREMBI</span>;
        ISSN:<span class="NLM_cas:issn">1744-6651</span>.
    
            (<span class="NLM_cas:orgname">Future Drugs Ltd.</span>)
        </div><div class="casAbstract">A review.  Mineral metab. disorders, including those related to secondary hyperparathyroidism, affect a large no. of patients with chronic kidney disease and are assocd. with increased relative risk of morbidity and mortality in hemodialysis patients.  The traditional therapy of secondary hyperparathyroidism based on vitamin D compds. and calcium-based phosphate binders is often limited by the increase of serum calcium and phosphorus levels limiting the dose that can be given safely, and thus, preventing the attainment of treatment targets.  Cinacalcet hydrochloride (Sensipar, Mimpara, Parareg) is the first in a new class of therapeutic agents, the calcimimetics, that increase the sensitivity of calcium-sensing receptors to the extracellular calcium ions, thus lowering parathyroid hormone prodn. and release, decreasing serum calcium and phosphorous concns. simultaneously.  Different randomized, double-blind, placebo-controlled trials evaluated the safety and ability of cinacalcet hydrochloride treatment to improve achievement of target levels of parathyroid hormone, calcium, phosphorus and calcium phosphorus product in dialysis patients.  Cinacalcet hydrochloride has also demonstrated to be effective in reducing parathyroid hormone and serum calcium concns. in patients with primary hyperparathyroidism.  On the basis of available data, calcimimetics represent an important innovation and will change the management of mineral metab. disorders in patients with chronic kidney disease and primary hyperparathyroidism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqokYx_j51YkLVg90H21EOLACvtfcHk0lgvcYa4q2zfRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjsVyjtLg%253D&md5=1f846e815b348b14531f5232dd19b37a</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1586%2F17446651.1.2.167&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1586%252F17446651.1.2.167%26sid%3Dliteratum%253Aachs%26aulast%3DLocatelli%26aufirst%3DF.%26aulast%3DPontoriero%26aufirst%3DG.%26aulast%3DLimbardo%26aufirst%3DM.%26aulast%3DTentori%26aufirst%3DF.%26atitle%3DCinacalcet%2520hydrochloride%253A%2520calcimimnetic%2520for%2520the%2520treatment%2520of%2520hyperparathyroidism%26jtitle%3DExp.%2520Opin.%2520Endocr.%2520Metab.%26date%3D2006%26volume%3D1%26spage%3D167%26epage%3D179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7a"><span><span class="NLM_contrib-group">Dong, B. J.</span><span> </span><span class="NLM_article-title">Cinacalcet: an oral calcimimetic agent for the management of hyperparathyroidism</span> <span class="citation_source-journal">Clin. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">1725</span><span class="NLM_x">–</span> <span class="NLM_lpage">1751</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=16&amp;doi=10.1021%2Fjm900364m&amp;key=10.1016%2Fj.clinthera.2005.11.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=8&amp;doi=10.1021%2Fjm900364m&amp;key=16368445" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=32&amp;doi=10.1021%2Fjm900364m&amp;key=1%3ACAS%3A528%3ADC%252BD28XntlWnuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2005&pages=1725-1751&author=B.+J.+Dong&title=Cinacalcet%3A+an+oral+calcimimetic+agent+for+the+management+of+hyperparathyroidism"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7aR"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Cinacalcet: an oral calcimimetic agent for the management of hyperparathyroidism</span></div><div class="casAuthors">Dong, Betty J.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Therapeutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1725-1751</span>CODEN:
                <span class="NLM_cas:coden">CLTHDG</span>;
        ISSN:<span class="NLM_cas:issn">0149-2918</span>.
    
            (<span class="NLM_cas:orgname">Excerpta Medica, Inc.</span>)
        </div><div class="casAbstract">A review.  Uncontrolled hyperparathyroidism (HPT), particularly HPT resulting from chronic kidney disease (CKD), is assocd. with significant morbidity and cardiovascular mortality.  Traditional medical therapy (eg, vitamin D sterols, calcium, phosphate binders) has been inadequate for the management of HPT and its vascular and skeletal complications.  The goal of this article was to review the efficacy and safety profile of cinacalcet, a second-generation calcimimetic, in the management of HPT secondary to CKD, primary HPT, and parathyroid carcinoma.  MEDLINE, Web of Science, and International Pharmaceutical Abstrs. were searched from 1995 to July 2005 using the terms cinacalcet, AMG 073, KRN 1493, calcimimetics, hypercalcemia, and hyperparathyroidism.  Compared with placebo, cinacalcet significantly reduced parathyroid hormone levels within 2 to 4 h after administration (P < 0.05).  In Phase III trials involving 1136 patients with secondary HPT, 56% of those who received cinacalcet achieved the National Kidney Foundation Kidney Disease Outcomes Quality Initiative target of a redn. in parathyroid hormone to <300 pg/mL, 65% achieved a calcium-phosphorus product <55 mg2/dL2, and a resp. 49% and 46% achieved normalized serum calcium and phosphorus levels (P < 0.001).  Cinacalcet's effects were similar regardless of patients' demog. characteristics, duration or mode of dialysis, severity of HPT, or use of concomitant medical therapy.  Preliminary evidence suggests that cinacalcet may reverse cortical bone loss.  Cinacalcet was well tolerated, with nausea (31%) and vomiting (27%) being the most commonly reported adverse effects.  Hypocalcemia was transient in 5% of patients, was usually asymptomatic, and was cor. by dose redn.  Based on the available evidence, cinacalcet is effective and well tolerated in the treatment of secondary HPT and refractory parathyroid carcinoma.  Its use in primary HPT appears promising.  Further investigations are needed to det. if cinacalcet can prevent the long-term complications of HPT and reduce mortality.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpua2ISxtUru7Vg90H21EOLACvtfcHk0lgvcYa4q2zfRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XntlWnuw%253D%253D&md5=fb128fa6543bc3e7dd33c05892a5979c</span></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=10.1016%2Fj.clinthera.2005.11.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.clinthera.2005.11.015%26sid%3Dliteratum%253Aachs%26aulast%3DDong%26aufirst%3DB.%2BJ.%26atitle%3DCinacalcet%253A%2520an%2520oral%2520calcimimetic%2520agent%2520for%2520the%2520management%2520of%2520hyperparathyroidism%26jtitle%3DClin.%2520Ther.%26date%3D2005%26volume%3D27%26spage%3D1725%26epage%3D1751" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7b"><span><span class="NLM_contrib-group">de Francisco, A. L. M.</span><span> </span><span class="NLM_article-title">Cinacalcet HCL: a novel therapeutic for the treatment of hyperparathyroidism</span> <span class="citation_source-journal">Exp. Opin. Pharmacother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">441</span><span class="NLM_x">–</span> <span class="NLM_lpage">452</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=16&amp;doi=10.1021%2Fjm900364m&amp;key=10.1517%2F14656566.6.3.441" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=8&amp;doi=10.1021%2Fjm900364m&amp;key=15794735" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=32&amp;doi=10.1021%2Fjm900364m&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjvVyrtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2005&pages=441-452&author=A.+L.+M.+de+Francisco&title=Cinacalcet+HCL%3A+a+novel+therapeutic+for+the+treatment+of+hyperparathyroidism"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7bR"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Cinacalcet HCl: A novel therapeutic for hyperparathyroidism</span></div><div class="casAuthors">de Francisco, Angel L. M.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Pharmacotherapy</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">441-452</span>CODEN:
                <span class="NLM_cas:coden">EOPHF7</span>;
        ISSN:<span class="NLM_cas:issn">1465-6566</span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications Ltd.</span>)
        </div><div class="casAbstract">A review.  Hyperparathyroidism (HPT) is a significant clin. concern for patients with a variety of diseases, notably the secondary HPT assocd. with chronic kidney disease requiring dialysis.  Secondary HPT is assocd. with elevated parathyroid hormone (PTH) levels, decreased levels of 1,25 dihydroxyvitamin D, and disordered mineral levels (usually high calcium and phosphorus).  If not controlled, secondary HPT can result in bone disease, vascular calcification, and ultimately, patient mortality.  Established, conventional therapies, such as 1,25 dihydroxyvitamin D analogs (vitamin D analogs) and phosphate binders, have proven to be inadequate in enabling patients to meet the National Kidney Foundation's-Kidney Disease Outcomes Quality Initiative (NKF-K/DOQI) treatment goals for PTH, calcium and phosphorus levels.  A novel therapeutic, cinacalcet HCl (formerly AMG 073; Sensipar in the US and Mimpara in Europe; Amgen, Inc.), binds directly to the calcium-sensing receptor (CaR) on the cells of the parathyroid gland, increasing the receptor's sensitivity to calcium and reducing PTH, serum calcium and phosphorus levels.  Treatment with cinacalcet in clin. trials has safely and effectively improved achievement of the NKF-K/DOQI goals.  Cinacalcet has also reduced serum calcium levels in patients with primary HPT, including parathyroid carcinoma, in the clin. trial setting.  Evidence suggesting the utility of cinacalcet in these diseases and the potential for addnl. therapeutic applications will be discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotj4JefW4n8rVg90H21EOLACvtfcHk0lgvcYa4q2zfRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjvVyrtr0%253D&md5=6047d3cacc2148532f4d737c9c0c8cfc</span></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=10.1517%2F14656566.6.3.441&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14656566.6.3.441%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BFrancisco%26aufirst%3DA.%2BL.%2BM.%26atitle%3DCinacalcet%2520HCL%253A%2520a%2520novel%2520therapeutic%2520for%2520the%2520treatment%2520of%2520hyperparathyroidism%26jtitle%3DExp.%2520Opin.%2520Pharmacother.%26date%3D2005%26volume%3D6%26spage%3D441%26epage%3D452" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Nemeth, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delmar, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heaton, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conklin, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gowen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gleason, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhatnagar, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, J.</span><span> </span><span class="NLM_article-title">Calcilytic compounds: Potent and selective Ca<sup>+2</sup> receptor. antagonists that stimulate secretion of parathyroid hormone</span> <span class="citation_source-journal">J. Pharm. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">299</span><span class="NLM_x">, </span> <span class="NLM_fpage">323</span><span class="NLM_x">–</span> <span class="NLM_lpage">331</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm900364m&amp;key=11561095" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm900364m&amp;key=1%3ACAS%3A528%3ADC%252BD3MXntFWltbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=299&publication_year=2001&pages=323-331&author=E.+F.+Nemethauthor=E.+C.+Delmarauthor=W.+L.+Heatonauthor=M.+A.+Millerauthor=L.+D.+Lambertauthor=R.+L.+Conklinauthor=M.+Gowenauthor=J.+G.+Gleasonauthor=P.+K.+Bhatnagarauthor=J.+Fox&title=Calcilytic+compounds%3A+Potent+and+selective+Ca%2B2+receptor.+antagonists+that+stimulate+secretion+of+parathyroid+hormone"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Calcilytic compounds: potent and selective Ca2+ receptor antagonists that stimulate secretion of parathyroid hormone</span></div><div class="casAuthors">Nemeth, Edward F.; Delmar, Eric G.; Heaton, William L.; Miller, Michael A.; Lambert, Lyssa D.; Conklin, Rebecca L.; Gowen, Maxine; Gleason, John G.; Bhatnagar, Pradip K.; Fox, John</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">299</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">323-331</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Despite the discovery of many ions and mols. that activate the Ca2+ receptor, there are no known ligands that block this receptor.  Reported here are the pharmacodynamic properties of a small mol., NPS 2143, which acts as an antagonist at the Ca2+ receptor.  This compd. blocked (IC50 of 43 nM) increases in cytoplasmic Ca2+ concns. [Ca2+]i elicited by activating the Ca2+ receptor in HEK 293 cells expressing the human Ca2+ receptor.  NPS 2143, even when tested at much higher concns. (3 μM), did not affect the activity of a no. of other G protein-coupled receptors, including those most structurally homologous to the Ca2+ receptor.  NPS 2143 stimulated parathyroid hormone (PTH) secretion from bovine parathyroid cells (EC50 of 41 nM) over a range of extracellular Ca2+ concns. and reversed the effects of the calcimimetic compd. NPS R-467 on [Ca2+]i and on secretion of PTH.  When infused i.v. in normal rats, NPS 2143 caused a rapid and large increase in plasma levels of PTH.  Ca2+ receptor antagonists are termed calcilytics and NPS 2143 is the first substance (either at. or mol.) shown to possess such activity.  The pharmacodynamic properties of NPS 2143 together with the recently demonstrated effects of this compd. on bone formation support the view that orally active calcilytic compds. might provide a novel anabolic therapy for osteoporosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5irxzzwLOvbVg90H21EOLACvtfcHk0liWqwbfjJbX2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXntFWltbk%253D&md5=14cedbe167bc3f0de96cec16d9ce73b4</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNemeth%26aufirst%3DE.%2BF.%26aulast%3DDelmar%26aufirst%3DE.%2BC.%26aulast%3DHeaton%26aufirst%3DW.%2BL.%26aulast%3DMiller%26aufirst%3DM.%2BA.%26aulast%3DLambert%26aufirst%3DL.%2BD.%26aulast%3DConklin%26aufirst%3DR.%2BL.%26aulast%3DGowen%26aufirst%3DM.%26aulast%3DGleason%26aufirst%3DJ.%2BG.%26aulast%3DBhatnagar%26aufirst%3DP.%2BK.%26aulast%3DFox%26aufirst%3DJ.%26atitle%3DCalcilytic%2520compounds%253A%2520Potent%2520and%2520selective%2520Ca%252B2%2520receptor.%2520antagonists%2520that%2520stimulate%2520secretion%2520of%2520parathyroid%2520hormone%26jtitle%3DJ.%2520Pharm.%2520Exp.%2520Ther.%26date%3D2001%26volume%3D299%26spage%3D323%26epage%3D331" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Gowen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stroup, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodds, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, I. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Votta, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhatnagar, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lago, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Callahan, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Del Mar, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nemuth, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, J.</span><span> </span><span class="NLM_article-title">Antagonizing the parathyroid calcium receptor stimulates parathyroid secretion and bone formation in osteopenic rats</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">1595</span><span class="NLM_x">–</span> <span class="NLM_lpage">1604</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2000&pages=1595-1604&author=M.+Gowenauthor=G.+B.+Stroupauthor=R.+A.+Doddsauthor=I.+E.+Jamesauthor=B.+J.+Vottaauthor=B.+R.+Smithauthor=P.+K.+Bhatnagarauthor=A.+M.+Lagoauthor=J.+F.+Callahanauthor=E.+G.+Del+Marauthor=M.+A.+Millerauthor=E.+F.+Nemuthauthor=J.+Fox&title=Antagonizing+the+parathyroid+calcium+receptor+stimulates+parathyroid+secretion+and+bone+formation+in+osteopenic+rats"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGowen%26aufirst%3DM.%26aulast%3DStroup%26aufirst%3DG.%2BB.%26aulast%3DDodds%26aufirst%3DR.%2BA.%26aulast%3DJames%26aufirst%3DI.%2BE.%26aulast%3DVotta%26aufirst%3DB.%2BJ.%26aulast%3DSmith%26aufirst%3DB.%2BR.%26aulast%3DBhatnagar%26aufirst%3DP.%2BK.%26aulast%3DLago%26aufirst%3DA.%2BM.%26aulast%3DCallahan%26aufirst%3DJ.%2BF.%26aulast%3DDel%2BMar%26aufirst%3DE.%2BG.%26aulast%3DMiller%26aufirst%3DM.%2BA.%26aulast%3DNemuth%26aufirst%3DE.%2BF.%26aulast%3DFox%26aufirst%3DJ.%26atitle%3DAntagonizing%2520the%2520parathyroid%2520calcium%2520receptor%2520stimulates%2520parathyroid%2520secretion%2520and%2520bone%2520formation%2520in%2520osteopenic%2520rats%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2000%26volume%3D105%26spage%3D1595%26epage%3D1604" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Arey, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seethala, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fura, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swartz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vyas, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, W.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feyen, J. H. M.</span><span> </span><span class="NLM_article-title">A Novel Calcium-Sensing Receptor Antagonist Transiently Stimulates Parathyroid Hormone Secretion in Vivo</span> <span class="citation_source-journal">Endocrinology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1131</span><span class="NLM_x">–</span> <span class="NLM_lpage">1136</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=1131-1136&author=B.+J.+Areyauthor=R.+Seethalaauthor=Z.+Maauthor=A.+Furaauthor=J.+Morinauthor=J.+Swartzauthor=V.+Vyasauthor=W.+Yangauthor=J.+H.+M.+Feyen&title=A+Novel+Calcium-Sensing+Receptor+Antagonist+Transiently+Stimulates+Parathyroid+Hormone+Secretion+in+Vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DArey%26aufirst%3DB.%2BJ.%26aulast%3DSeethala%26aufirst%3DR.%26aulast%3DMa%26aufirst%3DZ.%26aulast%3DFura%26aufirst%3DA.%26aulast%3DMorin%26aufirst%3DJ.%26aulast%3DSwartz%26aufirst%3DJ.%26aulast%3DVyas%26aufirst%3DV.%26aulast%3DYang%26aufirst%3DW.%26aulast%3DFeyen%26aufirst%3DJ.%2BH.%2BM.%26atitle%3DA%2520Novel%2520Calcium-Sensing%2520Receptor%2520Antagonist%2520Transiently%2520Stimulates%2520Parathyroid%2520Hormone%2520Secretion%2520in%2520Vivo%26jtitle%3DEndocrinology%26date%3D2005%26volume%3D5%26spage%3D1131%26epage%3D1136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Dauban, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferry, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faure, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruat, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodd, R. H.</span><span> </span><span class="NLM_article-title"><i>N</i><sup>1</sup>-Arylsulfonyl-<i>N</i><sup>2</sup>-(1-aryl)ethyl-3-phenylpropane-1,2-diamines as Novel Calcimimetics Acting on the Calcium Sensing Receptor</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">2001</span><span class="NLM_x">–</span> <span class="NLM_lpage">2004</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2000&pages=2001-2004&author=P.+Daubanauthor=S.+Ferryauthor=H.+Faureauthor=M.+Ruatauthor=R.+H.+Dodd&title=N1-Arylsulfonyl-N2-%281-aryl%29ethyl-3-phenylpropane-1%2C2-diamines+as+Novel+Calcimimetics+Acting+on+the+Calcium+Sensing+Receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDauban%26aufirst%3DP.%26aulast%3DFerry%26aufirst%3DS.%26aulast%3DFaure%26aufirst%3DH.%26aulast%3DRuat%26aufirst%3DM.%26aulast%3DDodd%26aufirst%3DR.%2BH.%26atitle%3DN1-Arylsulfonyl-N2-%25281-aryl%2529ethyl-3-phenylpropane-1%252C2-diamines%2520as%2520Novel%2520Calcimimetics%2520Acting%2520on%2520the%2520Calcium%2520Sensing%2520Receptor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2000%26volume%3D10%26spage%3D2001%26epage%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Kessler, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faure, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruat, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dauban, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodd, R. H.</span><span> </span><span class="NLM_article-title"><i>N</i><sup>2</sup>-Benzyl-<i>N</i><sup>1</sup>-(1-(1-naphthyl)ethyl)-3-phenylpropane-1,2-diamines and conformationally constrained indole analogs: development of calindol as a new calcimimetic acting at the calcium sensing receptor</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">3345</span><span class="NLM_x">–</span> <span class="NLM_lpage">3349</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=3345-3349&author=A.+Kesslerauthor=H.+Faureauthor=M.+Ruatauthor=P.+Daubanauthor=R.+H.+Dodd&title=N2-Benzyl-N1-%281-%281-naphthyl%29ethyl%29-3-phenylpropane-1%2C2-diamines+and+conformationally+constrained+indole+analogs%3A+development+of+calindol+as+a+new+calcimimetic+acting+at+the+calcium+sensing+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKessler%26aufirst%3DA.%26aulast%3DFaure%26aufirst%3DH.%26aulast%3DRuat%26aufirst%3DM.%26aulast%3DDauban%26aufirst%3DP.%26aulast%3DDodd%26aufirst%3DR.%2BH.%26atitle%3DN2-Benzyl-N1-%25281-%25281-naphthyl%2529ethyl%2529-3-phenylpropane-1%252C2-diamines%2520and%2520conformationally%2520constrained%2520indole%2520analogs%253A%2520development%2520of%2520calindol%2520as%2520a%2520new%2520calcimimetic%2520acting%2520at%2520the%2520calcium%2520sensing%2520receptor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D3345%26epage%3D3349" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Kessler, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faure, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roussanne, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferry, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruat, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dauben, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodd, R. H.</span><span> </span><span class="NLM_article-title"><i>N</i><sup>1</sup>-Arylsulfonyl-<i>N</i><sup>2</sup>-(1-(1-naphthyl)ethyl)-1,2-diaminocyclohexanes: A New Class of Calcilytic Agents Acting at the Calcium-Sensing Receptor</span> <span class="citation_source-journal">ChemBioChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1131</span><span class="NLM_x">–</span> <span class="NLM_lpage">1136</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2004&pages=1131-1136&author=A.+Kesslerauthor=H.+Faureauthor=M.+C.+Roussanneauthor=S.+Ferryauthor=M.+Ruatauthor=P.+Daubenauthor=R.+H.+Dodd&title=N1-Arylsulfonyl-N2-%281-%281-naphthyl%29ethyl%29-1%2C2-diaminocyclohexanes%3A+A+New+Class+of+Calcilytic+Agents+Acting+at+the+Calcium-Sensing+Receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKessler%26aufirst%3DA.%26aulast%3DFaure%26aufirst%3DH.%26aulast%3DRoussanne%26aufirst%3DM.%2BC.%26aulast%3DFerry%26aufirst%3DS.%26aulast%3DRuat%26aufirst%3DM.%26aulast%3DDauben%26aufirst%3DP.%26aulast%3DDodd%26aufirst%3DR.%2BH.%26atitle%3DN1-Arylsulfonyl-N2-%25281-%25281-naphthyl%2529ethyl%2529-1%252C2-diaminocyclohexanes%253A%2520A%2520New%2520Class%2520of%2520Calcilytic%2520Agents%2520Acting%2520at%2520the%2520Calcium-Sensing%2520Receptor%26jtitle%3DChemBioChem%26date%3D2004%26volume%3D5%26spage%3D1131%26epage%3D1136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Arey, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seethala, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fura, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swartz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vyas, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, W.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feyen, J. H. M.</span><span> </span><span class="NLM_article-title">A Novel Calcium-Sensing Receptor Antagonist Transiently Stimulates Parathyroid Hormone Secretion in Vivo</span> <span class="citation_source-journal">Endocrinology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1131</span><span class="NLM_x">–</span> <span class="NLM_lpage">1136</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=1131-1136&author=B.+J.+Areyauthor=R.+Seethalaauthor=Z.+Maauthor=A.+Furaauthor=J.+Morinauthor=J.+Swartzauthor=V.+Vyasauthor=W.+Yangauthor=J.+H.+M.+Feyen&title=A+Novel+Calcium-Sensing+Receptor+Antagonist+Transiently+Stimulates+Parathyroid+Hormone+Secretion+in+Vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DArey%26aufirst%3DB.%2BJ.%26aulast%3DSeethala%26aufirst%3DR.%26aulast%3DMa%26aufirst%3DZ.%26aulast%3DFura%26aufirst%3DA.%26aulast%3DMorin%26aufirst%3DJ.%26aulast%3DSwartz%26aufirst%3DJ.%26aulast%3DVyas%26aufirst%3DV.%26aulast%3DYang%26aufirst%3DW.%26aulast%3DFeyen%26aufirst%3DJ.%2BH.%2BM.%26atitle%3DA%2520Novel%2520Calcium-Sensing%2520Receptor%2520Antagonist%2520Transiently%2520Stimulates%2520Parathyroid%2520Hormone%2520Secretion%2520in%2520Vivo%26jtitle%3DEndocrinology%26date%3D2005%26volume%3D5%26spage%3D1131%26epage%3D1136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Yang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberge, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawerence, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rotella, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seethala, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feyen, J. H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dickson, J. K.,  Jr.</span><span> </span><span class="NLM_article-title">Discovery and structure−activity relationships of benzylpyrrolidine substituted aryloxypropanols as calcium-sensing receptor antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">1225</span><span class="NLM_x">–</span> <span class="NLM_lpage">1228</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=1225-1228&author=W.+Yangauthor=Y.+Wangauthor=J.+Y.+Robergeauthor=Z.+Maauthor=Y.+Liuauthor=R.+M.+Lawerenceauthor=D.+P.+Rotellaauthor=R.+Seethalaauthor=J.+H.+M.+Feyenauthor=J.+K.+Dickson&title=Discovery+and+structure%E2%88%92activity+relationships+of+benzylpyrrolidine+substituted+aryloxypropanols+as+calcium-sensing+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DRoberge%26aufirst%3DJ.%2BY.%26aulast%3DMa%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DLawerence%26aufirst%3DR.%2BM.%26aulast%3DRotella%26aufirst%3DD.%2BP.%26aulast%3DSeethala%26aufirst%3DR.%26aulast%3DFeyen%26aufirst%3DJ.%2BH.%2BM.%26aulast%3DDickson%26aufirst%3DJ.%2BK.%26atitle%3DDiscovery%2520and%2520structure%25E2%2588%2592activity%2520relationships%2520of%2520benzylpyrrolidine%2520substituted%2520aryloxypropanols%2520as%2520calcium-sensing%2520receptor%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D1225%26epage%3D1228" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Gavai, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaz, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mikkilineni, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberge, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawrence, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corte, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bednarz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dickson Jr, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seethala, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feyen, J. H. M.</span><span> </span><span class="NLM_article-title">Discovery nof novel 1-arylmethyl pyrrolidin-2-yl ethanol amines as calcium-sensing receptor antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">5478</span><span class="NLM_x">–</span> <span class="NLM_lpage">5482</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=5478-5482&author=A.+V.+Gavaiauthor=R.+J.+Vazauthor=A.+B.+Mikkilineniauthor=J.+Y.+Robergeauthor=Y.+Liuauthor=R.+M.+Lawrenceauthor=J.+R.+Corteauthor=W.+Yangauthor=M.+Bednarzauthor=J.+K.+Dickson+Jrauthor=Z.+Maauthor=R.+Seethalaauthor=J.+H.+M.+Feyen&title=Discovery+nof+novel+1-arylmethyl+pyrrolidin-2-yl+ethanol+amines+as+calcium-sensing+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGavai%26aufirst%3DA.%2BV.%26aulast%3DVaz%26aufirst%3DR.%2BJ.%26aulast%3DMikkilineni%26aufirst%3DA.%2BB.%26aulast%3DRoberge%26aufirst%3DJ.%2BY.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DLawrence%26aufirst%3DR.%2BM.%26aulast%3DCorte%26aufirst%3DJ.%2BR.%26aulast%3DYang%26aufirst%3DW.%26aulast%3DBednarz%26aufirst%3DM.%26aulast%3DDickson%2BJr%26aufirst%3DJ.%2BK.%26aulast%3DMa%26aufirst%3DZ.%26aulast%3DSeethala%26aufirst%3DR.%26aulast%3DFeyen%26aufirst%3DJ.%2BH.%2BM.%26atitle%3DDiscovery%2520nof%2520novel%25201-arylmethyl%2520pyrrolidin-2-yl%2520ethanol%2520amines%2520as%2520calcium-sensing%2520receptor%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D5478%26epage%3D5482" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Shcherbakova, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balandrin, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghatak, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heaton, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conklin, R. L.</span><span> </span><span class="NLM_article-title">3<i>H</i>-Quinazolin-4-ones as a new calcilytic template for the potential treatment of osteoporosis</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">1557</span><span class="NLM_x">–</span> <span class="NLM_lpage">1560</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=1557-1560&author=I.+Shcherbakovaauthor=M.+F.+Balandrinauthor=J.+Foxauthor=A.+Ghatakauthor=W.+Heatonauthor=R.+L.+Conklin&title=3H-Quinazolin-4-ones+as+a+new+calcilytic+template+for+the+potential+treatment+of+osteoporosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShcherbakova%26aufirst%3DI.%26aulast%3DBalandrin%26aufirst%3DM.%2BF.%26aulast%3DFox%26aufirst%3DJ.%26aulast%3DGhatak%26aufirst%3DA.%26aulast%3DHeaton%26aufirst%3DW.%26aulast%3DConklin%26aufirst%3DR.%2BL.%26atitle%3D3H-Quinazolin-4-ones%2520as%2520a%2520new%2520calcilytic%2520template%2520for%2520the%2520potential%2520treatment%2520of%2520osteoporosis%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D1557%26epage%3D1560" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Shcherbakova, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geoffroy, O. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nair, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swierczek, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balandrin, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heaton, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conklin, R. L.</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">2537</span><span class="NLM_x">–</span> <span class="NLM_lpage">2540</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Shcherbakova%2C+I.%3B+Huang%2C+G.%3B+Geoffroy%2C+O.+J.%3B+Nair%2C+S.+K.%3B+Swierczek%2C+K.%3B+Balandrin%2C+M.+F.%3B+Fox%2C+J.%3B+Heaton%2C+W.+L.%3B+Conklin%2C+R.+L.Bioorg.+Med.+Chem.+Lett.+2005%2C+15%2C+2537%E2%80%932540"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShcherbakova%26aufirst%3DI.%26aulast%3DHuang%26aufirst%3DG.%26aulast%3DGeoffroy%26aufirst%3DO.%2BJ.%26aulast%3DNair%26aufirst%3DS.%2BK.%26aulast%3DSwierczek%26aufirst%3DK.%26aulast%3DBalandrin%26aufirst%3DM.%2BF.%26aulast%3DFox%26aufirst%3DJ.%26aulast%3DHeaton%26aufirst%3DW.%2BL.%26aulast%3DConklin%26aufirst%3DR.%2BL.%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D2537%26epage%3D2540" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Dobnig, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, R. T.</span><span> </span><span class="NLM_article-title">Evidence that intermittent treatment with parathyroid hormone increases bone formation in adult rats by activation of bone lining cells</span> <span class="citation_source-journal">Endocrinology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">136</span><span class="NLM_x">, </span> <span class="NLM_fpage">3632</span><span class="NLM_x">–</span> <span class="NLM_lpage">3638</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=1995&pages=3632-3638&author=H.+Dobnigauthor=R.+T.+Turner&title=Evidence+that+intermittent+treatment+with+parathyroid+hormone+increases+bone+formation+in+adult+rats+by+activation+of+bone+lining+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDobnig%26aufirst%3DH.%26aulast%3DTurner%26aufirst%3DR.%2BT.%26atitle%3DEvidence%2520that%2520intermittent%2520treatment%2520with%2520parathyroid%2520hormone%2520increases%2520bone%2520formation%2520in%2520adult%2520rats%2520by%2520activation%2520of%2520bone%2520lining%2520cells%26jtitle%3DEndocrinology%26date%3D1995%26volume%3D136%26spage%3D3632%26epage%3D3638" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit19a"><span><span class="NLM_contrib-group">Ishizuya, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yokose, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hori, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshiki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamaguchi, A.</span><span> </span><span class="NLM_article-title">Parathyroid hormone exerts disparate effects on osteoclast differentiation depending on exposure time in rat osteoblastic cells</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x">, </span> <span class="NLM_fpage">2961</span><span class="NLM_x">–</span> <span class="NLM_lpage">2970</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=1997&pages=2961-2970&author=T.+Ishizuyaauthor=S.+Yokoseauthor=M.+Horiauthor=T.+Nodaauthor=T.+Sudaauthor=S.+Yoshikiauthor=A.+Yamaguchi&title=Parathyroid+hormone+exerts+disparate+effects+on+osteoclast+differentiation+depending+on+exposure+time+in+rat+osteoblastic+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DIshizuya%26aufirst%3DT.%26aulast%3DYokose%26aufirst%3DS.%26aulast%3DHori%26aufirst%3DM.%26aulast%3DNoda%26aufirst%3DT.%26aulast%3DSuda%26aufirst%3DT.%26aulast%3DYoshiki%26aufirst%3DS.%26aulast%3DYamaguchi%26aufirst%3DA.%26atitle%3DParathyroid%2520hormone%2520exerts%2520disparate%2520effects%2520on%2520osteoclast%2520differentiation%2520depending%2520on%2520exposure%2520time%2520in%2520rat%2520osteoblastic%2520cells%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D1997%26volume%3D99%26spage%3D2961%26epage%3D2970" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit19b"><span><span class="NLM_contrib-group">Frolik, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Black, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cain, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Satterwhite, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown-Augsburger, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hock, J. M.</span><span> </span><span class="NLM_article-title">Anabolic and catabolic bone effects of human parathyroid hormone (1-34) are predicted by duration of hormone exposure</span> <span class="citation_source-journal">Bone</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">372</span><span class="NLM_x">–</span> <span class="NLM_lpage">379</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2003&pages=372-379&author=C.+A.+Frolikauthor=E.+C.+Blackauthor=R.+L.+Cainauthor=J.+H.+Satterwhiteauthor=P.+L.+Brown-Augsburgerauthor=M.+Satoauthor=J.+M.+Hock&title=Anabolic+and+catabolic+bone+effects+of+human+parathyroid+hormone+%281-34%29+are+predicted+by+duration+of+hormone+exposure"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFrolik%26aufirst%3DC.%2BA.%26aulast%3DBlack%26aufirst%3DE.%2BC.%26aulast%3DCain%26aufirst%3DR.%2BL.%26aulast%3DSatterwhite%26aufirst%3DJ.%2BH.%26aulast%3DBrown-Augsburger%26aufirst%3DP.%2BL.%26aulast%3DSato%26aufirst%3DM.%26aulast%3DHock%26aufirst%3DJ.%2BM.%26atitle%3DAnabolic%2520and%2520catabolic%2520bone%2520effects%2520of%2520human%2520parathyroid%2520hormone%2520%25281-34%2529%2520are%2520predicted%2520by%2520duration%2520of%2520hormone%2520exposure%26jtitle%3DBone%26date%3D2003%26volume%3D33%26spage%3D372%26epage%3D379" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit19c"><span><span class="NLM_contrib-group">Onyia, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Helvering, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelbert, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dow, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maran, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lotinun, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halladay, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miles, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kulkarni, N. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ambrose, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, Y. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frolik, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bryant, H. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, R. T.</span><span> </span><span class="NLM_article-title">Molecular profile of catabolic versus anabolic treatment regimens of parathyroid hormone (PTH) in rat bone: an analysis of DNA microarray</span> <span class="citation_source-journal">J. Cell. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x">, </span> <span class="NLM_fpage">403</span><span class="NLM_x">–</span> <span class="NLM_lpage">418</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2005&pages=403-418&author=J.+E.+Onyiaauthor=L.+M.+Helveringauthor=L.+Gelbertauthor=T.+Weiauthor=S.+Huangauthor=P.+Chenauthor=E.+R.+Dowauthor=A.+Maranauthor=M.+Zhangauthor=S.+Lotinunauthor=D.+L.+Halladayauthor=R.+R.+Milesauthor=N.+H.+Kulkarniauthor=E.+M.+Ambroseauthor=Y.+L.+Maauthor=C.+A.+Frolikauthor=M.+Satoauthor=H.+U.+Bryantauthor=R.+T.+Turner&title=Molecular+profile+of+catabolic+versus+anabolic+treatment+regimens+of+parathyroid+hormone+%28PTH%29+in+rat+bone%3A+an+analysis+of+DNA+microarray"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOnyia%26aufirst%3DJ.%2BE.%26aulast%3DHelvering%26aufirst%3DL.%2BM.%26aulast%3DGelbert%26aufirst%3DL.%26aulast%3DWei%26aufirst%3DT.%26aulast%3DHuang%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DP.%26aulast%3DDow%26aufirst%3DE.%2BR.%26aulast%3DMaran%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DLotinun%26aufirst%3DS.%26aulast%3DHalladay%26aufirst%3DD.%2BL.%26aulast%3DMiles%26aufirst%3DR.%2BR.%26aulast%3DKulkarni%26aufirst%3DN.%2BH.%26aulast%3DAmbrose%26aufirst%3DE.%2BM.%26aulast%3DMa%26aufirst%3DY.%2BL.%26aulast%3DFrolik%26aufirst%3DC.%2BA.%26aulast%3DSato%26aufirst%3DM.%26aulast%3DBryant%26aufirst%3DH.%2BU.%26aulast%3DTurner%26aufirst%3DR.%2BT.%26atitle%3DMolecular%2520profile%2520of%2520catabolic%2520versus%2520anabolic%2520treatment%2520regimens%2520of%2520parathyroid%2520hormone%2520%2528PTH%2529%2520in%2520rat%2520bone%253A%2520an%2520analysis%2520of%2520DNA%2520microarray%26jtitle%3DJ.%2520Cell.%2520Biochem.%26date%3D2005%26volume%3D95%26spage%3D403%26epage%3D418" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Fraher, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klein, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marier, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freeman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hendy, G. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glotzman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hodsman, A. B.</span><span> </span><span class="NLM_article-title">Comparison of the pharmacokinetics of parenteral parathyroid hormone-(1−34) [PTH-(1-34)] and PTH-related peptide-(1-34) in healthy young humans</span> <span class="citation_source-journal">J. Clin. Endocr. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">80</span><span class="NLM_x">, </span> <span class="NLM_fpage">60</span><span class="NLM_x">–</span> <span class="NLM_lpage">64</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm900364m&amp;key=10.1210%2Fjc.80.1.60" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm900364m&amp;key=7829640" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm900364m&amp;key=1%3ACAS%3A528%3ADyaK2MXjt1OktL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=1995&pages=60-64&author=L.+J.+Fraherauthor=K.+Kleinauthor=R.+Marierauthor=D.+Freemanauthor=G.+N.+Hendyauthor=D.+Glotzmanauthor=A.+B.+Hodsman&title=Comparison+of+the+pharmacokinetics+of+parenteral+parathyroid+hormone-%281%E2%88%9234%29+%5BPTH-%281-34%29%5D+and+PTH-related+peptide-%281-34%29+in+healthy+young+humans"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison of the pharmacokinetics of parenteral parathyroid hormone-(1-34) [PTH-(1-34)] and PTH-related peptide-(1-34) in healthy young humans</span></div><div class="casAuthors">Fraher, L. J.; Klein, K.; Marier, R.; Freeman, D.; Hendy, G. N.; Goltzman, D.; Hodsman, A. B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Endocrinology and Metabolism</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">60-4</span>CODEN:
                <span class="NLM_cas:coden">JCEMAZ</span>;
        ISSN:<span class="NLM_cas:issn">0021-972X</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">The amino-terminal fragments of human PTH[hPTH-(1-34)] and PTH-related peptide [PTHrP-(1-34)] appear to be equipotent in several rodent models.  However, continuous i.v. infusions of these peptides to young human volunteers suggested that a 10-fold higher molar dose of PTHrP was required to produce comparable circulating levels of the peptide and biochem. responses similar to PTH.  As PTHrP has a wide variety of target tissues in mammalian species and may, therefore, play a paracrine, rather than an endocrine, hormonal role in vivo, we evaluated whether enhanced metabolic clearance of injected PTHrP might explain its apparently reduced potency as a PTH-like hormone.  Ten healthy subjects [age, 25 yr] received in random order either hPTH-(1-34) or hPTHrP-(1-34) given by bolus i.v. injections in a dose of 10.7 nmol.  Measurements of plasma immunoreactive peptide indicated a comparable vol. of distribution for each, but the apparent t1/2 (8.3 min) and plasma clearance (4.0 L/min) for hPTHrP were accelerated compared to those of hPTH (t1/2, 10.2 min; clearance, 2.0 L/min).  Peak plasma cAMP levels were 9-fold lower in response to hPTHrP (29.5 vs. 190 pmol/L), and increases in urinary cAMP excretion were 5-fold lower (2.1 vs. 11.2 nmol/mmol creatine).  No major differences were obsd. in the urinary excretion of phosphate, Ca, or Na between the two peptides.  Although hPTHrP-(1-34) has a 2-fold higher MCR than hPTH-(1-34), this may not explain the more than 5-fold lower plasma or urinary cAMP response to PTHrP in humans.  The comparable effects of PTH and PTHrP on urinary phosphate, Ca, and Na may indicate a non-cAMP-dependent pathway for these responses, although the intracellular pool of cAMP generated to either peptide, and thus the local target tissue response, could not be estd. in the present study.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHfoMHmij3ybVg90H21EOLACvtfcHk0lhpx-iw8IMlhA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXjt1OktL4%253D&md5=f684656f2b98fa5c1fd4876d1a78aa64</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1210%2Fjc.80.1.60&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fjc.80.1.60%26sid%3Dliteratum%253Aachs%26aulast%3DFraher%26aufirst%3DL.%2BJ.%26aulast%3DKlein%26aufirst%3DK.%26aulast%3DMarier%26aufirst%3DR.%26aulast%3DFreeman%26aufirst%3DD.%26aulast%3DHendy%26aufirst%3DG.%2BN.%26aulast%3DGlotzman%26aufirst%3DD.%26aulast%3DHodsman%26aufirst%3DA.%2BB.%26atitle%3DComparison%2520of%2520the%2520pharmacokinetics%2520of%2520parenteral%2520parathyroid%2520hormone-%25281%25E2%2588%259234%2529%2520%255BPTH-%25281-34%2529%255D%2520and%2520PTH-related%2520peptide-%25281-34%2529%2520in%2520healthy%2520young%2520humans%26jtitle%3DJ.%2520Clin.%2520Endocr.%2520Metab.%26date%3D1995%26volume%3D80%26spage%3D60%26epage%3D64" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit20a"><span><span class="NLM_contrib-group">Revel, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sorbera, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, L.</span><span> </span><span class="NLM_article-title">Teriparatide: treatment of osteoporosis parathyroid hormone analog</span> <span class="citation_source-journal">Drugs Future</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">803</span><span class="NLM_x">–</span> <span class="NLM_lpage">808</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20a&amp;dbid=16&amp;doi=10.1021%2Fjm900364m&amp;key=10.1358%2Fdof.2000.025.08.589014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20a&amp;dbid=32&amp;doi=10.1021%2Fjm900364m&amp;key=1%3ACAS%3A528%3ADC%252BD3cXnvV2msL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2000&pages=803-808&author=L.+Revelauthor=L.+A.+Sorberaauthor=L.+Martin&title=Teriparatide%3A+treatment+of+osteoporosis+parathyroid+hormone+analog"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20aR"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Teriparatide: Treatment of osteoporosis parathyroid hormone analog</span></div><div class="casAuthors">Revel, L.; Sorbera, L. A.; Martin, L.</div><div class="citationInfo"><span class="NLM_cas:title">Drugs of the Future</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">803-808</span>CODEN:
                <span class="NLM_cas:coden">DRFUD4</span>;
        ISSN:<span class="NLM_cas:issn">0377-8282</span>.
    
            (<span class="NLM_cas:orgname">Prous Science</span>)
        </div><div class="casAbstract">A review with 25 refs. on the pharmacol., pharmacokinetics and clin. studies of teriparatide in patients with osteoporosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGquunAG-KMkQbVg90H21EOLACvtfcHk0lhC2tgdNRfXYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXnvV2msL4%253D&md5=d7391aff52d08e8b247886dd08db6592</span></div><a href="/servlet/linkout?suffix=cit20a&amp;dbid=16384&amp;doi=10.1358%2Fdof.2000.025.08.589014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1358%252Fdof.2000.025.08.589014%26sid%3Dliteratum%253Aachs%26aulast%3DRevel%26aufirst%3DL.%26aulast%3DSorbera%26aufirst%3DL.%2BA.%26aulast%3DMartin%26aufirst%3DL.%26atitle%3DTeriparatide%253A%2520treatment%2520of%2520osteoporosis%2520parathyroid%2520hormone%2520analog%26jtitle%3DDrugs%2520Future%26date%3D2000%26volume%3D25%26spage%3D803%26epage%3D808" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Nemeth, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steffey, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hammerland, L. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hung, B. C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Wagenen, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DelMar, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balandrin, M. F.</span><span> </span><span class="NLM_article-title">Calcimimetics with potent and selective activity on the parathyroid calcium receptor</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x">, </span> <span class="NLM_fpage">4040</span><span class="NLM_x">–</span> <span class="NLM_lpage">4045</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=1998&pages=4040-4045&author=E.+F.+Nemethauthor=M.+E.+Steffeyauthor=L.+G.+Hammerlandauthor=B.+C.+P.+Hungauthor=B.+C.+van+Wagenenauthor=E.+G.+DelMarauthor=M.+F.+Balandrin&title=Calcimimetics+with+potent+and+selective+activity+on+the+parathyroid+calcium+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNemeth%26aufirst%3DE.%2BF.%26aulast%3DSteffey%26aufirst%3DM.%2BE.%26aulast%3DHammerland%26aufirst%3DL.%2BG.%26aulast%3DHung%26aufirst%3DB.%2BC.%2BP.%26aulast%3Dvan%2BWagenen%26aufirst%3DB.%2BC.%26aulast%3DDelMar%26aufirst%3DE.%2BG.%26aulast%3DBalandrin%26aufirst%3DM.%2BF.%26atitle%3DCalcimimetics%2520with%2520potent%2520and%2520selective%2520activity%2520on%2520the%2520parathyroid%2520calcium%2520receptor%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1998%26volume%3D95%26spage%3D4040%26epage%3D4045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Crivori, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poggesi, I.</span><span> </span><span class="NLM_article-title">Predictive model for identifying potential CYP2D6 Inhibitors</span> <span class="citation_source-journal">Basic Clin. Pharm. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">96</span><span class="NLM_x">, </span> <span class="NLM_fpage">251</span><span class="NLM_x">–</span> <span class="NLM_lpage">253</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm900364m&amp;key=10.1111%2Fj.1742-7843.2005.pto960320.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm900364m&amp;key=15733226" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm900364m&amp;key=1%3ACAS%3A528%3ADC%252BD2MXisFSlsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=2005&pages=251-253&author=P.+Crivoriauthor=I.+Poggesi&title=Predictive+model+for+identifying+potential+CYP2D6+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Predictive model for identifying potential CYP2D6 inhibitors</span></div><div class="casAuthors">Crivori, Patrizia; Poggesi, Italo</div><div class="citationInfo"><span class="NLM_cas:title">Basic & Clinical Pharmacology & Toxicology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">251-253</span>CODEN:
                <span class="NLM_cas:coden">BCPTBO</span>;
        ISSN:<span class="NLM_cas:issn">1742-7835</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A model for predicting the cytochrome P 450 2D6 (CYP2D6) inhibition potential based on the mol. structures of drug candidates was developed and evaluated using Almond program.  The QSPR model was developed by correlating the exptl. inhibition consts. with the unscaled descriptors calcd. for all conformers generated for the training set.  GRIND descriptors appear to be a valuable tool for modeling CYP2D6 inhibitors.  Although the exptl. data utilized to train the model comes from different labs, the GRIND-based model appears robust and useful to predict CYP2D6 inhibition consts. of external sets of compds.  The performance of this model is at least as good as that reported for other computational models of CYP2D6 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoK2FQqoXFbirVg90H21EOLACvtfcHk0lhC2tgdNRfXYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXisFSlsrY%253D&md5=0fda143645d8ff0a469957247294c70c</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1111%2Fj.1742-7843.2005.pto960320.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1742-7843.2005.pto960320.x%26sid%3Dliteratum%253Aachs%26aulast%3DCrivori%26aufirst%3DP.%26aulast%3DPoggesi%26aufirst%3DI.%26atitle%3DPredictive%2520model%2520for%2520identifying%2520potential%2520CYP2D6%2520Inhibitors%26jtitle%3DBasic%2520Clin.%2520Pharm.%2520Toxicol.%26date%3D2005%26volume%3D96%26spage%3D251%26epage%3D253" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit22a"><span><span class="NLM_contrib-group">Ekins, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gianpaolo, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Binkley, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillespie, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ring, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winkel, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wrighton, S. A.</span><span> </span><span class="NLM_article-title">Three- and four dimensional-quantitative structure−activity relationship (3D/4D-QSAR) analyses of CYP2D6 inhibitors</span> <span class="citation_source-journal">Pharmacogenetics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">477</span><span class="NLM_x">–</span> <span class="NLM_lpage">489</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22a&amp;dbid=8&amp;doi=10.1021%2Fjm900364m&amp;key=10780267" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22a&amp;dbid=32&amp;doi=10.1021%2Fjm900364m&amp;key=1%3ACAS%3A528%3ADyaK1MXmtlGjs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1999&pages=477-489&author=S.+Ekinsauthor=B.+Gianpaoloauthor=S.+Binkleyauthor=J.+S.+Gillespieauthor=B.+J.+Ringauthor=J.+H.+Winkelauthor=S.+A.+Wrighton&title=Three-+and+four+dimensional-quantitative+structure%E2%88%92activity+relationship+%283D%2F4D-QSAR%29+analyses+of+CYP2D6+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22aR"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Three and four dimensional-quantitative structure activity relationship (3D/4D-QSAR) analyses of CYP2D6 inhibitors</span></div><div class="casAuthors">Ekins, Sean; Bravi, Gianpaolo; Binkley, Shelly; Gillespie, Jennifer S.; Ring, Barbara J.; Wikel, James H.; Wrighton, Steven A.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacogenetics</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">477-489</span>CODEN:
                <span class="NLM_cas:coden">PHMCEE</span>;
        ISSN:<span class="NLM_cas:issn">0960-314X</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Three- and four-dimensional quant. structure activity relationship (3D/4D-QSAR) pharmacophore models of competitive inhibitors of CYP2D6 were constructed using data from our lab. or the literature.  The 3D-QSAR pharmacophore models of the common structural features of CYP2D6 inhibitors were built using the program Catalyst (Mol. Simulations, San Diego, CA, USA).  These 3D-QSAR models were compared with 3D and 4D-QSAR partial least squares (PLS) models which were constructed using mol. surface-weighted holistic invariant mol. (MS-WHIM) descriptors of size and shape of inhibitors.  The first Catalyst model was generated from multiple conformers of competitive inhibitors (n = 20) of CYP2D6 mediated bufurolol 1'-hydroxylation.  This model demonstrated a correlation of obsd. and predicted Ki (apparent) values of r = 0.75.  A second Catalyst model was constructed from literature derived Ki (apparent) values (n = 31) for the inhibition of CYP2D6.  This model provided a correlation of obsd. and predicted inhibition for CYP2D6 of r = 0.91.  Both Catalyst Ki pharmacophores were then validated by predicting the Ki (apparent) of a test set of known CYP2D6 inhibitors (n = 15).  Ten out of 15 of these Ki (apparent) values were predicted to be within one log residual of the obsd. value using our CYP2D6 inhibitor model, while the literature model predicted nine out of 15 values.  Similarly, 3D- and 4D-QSARs derived from PLS MS-WHIM for our dataset yielded predictable models as assessed using cross-validation.  The corresponding cross-validated PLS MS-WHIM model for the literature dataset yielded a comparable 3D-QSAR and improved 4D-QSAR value.  Such computational models will aid in future prediction of drug-drug interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcRiE7XUQvY7Vg90H21EOLACvtfcHk0lhC2tgdNRfXYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmtlGjs7w%253D&md5=b714320963218c19c858e31376b9b528</span></div><a href="/servlet/linkout?suffix=cit22a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEkins%26aufirst%3DS.%26aulast%3DGianpaolo%26aufirst%3DB.%26aulast%3DBinkley%26aufirst%3DS.%26aulast%3DGillespie%26aufirst%3DJ.%2BS.%26aulast%3DRing%26aufirst%3DB.%2BJ.%26aulast%3DWinkel%26aufirst%3DJ.%2BH.%26aulast%3DWrighton%26aufirst%3DS.%2BA.%26atitle%3DThree-%2520and%2520four%2520dimensional-quantitative%2520structure%25E2%2588%2592activity%2520relationship%2520%25283D%252F4D-QSAR%2529%2520analyses%2520of%2520CYP2D6%2520inhibitors%26jtitle%3DPharmacogenetics%26date%3D1999%26volume%3D9%26spage%3D477%26epage%3D489" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit22b"><span><span class="NLM_contrib-group">De Groot, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ackland, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horne, V. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alex, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, B. C.</span><span> </span><span class="NLM_article-title">Novel approach to predicting P450-mediated drug metabolism: development of a combined protein and pharmacophore model for CYP2D6</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">1515</span><span class="NLM_x">–</span> <span class="NLM_lpage">1524</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm981118h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=1515-1524&author=M.+J.+De+Grootauthor=M.+J.+Acklandauthor=V.+A.+Horneauthor=A.+A.+Alexauthor=B.+C.+Jones&title=Novel+approach+to+predicting+P450-mediated+drug+metabolism%3A+development+of+a+combined+protein+and+pharmacophore+model+for+CYP2D6"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22b&amp;dbid=16384&amp;doi=10.1021%2Fjm981118h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm981118h%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BGroot%26aufirst%3DM.%2BJ.%26aulast%3DAckland%26aufirst%3DM.%2BJ.%26aulast%3DHorne%26aufirst%3DV.%2BA.%26aulast%3DAlex%26aufirst%3DA.%2BA.%26aulast%3DJones%26aufirst%3DB.%2BC.%26atitle%3DNovel%2520approach%2520to%2520predicting%2520P450-mediated%2520drug%2520metabolism%253A%2520development%2520of%2520a%2520combined%2520protein%2520and%2520pharmacophore%2520model%2520for%2520CYP2D6%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26spage%3D1515%26epage%3D1524" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit22d"><span><span class="NLM_contrib-group">Rowland, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blaney, F. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smyth, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leydon, V. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oxbrow, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tennant, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Modi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eggleston, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chenery, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridges, A. M.</span><span> </span><span class="NLM_article-title">Crystal structure of the human cytochrome P450 2D6</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">281</span><span class="NLM_x">, </span> <span class="NLM_fpage">7614</span><span class="NLM_x">–</span> <span class="NLM_lpage">7622</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2006&pages=7614-7622&author=P.+Rowlandauthor=F.+E.+Blaneyauthor=M.+G.+Smythauthor=J.+J.+Jonesauthor=V.+R.+Leydonauthor=A.+K.+Oxbrowauthor=C.+J.+Lewisauthor=M.+G.+Tennantauthor=S.+Modiauthor=D.+S.+Egglestonauthor=R.+J.+Cheneryauthor=A.+M.+Bridges&title=Crystal+structure+of+the+human+cytochrome+P450+2D6"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRowland%26aufirst%3DP.%26aulast%3DBlaney%26aufirst%3DF.%2BE.%26aulast%3DSmyth%26aufirst%3DM.%2BG.%26aulast%3DJones%26aufirst%3DJ.%2BJ.%26aulast%3DLeydon%26aufirst%3DV.%2BR.%26aulast%3DOxbrow%26aufirst%3DA.%2BK.%26aulast%3DLewis%26aufirst%3DC.%2BJ.%26aulast%3DTennant%26aufirst%3DM.%2BG.%26aulast%3DModi%26aufirst%3DS.%26aulast%3DEggleston%26aufirst%3DD.%2BS.%26aulast%3DChenery%26aufirst%3DR.%2BJ.%26aulast%3DBridges%26aufirst%3DA.%2BM.%26atitle%3DCrystal%2520structure%2520of%2520the%2520human%2520cytochrome%2520P450%25202D6%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2006%26volume%3D281%26spage%3D7614%26epage%3D7622" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Mitcheson, J. S.</span><span> </span><span class="NLM_article-title">hERG potassium channels and the structural basis of drug-induced arrhythmias</span> <span class="citation_source-journal">Chem. Res. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">1005</span><span class="NLM_x">–</span> <span class="NLM_lpage">1010</span></span><div class="citationLinks">[<a href="/doi/10.1021/tx800035b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2008&pages=1005-1010&author=J.+S.+Mitcheson&title=hERG+potassium+channels+and+the+structural+basis+of+drug-induced+arrhythmias"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Ftx800035b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx800035b%26sid%3Dliteratum%253Aachs%26aulast%3DMitcheson%26aufirst%3DJ.%2BS.%26atitle%3DhERG%2520potassium%2520channels%2520and%2520the%2520structural%2520basis%2520of%2520drug-induced%2520arrhythmias%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2008%26volume%3D21%26spage%3D1005%26epage%3D1010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit23a"><span><span class="NLM_contrib-group">Kramer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beck, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kriegel, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, T.</span><span> </span><span class="NLM_article-title">A composite model for hERG blockade</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">254</span><span class="NLM_x">–</span> <span class="NLM_lpage">265</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2008&pages=254-265&author=C.+Kramerauthor=B.+Beckauthor=J.+M.+Kriegelauthor=T.+Clark&title=A+composite+model+for+hERG+blockade"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKramer%26aufirst%3DC.%26aulast%3DBeck%26aufirst%3DB.%26aulast%3DKriegel%26aufirst%3DJ.%2BM.%26aulast%3DClark%26aufirst%3DT.%26atitle%3DA%2520composite%2520model%2520for%2520hERG%2520blockade%26jtitle%3DChemMedChem%26date%3D2008%26volume%3D3%26spage%3D254%26epage%3D265" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit23b"><span><span class="NLM_contrib-group">Stansfeld, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gedeck, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gosling, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitcheson, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutcliffe, M. J.</span><span> </span><span class="NLM_article-title">Drug block of the hERG potassium channel: insights from modeling</span> <span class="citation_source-journal">Proteins: Struct., Funct., Bioinf.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">568</span><span class="NLM_x">–</span> <span class="NLM_lpage">580</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2007&pages=568-580&author=P.+J.+Stansfeldauthor=P.+Gedeckauthor=M.+Goslingauthor=B.+Coxauthor=J.+S.+Mitchesonauthor=M.+J.+Sutcliffe&title=Drug+block+of+the+hERG+potassium+channel%3A+insights+from+modeling"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStansfeld%26aufirst%3DP.%2BJ.%26aulast%3DGedeck%26aufirst%3DP.%26aulast%3DGosling%26aufirst%3DM.%26aulast%3DCox%26aufirst%3DB.%26aulast%3DMitcheson%26aufirst%3DJ.%2BS.%26aulast%3DSutcliffe%26aufirst%3DM.%2BJ.%26atitle%3DDrug%2520block%2520of%2520the%2520hERG%2520potassium%2520channel%253A%2520insights%2520from%2520modeling%26jtitle%3DProteins%253A%2520Struct.%252C%2520Funct.%252C%2520Bioinf.%26date%3D2007%26volume%3D68%26spage%3D568%26epage%3D580" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit23c"><span><span class="NLM_contrib-group">Sanguinetti, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tristani-Firouzi, M.</span><span> </span><span class="NLM_article-title">hERG potassium channels and cardiac arrhythmia</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">440</span><span class="NLM_x">, </span> <span class="NLM_fpage">463</span><span class="NLM_x">–</span> <span class="NLM_lpage">469</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23c&amp;dbid=16&amp;doi=10.1021%2Fjm900364m&amp;key=10.1038%2Fnature04710" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23c&amp;dbid=8&amp;doi=10.1021%2Fjm900364m&amp;key=16554806" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23c&amp;dbid=32&amp;doi=10.1021%2Fjm900364m&amp;key=1%3ACAS%3A528%3ADC%252BD28Xis1OlsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=440&publication_year=2006&pages=463-469&author=M.+C.+Sanguinettiauthor=M.+Tristani-Firouzi&title=hERG+potassium+channels+and+cardiac+arrhythmia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23cR"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">hERG potassium channels and cardiac arrhythmia</span></div><div class="casAuthors">Sanguinetti, Michael C.; Tristani-Firouzi, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">440</span>
        (<span class="NLM_cas:issue">7083</span>),
    <span class="NLM_cas:pages">463-469</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  HERG potassium channels are essential for normal elec. activity in the heart.  Inherited mutations in the HERG gene cause long QT syndrome, a disorder that predisposes individuals to life-threatening arrhythmias.  Arrhythmia can also be induced by a blockage of hERG channels by a surprisingly diverse group of drugs.  This side effect is a common reason for drug failure in preclin. safety trials.  Insights gained from the crystal structures of other potassium channels have helped our understanding of the block of hERG channels and the mechanisms of gating.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopS3WBEpuAUrVg90H21EOLACvtfcHk0liYT3e0EMwamQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xis1OlsLs%253D&md5=3f355dcd51da3488d73c7c91cbe8d3b8</span></div><a href="/servlet/linkout?suffix=cit23c&amp;dbid=16384&amp;doi=10.1038%2Fnature04710&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature04710%26sid%3Dliteratum%253Aachs%26aulast%3DSanguinetti%26aufirst%3DM.%2BC.%26aulast%3DTristani-Firouzi%26aufirst%3DM.%26atitle%3DhERG%2520potassium%2520channels%2520and%2520cardiac%2520arrhythmia%26jtitle%3DNature%26date%3D2006%26volume%3D440%26spage%3D463%26epage%3D469" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit23d"><span><span class="NLM_contrib-group">Sanguinetti, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitcheson, J. S.</span><span> </span><span class="NLM_article-title">Predicting drug−hERG channel interactions that cause acquired long QT syndrome</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">119</span><span class="NLM_x">–</span> <span class="NLM_lpage">124</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2005&pages=119-124&author=M.+C.+Sanguinettiauthor=J.+S.+Mitcheson&title=Predicting+drug%E2%88%92hERG+channel+interactions+that+cause+acquired+long+QT+syndrome"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSanguinetti%26aufirst%3DM.%2BC.%26aulast%3DMitcheson%26aufirst%3DJ.%2BS.%26atitle%3DPredicting%2520drug%25E2%2588%2592hERG%2520channel%2520interactions%2520that%2520cause%2520acquired%2520long%2520QT%2520syndrome%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2005%26volume%3D26%26spage%3D119%26epage%3D124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit23e"><span><span class="NLM_contrib-group">Fernandez, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghanta, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kauffman, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanguinetti, M. C.</span><span> </span><span class="NLM_article-title">Physiochemical features of the hERG channel binding site</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x">, </span> <span class="NLM_fpage">10120</span><span class="NLM_x">–</span> <span class="NLM_lpage">10127</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=10120-10127&author=D.+Fernandezauthor=A.+Ghantaauthor=G.+W.+Kauffmanauthor=M.+C.+Sanguinetti&title=Physiochemical+features+of+the+hERG+channel+binding+site"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFernandez%26aufirst%3DD.%26aulast%3DGhanta%26aufirst%3DA.%26aulast%3DKauffman%26aufirst%3DG.%2BW.%26aulast%3DSanguinetti%26aufirst%3DM.%2BC.%26atitle%3DPhysiochemical%2520features%2520of%2520the%2520hERG%2520channel%2520binding%2520site%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D10120%26epage%3D10127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Tonioli, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crisma, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Formaggio, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peggion, C.</span><span> </span><span class="NLM_article-title">Control of peptide conformation by the Thorpe-Ingold effect (C-α tetrasubstitution)</span> <span class="citation_source-journal">Biopolymers</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">396</span><span class="NLM_x">–</span> <span class="NLM_lpage">419</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2001&pages=396-419&author=C.+Tonioliauthor=M.+Crismaauthor=F.+Formaggioauthor=C.+Peggion&title=Control+of+peptide+conformation+by+the+Thorpe-Ingold+effect+%28C-%CE%B1+tetrasubstitution%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTonioli%26aufirst%3DC.%26aulast%3DCrisma%26aufirst%3DM.%26aulast%3DFormaggio%26aufirst%3DF.%26aulast%3DPeggion%26aufirst%3DC.%26atitle%3DControl%2520of%2520peptide%2520conformation%2520by%2520the%2520Thorpe-Ingold%2520effect%2520%2528C-%25CE%25B1%2520tetrasubstitution%2529%26jtitle%3DBiopolymers%26date%3D2001%26volume%3D60%26spage%3D396%26epage%3D419" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><div class="note"><p class="first last">The conformational search of global energy minima for analogs <b>7</b> and <b>22</b> were carried out using the BatchMin module in Maestro. The conformational space was explored by 2000 iterations of Monte Carlo multiple minimum (MCMM) torsional angle sampling procedure in BatchMin, and the energy of each conformation was determined by the OPLS-2005 force field in GB/SA water solvation model.</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=The+conformational+search+of+global+energy+minima+for+analogs+7+and+22+were+carried+out+using+the+BatchMin+module+in+Maestro.+The+conformational+space+was+explored+by+2000+iterations+of+Monte+Carlo+multiple+minimum+%28MCMM%29+torsional+angle+sampling+procedure+in+BatchMin%2C+and+the+energy+of+each+conformation+was+determined+by+the+OPLS-2005+force+field+in+GB%2FSA+water+solvation+model."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Easson, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stedman, E.</span><span> </span><span class="NLM_article-title">Studies on the relationship between chemical constitution and physiological action. V. Molecular dissymmetry and physiological activity</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1933</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">1257</span><span class="NLM_x">–</span> <span class="NLM_lpage">1266</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=1933&pages=1257-1266&author=L.+H.+Eassonauthor=E.+Stedman&title=Studies+on+the+relationship+between+chemical+constitution+and+physiological+action.+V.+Molecular+dissymmetry+and+physiological+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEasson%26aufirst%3DL.%2BH.%26aulast%3DStedman%26aufirst%3DE.%26atitle%3DStudies%2520on%2520the%2520relationship%2520between%2520chemical%2520constitution%2520and%2520physiological%2520action.%2520V.%2520Molecular%2520dissymmetry%2520and%2520physiological%2520activity%26jtitle%3DBiochem.%2520J.%26date%3D1933%26volume%3D31%26spage%3D1257%26epage%3D1266" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit26a"><span><span class="NLM_contrib-group">Testa, B.</span><span> </span><span class="NLM_article-title">Mechanisms of chiral recognition in pharmacology</span> <span class="citation_source-journal">Acta Pharm. Nord.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">137</span><span class="NLM_x">–</span> <span class="NLM_lpage">143</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26a&amp;dbid=32&amp;doi=10.1021%2Fjm900364m&amp;key=1%3ACAS%3A528%3ADyaK3cXlvVCjt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1990&pages=137-143&author=B.+Testa&title=Mechanisms+of+chiral+recognition+in+pharmacology"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26aR"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms of chiral recognition in pharmacology.  The Easson-Stedman model revisited</span></div><div class="casAuthors">Testa, Bernard</div><div class="citationInfo"><span class="NLM_cas:title">Acta Pharmaceutica Nordica</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">137-44</span>CODEN:
                <span class="NLM_cas:coden">APNOEE</span>;
        ISSN:<span class="NLM_cas:issn">1100-1801</span>.
    </div><div class="casAbstract">A review with 30 refs.  The three-point attachment Easson-Stedman model is critically examd. and its limitations discussed.  Four proposals are formulated to render it more realistic in terms of binding interactions and mechanisms of chiral recognition.  The ligand should be viewed as a stereo-electronic pharmacophore, one of the interactions may be a repulsive one, the model could be rendered quant. by incorporating intrinsic binding energies of functional groups; and chiral recognition in the activation step can be depicted by viewing one of the sites as a trigger/catalytic group.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlZPKeSJtuP7Vg90H21EOLACvtfcHk0lh5Hferq3i0Xg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXlvVCjt7s%253D&md5=7339a86e59c08ae82aad8a0933f4206a</span></div><a href="/servlet/linkout?suffix=cit26a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTesta%26aufirst%3DB.%26atitle%3DMechanisms%2520of%2520chiral%2520recognition%2520in%2520pharmacology%26jtitle%3DActa%2520Pharm.%2520Nord.%26date%3D1990%26volume%3D2%26spage%3D137%26epage%3D143" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit26b"><span><span class="NLM_contrib-group">Ruffolo, Jr., R. R.</span><span> </span><span class="NLM_article-title">Chirality in α-and β-adrenoreceptor agonists and antagonists</span>. Tetrahedron<span class="NLM_x"> </span><span class="NLM_year">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">9953</span><span class="NLM_x">–</span> <span class="NLM_lpage">9980</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1991&author=R.+R.+Ruffolo%2C+Jr.&title=Chirality+in+%CE%B1-and+%CE%B2-adrenoreceptor+agonists+and+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DRuffolo%252C%2BJr.%26aufirst%3DR.%2BR.%26atitle%3DChirality%2520in%2520%25CE%25B1-and%2520%25CE%25B2-adrenoreceptor%2520agonists%2520and%2520antagonists%26jtitle%3DTetrahedron%26date%3D1991%26volume%3D47%26spage%3D9953%26epage%3D9980" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-ref27_1"><span><span class="NLM_contrib-group">Rogers, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunn, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hebert, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nemeth, E.</span><span> </span><span class="NLM_article-title">Pharmacological comparison of bovine parathyroid, human parathyroid, and rat kidney calcium receptors expressed in HEK 293 cells</span> <span class="citation_source-journal">J. Bone Miner. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl. 1</span><span class="NLM_x">) </span> <span class="NLM_fpage">S483</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=1995&pages=S483&issue=Suppl.+1&author=K.+Rogersauthor=C.+Dunnauthor=S.+Hebertauthor=E.+Brownauthor=E.+Nemeth&title=Pharmacological+comparison+of+bovine+parathyroid%2C+human+parathyroid%2C+and+rat+kidney+calcium+receptors+expressed+in+HEK+293+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=ref27_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRogers%26aufirst%3DK.%26aulast%3DDunn%26aufirst%3DC.%26aulast%3DHebert%26aufirst%3DS.%26aulast%3DBrown%26aufirst%3DE.%26aulast%3DNemeth%26aufirst%3DE.%26atitle%3DPharmacological%2520comparison%2520of%2520bovine%2520parathyroid%252C%2520human%2520parathyroid%252C%2520and%2520rat%2520kidney%2520calcium%2520receptors%2520expressed%2520in%2520HEK%2520293%2520cells%26jtitle%3DJ.%2520Bone%2520Miner.%2520Res.%26date%3D1995%26volume%3D10%26issue%3DSuppl.%25201%26spage%3DS483" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-si1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i56"><a href="/doi/suppl/10.1021/jm900364m">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_53043"></div></div></div></div></div><hr /></hr><p class="last">X-ray crystallographic data for antagonist <b>38</b> as well as HPLC purities with two separate conditions for antagonists <b>7</b>−<b>11</b>, <b>13</b>−<b>17</b>, <b>21</b>−<b>24</b>, <b>26</b>−<b>28</b>, and <b>31</b>−<b>33</b>. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm900364m/suppl_file/jm900364m_si_001.pdf">jm900364m_si_001.pdf (473.98 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm900364m&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Barticle%3Aarticle%3A10.1021%2Fjm900364m%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2009.52.issue-13" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm900364m" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                715KB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67992526986623e0","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
